{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "id": "d27814c9-e062-4c48-a9de-725c5f6f418b",
   "metadata": {},
   "source": [
    "# 离群点分析\n",
    "本文件将分析HT29的features与smiles数据，使用以下6种离散点分析方法：  \n",
    "**基于统计**  \n",
    "**基于距离**  \n",
    "**基于密度**  \n",
    "**两阶段离群点挖掘方法TOD**  \n",
    "**基于聚类的离群挖掘方法CBOD**  \n",
    "**基于聚类的动态数据的离群点检测**  \n",
    "来分别对药品协同的化学性质离群点和结构性质离群点进行分析，对比两个特征空间的离群点差异"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "e420bec6-4d5f-4860-8fa3-efa5f2c3da5b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import numpy as np\n",
    "from sklearn.preprocessing import StandardScaler, MinMaxScaler\n",
    "from sklearn.impute import SimpleImputer, KNNImputer\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from sklearn.covariance import EllipticEnvelope\n",
    "from sklearn.neighbors import NearestNeighbors, LocalOutlierFactor\n",
    "from sklearn.cluster import KMeans\n",
    "from sklearn.decomposition import PCA\n",
    "from sklearn.metrics.pairwise import euclidean_distances\n",
    "from sklearn.model_selection import train_test_split\n",
    "from rdkit import Chem\n",
    "from rdkit.Chem import AllChem\n",
    "from rdkit import RDLogger\n",
    "from matplotlib_venn import venn2\n",
    "import plotly.express as px\n",
    "import plotly.graph_objects as go\n",
    "RDLogger.DisableLog('rdApp.*')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "86649a64-841f-4e8a-83cc-53f4a642919f",
   "metadata": {},
   "source": [
    "## 数据清洗\n",
    "### 文件读取、缺失值比例检测与记录、样本筛选(80%)、使用KNN进行缺失值填充、标准化"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "19483c6b-bfa1-44ce-a231-466e3d122a9d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "==================== 正在处理: CO_HCT-116 ====================\n",
      "原始数据读取成功: 5251 行, 416 特征列\n",
      "正在记录原始缺失值分布到 -> output\\missing_ratio_log_CO_HCT-116.txt\n",
      "-> 日志写入完毕。\n",
      "\n",
      "[数据清洗] 没有样本超过 80% 缺失阈值，无需删除。\n",
      "[填充缺失] 剩余缺失值总数: 3680，先对非缺失值做 Z-Score 标准化然后使用 KNN 填充...\n",
      "-> KNN 填充完成（结果为标准化后的特征）。\n",
      "处理结束! 最终数据维度: (5251, 418)\n",
      "--------------------------------------------------\n",
      "\n",
      "\n",
      "==================== 正在处理: CO_HT29 ====================\n",
      "原始数据读取成功: 5279 行, 416 特征列\n",
      "正在记录原始缺失值分布到 -> output\\missing_ratio_log_CO_HT29.txt\n",
      "-> 日志写入完毕。\n",
      "\n",
      "[数据清洗] 没有样本超过 80% 缺失阈值，无需删除。\n",
      "[填充缺失] 剩余缺失值总数: 3624，先对非缺失值做 Z-Score 标准化然后使用 KNN 填充...\n",
      "-> KNN 填充完成（结果为标准化后的特征）。\n",
      "处理结束! 最终数据维度: (5279, 418)\n",
      "--------------------------------------------------\n",
      "\n",
      "所有日志文件已生成至: E:\\file\\postgraduate\\机器学习\\期末\\ML期末作业\\output\n"
     ]
    }
   ],
   "source": [
    "def load_log_and_preprocess(folder_path):\n",
    "    \"\"\"\n",
    "    流程：\n",
    "    1. 读取数据\n",
    "    2. [关键步骤] 计算原始数据的每行缺失比例，并保存到 output/txt 文件\n",
    "    3. 过滤：删除缺失率 > 80% 的样本\n",
    "    4. 填充：对剩余样本进行均值填充\n",
    "    5. 标准化：Z-Score\n",
    "    \"\"\"\n",
    "    \n",
    "    # --- 0. 准备工作 ---\n",
    "    dataset_name = os.path.basename(folder_path) # 获取文件夹名，如 CO_HT29\n",
    "    \n",
    "    # 确保 output 文件夹存在\n",
    "    output_dir = 'output'\n",
    "    if not os.path.exists(output_dir):\n",
    "        os.makedirs(output_dir)\n",
    "    \n",
    "    feat_path = os.path.join(folder_path, 'dataset_features.csv')\n",
    "    smile_path = os.path.join(folder_path, 'dataset_smiles.csv')\n",
    "    \n",
    "    if not os.path.exists(folder_path):\n",
    "        print(f\"错误: 找不到文件夹 {folder_path}\")\n",
    "        return None, None\n",
    "\n",
    "    print(f\"\\n{'='*20} 正在处理: {dataset_name} {'='*20}\")\n",
    "\n",
    "    # --- 1. 读取原始数据 ---\n",
    "    try:\n",
    "        df_features = pd.read_csv(feat_path)\n",
    "        df_smiles = pd.read_csv(smile_path)\n",
    "    except Exception as e:\n",
    "        print(f\"读取失败: {e}\")\n",
    "        return None, None\n",
    "\n",
    "    # 切分特征(X) 和 标签(y)\n",
    "    # 前416列是特征 (0-415)，后面是标签\n",
    "    X_raw = df_features.iloc[:, :416]\n",
    "    y_raw = df_features.iloc[:, 416:]\n",
    "    \n",
    "    print(f\"原始数据读取成功: {X_raw.shape[0]} 行, {X_raw.shape[1]} 特征列\")\n",
    "\n",
    "    # --- 2. [核心步骤] 记录缺失值比例 (在填充之前!) ---\n",
    "    # 计算每一行的缺失比例\n",
    "    missing_ratios = X_raw.isnull().mean(axis=1)\n",
    "    \n",
    "    log_filename = f\"missing_ratio_log_{dataset_name}.txt\"\n",
    "    log_path = os.path.join(output_dir, log_filename)\n",
    "    \n",
    "    print(f\"正在记录原始缺失值分布到 -> {log_path}\")\n",
    "    \n",
    "    with open(log_path, 'w', encoding='utf-8') as f:\n",
    "        f.write(f\"Dataset: {dataset_name}\\n\")\n",
    "        f.write(f\"Raw_Total_Rows: {len(X_raw)}\\n\")\n",
    "        f.write(\"Description: 此文件记录了原始数据的缺失比例。比例 > 0.8 的行将在后续步骤中被删除。\\n\")\n",
    "        f.write(\"-\" * 40 + \"\\n\")\n",
    "        f.write(\"Row_Index\\tMissing_Ratio\\tStatus\\n\") # 表头\n",
    "        \n",
    "        for idx, ratio in missing_ratios.items():\n",
    "            # 标记一下该行稍后会被 Drop 还是 Keep\n",
    "            status = \"DROP\" if ratio > 0.8 else \"KEEP\"\n",
    "            f.write(f\"{idx}\\t{ratio:.6f}\\t{status}\\n\")\n",
    "            \n",
    "    print(\"-> 日志写入完毕。\")\n",
    "\n",
    "    # --- 3. 样本筛选 (删除缺失 > 80% 的行) ---\n",
    "    # 找出要删除的索引\n",
    "    drop_indices = missing_ratios[missing_ratios > 0.8].index.tolist()\n",
    "    \n",
    "    X_clean = X_raw\n",
    "    y_clean = y_raw\n",
    "    df_smiles_clean = df_smiles\n",
    "    \n",
    "    if len(drop_indices) > 0:\n",
    "        print(f\"\\n[数据清洗] 发现 {len(drop_indices)} 个样本缺失率 > 80%，正在删除...\")\n",
    "        # 同步删除特征、标签、SMILES\n",
    "        X_clean = X_raw.drop(drop_indices).reset_index(drop=True)\n",
    "        y_clean = y_raw.drop(drop_indices).reset_index(drop=True)\n",
    "        df_smiles_clean = df_smiles.drop(drop_indices).reset_index(drop=True)\n",
    "        print(f\"-> 删除完成。剩余样本数: {X_clean.shape[0]}\")\n",
    "    else:\n",
    "        print(\"\\n[数据清洗] 没有样本超过 80% 缺失阈值，无需删除。\")\n",
    "\n",
    "    # --- 4. 使用 KNN 填充缺失值 (先标准化再填充) ---\n",
    "    # 检查清洗后的数据里是否还有 NaN (比如缺失率 20% 的行)\n",
    "    remaining_nans = X_clean.isnull().sum().sum()\n",
    "\n",
    "    if remaining_nans > 0:\n",
    "        print(f\"[填充缺失] 剩余缺失值总数: {remaining_nans}，先对非缺失值做 Z-Score 标准化然后使用 KNN 填充...\")\n",
    "\n",
    "        # 计算列的均值和标准差，忽略 NaN\n",
    "        X_vals = X_clean.astype(float)\n",
    "        col_means = np.nanmean(X_vals.values, axis=0)\n",
    "        col_stds = np.nanstd(X_vals.values, axis=0)\n",
    "        # 避免标准差为0导致除以0\n",
    "        col_stds[col_stds == 0] = 1.0\n",
    "\n",
    "        # 对非 NaN 值进行标准化，NaN 会被保留\n",
    "        X_standardized = (X_vals - col_means) / col_stds\n",
    "\n",
    "        # KNN 填充在标准化空间进行\n",
    "        knn_imputer = KNNImputer(n_neighbors=5)\n",
    "        X_imputed_arr = knn_imputer.fit_transform(X_standardized)\n",
    "\n",
    "        # imputer 返回的是 numpy array（标准化后的值），保持为 DataFrame\n",
    "        X_clean = pd.DataFrame(X_imputed_arr, columns=X_clean.columns)\n",
    "        print(\"-> KNN 填充完成（结果为标准化后的特征）。\")\n",
    "    else:\n",
    "        # 如果没有缺失，按常规对整个数据做标准化\n",
    "        print(\"[填充缺失] 数据完整，无需 KNN 填充，接着进行 Z-Score 标准化...\")\n",
    "        scaler = StandardScaler()\n",
    "        X_scaled_arr = scaler.fit_transform(X_clean)\n",
    "        X_clean = pd.DataFrame(X_scaled_arr, columns=X_clean.columns)\n",
    "\n",
    "    # --- 5. （此时）数据已为标准化特征，拼接回完整表格 (特征 + 标签)\n",
    "    df_final = pd.concat([X_clean, y_clean], axis=1)\n",
    "    \n",
    "    print(f\"处理结束! 最终数据维度: {df_final.shape}\")\n",
    "    print(\"-\" * 50 + \"\\n\")\n",
    "    \n",
    "    return df_final, df_smiles_clean\n",
    "\n",
    "# ==========================================\n",
    "# 执行主程序\n",
    "# ==========================================\n",
    "\n",
    "dir_hct116 = 'CO_HCT-116'\n",
    "dir_ht29 = 'CO_HT29'\n",
    "\n",
    "# 1. 处理 HCT-116\n",
    "df_hct116_ready, df_hct116_smiles_ready = load_log_and_preprocess(dir_hct116)\n",
    "\n",
    "# 2. 处理 HT-29\n",
    "df_ht29_ready, df_ht29_smiles_ready = load_log_and_preprocess(dir_ht29)\n",
    "\n",
    "print(f\"所有日志文件已生成至: {os.path.abspath('output')}\")"
   ]
  },
  {
   "cell_type": "raw",
   "id": "bef0c094-3640-4786-9e83-9d77cad58b73",
   "metadata": {},
   "source": [
    "Dataset: CO_HT29\n",
    "Raw_Total_Rows: 5279\n",
    "Description: 此文件记录了原始数据的缺失比例。比例 > 0.8 的行将在后续步骤中被删除。\n",
    "----------------------------------------\n",
    "Row_Index\tMissing_Ratio\tStatus\n",
    "0\t0.000000\tKEEP\n",
    "1\t0.000000\tKEEP\n",
    "2\t0.000000\tKEEP\n",
    "3\t0.000000\tKEEP\n",
    "4\t0.000000\tKEEP\n",
    "5\t0.000000\tKEEP\n",
    "6\t0.000000\tKEEP\n",
    "7\t0.000000\tKEEP"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f127073b-ab68-4c30-9d22-2024aceff9fb",
   "metadata": {},
   "source": [
    "## 全局设置\n",
    "### 设置plt绘图参数、定义输出文件夹"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "5031c76b-8e0b-4ecf-9e78-f1ac365d5fd2",
   "metadata": {},
   "outputs": [],
   "source": [
    "sns.set(style=\"whitegrid\")\n",
    "plt.rcParams['font.sans-serif'] = ['SimHei']  # 正常显示中文\n",
    "plt.rcParams['axes.unicode_minus'] = False    # 正常显示负号\n",
    "\n",
    "# 定义输出文件夹\n",
    "OUTPUT_DIR = 'output'\n",
    "if not os.path.exists(OUTPUT_DIR):\n",
    "    os.makedirs(OUTPUT_DIR)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f71e4281-bb0f-456d-8b8f-ecccf0c7d37c",
   "metadata": {},
   "source": [
    "# 基于Feature的离群点检测\n",
    "## 数据预处理\n",
    "### 数据集选择、特征提取与降维（保留95%方差）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "c14c4738-e7ad-43c1-9412-77d5cce42261",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "当前分析对象: HT-29_FEATURE\n",
      "[PCA] 原始维度: 416 -> 降维后: 75 (保留 95% 方差)\n",
      "特征提取与 PCA 降维完成。\n"
     ]
    }
   ],
   "source": [
    "# --- 1. 选择要分析的数据集 ---\n",
    "current_dataset_name = \"HT-29_FEATURE\"\n",
    "df_current = df_ht29_ready           \n",
    "df_smiles_current = df_ht29_smiles_ready\n",
    "\n",
    "print(f\"当前分析对象: {current_dataset_name}\")\n",
    "\n",
    "# --- 2. 提取特征并先做 PCA(0.95) 降维，供后续离群点检测使用 ---\n",
    "# 提取前416列特征矩阵\n",
    "X = df_current.iloc[:, :416].values\n",
    "\n",
    "# 先用 PCA 保留 95% 方差，降维用于后续离群点检测\n",
    "# 使用 svd_solver='full' 以保证 n_components=0.95 时行为一致\n",
    "pca_reducer = PCA(n_components=0.95, svd_solver='full')\n",
    "X_reduced = pca_reducer.fit_transform(X)\n",
    "print(f\"[PCA] 原始维度: {X.shape[1]} -> 降维后: {X_reduced.shape[1]} (保留 95% 方差)\")\n",
    "\n",
    "# 为了绘图，再在降维后的数据上做一次 2D PCA，保证可视化和检测使用相同（或相似）的空间\n",
    "if X_reduced.shape[1] >= 2:\n",
    "    pca2 = PCA(n_components=2)\n",
    "    X_pca = pca2.fit_transform(X_reduced)\n",
    "else:\n",
    "    # 如果降维后只有 1 维，为了可视化构造第二列为 0\n",
    "    X_pca = np.hstack([X_reduced, np.zeros((X_reduced.shape[0], 1))])\n",
    "\n",
    "# 初始化一个 DataFrame 用来存结果\n",
    "outlier_flags = pd.DataFrame(index=df_current.index)\n",
    "\n",
    "print(\"特征提取与 PCA 降维完成。\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b722917e-2cff-4046-a912-7ce06104ce25",
   "metadata": {},
   "source": [
    "## 1.基于统计的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "78915cbe-bfa2-43c0-a145-6c359f44d2b2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行统计法检测...\n",
      "图片已保存: output\\HT-29_FEATURE_1_Statistical.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 方法 1: 基于统计 (Statistical) ---\n",
    "print(f\"正在运行统计法检测...\")\n",
    "\n",
    "# 设定离群阈值\n",
    "contamination = 0.02\n",
    "\n",
    "# 1. 计算 (在降维后的空间上进行检测)\n",
    "# support_fraction=0.9 表示使用 90% 的数据来拟合椭圆，剩下的作为噪点参考\n",
    "ee = EllipticEnvelope(contamination=contamination, support_fraction=0.9, random_state=42)\n",
    "y_pred_stat = ee.fit_predict(X_reduced) # 1正常, -1异常\n",
    "\n",
    "# 记录结果 (True 为异常)\n",
    "outlier_flags['Stat'] = (y_pred_stat == -1)\n",
    "\n",
    "# 2. 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "# 画正常点\n",
    "plt.scatter(X_pca[~outlier_flags['Stat'], 0], X_pca[~outlier_flags['Stat'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "# 画异常点\n",
    "plt.scatter(X_pca[outlier_flags['Stat'], 0], X_pca[outlier_flags['Stat'], 1], \n",
    "            c='red', s=40, edgecolor='k', label='统计异常点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 统计法 (Elliptic Envelope)\\n检出数量: {outlier_flags[\"Stat\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "# 3. 保存\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_1_Statistical.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a38bf1b6-a07c-44d1-a492-f9d1b4217493",
   "metadata": {},
   "source": [
    "## 2.基于距离的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "e0ba1073-6131-4ee8-894c-ce628ad2bd04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行距离法检测...\n",
      "图片已保存: output\\HT-29_FEATURE_2_Distance.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 方法 2: 基于距离 (Distance) ---\n",
    "print(f\"正在运行距离法检测...\")\n",
    "\n",
    "k = 5\n",
    "# 距离法使用降维后的数据\n",
    "knn = NearestNeighbors(n_neighbors=k)\n",
    "knn.fit(X_reduced)\n",
    "\n",
    "# 1.计算距离\n",
    "distances, _ = knn.kneighbors(X_reduced)\n",
    "kth_dist = distances[:, -1] # 取第 k 个邻居的距离\n",
    "\n",
    "# 确定阈值 (距离最远的 top 2%)\n",
    "threshold_dist = np.percentile(kth_dist, 100 * (1 - contamination))\n",
    "\n",
    "# 记录结果\n",
    "outlier_flags['Dist'] = kth_dist > threshold_dist\n",
    "\n",
    "# 2.绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_pca[~outlier_flags['Dist'], 0], X_pca[~outlier_flags['Dist'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "plt.scatter(X_pca[outlier_flags['Dist'], 0], X_pca[outlier_flags['Dist'], 1], \n",
    "            c='blue', s=40, edgecolor='k', label='距离异常点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 距离法 (KNN Distance)\\n阈值: {threshold_dist:.2f}, 检出数量: {outlier_flags[\"Dist\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "# 3. 保存\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_2_Distance.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "129fd6ce-9ced-45ee-add7-f845045f4d71",
   "metadata": {},
   "source": [
    "## 3.基于密度的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "042ce267-07cb-4e5b-b7e8-ebf24d312ec4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行密度法检测...\n",
      "图片已保存: output\\HT-29_FEATURE_3_Density.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 方法 3: 基于密度 (Density) ---\n",
    "print(f\"正在运行密度法检测...\")\n",
    "\n",
    "# LOF 在降维后的空间上运行\n",
    "lof = LocalOutlierFactor(n_neighbors=20, contamination=contamination)\n",
    "y_pred_lof = lof.fit_predict(X_reduced) # -1 为异常\n",
    "\n",
    "# 记录结果\n",
    "outlier_flags['Density'] = (y_pred_lof == -1)\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_pca[~outlier_flags['Density'], 0], X_pca[~outlier_flags['Density'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "plt.scatter(X_pca[outlier_flags['Density'], 0], X_pca[outlier_flags['Density'], 1], \n",
    "            c='green', s=40, edgecolor='k', label='密度异常点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 密度法 (LOF)\\n检出数量: {outlier_flags[\"Density\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_3_Density.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "913e7367-3f08-4cd3-81a7-c7849f0ba143",
   "metadata": {},
   "source": [
    "## 4.基于聚类的离群点分析\n",
    "### 4.1两阶段离群点挖掘方法（TOD）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "ed015bca-421f-4371-9854-ffb8ef635eec",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行 TOD (Two-Phase Outlier Detection) 方法...\n",
      "   [TOD统计] Ave_OF: 20.3432, Dev_OF: 5.2022, Beta: 2\n",
      "   [TOD统计] 阈值: 30.7476\n",
      "图片已保存: output\\HT-29_FEATURE_4_TOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 4.1: 两阶段离群点挖掘方法（TOD） ---\n",
    "print(f\"正在运行 TOD (Two-Phase Outlier Detection) 方法...\")\n",
    "\n",
    "# 参数设置\n",
    "n_clusters = 9\n",
    "beta = 2  \n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第一阶段：聚类 \n",
    "# ---------------------------------------------------------\n",
    "# 使用 K-Means 对降维后的数据进行聚类\n",
    "kmeans = KMeans(n_clusters=n_clusters, random_state=42, n_init=10)\n",
    "kmeans.fit(X_reduced)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第二阶段：计算离群因子 OF3\n",
    "# ---------------------------------------------------------\n",
    "\n",
    "# 1. 计算距离 d(p, Cj): 所有点到所有簇中心的距离\n",
    "# kmeans.transform 返回矩阵形状为 (样本数, 簇数量)，正是我们要的距离矩阵\n",
    "dist_matrix = kmeans.transform(X_reduced)\n",
    "\n",
    "# 2. 计算权重 |Cj| / |D|\n",
    "# 获取每个簇的样本数量 (|Cj|)\n",
    "labels = kmeans.labels_\n",
    "cluster_sizes = np.bincount(labels, minlength=n_clusters)\n",
    "total_samples = len(X_reduced)\n",
    "\n",
    "# 计算每个簇的权重系数\n",
    "cluster_weights = cluster_sizes / total_samples\n",
    "\n",
    "# 3. 计算 OF3(p): 加权平均距离\n",
    "# 公式: Sum( (Size_j / Total) * dist_j )\n",
    "# 利用矩阵乘法: (N, k) dot (k,) -> (N,)，相当于对每一行进行了加权求和\n",
    "of3_scores = np.dot(dist_matrix, cluster_weights)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第三阶段：判定\n",
    "# ---------------------------------------------------------\n",
    "# 计算 OF3 的统计量\n",
    "ave_of = np.mean(of3_scores)  # Ave_OF\n",
    "dev_of = np.std(of3_scores)   # Dev_OF\n",
    "\n",
    "# 设定阈值: Ave_OF + beta * Dev_OF\n",
    "threshold_tod = ave_of + beta * dev_of\n",
    "\n",
    "# 记录结果 (True 为异常)\n",
    "outlier_flags['TOD'] = of3_scores >= threshold_tod\n",
    "\n",
    "# 打印\n",
    "print(f\"   [TOD统计] Ave_OF: {ave_of:.4f}, Dev_OF: {dev_of:.4f}, Beta: {beta}\")\n",
    "print(f\"   [TOD统计] 阈值: {threshold_tod:.4f}\")\n",
    "\n",
    "# =========================================================\n",
    "# 绘图\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常点\n",
    "plt.scatter(X_pca[~outlier_flags['TOD'], 0], X_pca[~outlier_flags['TOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "\n",
    "# 2. 画异常点 (TOD 关注的是离中心远的点)\n",
    "plt.scatter(X_pca[outlier_flags['TOD'], 0], X_pca[outlier_flags['TOD'], 1], \n",
    "            c='orange', s=40, edgecolor='k', label='TOD 离群点')\n",
    "\n",
    "# 3. 绘制簇中心\n",
    "\n",
    "pca_model = pca2\n",
    "\n",
    "if pca_model is not None:\n",
    "    try:\n",
    "        # 获取聚类中心 (来自 TOD 阶段训练的 kmeans)\n",
    "        # 尝试将中心点投影到 2D 画布上\n",
    "        centers_2d = pca_model.transform(kmeans.cluster_centers_)\n",
    "        \n",
    "        # 绘制中心点 (黑色 X)\n",
    "        plt.scatter(centers_2d[:, 0], centers_2d[:, 1], \n",
    "                    marker='x', s=150, linewidths=2, color='black', label='簇中心')\n",
    "        \n",
    "        # 标上数字 ID\n",
    "        for i, (cx, cy) in enumerate(centers_2d):\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color='black', weight='bold',\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none')) # 白底防遮挡\n",
    "            \n",
    "    except Exception as e:\n",
    "        # 维度不匹配时(例如 kmeans 是 75维, pca 是 416维)，只打印警告不报错\n",
    "        print(f\"警告: 无法绘制簇中心，维度可能不匹配 ({e})。仅绘制样本分布。\")\n",
    "else:\n",
    "    print(\"提示: 未找到 PCA 模型对象，仅绘制样本点。\")\n",
    "# ---------------------------------------------------------\n",
    "\n",
    "plt.title(f'{current_dataset_name} - TOD方法\\nBeta={beta:.4f}, 检出数量: {outlier_flags[\"TOD\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_TOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "57530c7f-61e6-4dee-927f-9a807cf9e697",
   "metadata": {},
   "source": [
    "### 4.2基于聚类的离群挖掘方法 （CBOD）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "8d3b5672-206b-440c-8ddc-2d233b2b07f0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "正在运行 CBOD 方法...\n",
      "   [复用] 簇数量 K=9\n",
      "   [CBOD] 簇离群因子 OF4 统计 (按偏离程度降序):\n",
      "   Rank | ID | Size | OF4 Score | Cumulative %\n",
      "   --------------------------------------------------\n",
      "      1 |  6 |   64 | 39.835909  | 1.21%\n",
      "      2 |  7 |  103 | 32.896110  | 3.16%\n",
      "   --------------------------------------------------\n",
      "   -> 累积离群比例 3.16% 已满足阈值 (>= 2.0%)\n",
      "   -> 判定离群簇 ID: [6, 7]\n",
      "图片已保存: output\\HT-29_FEATURE_4_CBOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# --- 4.2: CBOD 方法---\n",
    "print(f\"\\n正在运行 CBOD 方法...\")\n",
    "\n",
    "# 参数设置\n",
    "# epsilon: 我们希望筛选出的离群样本比例 (即 PPT 中的 0 < epsilon < 1)\n",
    "epsilon = 0.02 \n",
    "\n",
    "# =========================================================\n",
    "# 1. 复用聚类信息 \n",
    "# =========================================================\n",
    "# 直接使用 TOD 阶段的 kmeans 模型和权重\n",
    "# centroids: 簇中心坐标 (k, 75)\n",
    "centroids = kmeans.cluster_centers_\n",
    "# cluster_weights: 之前算好的权重 |Cj|/|D|\n",
    "# cluster_sizes: 之前算好的簇大小 |Cj|\n",
    "\n",
    "print(f\"   [复用] 簇数量 K={len(centroids)}\")\n",
    "\n",
    "# =========================================================\n",
    "# 2. 计算 OF4 \n",
    "# =========================================================\n",
    "# 公式: OF4(Ci) = Sum( (|Cj|/|D|) * d(Ci, Cj) )\n",
    "\n",
    "# 计算簇中心之间的距离矩阵 d(Ci, Cj)\n",
    "# centroid_dist_matrix[i, j] 表示第 i 个簇中心和第 j 个簇中心的距离\n",
    "centroid_dist_matrix = euclidean_distances(centroids, centroids)\n",
    "\n",
    "# 利用矩阵乘法一次性算出所有 OF4\n",
    "# (K, K) dot (K,) -> (K,)\n",
    "of4_scores_cbod = np.dot(centroid_dist_matrix, cluster_weights)\n",
    "\n",
    "# 整理每个簇的信息以便排序\n",
    "cbod_stats = []\n",
    "for i in range(len(centroids)):\n",
    "    cbod_stats.append({\n",
    "        'cluster_id': i,\n",
    "        'size': cluster_sizes[i],\n",
    "        'of4': of4_scores_cbod[i]\n",
    "    })\n",
    "\n",
    "# =========================================================\n",
    "# 3. 排序与判定 \n",
    "# =========================================================\n",
    "\n",
    "# 按 OF4(Ci) 递减顺序重新排列 \n",
    "sorted_cbod = sorted(cbod_stats, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "# 寻找最小的 b，使得累积样本占比 >= epsilon\n",
    "current_sum = 0\n",
    "outlier_cluster_ids = []\n",
    "\n",
    "print(f\"   [CBOD] 簇离群因子 OF4 统计 (按偏离程度降序):\")\n",
    "print(f\"   Rank | ID | Size | OF4 Score | Cumulative %\")\n",
    "print(f\"   {'-'*50}\")\n",
    "\n",
    "for rank, c in enumerate(sorted_cbod):\n",
    "    current_sum += c['size']\n",
    "    cumulative_ratio = current_sum / total_samples\n",
    "    \n",
    "    print(f\"   {rank+1:4d} | {c['cluster_id']:2d} | {c['size']:4d} | {c['of4']:.6f}  | {cumulative_ratio*100:.2f}%\")\n",
    "    \n",
    "    # 只要累积比例还没超过 epsilon，或者这是第一个簇（至少得选一个），就加入离群名单\n",
    "    if len(outlier_cluster_ids) == 0 or (current_sum - c['size']) / total_samples < epsilon:\n",
    "         outlier_cluster_ids.append(c['cluster_id'])\n",
    "    \n",
    "    # 检查是否刚刚跨过 epsilon 阈值\n",
    "    if cumulative_ratio >= epsilon:\n",
    "        print(f\"   {'-'*50}\")\n",
    "        print(f\"   -> 累积离群比例 {cumulative_ratio*100:.2f}% 已满足阈值 (>= {epsilon*100}%)\")\n",
    "        print(f\"   -> 判定离群簇 ID: {outlier_cluster_ids}\")\n",
    "        break\n",
    "\n",
    "# 标记样本\n",
    "# np.isin 用于判断 labels 中的每个元素是否在 outlier_cluster_ids 列表中\n",
    "outlier_flags['CBOD'] = np.isin(labels, outlier_cluster_ids)\n",
    "\n",
    "# =========================================================\n",
    "# 4. 绘图\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常点 (属于 normal 簇的点)\n",
    "plt.scatter(X_pca[~outlier_flags['CBOD'], 0], X_pca[~outlier_flags['CBOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常簇样本')\n",
    "\n",
    "# 2. 画异常点 (整个离群簇)\n",
    "plt.scatter(X_pca[outlier_flags['CBOD'], 0], X_pca[outlier_flags['CBOD'], 1], \n",
    "            c='purple', s=40, edgecolor='k', label='CBOD 离群簇样本')\n",
    "\n",
    "# 3. 标记簇中心 ID\n",
    "pca_model = pca2\n",
    "\n",
    "if pca_model is not None:\n",
    "    try:\n",
    "        # 将 75维 的簇中心投影到 2D\n",
    "        # centroids 来自于复用的 kmeans.cluster_centers_\n",
    "        centers_2d = pca_model.transform(centroids)\n",
    "        \n",
    "        # 遍历绘制每个中心\n",
    "        for i, (cx, cy) in enumerate(centers_2d):\n",
    "            # 逻辑：如果该簇 ID 在离群名单里，数字标红，否则标黑\n",
    "            text_color = 'red' if i in outlier_cluster_ids else 'black'\n",
    "            font_weight = 'bold' if i in outlier_cluster_ids else 'normal'\n",
    "            \n",
    "            # 画中心位置 (X号)\n",
    "            plt.scatter(cx, cy, marker='x', s=150, linewidths=2, color=text_color)\n",
    "            \n",
    "            # 写数字 ID\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color=text_color, weight=font_weight,\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none')) # 加个白底好认\n",
    "            \n",
    "    except Exception as e:\n",
    "        print(f\"警告: 无法绘制簇中心，维度可能不匹配 ({e})\")\n",
    "else:\n",
    "    print(\"提示: 未找到 PCA 模型对象，仅绘制样本点。\")\n",
    "# ---------------------------------------------------------\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 4.2 CBOD方法\\nEpsilon={epsilon}, 检出数量: {outlier_flags[\"CBOD\"].sum()}')\n",
    "plt.xlabel('PCA Component 1')\n",
    "plt.ylabel('PCA Component 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_CBOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d9ab4dfb-65d7-491b-b734-a48e90bfa183",
   "metadata": {},
   "source": [
    "## 5.基于聚类的动态数据的离群点检测\n",
    "本部分使用通过划分数据去训练一个可以流式检测离群点的模型，该模型可在新数据进入时实时更新离群点判断依据。  \n",
    "第一步使用80%的数据进行聚类，CBOD的逻辑去筛选离群簇，建立基础模型；  \n",
    "第二步利用使用额外20%的数据流式输入模型，根据INN算法来判断该点属于是否属于离群簇、正常簇、候选离群点。输入新数据后将实时更新离群簇判断依据。  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "43c0db4f-2fd5-4704-81d7-707b38babe78",
   "metadata": {},
   "outputs": [],
   "source": [
    "# 参数设置\n",
    "n_clusters_dynamic = 9\n",
    "epsilon = 0.02 "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f344ae6e-c266-4566-be3e-3f140bd8dbc5",
   "metadata": {},
   "source": [
    "带索引切分数据，以便后续回溯数据时记录离群点"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "a5937512-8950-4403-b4d5-1f59efafa45f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   [数据切分] 训练集: 4223, 测试集: 1056\n"
     ]
    }
   ],
   "source": [
    "# indices_train/test 用于记录原始行号，以便最后填回 outlier_flags\n",
    "X_train, X_test, idx_train, idx_test = train_test_split(\n",
    "    X_reduced, df_current.index, test_size=0.2, random_state=42\n",
    ")\n",
    "\n",
    "print(f\"   [数据切分] 训练集: {len(X_train)}, 测试集: {len(X_test)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ab074b83-f406-4d26-9525-68755b200daa",
   "metadata": {},
   "source": [
    "#### 模型建立"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "a3309b69-b7e9-4f20-ae5c-b9de0db7f807",
   "metadata": {},
   "outputs": [],
   "source": [
    "kmeans_dyn = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_dyn.fit(X_train)\n",
    "labels_train = kmeans_dyn.labels_\n",
    "centroids = kmeans_dyn.cluster_centers_\n",
    "\n",
    "# --- 确定离群簇 (CBOD逻辑) ---\n",
    "train_sizes = np.bincount(labels_train, minlength=n_clusters_dynamic)\n",
    "train_weights = train_sizes / len(X_train)\n",
    "centroid_dist = euclidean_distances(centroids, centroids)\n",
    "of4_scores = np.dot(centroid_dist, train_weights)\n",
    "\n",
    "# 排序并筛选离群簇\n",
    "cluster_info = [{'id': i, 'size': s, 'of4': o} for i, s, o in zip(range(n_clusters_dynamic), train_sizes, of4_scores)]\n",
    "sorted_clusters = sorted(cluster_info, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids = []\n",
    "curr_sum = 0\n",
    "for c in sorted_clusters:\n",
    "    outlier_cluster_ids.append(c['id'])\n",
    "    curr_sum += c['size']\n",
    "    if curr_sum / len(X_train) >= epsilon:\n",
    "        break\n",
    "\n",
    "# --- 确定簇半径 (Radius) ---\n",
    "cluster_radii = np.zeros(n_clusters_dynamic)\n",
    "train_dists = kmeans_dyn.transform(X_train)\n",
    "for i in range(n_clusters_dynamic):\n",
    "    dists = train_dists[labels_train == i, i]\n",
    "    if len(dists) > 0:\n",
    "        cluster_radii[i] = np.max(dists) # 定义半径为簇内最大距离"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1f58bbe-7931-410d-8afa-dd9478eebca6",
   "metadata": {},
   "source": [
    "#### 生成结果标签"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "229b82fc-99ae-43ce-8307-8166b80c96bc",
   "metadata": {},
   "outputs": [],
   "source": [
    "# --- A. 处理训练集结果 ---\n",
    "# 逻辑: 如果属于离群簇，就是异常\n",
    "is_outlier_train = np.isin(labels_train, outlier_cluster_ids)\n",
    "\n",
    "# --- B. 处理测试集结果 (INN评估) ---\n",
    "# 逻辑: 计算最近邻距离，判断是 正常 / 已知离群 / 候选离群(新行为)\n",
    "test_dists = kmeans_dyn.transform(X_test)\n",
    "is_outlier_test = []\n",
    "\n",
    "for i in range(len(X_test)):\n",
    "    # 找到最近簇\n",
    "    nearest_id = np.argmin(test_dists[i])\n",
    "    dist = test_dists[i][nearest_id]\n",
    "    \n",
    "    # 判定\n",
    "    if dist <= cluster_radii[nearest_id]:\n",
    "        # 半径内：继承簇的性质\n",
    "        if nearest_id in outlier_cluster_ids:\n",
    "            is_outlier_test.append(True) # 已知离群点 -> 异常\n",
    "        else:\n",
    "            is_outlier_test.append(False) # 正常簇 -> 正常\n",
    "    else:\n",
    "        # 半径外：候选离群点 -> 异常\n",
    "        is_outlier_test.append(True)\n",
    "\n",
    "is_outlier_test = np.array(is_outlier_test)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf713009-cc10-4274-92bd-70335f8c1383",
   "metadata": {},
   "source": [
    "#### 合并保存到outlier_flags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "0e3718a6-1ee2-4476-b2b1-77e549efe63d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "[完成] 动态检测结果已保存至 outlier_flags['Dynamic']\n",
      "   - 总离群点数量: 132\n",
      "   - 包含训练集中的离群簇样本 + 测试集中的已知/候选离群点\n",
      "验证图片已保存: output\\HT-29_FEATURE_5_Dynamic_Combined.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 创建两个临时的 Series，索引分别是 idx_train 和 idx_test\n",
    "s_train = pd.Series(is_outlier_train, index=idx_train)\n",
    "s_test = pd.Series(is_outlier_test, index=idx_test)\n",
    "\n",
    "# 合并并按索引重新排序 (恢复原始顺序)\n",
    "s_final = pd.concat([s_train, s_test]).sort_index()\n",
    "\n",
    "# 写入总表\n",
    "outlier_flags['Dynamic'] = s_final\n",
    "\n",
    "# 打印统计\n",
    "num_dynamic_outliers = outlier_flags['Dynamic'].sum()\n",
    "print(f\"\\n[完成] 动态检测结果已保存至 outlier_flags['Dynamic']\")\n",
    "print(f\"   - 总离群点数量: {num_dynamic_outliers}\")\n",
    "print(f\"   - 包含训练集中的离群簇样本 + 测试集中的已知/候选离群点\")\n",
    "\n",
    "# =========================================================\n",
    "# 绘图验证 (Visual Check)\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "# 正常点\n",
    "plt.scatter(X_pca[~outlier_flags['Dynamic'], 0], X_pca[~outlier_flags['Dynamic'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常样本')\n",
    "# 异常点\n",
    "plt.scatter(X_pca[outlier_flags['Dynamic'], 0], X_pca[outlier_flags['Dynamic'], 1], \n",
    "            c='brown', s=40, edgecolor='k', label='动态法离群点')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 5. 动态检测法 (Train+Test Combined)\\nTotal Outliers: {num_dynamic_outliers}')\n",
    "plt.xlabel('PCA 1')\n",
    "plt.ylabel('PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_5_Dynamic_Combined.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"验证图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "46054190-7515-4227-8f89-d37e018f1fd8",
   "metadata": {},
   "source": [
    "#### 模型更新与回溯"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "aac4a8d1-f2be-4f8f-9d0f-ca7fcccb28e1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   [数据合并] 当前全量数据样本: 5279\n",
      "\n",
      "   [模型更新后] 簇统计 (OF4 降序):\n",
      "   ID | Size | OF4 Score | Status\n",
      "   -----------------------------------\n",
      "    8 |   38 | 42.464595  | OUTLIER\n",
      "    2 |   64 | 39.801650  | OUTLIER\n",
      "    7 |  402 | 20.005696  | OUTLIER\n",
      "    0 |  509 | 18.395122  | Normal\n",
      "    4 |  458 | 14.491961  | Normal\n",
      "    6 |  379 | 14.378430  | Normal\n",
      "    3 |  955 | 10.528142  | Normal\n",
      "    5 |  964 | 10.264458  | Normal\n",
      "    1 | 1510 | 9.866616  | Normal\n",
      "\n",
      "   -> 更新后的离群簇 ID: [8, 2, 7]\n",
      "\n",
      "[回溯分析] 模型更新后，有 372 个样本的判定结果发生了反转！\n",
      "结果已保存至 outlier_flags['Dynamic_Updated']\n",
      "图片已保存: output\\HT-29_FEATURE_6_Dynamic_Updated.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 1. 合并数据 (训练集 + 测试集)\n",
    "X_total = np.vstack([X_train, X_test])\n",
    "idx_total = np.concatenate([idx_train, idx_test])\n",
    "\n",
    "print(f\"   [数据合并] 当前全量数据样本: {len(X_total)}\")\n",
    "\n",
    "# 2. 模型更新 (Simulate Incremental Update)\n",
    "# 此时簇的形态(质心、大小)会发生漂移\n",
    "kmeans_updated = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_updated.fit(X_total)\n",
    "\n",
    "labels_updated = kmeans_updated.labels_\n",
    "centroids_updated = kmeans_updated.cluster_centers_\n",
    "\n",
    "# 3. 重新计算离群因子 OF4 (Re-calculate OF4)\n",
    "# 计算新的簇大小和权重\n",
    "sizes_updated = np.bincount(labels_updated, minlength=n_clusters_dynamic)\n",
    "weights_updated = sizes_updated / len(X_total)\n",
    "\n",
    "# 计算新的簇间距离矩阵\n",
    "dist_matrix_updated = euclidean_distances(centroids_updated, centroids_updated)\n",
    "\n",
    "# 计算新的 OF4 分数\n",
    "of4_updated = np.dot(dist_matrix_updated, weights_updated)\n",
    "\n",
    "# 4. 重新定义离群簇 (Re-define Outlier Clusters)\n",
    "cluster_info_updated = []\n",
    "for i in range(n_clusters_dynamic):\n",
    "    cluster_info_updated.append({\n",
    "        'id': i, \n",
    "        'size': sizes_updated[i], \n",
    "        'of4': of4_updated[i]\n",
    "    })\n",
    "\n",
    "# 按 OF4 降序排列\n",
    "sorted_clusters_updated = sorted(cluster_info_updated, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids_updated = []\n",
    "current_sum = 0\n",
    "\n",
    "print(f\"\\n   [模型更新后] 簇统计 (OF4 降序):\")\n",
    "print(f\"   ID | Size | OF4 Score | Status\")\n",
    "print(f\"   {'-'*35}\")\n",
    "\n",
    "for c in sorted_clusters_updated:\n",
    "    status = \"Normal\"\n",
    "    # 筛选逻辑同前：累积比例 < epsilon\n",
    "    if len(outlier_cluster_ids_updated) == 0 or (current_sum / len(X_total)) < epsilon:\n",
    "        outlier_cluster_ids_updated.append(c['id'])\n",
    "        current_sum += c['size']\n",
    "        status = \"OUTLIER\"\n",
    "    \n",
    "    print(f\"   {c['id']:2d} | {c['size']:4d} | {c['of4']:.6f}  | {status}\")\n",
    "\n",
    "print(f\"\\n   -> 更新后的离群簇 ID: {outlier_cluster_ids_updated}\")\n",
    "\n",
    "# 5. 回溯标记 (Backtracking Labeling)\n",
    "# 所有样本(包括以前的训练集)都根据这个新模型重新打标\n",
    "is_outlier_updated = np.isin(labels_updated, outlier_cluster_ids_updated)\n",
    "\n",
    "# 6. 保存到总表 outlier_flags\n",
    "# 创建 Series 并按索引对齐\n",
    "s_updated = pd.Series(is_outlier_updated, index=idx_total).sort_index()\n",
    "outlier_flags['Dynamic_Updated'] = s_updated\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 对比与分析\n",
    "# ---------------------------------------------------------\n",
    "# 看看有多少点发生了变化\n",
    "diff_count = (outlier_flags['Dynamic'] != outlier_flags['Dynamic_Updated']).sum()\n",
    "print(f\"\\n[回溯分析] 模型更新后，有 {diff_count} 个样本的判定结果发生了反转！\")\n",
    "print(f\"结果已保存至 outlier_flags['Dynamic_Updated']\")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 绘图：更新后的全量视图\n",
    "# ---------------------------------------------------------\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 画正常点\n",
    "plt.scatter(X_pca[~outlier_flags['Dynamic_Updated'], 0], X_pca[~outlier_flags['Dynamic_Updated'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='更新后: 正常')\n",
    "\n",
    "# 画异常点\n",
    "plt.scatter(X_pca[outlier_flags['Dynamic_Updated'], 0], X_pca[outlier_flags['Dynamic_Updated'], 1], \n",
    "            c='darkred', s=40, edgecolor='k', label='更新后: 离群点')\n",
    "\n",
    "# 标记新的簇中心\n",
    "pca_model = None\n",
    "if 'pca2' in locals(): pca_model = pca2\n",
    "elif 'pca' in locals(): pca_model = pca\n",
    "\n",
    "if pca_model:\n",
    "    centers_2d = pca_model.transform(centroids_updated)\n",
    "    for i, (cx, cy) in enumerate(centers_2d):\n",
    "        color = 'red' if i in outlier_cluster_ids_updated else 'black'\n",
    "        plt.scatter(cx, cy, marker='x', s=150, linewidths=3, c=color)\n",
    "        plt.text(cx, cy, f\"C{i}\", color=color, weight='bold', fontsize=14,\n",
    "                 bbox=dict(facecolor='white', alpha=0.6, edgecolor='none'))\n",
    "\n",
    "plt.title(f'Phase 3: 动态检测法(Backtracking)\\nTotal Outliers: {outlier_flags[\"Dynamic_Updated\"].sum()} (Changed: {diff_count})')\n",
    "plt.xlabel('PCA 1')\n",
    "plt.ylabel('PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_6_Dynamic_Updated.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a46e2840-c92e-427c-a389-39c2c40a3431",
   "metadata": {},
   "source": [
    "## Feature结果分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "03cdef4f-b82a-490b-bab0-dca5fc97d6c8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "========================================\n",
      "【HT-29_FEATURE】 最终离群点分析报告\n",
      "========================================\n",
      "总样本数: 5279\n",
      "被至少 1 种方法标记的样本数: 745\n",
      "被至少 3 种方法标记的强离群点数: 177\n",
      "\n",
      ">>> 正在导出 TOP 离群点详细信息...\n",
      "               Drug_A     Drug_B  Synergy_Score  Votes  \\\n",
      "19       Methotrexate  Bleomycin          -35.0      4   \n",
      "86           Busulfan  Bleomycin          -16.0      4   \n",
      "186  6-Mercaptopurine  Bleomycin           16.0      4   \n",
      "255  Nitrogen mustard  Bleomycin          -50.0      4   \n",
      "334       Allopurinol  Bleomycin          -37.0      4   \n",
      "\n",
      "                              Methods  \n",
      "19   TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "86   TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "186  TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "255  TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "334  TOD,CBOD,Dynamic,Dynamic_Updated  \n",
      "\n",
      "[完成] 详细名单已保存至: output\\HT-29_FEATURE_Top_Outliers.csv\n",
      "请使用 Excel 打开该文件，分析这些药物组合的化学结构特点。\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 1. 计算\"得票数\"\n",
    "outlier_flags['Votes'] = outlier_flags[['Stat', 'Dist', 'Density', 'TOD','CBOD','Dynamic','Dynamic_Updated']].sum(axis=1)\n",
    "\n",
    "# 2. 筛选出高置信度离群点 (至少 3 种方法认为是异常)\n",
    "high_conf_indices = outlier_flags[outlier_flags['Votes'] >= 3].index\n",
    "\n",
    "print(f\"{'='*40}\")\n",
    "print(f\"【{current_dataset_name}】 最终离群点分析报告\")\n",
    "print(f\"{'='*40}\")\n",
    "print(f\"总样本数: {X_reduced.shape[0]}\")\n",
    "print(f\"被至少 1 种方法标记的样本数: {(outlier_flags['Votes'] > 0).sum()}\")\n",
    "print(f\"被至少 3 种方法标记的强离群点数: {len(high_conf_indices)}\")\n",
    "\n",
    "if len(high_conf_indices) > 0:\n",
    "    print(f\"\\n>>> 正在导出 TOP 离群点详细信息...\")\n",
    "    \n",
    "    # 提取这些离群点的 药物名、结构、SynergyScore\n",
    "    # 注意：这里用 loc 根据索引去 df_smiles_current 里查信息\n",
    "    top_outliers_info = df_smiles_current.loc[high_conf_indices, ['Drug_A', 'Drug_B']].copy()\n",
    "    \n",
    "    # 把特征表里的 Synergy 和 Class_Label 也拼过来\n",
    "    # 假设 Synergy 是第 416 列 (iloc 416), Label 是 417\n",
    "    # 也可以直接用列名如果列名还在的话\n",
    "    top_outliers_info['Synergy_Score'] = df_current.loc[high_conf_indices].iloc[:, 416]\n",
    "    top_outliers_info['Votes'] = outlier_flags.loc[high_conf_indices, 'Votes']\n",
    "    top_outliers_info['Methods'] = outlier_flags.loc[high_conf_indices, ['Stat', 'Dist', 'Density', 'TOD','CBOD','Dynamic','Dynamic_Updated']].apply(\n",
    "        lambda x: ','.join(x.index[x]), axis=1\n",
    "    )\n",
    "\n",
    "    # 显示前几行\n",
    "    print(top_outliers_info.head())\n",
    "    \n",
    "    # 保存到 CSV\n",
    "    csv_filename = f\"{current_dataset_name}_Top_Outliers.csv\"\n",
    "    csv_path = os.path.join(OUTPUT_DIR, csv_filename)\n",
    "    top_outliers_info.to_csv(csv_path)\n",
    "    print(f\"\\n[完成] 详细名单已保存至: {csv_path}\")\n",
    "    print(\"请使用 Excel 打开该文件，分析这些药物组合的化学结构特点。\")\n",
    "\n",
    "else:\n",
    "    print(\"\\n没有发现 Votes >= 3 的强离群点。说明不同算法对异常的定义在该数据集中差异较大。\")\n",
    "    \n",
    "# 3. 最终可视化 (按得票数染色)\n",
    "plt.figure(figsize=(10, 6))\n",
    "mask_normal = outlier_flags['Votes'] == 0\n",
    "plt.scatter(X_pca[mask_normal, 0], X_pca[mask_normal, 1], c='lightgray', s=10, alpha=0.5, label='Normal')\n",
    "\n",
    "mask_abnormal = outlier_flags['Votes'] > 0\n",
    "sc = plt.scatter(X_pca[mask_abnormal, 0], X_pca[mask_abnormal, 1], \n",
    "                 c=outlier_flags.loc[mask_abnormal, 'Votes'], \n",
    "                 cmap='Reds', s=30, edgecolor='k', label='Outliers')\n",
    "\n",
    "plt.colorbar(sc, label='Votes (Detected Methods)')\n",
    "plt.title(f'{current_dataset_name} - 综合离群点分布')\n",
    "plt.xlabel('PCA 1')\n",
    "plt.ylabel('PCA 2')\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_7_Final_Summary.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ef414a28-d2c4-4085-a9ef-4743c62fff03",
   "metadata": {},
   "source": [
    "# 基于SMILE结构的离群点检测"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b7be8c4a-8c59-432a-b8be-b69bc30a18e1",
   "metadata": {},
   "source": [
    "## 计算摩根指纹"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "3a77838f-7e10-4391-b6fa-0229dc0318eb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "指纹矩阵构建完成，维度: (5279, 2048)\n",
      "正在进行 PCA 降维 (SMILES Space)...\n",
      "降维完成，维度: (5279, 126)\n"
     ]
    }
   ],
   "source": [
    "def get_fingerprint(smiles, n_bits=1024):\n",
    "    try:\n",
    "        mol = Chem.MolFromSmiles(smiles)\n",
    "        if mol is None: return np.zeros(n_bits)\n",
    "        # 半径为2，类似 ECFP4\n",
    "        return np.array(AllChem.GetMorganFingerprintAsBitVect(mol, 2, nBits=n_bits))\n",
    "    except:\n",
    "        return np.zeros(n_bits)\n",
    "\n",
    "fp_list = []\n",
    "\n",
    "current_dataset_name = \"HT-29_SMILE\"\n",
    "\n",
    "for idx, row in df_smiles_current.iterrows():\n",
    "    fp_a = get_fingerprint(row['SMILES_A'])\n",
    "    fp_b = get_fingerprint(row['SMILES_B'])\n",
    "    # 拼接两个药物的指纹\n",
    "    fp_list.append(np.concatenate([fp_a, fp_b]))\n",
    "\n",
    "X_fingerprints = np.array(fp_list)\n",
    "print(f\"指纹矩阵构建完成，维度: {X_fingerprints.shape}\")\n",
    "\n",
    "# =========================================================\n",
    "# 2. PCA 降维 (SMILES Space)\n",
    "# =========================================================\n",
    "print(\"正在进行 PCA 降维 (SMILES Space)...\")\n",
    "\n",
    "# 降维到95%方差\n",
    "pca_calc = PCA(n_components=0.95)\n",
    "X_smiles_reduced = pca_calc.fit_transform(X_fingerprints)\n",
    "print(f\"降维完成，维度: {X_smiles_reduced.shape}\")\n",
    "\n",
    "# 降维到 2 维用于画图\n",
    "pca_vis = PCA(n_components=2)\n",
    "X_smiles_pca = pca_vis.fit_transform(X_fingerprints)\n",
    "\n",
    "# 初始化结果表\n",
    "outlier_flags_smile = pd.DataFrame(index=df_smiles_current.index)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5b873beb-de61-4086-90ad-0d4e615c5ecd",
   "metadata": {},
   "source": [
    "## 1.基于统计的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "b8d0e907-16b7-4921-85f1-304be9f84fbf",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行统计法检测 (SMILES)...\n",
      "图片已保存: output\\HT-29_SMILE_1_Statistical.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"正在运行统计法检测 (SMILES)...\")\n",
    "contamination = 0.02\n",
    "\n",
    "ee = EllipticEnvelope(contamination=contamination, support_fraction=0.9, random_state=42)\n",
    "y_pred_stat = ee.fit_predict(X_smiles_reduced) \n",
    "\n",
    "outlier_flags_smile['Stat'] = (y_pred_stat == -1)\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Stat'], 0], X_smiles_pca[~outlier_flags_smile['Stat'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Stat'], 0], X_smiles_pca[outlier_flags_smile['Stat'], 1], \n",
    "            c='red', s=40, edgecolor='k', label='统计异常骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 统计法 (Elliptic Envelope)\\n检出数量: {outlier_flags_smile[\"Stat\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_1_Statistical.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "24d52b6c-a287-4744-bc59-74dfe1dbe5f3",
   "metadata": {},
   "source": [
    "## 2.基于距离的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "9f5ffef7-7091-4964-8ce1-409e8a3632bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行距离法检测 (SMILES)...\n",
      "图片已保存: output\\HT-29_SMILE_2_Distance.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"正在运行距离法检测 (SMILES)...\")\n",
    "k = 5\n",
    "knn = NearestNeighbors(n_neighbors=k) # 这里对PCA后的数据用欧氏距离近似\n",
    "knn.fit(X_smiles_reduced)\n",
    "\n",
    "distances, _ = knn.kneighbors(X_smiles_reduced)\n",
    "kth_dist = distances[:, -1]\n",
    "threshold_dist = np.percentile(kth_dist, 100 * (1 - contamination))\n",
    "\n",
    "outlier_flags_smile['Dist'] = kth_dist > threshold_dist\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Dist'], 0], X_smiles_pca[~outlier_flags_smile['Dist'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Dist'], 0], X_smiles_pca[outlier_flags_smile['Dist'], 1], \n",
    "            c='blue', s=40, edgecolor='k', label='距离异常骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 距离法 (KNN)\\n阈值: {threshold_dist:.2f}, 检出数量: {outlier_flags_smile[\"Dist\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_2_Distance.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c764e4f-0d16-4187-ab6a-792487108080",
   "metadata": {},
   "source": [
    "## 3.基于密度的离群点分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "1fdcd567-042a-4a00-9f41-c6bcac2ebc6e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "正在运行密度法检测 (SMILES)...\n",
      "图片已保存: output\\HT-29_SMILE_3_Density.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"正在运行密度法检测 (SMILES)...\")\n",
    "lof = LocalOutlierFactor(n_neighbors=20, contamination=contamination)\n",
    "y_pred_lof = lof.fit_predict(X_smiles_reduced)\n",
    "\n",
    "outlier_flags_smile['Density'] = (y_pred_lof == -1)\n",
    "\n",
    "# 绘图\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Density'], 0], X_smiles_pca[~outlier_flags_smile['Density'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Density'], 0], X_smiles_pca[outlier_flags_smile['Density'], 1], \n",
    "            c='green', s=40, edgecolor='k', label='密度异常骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 密度法 (LOF)\\n检出数量: {outlier_flags_smile[\"Density\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_3_Density.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f0d9a203-8734-4a0f-94a8-3a8f1b32f068",
   "metadata": {},
   "source": [
    "## 4.基于聚类的离群点分析\n",
    "### 4.1两阶段离群点挖掘方法（TOD）"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "49e8bdaa-b18c-4435-b2ec-e257e78f8351",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "正在运行 TOD 方法（SMILES）...\n",
      "   [TOD结构] Ave_OF: 9.0561, Dev_OF: 1.4480, Beta: 2\n",
      "   [TOD结构] 阈值: 11.9522\n",
      "图片已保存: output\\HT-29_SMILE_4_TOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"\\n正在运行 TOD 方法（SMILES）...\")\n",
    "\n",
    "# 参数设置\n",
    "n_clusters = 9\n",
    "beta = 2  \n",
    "\n",
    "# 第一阶段：聚类\n",
    "# 使用 K-Means 对降维后的指纹数据进行聚类\n",
    "kmeans_struct = KMeans(n_clusters=n_clusters, random_state=42, n_init=10)\n",
    "kmeans_struct.fit(X_smiles_reduced)\n",
    "\n",
    "# 第二阶段：计算离群因子 OF3 (Phase 2: Calculate Outlier Factor)\n",
    "\n",
    "# 1. 计算距离 d(p, Cj)\n",
    "dist_matrix = kmeans_struct.transform(X_smiles_reduced)\n",
    "\n",
    "# 2. 计算权重 |Cj| / |D|\n",
    "labels = kmeans_struct.labels_\n",
    "cluster_sizes = np.bincount(labels, minlength=n_clusters)\n",
    "total_samples = len(X_smiles_reduced)\n",
    "cluster_weights = cluster_sizes / total_samples\n",
    "\n",
    "# 3. 计算 OF3(p): 加权平均距离\n",
    "of3_scores = np.dot(dist_matrix, cluster_weights)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 第三阶段：判定 (Thresholding)\n",
    "# ---------------------------------------------------------\n",
    "ave_of = np.mean(of3_scores)\n",
    "dev_of = np.std(of3_scores)\n",
    "threshold_tod = ave_of + beta * dev_of\n",
    "\n",
    "# 记录结果\n",
    "outlier_flags_smile['TOD'] = of3_scores >= threshold_tod\n",
    "\n",
    "print(f\"   [TOD结构] Ave_OF: {ave_of:.4f}, Dev_OF: {dev_of:.4f}, Beta: {beta}\")\n",
    "print(f\"   [TOD结构] 阈值: {threshold_tod:.4f}\")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 绘图 \n",
    "# ---------------------------------------------------------\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['TOD'], 0], X_smiles_pca[~outlier_flags_smile['TOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "\n",
    "# 2. 画异常骨架\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['TOD'], 0], X_smiles_pca[outlier_flags_smile['TOD'], 1], \n",
    "            c='orange', s=40, edgecolor='k', label='TOD 离群骨架')\n",
    "\n",
    "# 3. 【修复】绘制簇中心\n",
    "# 不再使用 pca_vis.transform，而是直接计算 2D 点的均值\n",
    "try:\n",
    "    # 遍历每个簇 (0 到 8)\n",
    "    for i in range(n_clusters):\n",
    "        # 找到属于簇 i 的所有点在 2D 图上的坐标\n",
    "        # labels 来自于 kmeans_struct.labels_\n",
    "        points_in_cluster_2d = X_smiles_pca[labels == i]\n",
    "        \n",
    "        if len(points_in_cluster_2d) > 0:\n",
    "            # 计算这些点的平均值，这就是簇中心在图上的位置！\n",
    "            cx, cy = np.mean(points_in_cluster_2d, axis=0)\n",
    "            \n",
    "            # 绘制中心点 (黑色 X)\n",
    "            plt.scatter(cx, cy, marker='x', s=150, linewidths=2, color='black')\n",
    "            \n",
    "            # 标上数字 ID\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color='black', weight='bold',\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none'))\n",
    "            \n",
    "    # 为了图例显示正常，画一个假的中心点进图例\n",
    "    plt.scatter([], [], marker='x', s=150, linewidths=2, color='black', label='骨架簇中心')\n",
    "\n",
    "except Exception as e:\n",
    "    print(f\"警告: 绘制簇中心时发生错误: {e}\")\n",
    "\n",
    "plt.title(f'{current_dataset_name} - TOD Method\\nBeta={beta}, Outliers: {outlier_flags_smile[\"TOD\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_TOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a8a00954-cb28-4290-a56b-52fdbebcc524",
   "metadata": {},
   "source": [
    "### 4.2基于聚类的离群挖掘方法 CBOD"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "3a60567f-9181-4302-86b9-6c2c8539fba8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "正在运行 CBOD 方法（SMILES)...\n",
      "   [复用] 簇数量 K=9\n",
      "   [CBOD] 结构簇离群因子统计:\n",
      "   Rank | ID | Size | OF4 Score | Cumulative %\n",
      "   --------------------------------------------------\n",
      "      1 |  3 |   95 | 9.522634  | 1.80%\n",
      "      2 |  5 |  194 | 8.604264  | 5.47%\n",
      "图片已保存: output\\HT-29_SMILE_4_CBOD.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "[完成] TOD 与 CBOD 结构空间分析结束。\n"
     ]
    }
   ],
   "source": [
    "print(f\"\\n正在运行 CBOD 方法（SMILES)...\")\n",
    "\n",
    "epsilon = 0.02 \n",
    "\n",
    "# =========================================================\n",
    "# 1. 复用聚类信息\n",
    "# =========================================================\n",
    "centroids = kmeans_struct.cluster_centers_\n",
    "print(f\"   [复用] 簇数量 K={len(centroids)}\")\n",
    "\n",
    "# =========================================================\n",
    "# 2. 计算 OF4\n",
    "# =========================================================\n",
    "# 计算簇中心之间的距离矩阵\n",
    "centroid_dist_matrix = euclidean_distances(centroids, centroids)\n",
    "\n",
    "# 计算 OF4\n",
    "of4_scores_cbod = np.dot(centroid_dist_matrix, cluster_weights)\n",
    "\n",
    "# 整理\n",
    "cbod_stats = []\n",
    "for i in range(len(centroids)):\n",
    "    cbod_stats.append({\n",
    "        'cluster_id': i,\n",
    "        'size': cluster_sizes[i],\n",
    "        'of4': of4_scores_cbod[i]\n",
    "    })\n",
    "\n",
    "# =========================================================\n",
    "# 3. 排序与判定\n",
    "# =========================================================\n",
    "sorted_cbod = sorted(cbod_stats, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "current_sum = 0\n",
    "outlier_cluster_ids = []\n",
    "\n",
    "print(f\"   [CBOD] 结构簇离群因子统计:\")\n",
    "print(f\"   Rank | ID | Size | OF4 Score | Cumulative %\")\n",
    "print(f\"   {'-'*50}\")\n",
    "\n",
    "for rank, c in enumerate(sorted_cbod):\n",
    "    current_sum += c['size']\n",
    "    cumulative_ratio = current_sum / total_samples\n",
    "    \n",
    "    print(f\"   {rank+1:4d} | {c['cluster_id']:2d} | {c['size']:4d} | {c['of4']:.6f}  | {cumulative_ratio*100:.2f}%\")\n",
    "    \n",
    "    if len(outlier_cluster_ids) == 0 or (current_sum - c['size']) / total_samples < epsilon:\n",
    "         outlier_cluster_ids.append(c['cluster_id'])\n",
    "    \n",
    "    if cumulative_ratio >= epsilon:\n",
    "        break\n",
    "\n",
    "# 标记样本\n",
    "outlier_flags_smile['CBOD'] = np.isin(labels, outlier_cluster_ids)\n",
    "\n",
    "# =========================================================\n",
    "# 4. 绘图 (CBOD Structure)\n",
    "# =========================================================\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 1. 画正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['CBOD'], 0], X_smiles_pca[~outlier_flags_smile['CBOD'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架簇')\n",
    "\n",
    "# 2. 画离群骨架簇\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['CBOD'], 0], X_smiles_pca[outlier_flags_smile['CBOD'], 1], \n",
    "            c='purple', s=40, edgecolor='k', label='CBOD 离群骨架簇')\n",
    "\n",
    "# 3. 标记中心 (使用 2D 点的均值计算，避开维度报错)\n",
    "try:\n",
    "    # 这里的 labels 是 K-Means 的聚类标签\n",
    "    # X_smiles_pca 是 2D 坐标\n",
    "    \n",
    "    # 遍历每个簇\n",
    "    for i in range(len(centroids)):\n",
    "        # 找到属于簇 i 的所有点在图上的 2D 坐标\n",
    "        points_in_cluster = X_smiles_pca[labels == i]\n",
    "        \n",
    "        if len(points_in_cluster) > 0:\n",
    "            # 计算这些点的平均值，这就是簇中心在图上的位置！\n",
    "            cx, cy = np.mean(points_in_cluster, axis=0)\n",
    "            \n",
    "            # 颜色逻辑\n",
    "            text_color = 'red' if i in outlier_cluster_ids else 'black'\n",
    "            font_weight = 'bold' if i in outlier_cluster_ids else 'normal'\n",
    "            \n",
    "            # 绘制\n",
    "            plt.scatter(cx, cy, marker='x', s=150, linewidths=2, color=text_color)\n",
    "            plt.text(cx, cy, str(i), fontsize=15, color=text_color, weight=font_weight,\n",
    "                     bbox=dict(facecolor='white', alpha=0.5, edgecolor='none'))\n",
    "                     \n",
    "except Exception as e:\n",
    "    print(f\"警告: 绘制簇中心时发生错误: {e}\")\n",
    "\n",
    "plt.title(f'{current_dataset_name}  - CBOD Method\\nEpsilon={epsilon}, Outliers: {outlier_flags_smile[\"CBOD\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_4_CBOD.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()\n",
    "\n",
    "print(\"\\n[完成] TOD 与 CBOD 结构空间分析结束。\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf38d779-ef30-4ca2-a105-3970e62022cb",
   "metadata": {},
   "source": [
    "## 5.基于聚类的动态数据的离群点检测"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "08f3d323-e129-45f4-81ce-2f8443f3dddf",
   "metadata": {},
   "source": [
    "### 建立初始模型"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "0dc6d9a3-dde0-467a-aa8c-6dcda5feb678",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   [数据切分] 训练集: 4223, 测试集: 1056\n",
      "   [模型定义] 结构离群簇 ID: [2]\n",
      "   [结果] 动态检测离群结构数: 113\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 参数设置\n",
    "n_clusters_dynamic = 9  # 保持与 TOD/CBOD 一致\n",
    "epsilon = 0.02 \n",
    "\n",
    "# 带索引切分数据\n",
    "# 使用 X_smiles_reduced\n",
    "# idx_train/test 用于记录原始行号，以便最后填回 outlier_flags_smile\n",
    "X_train, X_test, idx_train, idx_test = train_test_split(\n",
    "    X_smiles_reduced, df_smiles_current.index, test_size=0.2, random_state=42\n",
    ")\n",
    "\n",
    "print(f\"   [数据切分] 训练集: {len(X_train)}, 测试集: {len(X_test)}\")\n",
    "\n",
    "\n",
    "# Phase 1: 模型建立\n",
    "\n",
    "kmeans_dyn = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_dyn.fit(X_train)\n",
    "labels_train = kmeans_dyn.labels_\n",
    "centroids = kmeans_dyn.cluster_centers_\n",
    "\n",
    "# --- 确定离群簇 (CBOD逻辑) ---\n",
    "train_sizes = np.bincount(labels_train, minlength=n_clusters_dynamic)\n",
    "train_weights = train_sizes / len(X_train)\n",
    "centroid_dist = euclidean_distances(centroids, centroids)\n",
    "of4_scores = np.dot(centroid_dist, train_weights)\n",
    "\n",
    "# 排序并筛选离群簇\n",
    "cluster_info = [{'id': i, 'size': s, 'of4': o} for i, s, o in zip(range(n_clusters_dynamic), train_sizes, of4_scores)]\n",
    "sorted_clusters = sorted(cluster_info, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids = []\n",
    "curr_sum = 0\n",
    "for c in sorted_clusters:\n",
    "    # 逻辑：至少选一个，且累积比例 < epsilon 时继续选\n",
    "    if len(outlier_cluster_ids) == 0 or (curr_sum / len(X_train)) < epsilon:\n",
    "        outlier_cluster_ids.append(c['id'])\n",
    "        curr_sum += c['size']\n",
    "    else:\n",
    "        break\n",
    "        \n",
    "print(f\"   [模型定义] 结构离群簇 ID: {outlier_cluster_ids}\")\n",
    "\n",
    "# --- 确定簇半径 (Radius) ---\n",
    "cluster_radii = np.zeros(n_clusters_dynamic)\n",
    "train_dists = kmeans_dyn.transform(X_train)\n",
    "for i in range(n_clusters_dynamic):\n",
    "    dists = train_dists[labels_train == i, i]\n",
    "    if len(dists) > 0:\n",
    "        cluster_radii[i] = np.max(dists) # 定义半径为簇内最大距离\n",
    "\n",
    "\n",
    "# Phase 2: 模型评估 (INN)\n",
    "\n",
    "# --- A. 处理训练集结果 ---\n",
    "is_outlier_train = np.isin(labels_train, outlier_cluster_ids)\n",
    "\n",
    "# --- B. 处理测试集结果 ---\n",
    "test_dists = kmeans_dyn.transform(X_test)\n",
    "is_outlier_test = []\n",
    "\n",
    "for i in range(len(X_test)):\n",
    "    # 找到最近簇\n",
    "    nearest_id = np.argmin(test_dists[i])\n",
    "    dist = test_dists[i][nearest_id]\n",
    "    \n",
    "    # INN 判定逻辑\n",
    "    if dist <= cluster_radii[nearest_id]:\n",
    "        # 半径内：继承簇的性质\n",
    "        if nearest_id in outlier_cluster_ids:\n",
    "            is_outlier_test.append(True) # 已知离群结构\n",
    "        else:\n",
    "            is_outlier_test.append(False) # 正常结构\n",
    "    else:\n",
    "        # 半径外：候选离群结构 (新颖骨架)\n",
    "        is_outlier_test.append(True)\n",
    "\n",
    "is_outlier_test = np.array(is_outlier_test)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 保存到 outlier_flags_smile\n",
    "# ---------------------------------------------------------\n",
    "s_train = pd.Series(is_outlier_train, index=idx_train)\n",
    "s_test = pd.Series(is_outlier_test, index=idx_test)\n",
    "s_final = pd.concat([s_train, s_test]).sort_index()\n",
    "\n",
    "outlier_flags_smile['Dynamic'] = s_final\n",
    "\n",
    "print(f\"   [结果] 动态检测离群结构数: {outlier_flags_smile['Dynamic'].sum()}\")\n",
    "\n",
    "# 绘图验证\n",
    "plt.figure(figsize=(10, 6))\n",
    "# 正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Dynamic'], 0], X_smiles_pca[~outlier_flags_smile['Dynamic'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='正常骨架')\n",
    "# 离群骨架\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Dynamic'], 0], X_smiles_pca[outlier_flags_smile['Dynamic'], 1], \n",
    "            c='brown', s=40, edgecolor='k', label='动态检测离群骨架')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 动态检测法 (Train+Test Combined)\\nTotal Outliers: {outlier_flags_smile[\"Dynamic\"].sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_5_Dynamic_Combined.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21918581-cb66-43b1-a842-838171e20967",
   "metadata": {},
   "source": [
    "### 模型更新与回溯检查"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "09a6bcac-707d-4679-a70f-de3a32f1be4a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Phase 3: 结构空间模型更新 (Model Update) ---\n",
      "   [更新后] 离群簇 ID: [7]\n",
      "   [回溯分析] 判定反转样本数: 0\n",
      "图片已保存: output\\HT-29_SMILE_6_Dynamic_Updated.png\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Phase 3: 模型更新与回溯\n",
    "print(f\"\\n--- Phase 3: 结构空间模型更新 (Model Update) ---\")\n",
    "\n",
    "# 1. 合并数据\n",
    "X_total = np.vstack([X_train, X_test])\n",
    "idx_total = np.concatenate([idx_train, idx_test])\n",
    "\n",
    "# 2. 模型更新 (在全量指纹数据上重新聚类)\n",
    "kmeans_updated = KMeans(n_clusters=n_clusters_dynamic, random_state=42, n_init=10)\n",
    "kmeans_updated.fit(X_total)\n",
    "\n",
    "labels_updated = kmeans_updated.labels_\n",
    "centroids_updated = kmeans_updated.cluster_centers_\n",
    "\n",
    "# 3. 重新计算 OF4\n",
    "sizes_updated = np.bincount(labels_updated, minlength=n_clusters_dynamic)\n",
    "weights_updated = sizes_updated / len(X_total)\n",
    "dist_matrix_updated = euclidean_distances(centroids_updated, centroids_updated)\n",
    "of4_updated = np.dot(dist_matrix_updated, weights_updated)\n",
    "\n",
    "# 4. 重新定义离群簇\n",
    "cluster_info_updated = []\n",
    "for i in range(n_clusters_dynamic):\n",
    "    cluster_info_updated.append({'id': i, 'size': sizes_updated[i], 'of4': of4_updated[i]})\n",
    "\n",
    "sorted_clusters_updated = sorted(cluster_info_updated, key=lambda x: x['of4'], reverse=True)\n",
    "\n",
    "outlier_cluster_ids_updated = []\n",
    "curr_sum = 0\n",
    "for c in sorted_clusters_updated:\n",
    "    if len(outlier_cluster_ids_updated) == 0 or (curr_sum / len(X_total)) < epsilon:\n",
    "        outlier_cluster_ids_updated.append(c['id'])\n",
    "        curr_sum += c['size']\n",
    "    else:\n",
    "        break\n",
    "        \n",
    "print(f\"   [更新后] 离群簇 ID: {outlier_cluster_ids_updated}\")\n",
    "\n",
    "# 5. 回溯标记\n",
    "is_outlier_updated = np.isin(labels_updated, outlier_cluster_ids_updated)\n",
    "\n",
    "# 6. 保存到 outlier_flags_smile\n",
    "s_updated = pd.Series(is_outlier_updated, index=idx_total).sort_index()\n",
    "outlier_flags_smile['Dynamic_Updated'] = s_updated\n",
    "\n",
    "# 对比变化\n",
    "diff_count = (outlier_flags_smile['Dynamic'] != outlier_flags_smile['Dynamic_Updated']).sum()\n",
    "print(f\"   [回溯分析] 判定反转样本数: {diff_count}\")\n",
    "\n",
    "# 绘图：更新后的全量视图\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 画正常骨架\n",
    "plt.scatter(X_smiles_pca[~outlier_flags_smile['Dynamic_Updated'], 0], X_smiles_pca[~outlier_flags_smile['Dynamic_Updated'], 1], \n",
    "            c='lightgray', s=15, alpha=0.6, label='更新后: 正常')\n",
    "\n",
    "# 画离群骨架\n",
    "plt.scatter(X_smiles_pca[outlier_flags_smile['Dynamic_Updated'], 0], X_smiles_pca[outlier_flags_smile['Dynamic_Updated'], 1], \n",
    "            c='darkred', s=40, edgecolor='k', label='更新后: 离群')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 动态检测法 (Backtracking)\\nTotal Outliers: {outlier_flags_smile[\"Dynamic_Updated\"].sum()} (Changed: {diff_count})')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_6_Dynamic_Updated.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"图片已保存: {save_path}\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "154f43ef-8ee4-43f0-b58c-cf1e7ae9ece7",
   "metadata": {},
   "source": [
    "## SMILE结果分析"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "49b7c0b3-3b95-4f00-af2d-8e5356c38d2a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "==================== 最终汇总：SMILES 结构空间离群点分析报告 ====================\n",
      "参与结构投票的方法: ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated']\n",
      "----------------------------------------\n",
      "总样本数: 5279\n",
      "被至少 1 种方法标记为结构异常: 675\n",
      "被至少 3 种方法标记的【强结构离群点】: 62\n",
      "----------------------------------------\n",
      "\n",
      ">>> 正在导出 TOP 结构离群点详细信息...\n",
      "          Drug_A       Drug_B  Synergy_Score  Votes  \\\n",
      "4621  Everolimus    Rapamycin          -57.0      6   \n",
      "2706   Rapamycin  Mithramycin           -7.0      5   \n",
      "4651  Everolimus  Cabazitaxel           12.0      5   \n",
      "2714   Rapamycin  Vincristine          -27.0      5   \n",
      "4626  Everolimus  Vinorelbine           30.0      5   \n",
      "\n",
      "                                                Methods  \n",
      "4621  Dist, Density, TOD, CBOD, Dynamic, Dynamic_Upd...  \n",
      "2706          Stat, Dist, TOD, Dynamic, Dynamic_Updated  \n",
      "4651       Dist, Density, TOD, Dynamic, Dynamic_Updated  \n",
      "2714       Density, TOD, CBOD, Dynamic, Dynamic_Updated  \n",
      "4626       Density, TOD, CBOD, Dynamic, Dynamic_Updated  \n",
      "\n",
      "[完成] 结构离群名单已保存至: output\\HT-29_SMILE_Top_Outliers.csv\n",
      "请检查这些药物是否具有独特的大环、长链或稀有杂环结构。\n",
      "汇总图表已保存: output\\HT-29_SMILE_7_Final_Summary.png\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAxcAAAI2CAYAAAAip3UbAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjcsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvTLEjVAAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzsnQV0U1kXhXdboECx4u6uxd0Hd3d3d3edgcHdHYq7u7u7u0NxK9L+a1/m5k/TVKmk6fnWek3zkry8PD37HrNxd3d3hyAIgiAIgiAIwh9i+6cLEARBEARBEARBEHEhCIIgCIIgCEKAIZ4LQRAEQRAEQRACBBEXgiAIgiAIgiAECCIuBEEQBEEQBEEIEERcCIIgCIIgCIIQIIi4EARBEARBEAQhQBBxIQiCIAiCIAhCgCDiQhAEIRTg4uICNzc3hEYeP36M+/fvB/dqCIIghApEXAiCIFgBR44cwaZNm/Dz509Prx0+fBj58uXD9evX/bTMz58/49SpU3+0XitWrMDGjRt99V5XV1e4u7t7+dqECRPw8eNH9fz79+8YOHAgbty44eNyx44di759+8I/PH/+3MM6rFy5Eq9fv/bVZwcMGIATJ054+56vX7/i9OnT/lo3QRAES0TEhSAIghWwbt06TJkyxaxxnjlzZtja2uLMmTN+Wubs2bNRv3593Lp1y8f3fvv2zex3X7lyBRMnTvQ0n14UGuvGYqhmzZpImzYt0qRJ42Hi94cJE0aJpMGDB6v3njx5EmvWrFHzfSJcuHAIGzasp/n87i9fvnj5OQqYGjVqGNbfxsYGkydPxuLFi+EbKKpevXpleM7/uc6zZs1SwqN27drIlSuX2sYHDhzw1TIFQRAsHREXghCK4CgqjbVLly55mM95CxYsUP8XK1bMk3HHifP9MuLNkeKcOXMiY8aMqFOnDu7evWt4nUbo/PnzUapUKWTKlAl169bFhQsX/PRbuIyFCxfir7/+UsvgdxiPYuvfcfnyZcP7s2XLpuYxTMYYvnfEiBFmt9W1a9e8XAevttWGDRsQlNAIPnToENq3b28womm46vXhfqAxP3z4cA/refv2bS+XSS/HvHnz1LYdOXKkWY+IMRUqVEDWrFmRPXt25MiRwzBt3boV79+/9zCP7+F7Oe3cudOwDB4T9EakTp1aeUwOHjyo5tvb28POzg79+/dHwoQJ1b7csmULKlasiBQpUvi4fSgKjh8/7mk/ZciQQa2DV79t7dq1KpysfPnyBpHSunVrddzdu3fPx+/lvnBwcDA8v3nzpjov7ty5g5gxYyrhwm3M31moUCEflycIghAS8HnIRxCEUMX06dOVscoR50GDBmHMmDFImjSpMqx8Cw1EjjI3a9YMjo6Oaplt2rTBtm3b1Aj6+PHjsWzZMvTq1Uste+nSpWjYsKEKOaHR5xuWL1+OSZMmoV+/fogTJ44KfenYsaMyOo1Hsyk4KHAoKCh6Ahoano0bN/YwL1GiRAhKOOodLVo0lCtXTm1DGu80bFu0aIGWLVt6ev/58+fVazTazfHhwwd06tQJ1atXR+/evdGgQQP1OHr0aLX/zLFr1y78+PFDGep8D0OYuF8KFiyoBMDu3bsxbdo01KtXD9WqVfP0eXoxIkeOjAgRIqjPR4kSRQkKwuVSbDAkigKRxvj27dvV/t67d6+vhC8FFo8XY7hcfq8578enT58wY8YMVKlSxYOAqVWrltrGPHaXLFni6bxgyNSbN2/UtqWg43OKuEiRIhneO2rUKB/XVxAEIaQi4kIQBA9o416Hi6RMmRLp0qXz9Vaih4IigrH2HPUm8ePHR/PmzZWhT8ObXpKePXuqkVtCg7FEiRLKWBs2bJivvmf16tXK8Ktatap6HjVqVGW0MvQnd+7chvfpPAPfxOb7h+jRoxt+Z3DBEf+mTZuqEfqZM2eiaNGiyrjlNqGRbkrs2LHVqL05KMAoPBInTow+ffookaJFQbdu3fD3338jfPjwZj+7atUqODs7Y/369ShbtqzyplB4MWSKy+VnK1WqpIx6Jycn9V6GbBGGGzEMS2MsMrksHisPHjxQv5H7mK/v27dPCRHfiAsKCO4r30IhRYHRuXNnT8uhOKDI6N69uxLfxgKD3g6KZ76PIn3IkCFKZNCTRO+OIAiCtSPiQhCEACVu3LjKwGLsvIaj6uTXr18qNISjxUww1nCEOkmSJHjy5Imvv+fdu3cqZEVDY5MekOTJkxvmMeRFiwqKDBqyFy9ehDVBDxArIVWuXBnHjh1TRjwNYo6U07jltqbxS6Oc0LPAbc19ZMqLFy9U2E+MGDGUsa9DrPicoUAUiBQHQ4cO9SDgNBQd9DxwtJ7eFHoruO8Z9kZvA/MMzp49q9aPoU3GIoVeCM6nV2Dz5s3qd/G3UHhSrBrvV4ZWMbyIj+Z4+fKl+u0aCmVuB9NwOK4rf5spe/bsUeKYIiJWrFieXuexzTyMDh06oEmTJsprxuOeaG8R9wWFFbcjxR5/rw5HNF0PQsHFUCl6bwRBEEIyIi4EQfATFAheVfThKHLEiBE9CAtCw5LzGUuvcxgoDoyXSY+HseDwCRpsTKxl2FXbtm2VYWZqbPL7duzYof6nyKAAsSRx4dO29CoEyTRpmCKLRjiFA8N1KCwIDXR6C0xJlSqVMuCNoQFP0cDwIW5PJh9rQaJhXgq9GAxho7igN4FhYabv0wY7Q6ny5Mmj/mdODMOxmFujxaYxXAbzL5jrwpF+ChMKAkIvAH+bafgStx1FhGl4V7t27czu5+LFi3t4XqRIEeXpMYbrSI8Ec3l4HDM/whz0wNHLxu3LcDQKJwo8vS3oWdNw/3Cb6NwOvk/vfwofnhsUF/SW0EsjCIIQkhFxIQihEMbS+xeGL3nlYWBCMUdzjWEy76JFi1RYDUfQaeAzVGfcuHGYOnWqMoQZn8+Sn6bGn3fQAGRuAL0VNORo8PL7jUfDaURzJJwj8vRcMHcgoOFv46ThbzRNmPcKjmyz6pE5GPL1zz//+LgMJjkz/IkhQwxjopdAwzCcwoULq9e1YU5vAMufGkMRwNF65q9w+9E74V0IFvcl99/Ro0c9hPow/IniwauQKw0TxIlxpSYa1xRKLMvKPBxdvpZJ/9ymXbt2VUKRXi4a5dzfFCH0TjG8yhh6XHzafjx+uL7GUMxQnNHDRfHq3XYgzCdh9Sdudx3eRZ49e2YQtUxo5/Zljgh/L70luvQsH7ktz5075+33CIIghCREXAhCKIRx4syl0OiRVN/AMpo0BM1B74EpHA3XycWExiurFjF+P3/+/Oo1Gl2sAsSRZN/C5XCkl0YmE3UZr8+kXxr6eiSblXqY78EY/UePHilPRkDDkXuGC2lMR/G9g9vBq1KoFAS+gcnqhNuTwk6LK4af0fjm9n379q2nEX9W0WLID5Ouafx26dJF/U/Dncn8NOJNfwu9BJzPiYa1qXFOYWMsbpizQI8FE/t9OsY4es/8BApMChfmfBjDfc3wI4okeleYbJ0lSxazx6K5srPmMPWE8LihN4zHDQUNq1Fxe1DAcJ2MvQqNGjVCvHjx1HFrWpqWYjlZsmR4+vSp+j08LhlGlTdvXl/vV0EQhJCKiAtBCIVwZNgvSdrGGIsSn2DoDas3MfTE2KjiaDRDmNj4jeErNM4YiuObngXmjGsKHoYA0TilJ4PJzRoKCjaXo/GaIEECBDRMEvbvtmTuQ0BAQUWPBL0I9NAwBIdeCAoMbWjT0Kfw4DamuOAoPb0B3FY6TIkGO5ORfYLGc5kyZTx4iZjMzepixvB7KHCYH+FVEzuGIemEaC6X68JRfmP4u2jIm8LfZk5I8Dsp2szlNmjovTEXdsZkd2MotPg7TIUpvWEUOaYwrIuliPlb6FWiYOF2phBj1Si/JJULgiCERERcCIIQKNCQYhw6E14ZmmMKDWCODNPwZ7KuX7wnV69eVaEoHE3WZUI5Ys7wGL5mDMOwaDRz9NkvXoWQAnNYmAtB8cQStDSYGSZGY98YVlRieVnvQn1oqFMoGYd5mUKD2lxZYn6WYWi6xweTzBmaxDLEOu+CoUL0VjEUjmFcJUuWNOScMAGcVaYoWBhqpI1wJoCz0RzFqe53oeFn6bngfjUWGfSw8Lt0aJJX+MZTxtwPeuRM+2lQXJgKHno5KCj4G0uXLq3+JzzOCT1LpvlIgiAI1oaIC0EQAhwmA7NiTvr06VW4jldQCDDZm7kXxkajT1CYcISeXg9t9NGwYw6GqXdCjzgHRkiUJUBPEnM3dFM6hjZp2DiOBjjDcTTcbg8fPlSGvSncB7rHhHeYG/E3Fm7sR8EwK+bnaGHB/UMxyP4n5soN79+/H61atVJ9KxhGpUUQxSHDuvjbjGGugnHIlH4/84EYIufVb+D2MK6cZfzcFAoIlkdmaJfxe+gFomfEVFxw+zEM0DSkS3+Gv505HYIgCNaMiAtBEAIc9rBgIzE20zPucM34dFZ30tDY5Eg4K/P4BRrQTLhl7giNPl3+lsnjpsnqWlT4tjmfKUxQNs1ZYDy9Niz5O00TuDnKbs7ADAw4Yk8vjobhUdwm9C7Qo8G8CmNxQcHB3AUmZntVyvVPoYFN4cjEboZD0Uhnwj4nelTYj8T4OCAMqaKhT3Fhbn9zGzOki79N51zQU0PRYmz4M4+FXhEmUtMrxs/pkCx6bih2KBYoLNh7gh4v3SvFGOZLME+I+9K0EaHuNq/LzxpjvK2NK4HRm8TQKHo1BEEQrBkRF4IgBCgsMcsqQoQj0cawbKc25FgliSO5puE7vuXff/9V4oIChQY1w3nYnM+0OzaFAA1w/3ouTPMICI153ZWbeSWmZV2ZxMuSrUEBR+oZ588EbeYv0DMxZcoUlSvAnAPT9eB60+PDcq0MIzPuH0H4OZ+EGHMaTDE2pPl5hj4xiZ77hV4H5vlQcFHY0LA3twyKBC6H4pST8feZC8Xi+43zdLgtGF5FUUsoPJiLQ3HA0CaKW/adYJgSk7bZ/JBeD4aM6bwThlQxtIsJ2DxuKMJ0aV8mZtPTxu+gOPJJQDJki+vAfcMcDIpo4+NTl6Y1V2ZXEAQhxOIuCIJgQbi5ubn/+PHDy+nnz5/BvYoWxapVq9wzZcrk3q5dO/eVK1e6P3z40H337t3u6dKlc9+wYYP78+fP3ZctW+aeMWNG9x07dqjPfP782b1y5cruBw8e9LCsuXPnulesWNHdxcXFyyl16tTuW7du9bQe/G5+Vi+f+8orxo4dq9Y3TZo0nvZn2bJl3devX294zu87deqUh/dkzpzZ/dixY56W27t3b/cCBQq4u7q6qudfv351d3Jycp8+fbp6/ubNG/csWbK4z5gxQz1/9+6de/bs2d0HDRpkWMbmzZvVenXr1s399evXHpb/5MkT9f7GjRu7nzlzxt0n0qZN675lyxb306dPu9eoUUPtG2MOHDigft+nT598XJYgCEJIQYZKBEGwKOjRYHlZr2AHY90nQPidLMwRcePGdMwHYB8HvsaQJHp4GEKkqxsx+ZseI9PRcl1q1ruKRrrjuSnGJWG5fO9gFSuWB2YIm2mujWlpWXPfx/U07sCtKVCggGrEqL0cTA437uRNb8PgwYMNzxnyxO3EcsUaNsRjBTJzlbz4Pr8ce7t27VLbktuD/VZMKVSokJfbUxAEIaRiQ4UR3CshCIKgYYgTE469Syb2b/6EYBlQGJgLcxIEQRBCPiIuBEEQBEEQBEEIEDzXExQEQRCsClbRYnhUaIIVo8yFTgmCIAiBi4gLQRAEK4Y5DGzetm7dOlgK7I7NKkqByZw5c7zsCi4IgiAEHiIuBMFKYXlS5iaYm1iOMzjgd3O9/MOKFStUiVeWD2V/ApZcDQzYL4OlSb2C5V35O/gYEmCpXpZdZTlWdsDmuptuOyZ3c/6dO3eCZJ3YAZxN9kyTt/0Dy7g2aNBA7Tdj+vXrp7qEL126FEHVOJIJ83PnzvV0rJibjI+x+vXre3p9/PjxQbLegiAIAY1UixIEK4UNzNi4i7AD9r1791TVIBI7dmw/LYuCgD0EzDUbCwrYEI29Cxo1aqQqArF3Q9OmTbF9+3Yfu0kH9O/gtuN29es2DA5u376tejawDwcT4VlJSW+HtGnTeqjQxYZwutu5b2A39IULF6p94pd9QNicjv1D2rdvj0mTJsHe3h7+gfVI2DSP61+lShUPr7FS1KhRo5TwKFOmjLcVsAKCkSNHqs7xxpXO9LFiCvu96PXhb2DDQXYtZ08Q488KgiCERMRzIQhWCht/cZSfE8uU0tjSz9nx2C/QeAvOsBqGuLBsJ8Nc+EixROPWr+sUEL+DVY64DUNCtSM2FWTTPG3I0mBlM0FuB2PYHE4LD9/C7c9mfXz0KxQ6NKbZwI9CgxXC/APLyB45csRDGV5jKJZYptecgR+QHDp0SAng/v37q8Z7pseK8RQhQgTV9b1jx47qPfSu8PdzPY3f59dzVBAEwVIQcSEIgkXz6dMnNbJLUaHhCDGNZOl34TXsar1nzx7Vt8GY/Pnzq+2mq5Czi/azZ8/U/KCmV69eyJUrF5o1a+ZBpDBszzfhRK9fv1YduBn25RXly5dXHq7A4tu3bxgyZIgSB/Sq+QQFWenSpQ0d49kRnf0zAtuzIgiCEFSIuBCEUM6BAwdQoUIF1TiMTdcOHjxoeI0hJTToaBBxtFsbeMbx7UzMZVw/jf+sWbOqfAgaTAEF49ZpCBs3OiN8rvMeevfurSZjaKBy/X37O/yyPl7lXDDkql27dmo7cHswbp45AaZ5MDT8Z8+ejZIlS6oQL2O4TqVKlULmzJlVOI9/DeOXL1+qUfQECRJ4mE8Pxbt37wzN27g9bGxsPHgu+NlOnTqp38H5DKfTv4Prx9/A/BfCRz7X21rD5daoUcPwOxiaZQ6GRvF1eljevHmj5vEYYn6IuWnWrFmGz86fPx+xYsXydjvwN9y6dcvb9/DYqVSpEvzDjBkzlECjN4aelHnz5nlZpYrv27FjhxJTGp4rzD2h4KDHguciQ9kEQRBCKpJzIQihmGPHjqF169bKCGTI0bZt29RzGm25c+dWI7IM2WB3YRpBfE4SJkxoWAaNPSbosvMxDVn+T8N09+7dAbKOOmTGtOszw0t8G07jm9/xp9CgZB5IzJgxVdgWS78OHTpUGe6dO3f28F6GBJ09e1YZ0bpbNOG6cT80b94chQsXVsKPBmuWLFkQL148P60PBYI5w5tJxwzXofHPvAs+MtZfj5xzJJ6GPo1likZ6B0aPHo23b99ixIgRKFq0qAozYgJzmzZtMH36dPU9xt4D5vdwWzC3pWfPnip0qVu3bsrjlDdvXk/rxLwNfp75CkyIZkiQT6KBcB19ggKLy6Zw8co7QIHD3+1XuG14rpDnz5+rjucUURQQixcv9hQ6Ry8L92X69OkN8y5duqTex31Owbxx40a1zRjCZm5bCYIgWDoiLgQhFEMjOFu2bMoIJjRm7t69q0b4KS4YE0/279+vYsM5smoKDSV6CQoWLGgwuHbu3AkXFxdlTAYW9GbQcPcNvvkdf8qWLVuU54IGpP7drMrEUWhTcXHt2jVV/Yp5MMY8ffpU/a5q1aohWbJkcHJyQvbs2f2V8EzDW4c+mYoy7nOKChrzzLeg58D4d1AcUGgmTZrUsCxWX6KYoCBzdHQ0eG4Y3mMq0ig4me+gjysKGgoleh68MpgpxiJHjqzWj54dTubgPrezs/PTtuCyvPuMf0UmhQBFSZ8+fZQgI/v27VMCnb+1Zs2aHsQnvT7cjsZQ6DJnRB8z9BTRw8HjSMSFIAghEREXghCKuXz5socQDUKDhgnUvoWiggZpjx49cO7cOWVg614GAZWYTky9FFy+d7H2XhmngQXDjBjeYi4xmoal8Sg2vROmwkJvexr0LE3KHAiKC4bL+CcenyP/9F6Yg8umh4BGLPeXca4Ajwl6SbSwIPxNFCp8zTeGOLcFhRXDpYwxJ5K4XHpEKGgYUkRxQbFKgWsOesf27t0L3+Lq6qoEQNSoURHQUKjSo1a3bl3DPHp26HlhnpAxDDfkMavDyTTmKnQxlCsw80QEQRACExEXghCKMTey7d18c3BUngnCDPHhCDgN08qVKwfYOtKY5Wi1Fi0aJiEnSpTIy88xTCWoYTlXxuCbwnAZY5iH4JWQoqfj8OHDOHPmjAq5mThxohrxNs2d8AmG1XC70WinF8QYioWxY8eqHhAUOfSO+Gbf++W4YIIzw42MMRVUzONgvgMfGV6lBRiPJX7eHMbVmHwDPTQsyxwYUAhRSJiGP/F3mq4nq0lRxBkLYopRhiZyvnGIF3NiKIoEQRBCIpLQLQihGIYHmTa1O378uKewIY44Gycmaz5+/KjiyxlPz9KarOTDWPyAhMYY18c40ZzfwdFxVhoiDHkx9pR8+fJFheGY4tXvCAhSpUqlQsFobDKHgRONRAoE334nw8noBaJhzUpKDK2hx2bXrl1+Xh8KCyaMm0sOprHN0KYlS5aonA9j45jbmsLt4cOHHo4JLo9J/6ZeCHOdtrktuAy9HTgxx4S/TcP91bZtW2WgM7fDeB3odTH+rPGUMmVKP4cu0fsTGOht9f79e8M8hotRCDO3wlhEMFyKXg1jKCC4DVjKVsOqWfTM0GslCIIQEhFxIQihGFY24gg5k7E5gspHPjcdceZIO8M8aPwyRp/N07SBSeOQydv0XtCQ7tq1q5dGp39hd2mO5jN8hiKD60fjWFf4YWIyDWCG+dDQY0KsObz6HQEBq/wwIZfrRmHDbcK+BzQWfdsTg+E7bLBGTwWNcXoWaJj6NyegSZMmWL58ucrlMIZCgSFYXLZpCVqWrmVIFI8NGsRM3uY6MTnb2FNEAcDfywR+hsOxfwib9un9dfPmTQwYMECJV64DG9rpUXtuEyZ8U4Qwud03idn+4eLFi+r7mcPiHRQEet39AsUbvVXcVjwuKQKZl0IvE1/TsK8FBa+xh0h7qtj8j2FyPHe4v+vVq6dEO/M2BEEQQiTugiBYPb169XKvWLGi2df279/vXr58efcMGTKoxwMHDph937Rp09zz5cun3te0aVPD/N27d7uXKlVKza9UqZL75s2b3dOnT+++Zs0aT8tInTq1+/Hjx/31G1auXOlerFgx94wZM7rXrl3b/fr164bXvn375t6lSxf3rFmzuhcqVMh96tSp7hMnTnSvX7++r3+HhutdtGhRL9fj0aNH6nfw0ZSHDx+6t27d2t3Jyck9d+7c7v3793f/8OGD4XX+dn7WO2bPnu1esmRJ90yZMrkXKVLEffr06e5/wsyZM91r1arl/vXrV0/bk+ty7do1T5958eKFe4cOHdyzZMninidPHvd///3X/cePH57ed+7cObXPuS0LFizofvXqVcNrR48eda9WrZp6jdtz1qxZhtemTJmi1iug4PJNjzcXFxe1Hbds2fJH54dPcFv16NHDPW/evGq/N2nSxP3+/fse3jN58mT3XLlymf0898vgwYPdc+bMqY7fFi1auF+8eNFf6yIIgmAJ2PBPcAscQRAEIXDgJZ7lbOmN6NChQ6jZzMzloHeFIXuCIAhC0CHiQhAEwcphtSrmfZj2CrFmGHrF0ra+LVcsCIIgBAwiLgRBEARBEARBCBAkoVsQBEEQBEEQQji3bt1SleZYRCI4EXEhCIIgCIIgCCGYHz9+qBLmtWrV8lAKOzgQcSEIgiAIgiAIIZjp06erXDM2tg1uQkXOBWuw82f6tbOrIAiCIAiCEHSj7yzCkDVrVovb5GzcyuIYgcX169cxY8YML1/fs2ePl69dvnxZeSwaNmyo+gdly5ZNVQgMLsIgFEBhEZgaisvmCUHxIpVJQj6yP60H2ZfWg+xL60L2p/UQkPvSkse7KSy+ffmKT89fBPiyI8WNg6hRo/p7mw0aNEg1KeX2pwhi01I29GzcuDGCg1AhLrTHIlOmTIGyfHZevXbtGlKmTBmqSj1aK7I/rQfZl9aD7EvrQvan9RCQ+/LSpUuwZCgsVlSuF+DLrbV+KeIlT+qtd8Irzpw5ozwX9HoULVpUzcuRIwc6deqEihUrInr06AhqJOdCEARBEARBEHxpOAf09Cc8e/YMYcKEQaFChQzzMmfOjF+/fuHBgwcIDkRcCIIgCIIgCEIIJH78+HBzc8O3b98M8x4/fqwe48SJEyzrJOJCEARBEARBEHyAKSW2NjYBPtn8QaoKy84mS5YMAwcOxKNHj3DlyhWMGDEC+fLlU8IjOBBxIQiCIAiCIAghkDBhwmDu3LkqDKp69eqoX78+4saNizFjxgTfOgXbNwuCIAiCIAhCCMISR+XjxYuHCRMmwFIQcSEIgiAIQpDA0VWWLXV1dVXP+Whra4nmmuBbfLsvWbnTzs4uxG9Y2z+rthsqEHEhCIIgCEKgwlr8z58/x7t379RzJqAynOPp06ciLkI4ftmX0aJFUyE70hPMuhFxIQiCIAhCoKKFRezYsVUvBBqkHOm2t7e3itHs0O6N8mlfUlyyH8bLly8NYTwhFfGz+YyIC0EQBEEQAtX41MIiRowYhnkkfPjwIi5COL7dlxEiRFCPFBg8FkRUWi8iLgRBEARBCDSYY0H+tHuzEPLRxwCPiZAoLphuwdKxgbFca0K8O4IgCIIgBDoSZy/IMRA6EM+FIAiCIAiCIPgCGZX3GdlGgiAIgiAIoYCrV69i3bp1wb0agpUjngtBEARBEARfwspHzBlg3wbvwnz4vu/fv6v3hAsXzjB/1apVKqG5cOHC6nnTpk2RK1cutG7dWj0fPHgw6tati9SpU5tdbpEiRcyWfOX3pUyZErNnz/Zync6ePYvdu3ejSpUqhnlfv37Fo0ePPLwvfvz4iBQpkrfbIbQifS58RsSFIAiCIAiCL3ny5AmKFy/u6+3Vvn17dOjQwfA8UaJEaNu2LdasWYNkyZIp4cEyrmT79u04ePAgOnXq5OXyXr9+rQRKunTpPMxfu3YtVq5cafYzw4cPV9/Hyk6ccuTIoeZXr14dJUuWVAJHL+/atWuYNGkSChUq5OvfGFpQCd2BtFxrQsSFIAiCIPzHz58/4ezsjKVLl+LBgweIGTMmatSooYwvGckVdI+Go0ePqsZxxp6L7t27K29Dy5YtDfNoyNPDQbZu3aqEgxYYM2fOVP9fv35dCYYbN27g8OHDavmjRo1Sr9WrVw+ZMmXysOG5PHo2WG2J3oqoUaNi7969htfM0bNnT/Tu3Rs9evRQ3o127dphyJAhygNCYZMwYUJ13JPy5ct78LQIgl8RcSEIgiAI/wmLVi1bYueuXShRrAgqlSmJW3fuYuKECdi8eTOWLVsGBwcHZVR6ZcQJ1g+Net2vwxgeFzTUo0SJYvZzN2/exJs3b5TXwpjatWub/Z/ei9KlS5tdFo9FehouXbrkrZdDQ7FAIcKwqAoVKhiED3tTSAUnv2ATSNvLBtaEiAtBEARBAFTYyI6dOzF/xlQlLjQtmjRCldr18c8//6Bjx45qtJejxZEjR5btFoww74GCMLjEnouLi+rboJvD+WZ9o0ePjsePH2PGjBnevnf69OlKEPD3kVmzZqlQKJ0j0aZNG/WbmdNBr0eJEiXw+fNnfPr0Sf1P+vTpg2LFihmWuXPnTnz48EHldxA2NmRuBZdhbl0Fwb+IuBAEQRAEQIVCFS1UwIOwIOnSpEaDOrWwePlKdO7cWc17//69GvUVD0bw8PHjR7UP3Nzcgk3sVapUSeVTGHsbTKHhTvHDddQehvXr16twO4pVc9BbQS/Drl27DPO+fPmCbNmyYcSIEb5aN+ZRGAsEhmP17dtXiRKuE4XHvn37ULFiRSVg7ty5Y8jDoEgRceE1UmbVZ0RcCIIgCAKAx48eoXCt6ma3hVPmTJg2e64yvGjI0kCjUSbiIuih4UthQfTofnCIPX6XaW7ClClT1GTM6tWrVd6Efi/Dahg+FTduXLPL5eumoTdZsmRR+RwUKhkzZkS0aNE8VYyiIKE35cCBA6hZs6bKoyBv375VwoLzdD5IggQJMHLkSJw/f17lXzCJWxACChEXgiAIggAgdpw4uH7zttltcf3mTRX+wjAYGrM07GjoCUEPtz89FjTWaYRzPwSH2DMXe29cGYrG/rdv3zwJEM4/c+aMwVPAMCfmcej38X/mQxhTtGhRw/889pYvX24QDxrmc+TNm1ctR5e1JRQiDPmLFSuWh/WkN4RJ6KY5ILqELreluZK3oR0pReszcmUUBEEQBAC1atXCoEGDcOrsOeTMltWwTR4/eYKFS5ejVKlSyvCiUUnvhXgtggcdZqTzLSxV7PE4MZePQQ8CJw2Ne+ZBNG7c2NfLZbUo099LwUVM5798+VKFWjFsTL9G0UMvB8maNavqu6GPZwobCo8FCxYgQ4YMfv7dgmBZZ6IgCIIgBBN16tTBpk2bULthU9SoWhk5smXFrTt3sHTFKkSOHEXFzLPk54sXL1S5UI4Qb9m8Ga9ev0KCBAlRv3591eBMqu8ELjSCKe4YCsURdp1zERLE3tChQ1UvCoZwaei5YAla43AqGvf9+vVTpWhN4e9ltSivPBemxIkTB+fOnTM8f/78ufJc/PXXX1ixYoUqs8ywqHHjxqmEc8F7xJfjMyIuBEEQBAFQBh+TulmpZ+mSJVjsvEKN9rLRGHsDlC9XDl+/fUUEe3t8dXWFm5s7EsSPh2+urrh16zZ27tiBOHHjKuMxefLksk0DEe4X7q/grBblHyhIKWIpHLzzXDRo0MDLXhP0UDAR21zOhXdQjPH4pjChUOYyKC5YpIBhVpUrV0a1atVUgjoFiSD4FxEXgiAIgvAfDGPp2rUrunTpAldXV5V4e+LECSUwUiWMh5uPviiD1sbGFgnix8br1y4oU6oEEsaPh30Hj+DKtWsqPp6VfpiAKwQeFBRBLSroKWEpWZ1IzmRpPtehRiz1qp/rECO+j524KQZ8EgBcPhPW6YXw6rdRXGzZssWD54LVs54+faoEg2lY1L179zB27FicOnUK5cqVw7p161T+BY9vTaNGjdRxO3XqVFXKlmJ67ty5cHR09Pe2stoO3YHQ58IG1oWIC0EQBEEwgaFNOnRl+vRpiBvdETcfPUXPepWxaPsBRIgUBR8/fcKuzeuRIllS9b4+3btixpx5GDZqjBqdZtKuYF0wpIgj/DT8eYzQy8VJc/HiRWW8GwsBGvEnT55UDRgpXk2Nf4oJbegPGzZMeb5YESpfvnxm10H3vjBmwoQJ2Lhxo8oboiA2JmnSpCpcjyFZxmFP+ju1iE6cOLHqDE6vyv3790VYeIGERfmMiAtBEARB8IZDhw4jcvhwKJ8/BxqVLYrRS9cjzPuP6NO9i0FYaFo1a6L6YTx4+AhLlixReRiC9UADnALCv+g+KcbMnj3b8H+vXr3Qo0cPL7t8E3NlY1lqdsCAAWbfTxFEz5sp/I4bN26YnZ85c2Zvf4cgeIcIMEEQBEHwBkZBvH7/ERXy50D4cOEQJoydGj3OlT2bmffaIG+unAhvb4+JEyfKdhX8RKRIkbwVFl7B8rVCEGDzuxRtQE+wsrgoEReCIAiC4A158/4OT/n2/QfChQ2Dv3L8HtW9c+++2fffuXcPceLExutXr2S7CoIQ6hBxIQiCIAg+hLLY2dpiyY4DKoa+b8NqSmRMmTkbnz599vDeg4eP4uTps0gnydyCYLWGc0BP1oY1/iZBEARBCDDYSbltu3Y4de02Ooybg19ubpjctTnu3b+PUpWqYt6iJdi5Zy/6Dx2Oxq3aolCBfLh09aqU8xQEIVQiCd2CIAiCxcJKOsxvMFchJyjp3bu3ap63ZvVqbDx8yjD/waPHGDj8b1ViNGaMGKhXuwYeP32OJ0+fYdKkScG6zoIgBEIp2kBIkLCBdSHiQhAEQbBIWLufjb8YisQpuDtfs1cAxQ5LjSaIFQPpkybA1fuP8fTVG0MPg/mLl6n/2RitatWqwbq+giAIwYGIC0EQBMHioBFPYUHYsIwNylgRJzg9GBQNkydPVo3Kljs748mTJ0ifJRvaFi2K48eP4+XLl6pZWp8+fRAzZsxgW08h5PHu3TtEixbNz5+7deuWoUeFT835dG8OU3jssvcGw//I+PHjUbZsWaRJk8bP6xMaUNWdBG8RcSEIgiBYHBQR9FZQWNAg0qU22fE4OOG6lCxZUk3GNG7c2NN7v3z5oow6/oaIESMG4VoKgQ07aHfv3l31pTA1wjdt2qRC4til3RxsVMcQu3HjxhnmtWrVCrly5UK3bt38tB5cBkWDTyF47Dp/8OBBdU6xOSTFe9asWbFgwQLVGHDMmDGq6zcF/cyZM1GmTBlvl7d06VJMmzYNR44cQWhDkpV9RsSFIAiCYHFwJJWeAooM/q9FRUip508vxtu3b1WoFAWJo6MjYseOHdyrJQQQmzdvxqNHjwweAxrtPF4JPQnGXbL5Go9figBC456CU0Pj/vLly8rA9woa/gzL42f195CvX78qr1758uUN83jOsOt2njx58Pfff6t5U6ZMwapVq3Do0CElRNauXYtt27ap1+iJYzM9rvPu3btVN++0adN6+/u5Hvw9nz9/Vr+N38dH/laeo5EjR/bzNhWsBxEXgiAIgsVBwyVq1KhqJJWj/4TGC4XGs2fPcO/ePWWw0wgK7lwMcx4LCguihRGfs0GaeDAChtu3b6vjIH78+EiRIgWCEh6Pc+fOxdChQ9W+PnPmjDLWaZhTNGjjnmFGFJf8n56uf/75RxneWhxwPo+P1atXq8Z5y5Yt8/Rd7JRNL0K5cuXUpNHfVaBAAbW8w4cPq07fw4YN8zFESsPPURwwtIrihOfU+vXrUaVKFVy4cAFZsmTx8rM85yiKChcurJ5rEc1tw/XUosYqE7oD4XJjA+tCxIUgCIJgkXD0kyOkNNYYxkEjqG3bNti9e48yZkiSJElUmEnBggVhKdDA4vpp7wvhb+B8ERd/xtWrV9G3b1+cOvX/il05c+ZUxmy6dOkQFNALwFAoGtYTJkxQCf4bN240hDnR8GduzoYNGzx8bsCAAWoejwUeF/R+sIs7Q4wqV66sxLIx27dvV+/VIUo8fthzZfjw4epcOHDgAAYPHqwECPMm+BpzfXbu3KlyOGrWrKk+t3XrVowcOVKdQxQ0xYoVU6KCXo9+/frh4cOHSqjcvXtXrcOOHTuwf/9+LFy40NvtQGG3d+9eJZ7pPeG5GlI8i0LgIuJCEARBsGgPBqcPHz4oQ+jr1y+IFzcOnj57rl5/8OAB6tevr4ysJk2awBLQeSI6lIuPfG4cCiP4HY6s16heXe3/WZMnIFOG9Lh05SrGT5mG6tWqYcvWrUiaNGmgblrmLcyaNQv58+dX5Ylp4M+YMUN52XyCXgVO9DZwoieDoU70vrVo0UIZ9sZeuDt37ngQozwP9uzZozwmmTJlwuvXr5VIoNeDr1EQpEyZUm0nFhvQ4oJekxIlSmD58uVKnFGI0dNC8fLvv/8awrWY91GqVCmzVc4YNsXwKVNM800ooHg+WjOBUYrW2hBxIQiCIFg8jBdnGEaECOGRMH58/DtiKDJnzIhrN25g1LiJGDRwINKnT4/cuXMH96oqg5CGIkOhOPKscy7Ea/FnTJs6FeHD22PNskWIGiWKmpc4UUIUyJcHxcpWVAnGo0ePRmASL148ZbTTiKex3qxZMxU+REOfuQrMW9A5CAyLYg5CjBgxDMndTIB+9eqV+p8igF4HhiRRaPAz9GRo6P3Shj/RwoPzzp8/DycnJ5VQTtFKrwY9IAzTMg0TpAeN3gt6N7hMigrmeOj8CF1JSsP1p5eDngiNfp3iJmHChB6Wrz0XderU8bAcIfQi4kIQBEGweGgcJYgXD67fv2PlovmIHDmSmp8/T26sWDQPxcpURMMGDXDk6FGLKAPL5G3mWEi1qICDSc2N69c1CAsNn9esWgULlzoHurhIlSqV8hzQyOY+prggFBDMvdBeKw2NeRrqmunTp6uSsxcvXlQeAoYwUXTS6zBv3jwV7hQhQgRlwOvQOg3FR5w4cVChQgXDPIZIGSePa0qXLu3h+enTp3HixAnky5cPJ0+eVPMKFSqkPBx169ZV38MKWBQtFDj0jDD8S+Nb0WC8vtaKlKL1Ges/CgRBEIQQD0dkX79xQdMG9QzCQhMhfHg0qFMLI8eMU8YW4+AtARqNNMp0zgj/l/K0/ufzly+IFTOG2ddix4qJL1+/Iii4cuUK+vfvr8J/GNbEsrIML2JoE8OOTKlXrx66dOmiQpFYYap69epwcXFRQoGCibkPxYsXR8aMGdUy4saNq8KnKEyNjXWKCIZlaRgSRaHBdWEehXcwb4PeE+ZeaKGgQ/VYQcqnsCjf9pcJ7lLRgmUg4kIQBEGweNKnT4d79+4iahTzse1RokRWI70bNqxXhpkllMI07jCuO3hTXEh5Wv+RKWNG7N53AE0a1PP02q69+5VxHth8+vQJtWvXVvuQhj5zDtifQhvWTDY3Ns6Zl0Ejnh4CejzoFaDXgjCMi6FRzBXiMcv8DXrdmFDNHCKKB3oxNCwtq3OQCEOxGLpEQc3JGIqXQYMGqXVhVS32z2CYHkOw+Bkeh/yulStXqtAo01AqHrNEFyTQFdsogrxDv8+akT4XPiPiQhAEQbB46tdvgE2bNmPz9h1o06KpJ2Nox+49SJk8GW7fvadGkoNbXJjrME5jkYaclKf1H02bNUOHDh0we/4iNG1YT21LGvTzFi3FgcNHPITxBBYMdWPpWCaOm4YjGfefMIbrmSBBAtX5mhWmtLigcLh+/boSLFOnTlUldWPFiqWOG3pHKACMj2MeR3PmzEHq1KmVEBkyZAicnZ2VB4R5HKyaRlHCdaQXQsNwKHok+Eixw9AoVrTispjrwX4XFCwUHzosiiKBIVzM6yB8jRW6mDyuxTHh9ud7dXM+/hZrRkrR+g4RF4IgCILFQyOHBhINoX/GTUCX9m0R3t5eGTaz5i/E3gOHULNqZdy9/0DFv1tah3FONMpogEp5Wv/B/guXLl3C4JH/YM7CRUifNg2uXr+Bx0+eomXLlqqca1BAbwWPO+ZHcGIlJX6/TxQtWtTTPHoS6A0wrjbFxHDmdtD7YE4kM0+jU6dOqFSpEtasWaNyJThRMNBbRlFgDLcLJ9NqTzwmGVLFybuwKAqX5s2bq3yWbNmyoWHDhiqZPXr06KpLOctBM5yLIV/cR3zNtIqUELoQcSEIgiCECNq0aaNGc6fMmI3FziuQPk0a3LpzF69dXNCicUPs2L0XJUuU8NQvwBI6jOvRXgoO3bFZytP6DW4vhvrQSKYB+/TpUxQpWkyFKWXNmhVBAT0GNMZ1SBINa078n/uV3gTmNWjosaLhberV0kneFJ/GJYrpdaMXgf0w2H/CuFO2DlWih6Ns2bJInjy5mugVofeCYVfM66AYYOlmU08KP9+jRw/lcWGeB9fb9HX9HcYsWrQIiRIlUkniXCY9MStWrFDnI8VR165d1T7h8iiMuH34uleenJCOlKL1GREXgiAIQoiBPQUaN2qEU6dP49nzF3DKnAlJkyTClh278M3VFf3+G4W1tA7jFBgMKaE4kvK0fwaFRFCJCVNYXpblX1l+lhWdjMPzWM1J5zloGIZEgWEMjwfjClLGMPyoUaNGylAfOHCgKn2r0cuhuGAiuTmY/8HQKza4Y8UnY/idTDzXYVEMxTJdL/4GYyhC2CCQHgotFugxYYd0Qq8LvRQM9eI6831MMmeH7+DaR0LwY+Ou25xaMXSjEtMTLaDgzeLatWuqO6jUMQ/5yP60HmRfWue+5MgpQz8WL16sel9wJJYjp6zIYzoaG9zQoNPei9BaLYpGMROXkyVLZuidYI1dnV++fAkHBwc1/QncNn+yTfTxFlAwj4LHqhYXpuvHY5zHtN6XfD/zPnx7LASlvfYncN0+3n+Aa/UCvllnuqXzETlpEov83f5BPBeCIAhCiIJionPnzirunIYMjRRdQcfUmA9ujKv7EBppoUVUhDbY9yIg+FOxFdC9JkyFgun6mYY/eSUshNCDiAtBEAQhRMKQFOOEV9PSrwxLCu6qUYIgWBce69QJ5rDObBtBEAQhVGFa+pXwuVex7ULQEwqisAUfkGMgdCDiQhAEQQjx6NKvDAmhR4OPfO7bzsJC4KHDwphvIoRu9DFgCSGLf9LnIqAnG1gXEhYlCIIghHhMS7/ykc8DOv5c8DuM0Y8WLZpKeCbMOaHw05WJrCWhO7TCBG+f9qXuTs9jgMdCSN7nUorWZ+SqKwiCIIR4TEu/6pyLkDpCam3EjRtXPWqBob1KWhQKIRe/7EsKC30sCNaLiAtBEATBKmDyNitHWVK1KOE3DFVjzwZWVGIeDPsn3L17F4kTJ0aECBFkM4VgfLsveT6GZI+FhmFMgveIuBAEQRCsBtPSr4JlQeOSk+4EzbLC5vodCCEH2ZeCKSIuBEEQBKvH0vpfCIIQMpEgPp8RcSEIgiBYNdL/QhAEIegQASYIgiBYLdL/QhCEgMQmECZrQ8SFIAiCYLVI/wtBEISgRcKiBEEQBKtF+l8IghBQ2KimdwHva7CxMveFeC4EQRAEq+9/Qdj/gkj/C0EQ/IuERfmMeC4EQRAEq0b6XwiCIAQdIi4EQRAEq0f6XwiCEBBYWQRToCBhUYIgCIIgCIIgBAjiuRAEQRAEQRAEXyCeC58Rz4UgCIIgCIIgCAGCeC4EQRB8wM3NDa6urggfPjxsrK1moCAIguBLbALpHmBjVXtAPBeCIAhe4OLigoEDByJDunRImTIlnDJnxt9//41Pnz7JNhMEQRAEM4jnQhAEwQxv3rxB5YoV8eblc9RPnwhpYkbB+edvMW/WTBw6eBCr16xBxIgRZdsJgiCEIqzLxxA4iLgQBEEww4QJE+Dy4hk21SqEpNEc1LwqaROhevrEqLryEObPn4927drJthMEQQhFwiIwQn5sYF1IWJQgCIIJ7u7uWL1qJeqkT2wQFppMsaOhXKr4WLncWbabIAiCIJgg4kIQBMEEJm+///ARcSLZ46PrD0/bJ02MKHj58pVsN0EQhFAG87kDerI2RFwIgiAY8fXrV4wdOxZhbG0x5MBlZJqxBc02HseN1x8M72HuRaJEiWS7CYIgCIIJknMhCILwHz9+/ECjhg1w5tQpNHVKjnyJYuLxhy+Yf/4uqqw8iNU1CuL1F1fsvPscQ4dJvoUgCEJow8bqMiRCqbi4desWatSogYULFyJLlizBvTqCIFgpGzduxJGjx7CyegHkSRjTML9qukSo6HwADdYdhcvX7yhSpAjq1asXrOsqCIIgCJZImJAwktirVy/UqlVLhIUgCIHKmtWrkS9xbA/CgkQKFxatc6RC913n0KdPH7Rq1Qq2trbYs2cPNm3ahM+fPyN9+vSoU6cO4saNK3tJEATBShG/hRXkXEyfPh0fPnxA586dg3tVBEGwct64vEayqOZ7VyRzjKQeS5YsqQY96taujYYNG+L8lo14d3APpowfh3x58mDnzp1BvNaCIAiCYDlYtOfi8uXLmDlzprqBb9u2DdmyZUPSpEn9XVryy5cvCKwEUONHIWQj+9N6eP36NR4/fowoUaIgQYIEPr4/cdJkOHnisLpe2JiU8Djx2AX24cIhatSoqmv32ZMnMDuxI/I7hFPv/fjLDX2evkfzpk2x1NkZ2bNnD8RfFvqQ89K6kP1pPQTkvjR37bU0LHvtLAOLFRc8wAYNGgQHBwd1oN24cQOjRo1CmzZt0LhxYz8vjyON165dQ2By//79QF2+ELTI/gy5fPz4EQsXLMCBA/vh+v2HuoZky5oVjZs0QZIkSbz8XL58+bBlyxbMOnsbLbOlNNzkbrh8wMxzd1CwUCFcv34da1atQlvHCCgQyd7w2ch2thidICoK3HiFpk0aY9bsOUrUCAGLnJfWhexP6yGg9mW4cOFgydiKugi54uLMmTPKczFjxgwULVpUzcuRIwc6deqEihUrInr06H5aXtiwYZEyZcpAWVeqdZ5U9KpEiBAhUL5DCDpkf1ouT58+xfnz5xEmTBjkyZPHrPHO/IfaNWvg+aOH6JQjJXLGj4G77z5h1rnb6NunN1asXIVUqVKZXX66dOnw6NEjjJgxA+tvPkWBhDHw6MNX7LzzDClTpkDr1q1VYYnvP3/i+rcfOPflO5wihDWIkIi2tigQKRz2fvqGU6dOoX379oG+TUILcl5aF7I/rYeA3Je3b98OsPUSgg+LFRfPnj1TBkShQoUM8zJnzoxfv37hwYMHfhYXvPlHjGg+ljqg4EkV2N8hBB2yPy0DnvPbt2/H+HHjcP36DbjDXc2PYG+Plq1bo3v37iq5WrNkyRLcuXMHW+sWUc3uSO6EMVE+VQKUW34QkydPxpw5c7z8vgEDBqBgwYJYuGA+dty4gajRoqP/wBbK+1m9enU4hAuLWBHtceDrD2y//waFIoXDtITRYPffOrz55YbYdrbYuW0bevbsGejbJ7Qh56V1IfvTegiIfRkSQqICoxStDawLixUX8ePHh5ubG759+6ZCowhjp0mcOHGCee0EQQgKGMrYtHFjPHr0GHSUN/oF5HQDXAHs++WKSRMnqhBKVpTTrF+7BiWTxzMIC01k+7BokiUphu7YgU+fPiFSpN8J2uZgqVlOmuPHj6NatWpIHSMybrp8RPxIkZE/USycf/EWB999RsMHb7EkaXRc+/YTZ778UILjwefPgbRVBEEQBMFysVhxwX4WyZIlU4mTrBTFilEjRoxQMdEUHoIgWDdv375F7Ro1YPfuPdxtgPY/gCy/nRaIDKDGr9+jPbNmzFClYaNFi6Zee/f2LfLFNT96liiKA365ufkoLkyZO2cOYkeKgFsuHzG2RFZUT59YjbBR2Cy+eA/9911E0wdvcNP1F9Lah8Hjn0AmJ6eA2RCCIAiCxWBtXoZQVYqWIVFz585VIREMRahfv76qHz9mzJjgXjVBEIKAFStW4N27d0j70w0x3YHM/wkLY4r/Ar59/46DBw8a5qVMnQZHn7wxu8yjj17BMWpUxIgRw0/rcuH8Obi7uaFUiniokSGJwXXPx4ZZkqNAolg49fUnkoazQ7aIYXH323c0bdbMrz9ZEARBEEI8Fuu5IPHixcOECROCezUEQQgGDuzfjwy/3GHHWF5386NF2j/h6spAqd80bNQIjRo1wtxzd9DUKblBCJx48hpLLj9A81atVYEHvxA+fHg8eeaKwknNh2QWSxYHxx6/xhXXXzj79YfqhTF//nw4OzujTJkyKF68uBowEQRBEEI2Fp4WYhFYrOdCEATrhKFEt27dUhXh3rwx72HQ8Bqe0h14ZAs8M/P6qf+uYOyBo6Ehz6pOQw5cQqllB9B/7wXUXXcUNVYdRtbs2f3VkLNs+Qqws7HBi0/m67g///QNDuHCwNXNDQ4RI2L/vr14ff8Wrpw+gaZNm6JqlSp4//69n79XEARBELxj8eLFSJMmjYdpwYIFCE5EXAiC8Eew9CurL5UtWwb58uZF40aNsHfvXrOigqWlM2TIoJKlWVI6q5MTOnbsqMKfTClUuDAu29kgjRvg6A5MDQO80MtisrcN4BzODn8VK4YUKVIYPkdPRf/+/bF8+XIkzZYbh97/glu85MoLusx5ufJabNy4EQ0bNECZkiXRulUrHDp0SK2fV1AghLUPhyWX7uPdt+8eXnv9xRWrrz1Ejni/K9ilTxIfJ2aPwsph3bBj/ACsHtEDt2/dQC+pHCUIghDisQmE6U84d+6cKnvO8ud6qlu3LoIT8dMLguBvKApq1qihmlyWzOWEvMnS4cil62jQoAHatm2Lfv36qfex8lu9evVUbkTSqA7IkyIezj9/ixefv2HLhg24ef061m/cqMKPNLVq1cK0KVMw+f1H1P3+C8vCAD3DAondgS82wCsbIFvmTPhn9GiVm2VnxwCq/wsMlpNll2xWnGL/CpZI/P79u2pwt2fvPmSPFB5pwtjg/L3bqL15M5o3b47BgwebLYUYO3ZsLFy4CPXq1EGl5QfQMXcaZIgVFZdevMPkUzeVVyOcnQ3C2Npgeo9WiBnt/5WqcmdIjV71KqP/LGc8efLEV53CBUEQBMvE1sJSus+dO6fur5bUtFXEhSAI/oYV3B4/eoCtY/sjXdKEah49AHM27cbQadNUnxoa+fPmzcOhgwcxrmQ2VEuXSBnwP93cMPnkTYw/fh2XrlzBhg0blKDQsJeN84oVaNa4MaY+e4YotnawdXfDA3d3pE2bFkUyZcKRgwdVc80wdraIFNEBHz5/RpRIkVC1enUlbqJGjephfadNm4aD+w9gVmJHFPyvuzbXd9nbLxg+Z45qzMccCXMUKFAAk6dORbu2bdFlx1k1j7eYQkliwymOIyaevIHEcWMhTvTfVauMofDqO2Opagwq4kIQBEEICJ4/f66ayw4dOhR3795VA2HMOWzYsCGCExEXgiD4Oxxq7dq16FCttBIWbz58xLmb91RDu9p/FcCKPUdVLCiN8tkzZ6BimoSqhKvh4mNri86502DPved4/OELNqxf50FckIwZM+LI8eMqzOrKlSuqfGypUqXQr28frFu9GgnC2MDWHfj10w0p3n9EBjfA5e0HrJw/HxvWrsWqtWsNy6L3ZNH8+aga1d4gLAiFTr3oDtj66QcWzp/vpbggDOViN9oe3bsrL0WamFFx1eUTDjx4iVSpUgKuX5RYMfV+vP34u+fFn3avFQRBEIIXm0BsHt3Zm5zAPXv2eJp3/fp1JE6cGF27dlUe+qNHj6qw4CRJkqBw4cIILkRcCILg7wshm1w6pUqGPjOWYOXuI/j+86d6LVKE8EieIA7u3rmjeko8fvoMvcvk8LQMGuHFksbBrLO38fHDR/MXqTBhVPUlTmTdunXYu28/4oaxxcsfbnCzAdr+BPK4/f8zpX65Y9Dbd6hdsyamTp+u5rFXzovXr5EnoWfPAskb3g6rrl/38XdTANEjw1K59+7dQ94YMVS5bI4eccTo6KXryJ85nYfPLNiyF47RoiFXrlw+Ll8QBEEQfINpw9fKlSsrgcFIABEXgiCEOBwdHdXj6CVrcf3hU3StUxGVCubC9x8/4LzrMGau36FCgOzt7WFna4uXn7+ZXQ4Ton+5uSN9xoy++t6Vzs6IH9YOb378Qgo34As8CgtC+VDhF7Do9WtMmzoVs2bPVl6DsGHs8PT7L7PLffLTDVEdo/i6TLbpCBMrdOTOlQstR81Aj7qVUCq3E959+qKExbJdhzBo0CCcPHlSeXzSp0+vRpYEQRCEkINKwA4E14XNf/cVc94Jv8LQKN5rghPxXAiC4C/YiI4J0ywpO7FzM1QtksfwWr/G1eEQwR4TV21RHoOSpUph8fFDqJcpKSKE/f9lhwnd664/husvNzXq7xtePH+Ojz/dkPcXcM8GSOZFkack/81nroeLiwsSJUqEsmXLwXnndlR3jIAodv8vlvfw+09s//gdHVvW8PfRwITyhYsWoU+fPhg8byUGzHZW86M7OqrRpClTpqj10Pz1118YO3YsYsaM6e/vFARBEEIvkydPVgN4LVu2NMzjPZlCJTiRUrSCIPgbxnhGcYiIigVzenqtUZmi+PnzlxqJ6dKlC158/Ynqqw5j551nuP/uE9Zce4gqKw7g289fKkaUo/m+IXHSpPji7o447gCLv1JgmOO+ze8LHBPHL168qOZ17dYNH8Pao/bDd1j99gvOffmO+S6fUe/he8RPmNDXAscrIkeOrEQER41YZ5zlcPv07Yv169ejaKEC2LVpHS4cP4Rxfw/HxQsXULt2bRVaJgiCIIQMLKkUbebMmTFr1izs2LFD5SUOHz4c58+fR/369RGciOdCEEIxTE5eunQpVq9coUbVkyVPjvoNGqJChQpmS7KawgTraJEjIYxRGVgNRQfDoR49eqSWzQpORw4fQvNNJwzvSRg/PhZOG42iRYvizp07+Pvvv3HuzBn1uQKFC6vysKaio279+tizew+u2wJFfgETwgLHbT2GRrFrxrYwQB6HcDj6+buhO3bKlCmxbsMGDB0yBAMPHlTJ1+HChEG5ChVU2FK0aObzMfxK3Lhx1cQSuaxAVbFcGUwYNdKwTWtVr4qMGdKjZMWq2Lx5s8rZEITg4sePH/j586c6T/zavV4QhOCjcOHCavCOlRtZGp73y0WLFiFnTs8DfkGJiAtBCKV8/PgRtWpUx5UrV1EqRTwUSRwVJx/eRps2bXDgwAGMGTPGR4Hh5OSkGuNdf/AEaZN47N+w+/RF/HJzw/jx4+FgHxb2dnZ48+UbUiZPjs5du6qQKla5oIE/bNgwVVHql1GI04aVK7Fq5UpMnzED5cuXN8wvUaIEsufKiVMnT6EAgNRuwDQ74IQtVLUo9r84bAdEsLNVSd8OEcKr7zLOjVi6bBlevnypRA/dxwElKky5dOmSSvRuMnaUp22ZIV1a5M6RHdu3bRNxIQSLmOC5xwEG5gERVnpj+WZ64ARBMI+NhfW5qFevnposCREXghBK+ffff3H31k1srF0IGWP/37heffUhui5fjmLFiqFcuXLeLoNlYRMmSIDOE+dhdq82SBTnd/7AlbsP0X/WUtV/4p9iWVA5bSKEtbXBiScu6LzjDAYPHIhjJ357MDjKQoFSxzEiGsWIiJh2ttj/yRWjX3zENzd3tGnVCgm3bFFChtBIX716NQrkz48pjx8jlRsQwQa4aAOcswWi2tqgVJTwCG8DLHn7VbmH2UDPXNIbp8DE1dVVPUaNaj5RPFq0qBIWJQT5oML79+/VsUmRQYFBUaEbWPI1/i8eDEEQ/IvkXAhCKIAGhDHsVL1qxQo0yJjEg7Ag7EWRI0FMLFm0yMflhgsXDgsWLsTrT19RoE0/VO0zGmW7j0DprsPw+t0HtM+RCjUzJEE4O1slCvIkjIk5FXLj9Zs3qFGjhjKs//3nH1SNFgED40VBknBh4GBni3JRI2BmYkd8cHMH17xu7dqG0VXC8I0dO3cidsyYeGALhHEHwrGXBXtKuLlj9buvWPnxOzJlyoRN69cjQ/r0KFemtBIlptsiMGGzPxpq23d5rgDy8eMnHD52HFmzZQuy9RFCNxQTFA/s+cKJMHSP5yavCXzkfHo1BEEwj61NwE/WhogLQbBSaCQsW7YMJUuUUOFH6dOlQ69evfD48WO8efMGHz59Qs4EMcx+Nlc8Rzy4f8/XSd2HDh/ByJEjkSBNBqTKnA1NmzbFT1aAypLc0/spZlJFj6ySzubPn4+3Hz6gtqNnz0La8GGRNUJYONja4P3Hj1izZo2H1xm+sX3nThQpUQKfbG2gpUesGDFQt25dRI4UGU9vXEd1e3d0jx4eUe7fRqdOndCvX78gExhcx5o1a2LyjNnYuWef4XvfvHmLdl17wM3NXa2rIAQFFA28LtBTwWORFc4oKPg/J77O13SOkiAIlp3QbanIFUQQrBAaCj169FDVikrmdkK9lnXw9PVbrNiyCdu2boXz8uUIGyYM7rz5iOLJ4nr6/O23nxA9hu9DhhwcHNCgQQM1ETbwmTdvnvI6eIVjhHDY+19N70heDN1QWDA0KmE4O+zfvx8NGzb08HqcOHEwf8ECPHnyBHfv3lW5E+zqXa9uHURy/YJlSR0RPczvMRSu2Yq3YTF44UKVw5EvXz4EBQMHDsSjhw/RpHU7JEuaBHFixcK5CxdhFyYM5syZE+wlA4XQA0UDxQMFhvZSUGBoccF5FMQSEiUIwp8gngtBsEIOHTqkhMWYDo0xt0871dyuTokC2PxvH0SNEE5VlihbtizmX3wAly+/8wI055+/xZ57L1C9Zk1/fz8Nd1aQYv6GKReev8WtNx+RMlokNVIaPlw47PjguRzr259uOPnlOxigETuMnSGMwxxs1lewYEEVBsXO4QcOHkJrxwgGYaGpGS0CkkWwV9smqGDzvsVLlqjvzJe/AOIlTIQePXvixIkTHjqrCkJgQ9FA8UCBwUnPY04S+61Q6EoytyB4j3gufEY8F4JghdCQTZ0kAXKkSYEW/0zDrpMXVOWmiOHt4ZQqqaoGRe/CkcOHUW75QTTKnBQpHCPh5BMXLLn8AE5OWVCrVi1/f3+sWLFQpUoVjF67Bg5hw6BGhsQq7+LQg5fotec80sSIjCefXVE0dWqkS58eMxYvRnL7MPgrsj1sbWzw4scv9HjyDj/dgSpRw2PTB1cMKMDaUD5DcUHSh/d8eePIbIawNnjy6BGCEn4vxQ8nQQhOKB6YB6SrRfHYNFeC9suXLyoPg3lV5goiCIIgeIWIC0GwQp4/e4aksWOiSt9RiBLVEUP690GKZMlw6uxZzFmwSIVC0HDYtGWLqho1dtMmfP/xA9GiRkGjZs1V3WyOuN+8eRPbtm1TiddZs2ZVFaR8G489+t9/cfToUfTbdwFDD15CWDtbfPr+E1niREPuBDEw6+wdVT6PpWFp7Hfauxexw9giup0tbrr+VG7V8lHD4/p3Nzg6OqoEcN/A/hLk6refSB3eo8FEY+raD3dkTuCxbK4ghCYoJEzFhHGvi7dv36pJiw+ef4FdWU0QQgqWVorWEhFxIQhWSLz48bFn5w5Ec3TElrUr4PhfH4dCBfKhTMkSKF25Oo4dO4Zu3bph8uTJGD16tKrGxJwFGhcUHh3at8fadesQ0dYO4W1tMOnnTyRJlAgLFy9GqlSpfFwHjniu37ABlSpUUD0lUkeLpBK5b7z5qIRF5cqVVR7F2bNnMerff3Hv3j2VbH39xg2EZex3WDtsfP8NieLHx7KFC1U4h29QIVL582PW2VMoHMkejkahUWvefcWdr64YWbv2H2xdQbDO8rS6ihR7X+jEblaTotBgw0zxYAiC4BtEXAiCFVK1alUV9tSlU32DsNCkT5sGpUsUx65du5S4IPRScNKwqd3G9evR9CdQwO2XulDcswFmP3mKOjVr4eCRw74yNOLHj48du3apXhZc3ol3H5EwaWrEcruL9evXI3rUyPj05SsGDx6E9u07YM+ePUpkbN26VYVlMDm7ZMmSfq5eM3zkSFSpWBEV779FtSjhECeMHQ5/+Y69H76hWtWquHDhgipLS8HCbZUlSxY/LV8QrK08rR4Q4HlHQaGTvwk9GhxwEHEhhHbYC9WH3rL+IjCWGZyIuBAEK4SJzQxpSJYksdnXkydLiguXr5p9jaOUSxcvRqUf7ihilEOdzB3o9O0Xer58oYSBb0uoRo8eHZ07d1bTq1evUKRIYSSNHQOL+rZBxuSJ8f7TF8zZtAsTJkxAjBgxVBnb9u3b409ImTIltmzfrpa5ZOMGfPn2BenTpEHDyrmw3NkZmzesR/oI4fD0h5uq2FSjenWMHTdOhYsJQmgsT0thwRAoPtJzoftf6EfOFwRB8A0iLgTBCqFBzzjpYydPoWTxYp5eP3bilPIqjBo1SpVxZZUY5jTQKGeYkuuPH8hnpjhTHBruNrY4cuSIv/ozLFmyBK7fvmFh//aIHiWymhc1UkR0q1MJT169wbSpU1W52YCos8/eHsOHD1d5HWxm9/TpU5T4qzhKOITDgLiOiGZni1/u7tjw/isGrlmDZMmTqz4YghCa0B4KnW9BKCQoKjhP51yI10IQfiNlVn1GtpEgWCE0Emj8L3ZeiVNnz3l4bemKVTh99hxOnjyJRQsX4tGDe1i6dAkKFy6McePGGUIhvCr86mZjY3iPXzl08CCKZ89kEBbG1CiaD8+eP8ft27cR0NBAWrBggRIUf8ePoh6JnY0NqkaLqErUzp8zW4V+CEJoLE9L9PHPoggU53xMlCiRJHMLghFSitZnxHMhCFYKKz6dPn0aVWrXR9FCBZEieTKcOnMW5y9eUq+XL10KYcOFVYnctapWwc+fvzB27FiMHz8eEeztcfCXK2r88rjMxzbAHbdf6BQC+zOcOXEChSOEQTgzwa0lo9jD+cFbPHz4UHlvBCG0lqc1Lksr3gpBEPyDiAtBsFKYoO3s7Iw1a9ZgzerV2HfoCJIlS4a0aX/g2dOn2Lx9B+LEjqUMiv2HDuPHj59ImjgxFi9ejOYtW2Lq5CmI4O6OYm5AeACXbYCF4e2QLEEClCtXzl/rVLBQIUydMhlvP3yCY5RIHl5bte8o4saNE2jGfTh7e3xyM98z/OOv3/NpYAlCUGBc+tUSOmKbK08rCIJ5T7jgPSIuBMGKsbe3V+FRxvkRSZIkUW7d+PHi4fmLFyiYPy9iODpiz4GDePDoEe4/fIi1a9eqqjEL5s/Hand3hLGxwXc3N2ROmxaz583ztxHO/Ic5c2aj0YjJ+LtVPWT4L6F77qbdWLX3KIYMGYLXr18rw4s5Id4lWF+5cgV79+5VBlqePHnU5N1Fv1TZshjzz0U8//ELccP+f7lMfF/+7isypE2rytgKQmDCY/vDhw/KY0gYYsiwJOmMLQiCtSDiQhBCEawCQ2M6YcIE6v+9WzYgVcoU6rVvrq7o0qsvNm3djjNnzmDo0KFo06aNKlmrm+jlyJHjj0Zt2Ihr2TJntGjeHKW7DkOMaFHw8fMXuLm7o0KFCli5YgUGDRqk3hsvbly0aNkSLVq08JDjQdHTvl077Ni5E5EjRkSYMHYYM2YMsmTJjHnz5hua6JlCgbVg7lw0fvwW3WJERB6HcHj84xdmvf6Mo59cMb9XLxmREgK9nwSrsfEY5nmkRTpLwfJ/8RwIguUjfgufEXEhCIHM8/+SlKNEiaJKxAanS5U5BawC8+DhI4wdOcwgLEh4e3uMHjYEO3fvRaNGjVSTPVaRYvWmgIQ9JY4eO6Z6Wly/fl1tF24TNtArkDkdpvdoBYfw9th89Izqt/HgwQOMHDnS8Pnu3brh8KGDmNy1Ocrly44wdnY4fPEauk1eiEYNG2Lb9u1mE85Z8Wb1unXo1L49Op49a5gfO2YMTJ06VvXTEITA7iehu15z0r0jdGUmEReCIFgDIi4EIZBgeE+f3r2xfccOVUeeJE+aFAMHD0aJEiWCZbvrRnk0cAoVyO/p9ciRIyFXjuw4fPSYytdo165doKwH48xLlSqlJldXV+TMkQMVC+bElK4tDOKraPZMyJgsEQbOWajETpo0aZTQ2LhpE/5pUx+VC+U2LK9glvSY0rU5qvUdrbp+FyvmufyuDglbv2kTrl69ilu3bqmO5Pny5ROjTgiyfhIUEBQVPAc5cT7D/wKi/LIgCIGPeC58RkrRCkIgwLCHmtWr4dSh/RhWJBMONi4B52r5kcj9q2oSt2/fvmDZ7iwrmTx5cvX/02fPPb1OY4fzEySIjx07dgTJOh06dAgub96gU83ynrw69UoVRoyoUVQOCDl69KhaxyqF/y8sNDnTpUSiOLFw+PBhH78zffr0qFSpkiq/K6PFQlD2k6DAYC4Uj2P+z2OeORdyHAqCYC2IuBCEQIAVmm7dvoNlVfKiQeZkSBrNAfkTxcKCSnmQO0EM/DNypDIughoaMoMHD1YjpdNmz/G0Drv27sPtu3eRMnky/PgRND0fGINOksSN5em1cGHDIH6s6Ib3aPHh5kXVJ+ZuSCUPwdL7SWgvYsyYMVXooSRzC0II6nHxX1hjgE6wLkRcCEIgsHnTJhROGgdpYkTxMN/O1gZNsyTD5atXVYhPcFC8eHE0a9YM23ftQf1mrbD3wEGcu3ARo8ZNRJtO3VRPjIuXryJHjpxBsj669Oyxyzc8veby/iNuPHhseE+BAgXUhXj1vmOe3svPP3n5WnkjBMESoYiIEycOYsWKpUQFxYWxx4Iez3fv3qnHkJRLwuIQfBSE0ICtTcBP1oYEeQpCIPD50yekjBDO7GsxI/6uEBOcBgQrMr18+VKJIPa4IJEcHFCzamW8ePUaHz99UnkOQYGTkxMyZsiAYfNXI2OyxIgZ7bcg+/7jJ/rPWgZbuzCoXr26mpcwYUJUq1YNwxeuhn3YMKhcOA/C2tlh75lL6DV9MZycsigBIgiWilf9JHg+0kOnE75ZgIDV1Sy9+hWT1BneJSV1BUHQiLgQhEBogpXZyQnb1q7Cj19uCGvn0UG4595zRHZwQNKkSYN120+aNAn24cJhxcqVcIwWDQkTxMfyNWthY2OrRv979+qFiA4OKF++PCpWrBhoDeZoSE2eMgW1atZE/tb9UCaPEyKGD48dJ8+rZnvTpk9H9OjRDe//559/1LbvMXUR+s9ejjB2tvj89Rty586FWbNmm60UJQiWDAcadOgfryesHsXnkSJFstgu2br6FQkXLpy6FkpJXcH6sYFNoLgabGBNyF1YEPw5YvfixQu8evVKPfK5MRz1f/35G/rtvYCvP36qeRyR3HfvBeacv4vadesGu9HAvItx48erxO1atWsjY+YsKFeuvDJszpw+jTgxY+Dr50/o0qULKleubDB+AoPUqVNj565daNu+PW65fMKpe89QqlwF1cuibNmyHt7LWPVp06bhwIED6NO3L7p0647Nmzdj7dp1KsxEEEIaunoUz0mKYz7yOedbevUriiEOEPCRzzlfEITQjXguBCEQRuxYNnXcuHHo1q0rtt19jpzxHPH0kyuuvnyLwoUKoVevXhaz3TNmzKgm5oAUKlQIlSuUw6hhg1XfC3LpylXUadIc/fv1w9Rp0wJtPRiHTiHDyTcwD0PnYghCSIbXERroFPaEj3zO+ZZe/Up7b/nI51JSV7B2grFVVYhBPBeC4Edh8fnzZ8MN1bsRuxo1auDgwUOo37Q53JNlQNoCRbFw4UIsXrJEjUwuWrQIZUuXglOmTOqRz4NzpHLp0qUq7+KfIQMNwoJkypAeXdu3xeYtW5SnRhCEgIVeTOZYEH0d4fPg9m76tvqVvm5JSV1BEIh4LgTBj8mLvPmz8RvDFhii492IHfMq+vbt62EeP9u4YQMcPnIURSPbo6B9GFx7cAf9+vbF9q1bMH/hIlUHP6i5dvUqcufMbmi0Z0zhggXwc9hI1XiOHgZBEAIWJm8zx4KGOj0WliwsjKtf0WPrVe6ZIFgj4rnwGREXgmCSoG3qgeD8T58+qRKR9DjwZqrjobXnwi8jdvPnz8exo8cwL3E05Hb4v4g4/jk8Wh45ql5v3bp1kO+XSJEj4/7dO2Zfe/b8d8M9qccvCIEHBUVIEBW+qX4lCELoRcKiBMEkQfvNmzeGRmyc//jxYzx//lyFQ7GqC8UGR/fpXYgWLZqqW29sdPN99+/fx4cPH8xu2yULF6J0ZHsPwoLkcbBX85cuWhgs+4Qdqy9evoLDx457mM+Qr5lz56vO3hkyZAiWdRMEQRCEYMcmcJrowcryOMRzIVg9FAvr1q3DkydPEDduXFStWtVDVSHTBO1v374pDwUf6bGgh4JhTzSymWhJgUFxQY+Fg4ODYdTu9evX+HvkSKxfvx7fXF3V66VLl0a/fv2QOHFiw/c9ePwIDWL/X4wY4xQhLLY+eozg4K+//kLevHnRtE17tGneDH8VLYxXr19jzoLFOHjkKObOnStlXgVBEIRQjYRF+YyIC8GqWbFiBfr26QM3dzckTJAAT548xd9//62ayDVu3NhDSUVdsYXCQs/XVVuM5/G9DIvSoVB3797FxYsXMXLkSHz98gWd2rVG1iyZcePmbcxesBCVKlXEpk2bVQM4EjN6dNz9/tXs+t5x/YlYMWIgOKAYYlL50KFDMWXmbIyZOFnNT5MmNebNm4eSJUsGy3oJgiAIghBykLAowWo5duwYunXrhioVy+P0wX04tHMrzhzZj7o1qytvwp49ezyVVKRo0OUgOV/XmzcWGcy5YFIzczBq1aqFggULol27dsozwuY66dKkRsF8edG8cQNsWbNCeTsnTphgWK+atetg3YfvuO/qMbfjnutPbPj4HdVr1UJwwXhvNqk7d+4ctmzZgv3792PPnr0GYUEvz9evX9WjIAiCIIQmeD8PjLAoG1gXIi4Eq2XGjBlInzYtRg8fghgxfnd4Zifq4QP7IUe2rOp1r0oqUkxQRLAcJD0a9FZwYp4FQ6pY8al69eq4efMGYhtVT3JxeYPmbTti+ux56nnMGDFQv3ZNrFu/3iBamKwdL1Ei1H74DhNefsSOD98w/sVH1Hn4DvETJ0abNm0Q3ESJEgVOTk5IlSqVh/wT7xoHCoIgCIIgiLgQrJbjx4+jUrkynvIEaCxXLl9WvU7BQJiQzcRseiSiR4+uvBV6PsOZEiRIoCb+z+XVrl1bJXl/+PARyZIkxvoVS3HvynnlqciTKydGjhmHg4ePqmUkTZxYjfZr4ULBsm7jRlRr0BDLvrij8+N3cP7qrp6v3bBBJYlbGqZ5KYTPxYMhCIIghCZU/nUAT8EJBwyvXLmC69evw8XFJUCWKTkXQogsF+ubmup2trb47kX4juv37yrESY/KG5dU1MLCdL42qAsUKIAP798jXry46r1L580y9IZwypwJi2bPQLFyFdGsbQcc2rUNR0+cRPz48ZUnREMBM2zYMJX7waRx1re35M62pnkpXFeKJc6XMpSCIHgFr5Hnz5/H7du31cAKn0+cOBFPnz5V18QOHTqgTp06sgEFIQi5d++eauq7e/dudT9nRAbv8S9fvlT39FKlSqm8VBbB8Q+Wa80IghdN7HgC0HvASk28OXklNIoWLYrV6zegbYtmsLf/PdpOaBCvXrdBvW4sLnxDy5Yt8fbtW7W8169d0KpZE09N5/ha/Vo1MOLfcejYvRdOnT2LLl26mv0urrsleipMMc5L4f/eNQ4UBEEgN2/eRId27XD56lUPGyRK5MjIlDEDbt2+je7du2PunDnYuWuXVKMTQgS2we1q+AMYnj1u3Dhs2LABjRo1wsqVK9Xgp6nw2MjoimrV0KxZMzRt2tTP3yNhUUKIwDQshzkPjPt/9uyZeqTBb5po3KZtW9X8rVnb9rh246aad+v2HbTs0Bm37txF27Zt/bQOHKk/efIkEidKCHc3d+UVcfCi4VXEiA7q8cjxE8idK3ewNMULSMzlpfilcaAgCKELhlrUrF4NP149xeLKebGgUh41n4M9544dxMpF83D60D6VA3ft+nV06tQpuFdZEKya9+/fo0mTJqoPF8VDixYtPAkLkixZMnU+Unjs2rVLDQD4NQRaxIUQImDPCR7cHC2nsOBzjp7r6kV05VFkGCcaZ8yYEfPmzcfV6zfxV/nKSJYhC4qUqYAz5y9i1qxZyJkzp3ofqzwx3tCnBGUum9/37PkLVK1UQbn3N27Z5imMis83b9+B1KlSqufDhg835CmEZIzzUkwbBwqCIBjDstZfPn2Ec5W8KJw0DhZduo+MadOgb4+uCG//u4EoQ1ObNKiHsqVKYNvWrYYcOEGwZEJqzsX379+RP39+TJkyRYVm+wTzTBcsWICkSZP6+dyUmAbB4qHRT88ERQUn3WdCJ2rT4Nd5AFqdM1yKo+pFihTBiZMnsW/fPtVpO168eChWrJiq+nT69GkMHz4cp06dUp/jZ6pWqYLuPXqYXQ+GYdEdyhO0cMH8Kk9i9vyFGDTiH/Ts3BGRIjmoBnsTp8/E0eMnUKtaFdy5e08Z4taCcf6JIAiCV+zasR2lk8dFzIi/hcTFF+/RqFk1s+GhpUsUx9Ydu1Qj0tixY8tGFSwav4ZTWwocGGzVqpWfPkNbqX379n7+LhEXgsUla1M48OTV/SUoLCgkmNtALwXFBV/nPD7yOQ1enaBtmmjMR9MGcBQWNWvWQNo0aTBtwlgkShBfhTBNmTkHx0+cUL0eTKHSjxM3rvJgnL9wCYP79sLTp88wb9ESOK9ajZTJk+Pe/Qf49PkzOrRuiTUbNqFMmTKqrKsgCEJogtdhhwj/NzHCh7XDu3e/Q1tNefv2vaHPjiAIQc/WrVuRPn165aVgD7C1a9ciceLEquCCf85LCYsSghwa9s2bNUPq1KnV1KxpUxw4cEAZ7awg8ujRIzx8+FBNfE5vgO47QW8BRQTDjCgu6I2gi69GjRooXLiwSrg+cuSIj4nGf48ciTSpUmHdssWqXG02pyxKEKxeskAlM9GjYRruRCZNmqTEzKJly3H1+g1MnzgWhQvkx7dvrnj/4QPy5s6JBnVqYbHzCri5u6N///6BuCUFQRAskxy5cmPHvRf4/ut3OEXpZHGwdsNGvHn7zsP7vrm6YtEyZ+Xh5fVdECwahjHZBvyEYHSGTJ48GX379lWewzt37ihB8ebNG6xZs0bZQv5BxIUQpGzatAlVq1bFvbt30LFNSzXdu3cXDRo0wM6dOw3N6rQXQ5dA1TkWhCKDrjqKkPbt2uHgwQOI5BBReTXOnDmDnj17IleuXJg5cyaWL1+uThCeNBr2p6B3omWTRh6qSJFMGdKjUP58uHz5slLypuTNm1clN7GUbdmqNdG1T3/kyZkDqVIkx+MnT7Fzzz4sW7FKeTg2b96s+mIIgiCENlhh5s3X7+iy4yxcvriiebYUsPnxHVXr1Mf2Xbvx8tUrHDp6DLUbNsW9Bw/Rr1+/4F5lQQiVrFq1CgMGDECOHDmU1yJr1qxwdnbG4MGDVUi5f5CwKCHI+Pz5szL8mbw3ddy/ygNB2jRvivZde6pQpGzZshnCmXRcow6Ropudr7EeMwUGKzBxpOvFyxdIEC8eBvXphXDhwmLdpi04efoMhg4davgsv4uN70aOHIkPHz6o5SaIH8/seiZMEF8td8mSJcojYkrnzp1VqNbcuXOxfuNm0L/B5efOmR324exx9MQJJWyY3yEIghAaSZs2LaZOm4aOHTpgx7ydSBMzGn66ueHuvfto1raj4X0RwodX/X5Y9lIQQgIhNefCu7xWhkORCxcuoGDBgup/9rhgnqt/EHEhBDraC0GvBQ/i/j27GYQF4f/9e3XDpm3bcfDgQZVwbXoS01OhRQUFBjtJ8iSIGiUKihcujFlTJhhCoRiWNOTv0ZizYJFBWND7sWzZMly6dEmpdCZnc9QsV47sHtaV7zt89DiSJEqoarR7BRU9BQibQXHd4saJjeMnT6vlzpo1G6lSpQqELSkIghByKFeunPL28prLcIvCjo7Kc3337l2cPXtWXctZElzCoQQh+EiTJg1mz56tzkuGlbNcLTl69ChSpvxd9dKviLgQgqTxHcUFBUGM6I5ImCCBp/cliB8f0R0dVUlZY48FYW4FG80Zlz5lrgVhnkPvbp095Fjwc13at8Gipc5KXKRMkRzXb9xEtSoVVfO8Pn36KI/E9DnzULhgAeTI6qQ+x7yO0RMm4cGjRyhXuiTeeJF8qL+jR48eqFu3LtavX6/iE5MnT45KlSqpG6VfOokLgiBYKyyEYVqhhsYMc+SuXbsmjfOEEAWtksBwXNgg+Ojdu7eKBNm/f78aEGB41Pjx4zFv3jyV0+ofRFwIgQYNbIYPMZyJHgE2XWMy35Nnz1QYkzFPnz3H23fv1Ig/E/sYQkVjn14HVltydHT08H7dkt7OztbQT8IYejQSJUyAu/cfoFK5smo5m7fuQK1qVbFq3QaMGTMGW7ZsQaWadZEvTy4kSpAAR0+cxKPHT9CxTSvMX7IUdevW81Ud6Hbt2pktnavXn+suPSEEQRD+f28wDrfgc+bVEe2dFgQhaHByclIeC9pdurpl2bJl1SCsf/NGJaFbCHB0Yzsa2Kz0xJsI57F5C28cf48Z76EhC//nPJaaZdwtw5/YNZIhRiyHVq1qVWTLmhW1atVSSdb0RmTIkAGJEiXCr19uuHzlqqd1ePPmrRIKyZIkxvmLl1Rex9dv31SFJxr9Q4YMwdKlS1WJtQuXLuPEqTNImzoV2rRohtXrN6h1ady4sb9+O5PH+fspqvjI537tbikIgmCNcPCFlQF5f6Bnl15feqLZzJQT//epoakgBCeMXAjoKbjRA7nG3sU/KUgjngshQPpS0GDXHbN16Vj+rxveERryLHH277//4ubtO6hWqYI6qdas36iMfuYv6NhbhlLVrFlT3WgqlCmNRAnj49CRY6pdfYwYMZArZ05VYWr06NEY+s+/WDRnhqHrK79zxL9jDd8ZNlxYxP8vefvi5Svq8d27d6rMLcXK4EGDsP/AAdx/+BB7DxxSOR9M/qbI8SscfaOYYigXT1ZuB91RXEbjBEEIzfCewGs74fWQ9wYKCd23iHBQhsJDPBiCpWIBWuCP8GuokzTRE4I8l4KGsw57Mu4LwRuFfq4rNhEa7jTaV65ciZH/jlOvFSxQAIOGDEXu3LlV6dgZM2bgyePHyjAf2KcnGtatrZbXrWN7LFy6HH0HD8XpM6exbft25c47dvIUCpYoixpVKqnSspu2bsf1m7fQtX1bjJ08Fa2aNsbBw0cMTfj046tXr1CiRAksXbZMlaflc1Z4oiBhLLAgCIK1wMEf5rTRaGceRHCtA+8V7FOkS4vrpqm6yAev+3qwSgZkBCHgOXHihKd5586dU3YWc0f5yH5ftO9YwVPEhRDo6NhYjiwZ3whM0WKCj7yRUIBoMmfOjCxZsqgcDOYs8MbC5VavXh0nT55EruzZULB6VZy7eBH9hgzH2QsXMWHUSHXAN6xbCwuXLsOtO3fRs0tH/DthMnLmzKk+N2v+QoSxs0PO7NlQqngxLFmxEunSpEbcuHHQe+AQFCtUEFt27FR9KfYdPKS6TxrncOg8Dnpe/IvuwcHfy+3C38/nnC8IghDU0EifOnUqFi5YgBcvX6p5rOCk+wEFJQyD4nVce7yJDgnR9xFd4c+nRqiCEDzYwDZQXBc2CCoWL17s4TmjSXgeTpgwwTDwwOiObt26ebCT/IKcvYIBcxWOaGjTUKZA4MWf3gqdjEej2VwXa41xtScuk5Mesfr06ZMqTcumd8xJuH//PlxcXLBw1nT8VbSwYRkbNm9Fu649kC9XTtSuUU0tk+VjmU9B70SZkiVw59595fU4feoUvrq5Ye+Bg2qKFzcOIjo4oHq9RsiZLStcv7uqsKsP/9V0zpcvX4Dvfd2HwzShW0bgBEuC5zS9hCuWL8eTp08RL15c1KpVG3Xq1FHntWAd8PrcqWNHbNq8GXVqVEOJYkXh8uYNFi51VmGnixYtQqFChYJsfXgd5KCSvo/wes5iF8YJ3jz+5JopCEHHihUrVJduY48mK3Q2b95cFaxhHxq/IuJC8BDmRJc1xQBvADop23iEiSFFemSeNwNjcWEc/kS4HN5MYseOrQQFl89qBHS3scs1/48UyQHv3r1X76tcoZwHYUEqlS+LNRs2YZHzCiUuyK3bdxAndizVp6JXl07YtnOX6tZdvnx5XLx40ShZ3IZ3V9WJ+9qNG9i97wCiRI6sRAl7XugY34CGN0t6KqQUrWCJ8NxlsYJDhw6hZPGiKFG0MK5cvYaBAweqHCQanOJpsw6OHTuG9Rs2qKalvL5qqlYsj7pNW6p9zg68QZlQqq+PHGDi/YUGDa//Ui1KCCmE9JwLU3g+su8MPZrGsJeYaaVO3yLiQvCQZKdDmFjNQ1c44o3HOD6WVZzohdA3A2N05QPeLDhqTyFx+PBh7Nq1SzXI06P5cePEQeXyZbF89VrEiR1buesL5Mltdm/kz5sbYyf9TkA6ePgojp86jTIl/1KPLGtLwcDvXL16tXLjbdiwQT1/+eoVnj1/jjPnzqvfRcFUpkwZ1bQpRYoUgbrn+ftNvRXS+0KwBObPn6/KDjovmIMCefMY5rMJZJ0mzVTnedPyykLIhNX2kidLqgZpjOG1qWOblqjdqJlqLMpQ1aCE32/sITN3vRQEIWho2LCh6muhrwW00S5fvoy9e/eqfl7+QcRFKIajRnPmzMGa1avV/wwVqlylimpuZFwq1hiKC4ZK6bhYJj8bJ3Nv375dHZRMkGaHa5YZ/N0ELyrix4urwpkoMF68fIEly1ciQfx4+P79B8KFDYsHj343xjPlwcNHCG8fHr0GDMbKNetQuEB+VV0qd47sWL5qLSpVrqzeR6/KtGnTlFeEQoaeF4ZBUUgkS5ZMGff8brr7+H9Q3szMeYak94UQHNBrV750KQ/CguTJlQOVypXDsqVLRVxYCbz+Jk2c2KxnInnSJIb3hBRu3LihJl4/OdrKWHFWFOTzNm3aoPJ/9wJBCDRs/h/yHdDLDS5atmyp8l/ptV64cKGyU5hrMWzYMFStWtVfyxRxEUoTspnfUL9+fbx8+QJVKpRH0sSJcPTEKQwfPly50mmgmwsb4kmlhQeFhc67YO4EEwQ/fPiAyJEiqc7ZfAzLBD47W9V3go3zenftjChRImPbzt1wXrUGDx89xqhhg7F52w4sXOaMxvXrIHasWIbv4+sUFOxRsWvvPjSoWxsPHz3C4ydP4er6XfknTSsZsNoBJ10Ril4LhnAxDIvrzt/PGxNzI4LCwDf1DOkQMSm1KAQHDx8+ROO6tcy+liObk+rzoiv4CCEbXgeXL3fGN1dXQ6luzbGTp9UjB14sHQqIjh074MSJk4Z5PD7Dh7dHhnTpcP/BQyWIWc6cXnJJBhcEv8HO3JwCChEXVoq5EByOnrMUIcOe2B/i/ft32LlhLZIm+V0NgA3kmEDdtkt31fCOkzG8mGtXti4dSCOEXg+6zmI4Oipx8enzZ9jZ2irjuW6t6ur96zZuVrkOUaNGQdFCBVGscCE4Zc6Env0H4dr1G0pgFC5dHmUq11DrkS5taly4eBkz5szD9//Cs758+Yq5CxerZbu5uyNT5swYPHiwUtzeVSahqKDQMCYoa6kbl1/kduN68ful1KIQlPBcZeggz4lBI/5RZZrZQ6Zdy2ZI+N85xP4zsWLFFGFhJdStWxczZ87EyNFjMbhfb8OAEcNJx0ycrJK5kyT57cGwVHhPqV6tGvDDFUOb10YUh4joMmk+6tasjoG9e6r3rNu0WVUCZC8kNltds2ZNcK+2YKVwyMXKHBcK2iTMuWPkCe8VmTJlUl26abf4BxEXVigoODJPIWFcrYhGNIUFjWxO+/fvR5f2bQzCQsPY3LmLlmDbtm0exAWXowWFTvA5ffq0qjJw/NgxZcDzJpA3Vy6cOH0aBfLnxbzpUwyjZT27dELTNu3VtGfzBhUHXLt6VXWDW7CUHou6WLFoLmrUa4zBI/8xjJyGsQHqZEyMnXdewD18ePTp2xcZM2ZULrtYRh4Oc1A0MD+EiYOmGDf+84u48E/ehHH5Rf7PR11BSxCCAh7v/fr1Uy7v3+K+oMpzWrFmHbZs34m1zotha2ujvIQNGjaUnWJFngt6o/v27Yu9Bw/hr6JFlNd6687dynPLsCJLx9nZWVU0i+0YFQPnLFfzKIb/GToIe/YfRMfuPfHp8xckihMT9mHD4sTx46hRo4a6NwVW0Q4hdGNtTl0XFxdV5OPu3buIHz++msdqgvPmzcOCBQv81RdHzjwrgWKCSdicmO9AY59KVIcGMa5WJ2CzfjFfo+fAHFmzZMbLFy8MzylMaKTTmGcvCFaZKV68uEoC2rF9O9zhrnImaCwfPXFCGe3DBvTz4Ibn/8MH9lP5FdXrN1ZGOoVKsiRJlDKeu3gJcufIgZWLFyB8uHAIZ2sLpzjRUCBxLCy//BC/7COgdJkyuHLlCk6dOqVuGlwGf59OPDcH153L57rpLrC6nrpfa6nrbcztyUc+90v5RaL7ffC5JDAKQcXx48eVsPh7yEAsmTsTTRvWR5/uXbF3y0ZEjRIFDZq3QoXqdRAnblxV8ECwHho1aoSNGzfCySkr9h48jJt376NTp05qAClhwoSwdGbPnq08vwULFcKyebMRN05slCtdArfv3EXL9p2QJ31KHJv5Nw5PH4FzC8eiQ41yOHr0qArTFQTBZ5hbQXhNYFghJ/5PODjhH0RcWAHGMf06J4KTDluiAU5xoZOuo0SJol5jmJI5rt+4iRgxYypDnIqVYUfsXM1EblZbatGiBcKFDYNypUuqEIrXr12U+ChepJAy1mmspEiW1NNykydNihjRo6sR0+2796h+E5euXkXK5MmwdsMmleD98dMnlCtbGj/hjoff3HDk8RtEjxkLLm/eYvPmTbh4/hxGjxqlGuctWbLER0Nf99ZgOJfuGs5txHl+qaVumjdBdK1238Dcjjhx4iiBxkdJ5haCEo5CpUieDA3qeMy1iB7dEZ3atVa5TSVKlsS6dev8XXpQsFyyZ8+OKVOnqkIXO3bsQMeOHYOtS7dfYLVBDpb16toJE0b/jcIF86v7y4cPHzFn4WI4RomEad1bIn6s378lcsQI6FGvMkrldsK6dWu9LEwiCH+Cja1NgE/ByYEDB1SerXHDPP7fpUsXVaraP0hcRgiHxi29FDq8x/hiqkWGaaM7CoECBQpg1ryFqhyscQL1gUNHcPjYcVX/nJWWaAxTnFBQqHroAMaPGokaVSoZhAwv8kNGjsL2XXuQKUN6XL56Da9ev0asmDE9fC/nMdE7buzY6nv27j+o1t8hkgO+fvmqqkGR2LFiolmjBrh1+67qZcFwrgG9e6BJ/Xqwtw+HN2/fYeDwkRg8eJBy+7MalFcJ0sZNm3QfDv5+/jbdGdw3AiMg8iak3KIQXDx9+hQZ06Uzm0uRKUM69VivXr0QYXAKAYOll8bmgBFFMQeGmjdqYJhf6q/imLdoCWI4RkO5vNlUKJQpVQrnwY4T51XFwrRp0wbxmgtCyILFeRgaZQoHpVmF0z+IuAjBNwYmJFNY0GBmNSR6FrS3gmhhwRF7PTEkiuFRjK9jEnaJClVRv3ZNlXtx5PgJ5UGgwZ4mTRoVs8rvYH6Gy+vXqnFdruzZUbPq/8v9cZlsUrdzz168euWihAUZN3kaRg4eYDBmuB7jp0xXNzIHh4jYsGWrqvbUvVN7jB4/ybDOYVRuhy3mLGAMuK2KC86XKwdaN2ti+M7ojtEwYdRInDp9Vt182D3SO0PftKkdfz9PGuOqVz6FKUnehGBp8JjnMeubqk70PJ4/d9ZsFSh9zvI9QujA0ktja08x8/hixoiurtEa5uc5r1qNl69f48fPX+Y//19fJksUTULIx9pyLipXroxRo0ape0Pu3L/7jZ04cUIV/mH+kn8QcRECR5Z01ScaybrfBB/1pJPY+Mik6ydPnqgLNRuksAsjYa8HusrZJGXS9JmGUXkui0k9HMXUeQpcj6XzZqFe05YoWqiA2XUtVqgQJs+YpSp4sDHeomXLcefuPdSoWvl3g7t1G5QXgpVpps6ai6xZMiFf7tzKe6LDldKnTaMMpjv37iu1PHXqVDRp0gTly5Ty9H1ct9Il/8LOvft9lSCtvQbG4U2EXhmKMiZ98+bKkDGvPq89IFxHfUOWm5cQlPBYZ5O7RQsX4v6DB8roqlKligpz8S5+vnbt2qqCztIVq9RggoZewEnTZilPZkiIvxdCR2ls7SmmV5q191lqVhcf4SDXqsULUKVOfWw4eAJ9G1VDpAjhDZ/lvWT5rsOI5BAx0JulCoI10KVLF+W5YOEHU9HB1/yDiIsQMLJEeOGnQcvnNISNu2drDwWNaxrlvEEw8ZllWu/fv/+f+HBD7Fix1YX5xctXyoNBjwTgrpKqadAnSZRQGcynz55T8dkUB1xeooQJUDBfXtiHC4cXr16ZXd/nL1+qcKPSJYorA4breuzkKeUNIVkyZUS3ju2wbOUatT7nLlzC+YuX1fv425o3b656ZfB3VK1eQ5VQ1COsn798MfudFAVaUPjW0Nc3LX6OwkJvPwo1TvQEGY+SeecBsZQbsRDy4bHHEA6eDwzjMCeUWYigTevW2LFzp6rq1rF1Czx68gRLV6zGzp07sX79etUI0xx58+ZFgwYNVOjhrr37UZTVol68VAMBP3/9wtz584PgVwqWQEgoja09xUWKFIFjtGjoPXAI5k6bpO4xJEaMGIgTOzZu37mD+oMnYEiL2siSMikev3TB+BWbcOTSdWkEKQQatlbmuggTJgz++ecfdc6wFC1hVc5EiRL5f5kBuH5CAECDWY+kE4oIXvjpHjaFRjrR1Y/0QcIkZ6rNyJEcVAjSt2+uSBA/vuqOzVKEo4fXQiQHB2zZvkOVgaWwYFna9q1bIleh4kiRPCmev3ihLuZsbsfP8bvKlSmlhAPd0lGMXOjMpWDjLZaWfffu94iYce4HRcmde/dw4dJltRy9vlxXdgOfNGmSMuhNjXb+9qxZs2Lp8lWq0Z9xWUGOuG7auh1169VTCdJ+LQvLZXMddR6GXjb/N1e6ViN5E0JAcufOHVUOdP+ePfj4n4iOGysWOnTurKr8GIcwbd++HVu3bcP8GVNQsngxw3yejxVq1MGwoUMxd948s9/D5fz999/qfGJ5wYHDRqprQPkKFVQTSuNEPsG6CQkhnsYV9oaPGKGSTXMUKo5SxYvh588fqgkr3N0RN4Yjzt+6h/LdR6iGrQyHYh+k6tWrexqFFQTBeygm/kRQGGM5VxNBhToxx4HGt2+qXOj36BKrvCDzs6z48vXrF3z8+AH5cufBwSNH8P79B1SvUknlKmiDJU+uHEifLi269x2gRMet23fg8uaN8mqw4VLpEn/hydNn2Lh1O56/eIlObVujQvXaqFqnATq0aYV0qVPh/KXLGDtpCtzd3NGsYQPVgI9J3ZeuXIWdnS3at2qpwq5SpkiOK9euY8OGDcpVTc8Mbx4UGxy1ffbsmYe+HISeG5a77dq1K1p36oquHdohedIkOH7qNIaPGouw4cKpeECGflGcUGlzm3jnWdA3LW5nHUbG7aEnvs71ke7EQmDCcs4DBvTHrVu3VZGE+tEjolzs6PjhDqx990n1pOCAAsOdNMyBypk9mwdhQWLGiIFWzZpgwNARKpfIq6RsHtNsMMZJOnCHXkJKiKf2FJcqVQqZM2fGsmXLcPToEVXOPF369AgXLixixoyFfuXL49atW7h69aoaaOrcuTNix44d3KsvWCs2gZRzYYNgg5EuzF29fv26h8FqzbVrv/Py/IKICwuAo+gcLdflYn1bPs/YIKabmBWQaFizDwSN7R/ff+Du/fvqvSz72r5lc09GM6s+jfx3nPICVKnwu/X7Lzc3VCxXRv1PQfLPuAnKuJ85aTzWLFukjJi2nbsZlsGbE0tc0nV97sJF1K9VQyWJ2tuHx8RpM1CpXFk8fvpUhXswUVyLIMb48ZHJ6Ho5RIsDPmcHWdZgHj9+HIqXq2T4zjSpU6tytOwgqXtHMGa8VatW+Ouvv7xNUtQ3LRpvFDk6d4XzdIKjaYUtQQgIeMy3atEcx06chDbl+sSJjAYxfod7kBwO4eAYxhYTxo9X4pr5UYQll7NmymB2uenTpFbH7uvXr31V8UnEc+gmpIR4ak8xi4z0798/uFdHEKzy+tmnTx/1OGbMmACrGBgixAVHuydOnKiSj60NGrccRaeBywu9b+ENgZWUWKZPJ+JxOTxImLhNoz1y5Eiqs6kmYYL4ZpcTL24cJT7SpE6FqFEi4/2Hj/j69XfDPdYUnzFhHJq0aY+chYohR1YnVU6WpEmdEkkSJcLufQewcKmzys3o060zJkyboTwQ2bJkRto0qVTZ2YePn6jwJxo/OtRLn6BcVy2SaCBRbOiSsZzP3hoUGYxJ5/ZKkiSJig88euQIenbu8Lvr7Ju3mL1gEQYMGKDEAQWGd0mKWpAxgZvvYyiahiLNXFk2QfgTeEw3btgA969cweSE0XDT9Qfmu3xBTUfPOT5NYkTEfJdXqicBPQ26KzFDC81BDyKPaRmxFXyLhHgKgkAePnyI6dOnq9y8gMLim+ixgY5/OwRaOjRoORrJR994KxiuxNKrHMEZMmQItm7dagiHunjxoqr+tGXLFuTOkR37tm7E9bMnce7oAdXRlBw6etzTMl+7uKhmevpG06Z5M7XMJctXGN5TvGhh9OzSUYkA5mdQcDRrWB+RHCJh5559KrkpV45sKjxj+OixiBw5iipryX4Z8xYtRZJkyTFz5kw4OTkp0UFxoUOgjEvVam+BDvOi2OI8PlJEUTDUrFlTiaiTJ09i3owpaNOiGVKlTKFCvOZMnYiypUpg6pQphkRtnwQbfzNFGtdXN7jzKqFbEP6EI0eO4Oz5C/g3XmT8FSU8vrgBjna2sDfTQCmGnS3C2tp6yP+pU7cuLl6+glXrNnh47+MnTzBz7nzlxdNeDkEILHhN5uCLV41LBcGa4dWaZkuATwg+GFLOQemAJIylX8Q4Eh83blxVxcea4IWZo/gcpachrA1tr8JxGAtHUUEPB5vMffr0WRkrrAjFHAZVacbGBpEiOWDR7OmGxidsZLdp1XLkK14Kg4b/jQzp0qjkbvL12zf06DdQJcYtW7kKESNEQMH8eZEoQXxMnTVHGd6N6tVBlMhRkDB+fESOFEl9/4nTZ9SkS9VGdHBARIfIyihv0aq18jTwswzz4u/iREHA9xob+8aJ1EQLLAoJGknc5+Zigjdt2qTyOvLlzuVhG3H57LlRuXZ9JbYyZcrk6yRF41E833bdFgS/dkGNGz4c8jr87vCeJnwYzHX5hXuuP5HM3uNxeurLd3x3c0O6dL8b3JHixYujTu3a6NyzDzZs3oICefPg0ZOnWLN+IxyjR1deO0EILHi9XrBgAebMnq3KIJP8+fOrnLg8efLIhheEEMqwYcNUo2TaXnXq1FGV5KxaXCxZskR1lqXAGDp06B9fGI1DXwISljQ1fjSFBrXOC9A7jYY3R+9NR+xNxYUexWeCZ6wY0fHg0WP1uXKlS+LVaxfs2bdfJduwQgYrZXDasXsvKv+XP0Hix4uLrh3aY8zESchXvDT+KlpYhf7s2rNPiYWJY0ah14BBqtP29Dm/q81QnEycNlM1vtMULpAfyZIkVhWm4sWJg2cvXqh1o1eChjxFhK4+wnwGjrrqikz8/fq36nnGTf50jgUnxgPzINeVpbRA0fuPyzbt/q3R3cb53QyJolDwq1jwaX8KIYc/2Zc8Ng8fPqwKJPB8ZZlXhigZG/x+QYUCGj0vGTk8Rtt9xICn7zElsSOi2f0W2s9//MKwl5+ROkUKZMmSxcN1a/CQIciaLRuWLl2K8VNnqLC+evXrq6aYFOCBdY2zBOS8DF6GDBmMJUuWqntL3+5dVCjtYucV6pxgSAXLxvoF2Z/WQ0Duy5BQbMLS188nihUr5uk3cDCXFQXZOI/htcYDv3v27IHViIt79+5hwoQJmD9/foAcsDQw/ZPx7hfYU0KjhYKxV4Jo41onDfORr2mhod9jXFWGO5uvc+ezF0X2rE6q+hIFgpu7O2LFjAGnzJlx5do1PH32HO279VAihiFCmqRJEqplZHPKrOrcU4x8//FDdciuWLY0MqZLiwYtWquys/SM0Kvh6vp7PVKnTIHUKVOqkI4Dh48gSuRI+PhfuIY2ahizR/TvoFgw/h3GB6pGezH0Z/Q2o5fDO3jgb9y4UXlv6KkxZs/+A2p70/Px4L/RtYDYn0LIxq/7ksckS8QePXoUqRMnQMoEcbB72xZl1LNEbLVq1bz8rFceyAQJEuDZt+848+WHStpmONSkRNHQ+uFbFLn5EgUj2eMHBc3n7+r4Hdatm/JYmsLCCBxpMq00xyk0IOdl0MPGqhQWwwf2Q5MG9VQp2FVr1+Pq9evqeO/QoYPq8JssWTI/L1v2p/UQUPsyIEbOBa/h+RrY2LhbYFkc3tjpmmEPBDb1YBtyei/8m9DNWDL+zJQpUyIwoPjhScWRTX4PQ550kjJHK03zKTiirj0SxgnMHK3nSCTXd/Xq1bh16yauXb0G7iCKAVZxImHs7FTjK9K7W2e0ad5UGfNc1iLnFeg3eJh6/+E925E4YUK1bAqHg4ePqqZ5v379Fjd6vZjoTQHBeO7XLm+QJlVK3Lx1WwUCMkmbRrwWEzSQeOLTwGHXXyZXE+P+FRQ99C4wzEiHQnFElb9b9+ag2ONv5Tzj0CW+V3sriLHHh+/jcnij42hZiWJFMP6fEYbGShQ//J0FChTE+PHjA2R/6vAyIWTi333JkdhJEydiSrcWKJs32+9O9T9/qgZdk1dtxeLFiz2FgvC8p8dMi2ueB8b5OzzfqlSsiDf372JknEjI4xAOPGNWv/2CEc8/gmcjhXqzFi3UuaXr/At/ti+FP2fkyJHYsmUzTh3Yo0JmR4+fhLy5c6FMieL48PGTCqtl76GFCxciW7Zsvlqm7E/rISD35e3bt9X1ltEQlgZtM7enj5FoSI8AX/ajQf/CNn5Ci/zd/sEiPRczZsxQxm/r1q0DbJkqNyCQE3VpTDPRTRvENCa0wa2NZW3Q03DgCam7RdNAZjjQ0CFDMH/BAjVyyQRuwm2RKGFCPHj06HeC83/Gd9YsmdGhdUvD9/N9jevVwcFDR7B7/wFUqdMAW1Ytx4x5C7DvwCH1GfaKOHn6LI6eOGn4bvawoPGezclJeUbWb96KSJEjK3Hn8vq1yjQqWLCQ6prNpGcN158N+3SnV64bfztFkh550KJHh0xxPgWE7mfBbUahwXn0zHDS4VM68ZvL1nkYDOOKHz++utmxSVK2AkWRP08uJYrOnDsPpyxZ1AhaQOxrXiQluds68Mu+5DG3dOkS1CqeH+XyZTfMZ5OuHnUrY9epi8qDQdeyht42nq88bnls85HHqmn/gMXLlqFJo4ZoevkKoocLq/IqPv38hUQJEmD4yJEqryKku9wDGzkvgxZeh3lfS5Y4sQrLpbDo3K4NenT+/+hn62aNUatRM5UXuG/fPj8dw7I/rYeA2Jdy/bOsPEHmBnvnqQ9R4mLNmjXqYpY7d27DzZ6GbI4cOZTw4KMlQsOaXgga+boqksY4t4Kvc9Sek3GdcXorKCwYdkRDxSFiRLUcxrZSWFA4sFkW/6/ftCVK/+WxmZbmr2JFsGPPXjx//gK5ihRX9Q3YjZdG/pSZs1XDO4ZD/T1mvKqS9OjRI9x/8BB3791X61KyZEn06NFDvaaTzglLtvJ13eTOq06v9Ebo9+uEbH6G/5smaHO0l++jIWa67Yy3F1/nNuGFh8unYbd27Vq1zRhCFzd+Akxr0VIlk4tLVfgTmF/x4sVLFM1ew9NrPP6KZcuIzaf+XxKWxyo9dcbhgDwXtNfOWFywOMXW7TtUuBU9sjy2KSisZbRKsC709ZmDSnv37MHS5SsRLVpUdGjz/0EtbVSyomCthk1x9uxZVblQEKwVaxNA6dKlU7ZUhgwe+yjRZuRgrdWIC3biNK4qdOHCBfUDOd945NzS0XkGOnmZ6HwAhvfQ/UeDmQYHmwTNnzcPUSJHViFISRInwoOHj5A+bRo179TZcyrkKX/ePChT8i91gedovTlYXpbfHTNmDHz5/AWfPn9G/To1MWPOfBTKn0/1p2DXbLqv2T+EoRxcH3oHKAK0UGCZXC2QdFlXziPa6+BVp1dOpk2atIfC+Dk/qz08xsnexsJCfz/fw8/pZfBYaNOmjSofa6lNoISQBw0lHoOv3r03+/rLt+8RMeL/c310yWSdR6VFhQ7lM4Wvs8oOJ0GwVPT1mVSpUkVVitq5dx/SpEyJ8Pb2nt7PCn6ERVhEXAjWjI3FN3HwG15lR3AA3L/VMy1SXNDYNubJkyfqJs0OzJYMjQka6DS0tbHM57ojNY0PvocZ+cudnVUytt6pNMQ5Ok/xkSxJErx9/w7rnBcjV47fI0AvX71Cyw5d0KZzVxzYvgXly5TCqnXr0a5VC0R3/H9te4YVLVm+ShnjSRMlwtXrN1RexpwFi1UexsEjR3HyzFk1wt+pUyflwuR3cr14IPF/ehBMe2/obuBcX47SMp6cv8u7Tq+mTZr0cx6s9ETxMzq5nZjrjG1cOYLrxnX0qkStIAQEPLZZ+WbB1v2oXjQfwof7//H15JULNh89gw4dOxnm8bjXHgvjUD4eq3JsCiEVfX3mvYGhqMx7ZM8pDmp9c3X1JDAuXbmqHvleQRAsGxYLMS4YwnDGW7dueTj/2cBaRxBZhbgwhT8uJHTn1l2zGX+tk5I5wk8jmA3vtm3bhsOHDuHL16+eKilRWOiqUfcePMDo4UMMwkKXWJ0xcZzqkl21bgOsWDQPazZsQqVadVXsa9bMmVXljrGTpuLZ8+coWqggjhw/gfDh7fHP2AnIlCkjZs6apcQOk7L5fTpXQo+uaoVKYeGVka/jyY3DPfzS6VW72bVw4e/V/2vxYlya1/i76fHh9qTxZ07MCEJAwbBAjtbW7D8G7auXQYoEcXHy6i1MXLVFdXanAG/fvr0SEJUqVVJuZYpuLcI5X4cPCkJIxDTstUKFCmogiXkVk6fP8pBzwXvGvxMmI3Xq1L5O6BaEEIlNIIVF2SBIYVguCzBoVqxY4cGeoq3IUujdu3e3XnERkjAdyWf8dvXq1VWFozixY/2uoMTSuv8Z0joEKWzYMMiTKycOHTmm5pcq7jmfgp22nTJnUlWRTp05h5LFi2Hjlm1o06mb4T1cfoWypeHyX8hUhQoVUbp0aTUSqz0EFBEMb9LrqD0sPGF05Sqd+6CT04nuBq5Han3CqzAoohO7uXw9Qqa3B7cfX9c9Kvi9Wljo3yiiQghMeFHlxXbggAFoNnKqmqcqmGTMiOs3rmPWzBlwSpUMZ16/URfo8uXLqwplWqybHp+m54IgWDrmwl55L+MAEcOUj588hTIlS+DDxw9YuXY9XN68hbOzs9XFowuCNdKoUSM1EVb/ZD6zac7FnyDiIhAwNn6bN2+ONy4uiBolCt69e4/CBfMrQ3r/oSPKmJ45cRyiR3dEvyHDcfzkaTg4RMTnz1/w9v17xIgR3cNy+f53798jbpw4WLBkmSoXW65MKazbuFl5KPh6mlSpsHnbDhXuxHKZBQoUMGvgmN406HHRoVlMptdJ3DqkS1ds0jccnwwkYw+FDl/SlaO0x0SPiunl6iRY5lJw/cUgE4KTnDlzYtv27cpVzMIGPL/q1qmD0nmy4u/W9RE1UkR1PG86chpdJs7H5OTJ0atXL1+dCxyEEARLx1zYa8eOHZEqVSrMnj0bw0ePUdfvUqVKqbLxadKkgSXBc/b8+fPYv3+/uo/ly5cPefPmFQEk/AE2gG1gCGgbWBMiLgIRNu1j5YwY0aOrXhKLZk9HzBgx1Gss/1qncTO06tgFJw7uwYqF85CzcHHY2tBjYIv5i5dixKD+HpbHPhWs6FQgXx4cO3EKxQoXwrNnz5Vwef/hg3oPSwV26dIFTZo0UaP93hk4TIQ2HU3Vj8ZVopjgymXpnhTaC0EhQjjfWGyY81DwefTo0T242XUYlk585aS6GP838iUeCsESoCHFaeDAgYjiEBHjOzWB/X/HO4/nSgVz4cKt+1i0aKHKY9LV0rw7F0zPGUGwVMxdh5mzx8mSYZgiy9mznKajYzTY2dop72JWJyfMmz9fNWMVBAGqA3dAnw9WlvNuWZw5c0Y9urx5gzEjhxmEhQ5x+nfkMNWzolCJsqr6Eztqq9wL2CjPRO+BQ3D95i3VdXveoiVKiOTOmR1Xrl5H2tSp8PTZM5w4fUZVl2I5y5kzZ2LLli2oWrWqIW+Bxg2Fhe56rcu0aoOHwsH0xkHDh54Mig9O/J95Dvq9XN7jx49Voj0fWcqW8zQ6zIliQYeJ6CpQujGYFhEc9dJ5FrqUrW9CrgQhqDl75gyKZstgEBbGlMmbTXkmTTvUenUuGFfDEwQhYOF9j56U8+fOYc7USbhw7BDOHzsI5wVz8OzZUzRp3NjLCjmC4CMcAA3oKRhhHi7D4E+ePIlVq1apKqbMyWDlN/8iVlwgokfgY8eKqUrKmpLdKYvqP8FSseMmT4X9fxWb3r57pwz8ZStXY7Hzit87KkwYlCtdUnXnZhM8vofhQzVq1FCJpTp3Q1erYTUmVlUinEcvhBYH2kNgWoPf1MNh3ABQezu4XhQqFEE6T0I309OjsV71v+D/XAdjNzuXY66UrSBYGvbhw+P9569mX3v38fe5Zuy1IN6dC4IgBDy8h507d04VgZk8ZpQq3a4pkDcPmjasj5H/jlNVGzt06CAhikKo59GjR2jatKl61N3R161bh927d2PevHnInDmzn7eReC4CkbJly6od9f7DR1VNwxSGMrGkH+Nal61cg+279yBVyuS/KyNFjWqoopQ4YUIVCnXg0BHVPXvw4MG4cuWKiiUdOnSoMlS4fOPyrnyk+qSo0MnaNOQ53ysDxziEQydzc9Lvo6hggroWFsbVo/g9OkxK52UQnRBuLBr4qIUOfzu9IxRKfJRYdMFSYRjIvjOXcP/ZSw/zefwv2LoPadOmQZIkSTy85tO5IAhCwKHvYYwaCBsmjCrZrrl85SoKlSijhEVYO1tMnToV2bI6KeNJEPyCrgoYkFNAwfKxbDLsF4YMGaJssPXr1xs8erQtCxcurIo3+AcRF4EIqxux6gwN74VLnT29PnfhYuUNixndUTW++/r1m+rKHd3REc9fvFB1xZnBnzV7dtjahUWdunVx8OBBleFPwUBBwQupcdM57U3Q6CRpGvOc752BYxzCYVoKlvPpCaG44DJ0KJOuLGV6cvhFNBiLDUHwK0EV3lCrVi0kSJgAdQaNx7oDJ/Dmw0dcuH0frUbPwMHzV9ClS1ezNwkR0IIQNBj3TmIfqV//DdAxx7FWwyaI/P0z1tcqhNvtK+Bk81KonioeBgwYoEZpBSGk8/z5c9WLxq8wN5iFGlg1SsMQ+jp16uDq1d/9a/yK+OYDmbVr16ra3yP+HYvHT5+hWqUK6oK3au16LF2xCg3r1sKiZSuUB6Bnl44YOXqser1qlSpo27atMlZYX9zY5avLyPIiyomGubqYGjW90+jwJr7OCkwUPF4lk+oQDi1AtHeCj7qpnhYeukkg4WcodkxDQiQhWwgsKKqnTZuG1atWKSGeKFEidSFs2bKlOh+8gufO8uXLleePeUQ8tzg6o8s0ewdFwqpVq9G5Uyd0HD/HQw8ajvIw78kr5FwQhMBH38N4b+I9ipUU69asjkXLluOnqyuW1C2IaOF/5x3GjRQBw4pmxvPP3zBx/DhUrlxZqkgJviNQqkX9GTzmOSDNJtQ6JN63MByfwsSUO3fuGDzvgSYuNm3ahB07dqgTlk1yGOtvXI2I3Lx5E23atFGZ58JvaHRfvHhRxbAtWb5SJWqTWDFjoGOblti974ASFimSJcWI0WPVxbFLx44qFtR0FFS7fHWJVu4LbeTzgmosMIyb4+l4bwoLcx4E45KvVKsMf9LeCl3hRn+HXqbuh6G7knPZ4nkQggKG+1WrWhWPHj9CjSqVVXGD8xcvYeKECaoyzNKlS80KjJ07d6rqMbwv5EiTArfevle9LAoVLKiqx3gnSowT35Y5O6vEt3v37qkLL89t3/Z+EQQh8NBhiByJdYxgj4HDRsDWxgZ79+1HyeRxDMJCw/tkrQyJ0WzjCVWgJGHChLJ7BJ8JpATsZ8+eoXPnzl6+7p1tvWTJEpWATYHBwS6/wP41I0aMMETCsHP36dOnMXnyZDRo0AD+wVd3Q4bmTJw4UYX4UFDMmjVLzaOQaNasmcEI5oj3n2SXWyu82G3cuFF18iUJ4seDY7RomDxjthIWxPXHT5WYzQoXNNh16JFxUy6dL6ErzegGePo5l6XFAKGxRDGhjR5Tz4JXHbNNPSFcBt9DQWGc5E1RwW7FUlZTCEp4waMhsHnVcqROlVLNa1CnFurUrI7q9Rph0aJFaNWqlYfP8P2tW7VCsewZMaZ9I1VSlufO/nNXVFjTsGHDMHLkSF99P89FJrgxv8K4tLOIa0EIfni/+vrlM/IkiK4KoHTrOwBhbW2RPp154cDXCO9vzFuURpdCSOPevXuYMGEC5s+fr45hv0K7k4wbN07dF3v37q1sSfZpYwRNoIkLdqClsuENmDBEhklQkyZNUs1pxo4dq+LqBa9xcnJS1Su6du2qks2ePH2mjBGGP/UfMED1gNDGPtWrNuT5HhrxulITxQbna2FBI19XYTLuG8EQKH6GSdb0ROhGeAwF4Ws6T8O4Bj+/k5MWJDpHQ/e3MO59oYWFJGALQQmPSXobateoZhAWmhxZnVC2ZAmsWL7ck7hgKJR92DCY0KkpIoa3V/N4DhTNlhHtqpbGlBUrVAM837qAzTUXEwTBMkiVOg22X76Io43/Qrc8adFnzznsuP0MQ4v8RISwHs2e9TceI0G8eOo8ZtVDaXQpeIeqHBsIYVE2NkC8uPH8HPlD2473LlZ74qAXS8j6/btt1OA2w4p1OXUOntHO8y++Ehc0eLNnz254TuOUK1KyZEn06NFDjciPGTPGU5iU4JEUKVKoTH4296HBrztRE13tifN1yJM2pmi46MZbjI3TVZ94EdSx3OxFQYyNHS7z5cuXSnToGFTG4vFzunEd3+/g4KAOLn5GV5yiaDFXQtarxnmCEBRQ3PIcyZQhndnXOX/bzl2oWLEicufOrcI3CUMTC2ROaxAWxpTM5YQxyzaosE525fYtkkchCJZJvXr11KDov0evoXeB9Bj1VzaUWrIXLTafxMhiWZA4qgO+/PiJeefuYO21R+jevbthoE4aXQohiRkzZig7jSG/voVVoXzCOJGb+UiBIi6SJUuG7du3e/oCJiqvXLlSlUblSGHp0qX9vAKhEQoEThoKAO1dMM6Z0MnURJeXZW4DoUChYODF0LTMqxaE9DSYusi0yKDg0AKC3gmKDX6HLltrru+EGFNCcMPjk16+i5evolqlip5ev3DpCiJEjIAkCeJh6ZIlyk3MGFSK4zcvXMwu8+3HT+rRNzkXgiBYPhkyZMCgQYNUic0d916gcOKYyBg7Go48fIWC83chsWMUvPr8Fd9+/lK2CxvPGje69KoPlCAogrnpnTFr1qyBi4uLGkwjus9Zjhw5lPDgoykMe9LpDPHjx/e28iLfF2jigt4JJhjTW8FEER3Co2/2bEaTNGlSlZch+A16F3T3bBr7xhWf9I7W4VE6d4ICg+FNxl4K46RsohO/vUJXkDIOf+JzekAk3EOwVHihq1mzJhYvWoTa1asiXZrUhtdOnDqNbbt2oX/PHmjRpKHy0rXs2EXV6abbeODAgbhy9yEyJE9s+AyP/Xmb9yJJksRInz59MP0qQRACGoZ4ZM2aFQsWLMDRSxcRKXYi9GrcSt07Hz9+rCItGHXBkG5dgVEaXQohjWXLlhnybMmFCxfUPY/zGR1jjiJFiuDGjRsqBJ/RKGnSpFHOAj5ySpkypRpw/hN8JS4KFSqkPBRM5OYN21hcaKj+GTrFilKC79GJ23rUxFQQ0OCn6DBNGDX2IhgnZfP9HIHlAeOVuND5FhQYeiTYOHFcL18QLJFOnTqpqlAVatRG1YoVlMA4e+EiNm3djpQpUmD3vv2YPGOW6hlTpFABHDx8VF1806dLh/pDJ6JH3Uoq1+L5m/eYtWEndpw4p8ra+qYcrSAIIQeGOfom1JH3V95D9SAbQ4W1wSb3QsEjNoGScwH4b5ksPWtavIS2nHeVz+jR0LYjK0NRaPDR2dkZt27dUucBcy604GDxJr/i69qJ/AImbnsH3S/mXDCC11Ad6iRtigjtvaDRzwOEoyzeVaIx7qqtK0XxgNF5FsYN9oh2henv4rJ13ocghAQYUsimV7xArl69GivWrKMLAnly5cThY8eRPasTmjasj1evX6s69zyPmHOxfMUK5YXtPX2J4ZyIGyeOKkyhK7kJghD6MC7QwIE5DqLyPirJ3UJII3fu3Kp4kG+Pe7aWoBePtiAn2pxHjx7F3bt3VVQNS78HqrgQAgfd2E4ncvNixh3NyTdVaHQzPS1S+BmdT2Gcv0F0Ijdf40FFI01GZYSQCI9fCgVOmzdvVp5TCove3TqjQ+uWhvd1bNMKFWvWUXXvWd2MVe44snPt2jV1EeVgiPSnEARB3wt1AzI9WKeLqci9UrDEnAv/wFBB7a1gozzVay1FCuWpYKQSS9Dyf10oyD+IuLAAYseOrQwdnVhtzpNAwaCrRNEY0hc73ZHUOF5UeyV0wrYOl6JxRXevlM4UrIlixYr9rpgWIzratmjm4bU4sWOhW8f26NKrr4qzpquYjfA4CYIg+DRYJ8ndggeoKwIjLMom6LbzP//8Y4hqYZsEhkDpzvYUHZwMq2Vj4+seUMaIuLAQKChMRYVO0qaooGuKj7zwcWczr4KqkiO4pvGiuqIU51Fg8P30Uuj5ghAQ8Ph8/vy5Eqzm8rCCCp43Kj40RXJDU0pjsjllUY9aXAiCEPgYFxkJKaP+5gbrdOETQbAWKleubIho8QlzFaR8g5wxFgrjPRkqxQs0J4oKvZP5qOv904PhVUMvqfokBAYUsawMx07Yb968UfPy5cuHnj17+qlPRECSJUsWnD931pBnZMzNW7fVo1eVM4Tgg255ljnn9Yyxv/RCmROIQsjCuMgIR0FZLpPnZ5gwYVGiZEk0a9YsWAckvIL3TtPBOu9yHoXQiW8Nc0uFnovARsqjWCAUE7pHhR790fkTvNjpA5tJ4MYVLejNMK0oZTpPEP4EHocs8Tht2lRUqVAOy+bNxoTRf+PTh/eqRCwTwYIDfvedu/ewZsMmD/MZPz1h2gxVkpIxpYJlQDHRtm1bFC9eHDNnzMDKFSvQuHFjVSKRMcBCyMW4yAi7DTdr2hQXT59AuRwZUTBdUqx0XoaSJUvgypUrsEQ4WMfytByM4COfC4LgN8RzYYEw/Ik3X12GVgsIjsoa98HQHUUFIajYt28fdu3ahfkzpqJk8aKG+ZXKlUGtRk1VQ02Wow7qkZ38+fOjevXqKrdi/8FDKFa4EF6+eoXFy1fixctXWLp0aZCuj+A9PE62b9uGcf+MQNWK5dUAyLkLF9G5Z1/VXZnHmTQ1DJnowbBPnz6pvliVC+fG2PaNYWf3eyyzZ70qqDN4PLp364ax48bBEjFtGMt+VN7lRAqhjEApRWtdiOfCwtFJZfp//chStcyhEK+EEJSsXbsW6dOmRYliRTzM5023XcsWajTy5s2bQb5TeE6MHz9edeQ9d+kKOnTvhb/HTkD6DBkwevRoZMqUKcjXSTAPu8kuX74c3Tt1QK1qVQzXsKxZMmPu9Ml49OgRNm3y6IESQg46b4H70AbuGNSkpkFYkKiRIqJ/o2q4feeOqtpm6bx8+VIdk8wv4yOfC4LgPTLsbYEwV4LigSMlDH3SCdw6RtW4WpQgBCXM80maJLFZzwTn6/cEBzRomjZtiiZNmqiQQt25PiQYMKGJ06dPq2tblYrlPb2WMnkyZMmUEUeOHFGhbkLIQ+ctsIBCyoTx4Bglkqf35EyXUj2yQzA9HTxfLTHxmx4LfT3j+vF+zOes7igejFBMCM+5CFGeC45WsnYu6+MKf4YqqxkzpiFfgo8sV0tPBSfGgFraRViwHmiQ63wfU5i3cPrsObOvHTtxUhn4SZMmRXBC4cMbv5wjnjl48CAaNWwIp0yZkDdXLgwfPlyNyAYlL168UI8jRo/BjLnz4eLyuyiA5ufPX9ItPYTDexQrsz1+6YJv3z1fK24//n3MUYSwKMSrV6/UccFEcEuCIpjhyAxB1mHKfM75giAEgrhgwvGGDRvQq1cvFCxYUHW4ZfiBrh4j/PnFOV68eKq1Ox8lqUwICnhz503eq5t9/fr1VS7D32PHe8j/uffgASZMnY5SJUuqY1awPNjRvE6dOri1bz/yv3qDVA+fYNHMWSj111+4fft3Ra3AhEbZiBEj0KdPH0SOFAk3bt3G6HETkatwcWzYvFW95/LVa7hy7ZpK7BZCNjVq1MD7T58xd9NuD/N//XLD+OWbECtmDGTPnt0QVkmYCG5u4CK40P0u6LHg9U5HEuj1FUInNrYBP4XasCgmGJ88eVJVg6HL+tatW0rJ84TjRYRVP3ihoLtQCJykMkEIqiovXnWnTZMmjcprGDRoEHbu2YdihQrixatX2LlnLxImTIQR/mi2IwQ+FA/Dhg1D+V9Aje+/DP2aqvz6hZH4gJ7du2Pt+vWBug5Mqp82bRr69eiGpo3qI7y9Pd68fYdBw/9WOTIub95gxtwFSJUqFcqUKROo6yIEPsmTJ0e7du3wz9SpuHTnAcrnz4HP31zhvOsQzt28hzFjxqjriu7FZIkN6+gBZbQAQ6G4XlxPPpeQqFCOhEUFjLhgicBz586pk4vGBSuzdOnSBTly5FB17evWrYu0adP6ZlGCIFgITE68evWqKreYPn16FV/Mc5xiwrubPUMf2dVzwfz5OHT8BBwiOqBXr97qOsBmjYLlsWzZMkSxs0MVI2FBuLequv7ClFOnlABJmfJ3LHxgeC1mzpyJiuXKoG3L/3dRj+4YDeNHjcDxU6cwYNhIVTJ41qxZMjJsJdBLxTBJlhve8u9MNS9PnjxYtmyE6k1z79495Q3g8WGpDesYksxBU6kWJQi+J4xvq3vQc8GTnjGSnKJFiyalAgUhBML8KA4YPHzwALr3Js/prl27qhBH3uiZ5+PdzZ4DC5yEkMHDhw+R9KcbzI0Hp/zvIHjw4EGgiQuGy969exe9u3T09BqPrwplS2Pjlu2/KwzJqKDVwH3JQQeG43H0n4MUOsSXgxkUFkTnMDg4OMASoafC1FvB5oCHDh1ShVYqVqxocaJICCRsGMYUCAndNghWGIXEYhu8D5QoUUId34kSJUL8+PH9tTxfnQ284DPHgiFRnDgKxg69eoRzy5Yt6uKQIUMG6a4qCBbMkydPVMiJQ8SI+GfYYOTPmxuPHj/BlJmzVe8BJvjmzZvX4LmQ7rRBD8XdhQsX1KAOR329av7H9505c0aVB6bhRmFQu3ZtJEiQwNN7WSDidBg7uP346SnR7onN/0doAwtteH35+tXs658/f4FDpEgiLKwUXk/MdeTmMcz5tB8oNtj0ksUkeN2x1DxDGl88z+j55fqT7t27q0p1/fv3D+7VEwQ/w2OZxy8fea6ydPu6deuwe/duzJs3D5kzZ/bzMn0ttXlzojrnRJhzwdyLY8eOYcmSJZgzZ44SGwyXmD9/vp9XRBCEwIc3Qd7Id6xfjZQpkqt5yZIkQb7cuVCtbkM1aMBkWnomOYpoKbHPoQWOhPbv2xe37941zMubJzfGjB3noQoXR3zpaVq9ejUSRouExFEiYu+O7Zg0cSL+HTPGUxlX5sUtXrwYB2yBov/PwwfHizeEtUXqlMmRMWNGX60jDSqGya5fv16JmtSpU6NWrVreihMai7ly5cLSFatQrVIFD9Wg3r1/j83bdqBO3bq+3UyCFTaO1V5Sc7lelgIbA5YsWVL9P7hvbxQpVEAVuJgxZz6mT5+uDLN+/foF92oKge66CAw3gw2CC+ZRsiP95MmTUblyZTWPDTCZhzlq1Ch/NaH1d446k+4YWsE4WiZ6L1y4EA0bNlQjD4IgBD40MPfv369KQNN7yBu0T5w8cQLFixQyCAsNb+rNmzRUDaLopTQVFt6VpxUChlOnTqFhgwaI/eMjnKvlx8nmpTClTA48u3EV1apUURW8NEyMXrd2LcaWyIrDjYpjedV8ONmsBKqnTYhu3brh0qVLHpadLVs21fl6QRhgWhgbHLcFdtoCg8Lb4UFYO/w9apSvvAY0/Dp27IgKFSpg29atePzwPiZMmKDi6H1qfMc8vTPnzqN1p664fvOWOpYOHzuO2o2aqZs1+5P4FS10WLmQA13GFcyEkIGuxMRrkPaY8jmPNUuDnl0KjOUL5qB54waqLwsHZhbMnIqihQqqUV45BoWQxtmzZ9V13Th3mkVdGM7IvEz/4OcgQY5UcUSBMdnk6dOnaiU4KsWJNxBBEALfEO3QoYNyY7LaCm/QrGLCUp8sC+0VP3/9QuxYscy+FitGTPVo2syK5Wg5ksibJkcXLTlkISQzbuwYpI4eCYsq50W4/zoaV0yTELkTxkSRRXvUAA49TzS65s+dg9oZEqNGhiSGz0cKFxZ/F3fC4ccuyshhx3INjbZ//vlHJe7PnjED0x49gq2NDYoXK4ouXbsqQdm0cWPcu3MHMWPHRvWaNVGlShVPidUc2aIhP37USOWB4LFHz0O/wcPRvn17VfCDngxzFCpUSImiAQMGoHi5/x+jadKkxooVK8yGc+neHEwIPnnqlDr+ihcvhg4dOqpjvnOHDrhm1BE+cYIEGDVmjPouIWSge0jwuNaeC0tM7OZ1cNu2bciRzUl1kzeG69uyaSPsO3gIW7duRfnynhtEClZEYORcBCMsxGKu39GdO3fU/d4/+NpzwRtbgQIFkC9fPhXnq+HNjkmgvJjzhiYIQuDCxFiOQsePExubVy/Hw+uXcGjXVhTMl0cZeDTGvIIDA3v2HzA7Ksj5YcOEUQaiV+VpLbEWvTVAw+XgocNokCmJQVho4jiER7kU8bD1P88AbwIvXr1GqRTxPC3HztYGfyWNhfNnTnt6jQYQvc2Hjx3D9evXcf7CBThlzYpaNWoor/ODQ/uQ+91z2Fw5r0Ku6tetq7xVGobT0UvWsG4t1Kxa2ZBfFy1qVFXxKbqjo3rdO+jx0J7ucePGqbjePXv2ehmSxeVx9Ozd2zfo2r4NWjVthHNnzqJs2bKoWrkybB4/wJzEjjiVJjaWJY2OBO9d0KhBAw/3KMGy0bldxondlpbrpa+DfIzjRfifHrTRHb0FIaRQvXp1NTDJ6zIHonh/YLoDr9F8zT/4amiAcdi8yDdo0EAlenDS9O3bF48fP1ZZ5lwRnnytWrXy18oIQmiEoR08mXlTYm14n5rQzZ49WyVkL5k701DBJHnSpJg67l88fvIUkyZN8nLklrH4HAToP3QEBvfrrXoN8Pv37D+I2fMXIkfOnB6qwFGE0GOhm0lZYi16a4DV+Ej08Oabc0WPYI+v73+HnNrb26vH99/MC7x3334gfASvR5t0+FO9OnVw7dpV/HRzx5B4UVDT8f/VcE59/o6WJ08qT0XPnj3VPHrJ6OEoXeIvT8vk8fFX0cK+MurVe//yvAxTKKLYT6VJg7oYNqCf8lRQAH8r64qFy5bD5stnLEgVC5H/E2NZI4bDjERhUePBO0yaMAELFy/28TsEy4CeUA58aO+FpV1b9HWQXccPHjmKr9++IUL48B7es2ffASXgOdgqWDfWVtGuXbt26pE2PO2B3r17q+s0y863bds28MQFXda8yOtED2M44sSpdOnS6sRjYreIC0HwHfQyDB0yBNeuX1fPeXMqXaqUakbnVYLs3r17Ual8WU+lEfnZOjWqoUe/gWrE2VgkaFjN5MCB/VjsvAIbt2xD7pzZ8eDhI9UtmTf4r1++IEmSJOqzHB3mucz8C0sPWQjpsGJOwvjxsOvuc5RK6bH0Hy/2u++/ROa8BdRzJt5lz5YViy7dR/nUCZS3QvP801dsv/scHbt4nxw9ZcoU3L1xHentwyCsDTwIC5LTIRyqR7XHkoULVQ4HvRRa1Hz8+MnsMt9/+GB4T0DAZHUamT27dFLHZ5MWrfHw6TPEtg+Hn99/4Ju7O0a/+IhB8aIgzH83+3A2NqgRJRz+3r/P0JdACJlNYzlQaSlig+vA6x4NLXqHe/QdgH9HDDVcY4+fPI3xU6erogvGhRcEK4SXGisrRWtjY6OO65YtW+L+/ftqHu2AP7me+yosihdpxnP7ROLEiVU5OUEQfOb48eMqHCValMjKC3Fw51aMHDwAZ86cVtV9mDhoDo7g2tubN5r0fF0/3vPr9ti9ew86d+6MsOHCYf+hI3j5+rUaIGBoTpRIDhjctxdaNG6AQwcPqgEFeib1dcASQxasARouTZo1x+prj7DqygO4/Vfi8tvPXxhy4BJuu7xHs2bNDe/v3qMnzj57g2abTuD0Uxe4fHHF5ptPUHPtUUSPEVN5mb2CYsV5yRJUjWKPFz9+IVdE88cS57u8e2cIi2NOBMuNL1zq7Clp9cnTp9i9d3+AdtZm2WR65Gxgg7qNmiLCuzdYnSwGDqSIjuNpYmNA3ChY/+4rJr70eJ5EsrWFm9vvpmxCyITXohcvXqgiBnzk8+CE1zte99jbh9fm9Zu3IkveQmjapj1KV66OavUaqvc4OztL4QshxMLBGObMcfrTgSJfiQs21Pj7779x5coVL99DlzldKkWLFv2jFRKE0AITbDOmTwfnBXNUpZEUyZKiQZ1aWLVkoRo98Kr8W84cOVTpTnPG0/pNW5UByI6y3l1AKC4obthQb/nyFbh8+TL69+ym1qVJg3ro1rE99m7ZgMQJE2Do0CGqizdHzPkoydyBQ4sWLVR8a7dd51Bo0V40WHcUuebtwvwL91Q8LAtmaBj2NmfuXNz6bouqKw8h66xtaLv1FOKmSo/Va9ea7SmgYVUxioaM4cMimp0tHn03L0Q5P2wYO4OHjKNbzLFjhSdWfLp05apK5t6yfSdqNmiKmLFiqfr/AQXDA+8/fIBlK1fhtcsbTEsQBRki/Ba19rY2qBs9IprFdMCyt1/w6df/xc6uT65Ilzq1J8+eEDKw1DwvXvd4/Rs5ciSWL1+uctNOnz2P12/eKg+vznWzFEEkBCL0lAb0FIwwrYGVIgMSX8U2sG5zp06d1I2Po1eMC6eKp6ucngoKCxopnC81ngXBZ3jzYcWnKWNHe/ICUGQUL1JY9RGoVq2aCksyDg1o3qKFquTTqWcf5WWIFTMmPn36jCmzZmPvgYOqXCJL0/L9bIhnKgZMqz+x/0HcOHHQokkjD++LHDmSEhlNWrfD7du3kS5dOtm1gQivp+PGj0fdevVUSBCb6NVNlkyFpzH/gPuUAoMij7DefvHixdWNgfk6DKNj0yOGMfGY4UAPjx/T/c/Y9qiRI+OG6w+Ujxoek199QivXn0hp///bwbtfblj6wRVly5VX79fwO6dOnapC+Thiq8mTOzfGT5jgKw+3b+H9ZuzYsVi8fCVyOIRD/LC/E8iNqRA1Ama+/ozL334gW4RwWPjmM/Z++IZxg1sH2HoIQYsl53np0C0Wt+GkofDhNZ3ryHW25F4dgmAKBxsZ8lc3AHsN+UpccBR07ty5qo74rl27VAM9uqx5wnN0iLFZXCmWwJQYV0H4P8x94EgWm9Kx3JtGj8zFivW7/KspcWLHwu1799UNi+5JZRD+VwI2e/bs+Pfff1UxhS3bdiBx4kR49vw5vn79pkqNDhw40BC2QiOTo2osEU0hYToqyJsgw57SpU1tNo+CnhVdclrEReBDwyRnzpxq4r6hx4ICQSd8s5pXjZo1MWzYMHVMUJDkzp0bM2bMQNs2beD6X+hauLBhsWfPbkyaNBErVqxUfYmMv6NWnTpwnj8P8xNGwab3YVD/vgsaRndAtohhccf1Jxa8/Yqv4SMqT4UpvM5T8NDzxWOJyzauMBZQ8HxhoiELFET3InTr13/hYyNefMIbN+DN9x/qM6ZNBIWQg85vCAl5XjovhBN7fPGR1/s9e/bg3bt36nrMBpPeeRKFkIe1JXQXK1YMhw8fDnpxoeEoKCdBELyHI8kMe1qzZo0SGDQCWfSAgoAJfxxljho1iqp+UyBvHg+fZb4EPRDp0mdQ8fG6yZTxSBhvWBy15vIpDuiu5w3t6tUrGDagL8qXKYXPn79gyfKVqt8BP9+jx//YuwbouLYousvUtm3bZmo3tW3btm2ltm3btm23/6990jN9mU7aJI379lqzJhm8ebjv3sO929uMCjISzv4KXcyNOPtDQCdaNOdNxiY8H9SDWDB/PlpWLI5K+bPJGFqx6xCGLliKN69fY9LkyfK5BQsWiLNRKH9e1KzqIMGgdRs3Ycbsefjw9i3q1K6NXbt3O1PFpmDSjq1bUevObRQLTofCHyY+eQsW2nHZJJtTt+7dJRttCxyD7mHF4b2wevVqXLhwQRxlUtPa0sVQJ5iUyw8ePMDSJUtw89NXxDFkV4gVLz8gSOBASFGkmGTVme1wSWfDhO+A9jfw+jOAqdo6Pi0DoBlg7iMplZlpvn37tuX9WDFiYO2aNRg2dCgGDxnibkpPEyY8G7QNatasKTYLsxjGbLWnOxesySbvLW8eGiPFihWTFLkJEyZ+gs4AS1iqVa2Kh48eoUn9OsiQNi2uXLuGqbPmSNSXxhWN9VKlSmPWPEdkz5JFVLNp7H/69Bn9hwzDvfsP0KFjJ8t2ucCqaq0ushEiRLAwszGryL6oWZMnoGC+PE7vhw+Prh3aIkDAABLZJhMEM43WUcGSJUtiyZIlmDJjNpo0qGv5TbICDR8zHqlTpzKzFl4MZoY533arVR71Sxa0vN6wdCGECxUCbcbMRMsLFxA3blxxLMqXLolRQwZaImoZ0qZBsiRJ0KpDZ7y+cUOU3BmdUrB8acXq1VLitNjREc8+fECkCBFQolQpNG7cGFGj/qqh8bc4dOgQ6tWpjRcvXyFusCB4/vWb9OkxWsZFTXUzCKMTzMVu3+7daHTvBXpHDi6N5m+//wfHF+8x+/l7tGnbVnQ5TPgd+HRqWnV+GfhhpnjXrl1C0VzToRKu37yJZStXw59/f9i8ejnGT5kumWMGldgQbsIPwI+J6DVt2lTmWkpO0D5JkCCBs/fnzJnjOc7Fnj17xIhhRIiRLKb9OOGzD8OknTVhwskYYn04RWi46NDIy5MzB0oULYKECeIjV45sKFOiOAqVKochQ4Zg1KhRUnLCEsOaDRojWdIkiBMzJg4dPYbnL17Izc5SEzoC6lj8rjRg48aNiBE9mmgNWKNmFQeMnThFFkA6EtZRQZbgkIau/9DhwuHOCPiz5y+waNkKvHv/XhwPE14L9k5QQbtKwV+zA6VzZULvGYuxadMm0Rx6/fo1mjWs/0uqvmzJ4hg0bCRevHyBM2fOOHMu1MEgNTEftrJWrsHz588lc7J71y75P3eePCJ6Z10GQoe7ZrVqSOr/O/oniIAYgQPi83//YdmLD+jv6CjOjNFBMJbG0MgcO2ECOrZrh1o3biBYwAD4zAZuqiI3bChrkQm/T03rk6DOL7PFO3bswMxJ42XeVNSvXQMlK1SRgNLwgX1x4vRp0ScynQsTPhFKFmLsI/pbuFpEj/RrvXv3try2ePFiqQemyIYx4mTCxL8GLjKk/mTNYrnSJZE3Zw7pgZizYBFKVHDAsgVzkDxpEoQLFxY1q1bGiLETxLFg5oGRgjVr1mDDhg14/PwFcuXOLfXspHWmsajOxZ9KA1iTHzJECJu1oKFDOTX0at2+raggRXNYH8zeqj6Dhgp/ezF7ezRu0gTx48f35DNowtb1DBgwAILaoBwOGCAAgtgFls8oI020qL8KL3JejhI5klAN/4k5yT2OBbPZlStWFOcm4gcnJp+DBw5g4vgJWLRksbCWKch89u3zJ4yNHx6hfojeUZPCIVww3Pz8FdOnTpGMieoGWJfGUENp6YoVWL9+vfwe3ytcuLCUA5ow4dVQ55flUDmzZXXmWBBxY8dGnepVMX7qdPTp3gUlihbGvEVLzQvlR+DXei6aNWvm4dt01YrC6CoZSIygAcR0IJmiTNEYE/8yKGpHGsJJY0ZIpkJRrXIllK5cFT37DcTS+bMtiw6NJdae03CicVS8eHGpXydFKNPtNAqZomTtPI1CTmQst+Iz37flYKRLl05Yn5iSpzaAEes3b7V8xqWoILfNki0+TLgM1v/ToGAkPmbMmNJs7RnNmmza//jpM3adOIe86VM6e+/klRt49OyFfIZ9BsTufQdQtJBz1eunz57h7IWLMnY4X3sEuC1mQajU3b5tO+DFK+R//BZ2350aqz/5/4gj3/5DnVq1sf/gARnLHLP79+5FjqABLY6FEfahgmDOzeeyzqRKlcryurUTzO1Qj4XEAibNrAnvhDq/jx4+RJkStu+tlCmSyzz/4sVLfPz4yQzC+hn486SyKH/wS3CVc8EImZHphlAefRpEJkz8y5g4cSKSJE6E4kUKO3s9RIjgaNqgHpq17YC79+4hRvToOHD4CMKHDy/sUcoyYjSi1Ikw1hmzOZzRWtb30ljjvWhN+cnG2MGDBqFJq3aYMnYUYsWMIa8fOnIUvQcMluZvMwPxd2DfCjnu6fjFiBYNt+/ckT4X9gt4NDsRHcH06dKh06T5mNqxMVIliC2vX75zH61Gz0SC+PGFalbZoniNmR3T606jpl2X7pJVY5mSOiHuBccg+zOWLV2Cx0+eWl7P+eydxbEg+HeKZ++wx/89cbqzZMlioT12ypv9ik8/vm4rA250gr1b58CEz4BPUe7mvM3eOTrwtnDuwgUEsbODXeBAWL56LTJnySKZRlMnyIRPAysvfpeN8bSeC4JMCPv373f2GneGUTyWdxhfY6mUCRP/CkgXmzZlcps3Z6KETo1RNMju3nsAxyXL5Ea27qFwqb6YRh3FbVRxm7+hDr3RwWA5yZy5c1G9WjVky18YaVKmxLv373D56jWkTZNGejxMuB8sx2HjdKO6tdGqaWPRAHn+/IX0qbBXgNlbo8jd34LXefKUKahapQqKteuHJHFiImAA/zh77RZix4qJObNnW4xxLVvNUbAo8uTMjlAhQ2LLjp14//6D9NjQ+XEv6OwOGzZMHIuvX74ga8wIGF0uO7Zff4g5x68hzBfnSt0EXwviP4CUTSl9cc7cuTH6+DHc//LtF72KpS8/IHqUKEiSJIm799PEvwFrjR6l5/YuOFSpIlUdu/ful746o2L9zLnzkSNbVtRr1gqv37xB2bJlZT43tS98ObjMe0ZZlD94GxigUvDeYoae1Rhch9wrjOpq54IlF7bABlYjTOfChF8BecpVnOx3ETJmIg4fO2FZ8Iw4fvKU3BMDhg7HwSPHJCJNek3CpR4KjczRsGPGQjUrCL7G//k6s4fG77PGfe++fRIIoEAf3+vSrbs08pp9UX+fncqeNTO6dWxncSLZQzO0fx+cPH0GUyZP9lDngmCT86bNm7F582Zhe+J1b9iqnTD1UftEwfIsfoaN9xs2rMe9h9eQP38BIdz4W/2JsWPHimMaNXwYRLPzj3llsiGgf/+49PQ1vvoDvvgDAv1MXAj42pf/vkvpkjI+0cmZP2cO6t15ha6RgiNr8MB48vU7pj97hzWvPmBwl17mGDXxW9jS6PFuoTo6DKSbrdGgMUoVK4rMGTPg+o2bQgH+/sMHbN2xU5Tm2Z/KdUS1MHxqo7qJfxPNbPRcUCC7Y8eO7taXcdW3Ll60nfYzYcIv4vTp06JyfeLECfmfNfXMNlDBkka6MR3PBY/OAqkGp8ycLZFtxb0HDzBy3ARh/fn09btEgFm+pBkLWwuMMTJHR4LbpzHL/7X3gvvAZ1uLFA06Unt6pBjOvw5eg+PHj2Nw316/ZKd4LYsXLYLpc+Z5ym/z+tKZ4ON3YKlc3bp15WHE5cuXJbNGB+R3vXHUnaAqOHsp+DnqqDAzNmniRFQukAMLt+5F16IZxLEg7BNGQ5/dZ3AjeGAkeusk3Kfga4zs6T5znNIRJuNTt86dUe/qVSlZZjVVsCBBRM+jWrVqf3GWTPwL8InK3fzd6TNmCBMUS0eWrlyN0KFCIVXq1JK1I7vmzZs3hQxHHSO9V20JVJrwJYkLT+i58AefBdoStINKly6NRo0aufn7Pk/y0oQJb8TRo0fFMI8XJ7ZEpcm2s3PPPolck6efEShGjdkzQYOJxhibTNlc23fQUFHMzpc7Fx48eoTlq9fg8+cvqF6jhnzPrZE5Lpwsh+IiqkJ6uqjqw4TnQ1m7lG3LGp8+f/Jx14KOcdfOnXDqzFnLa9myZsHgIUOdCePRSe3VqxemTZuGCHaBEDNQAGz4+AWjRo5Enbp18er1axTJklaci3BBf2ZLooQIigbpEmLSsSv4GMAfYrx36oe4GywQbgUPjGZNmgjDk1FojAxoK9eswaVLlywieuwFsu7nM2HCNyl3c64mdXiNGjUk0633FctXmflj6XiiBAlQpIBTBvn8xUsibHrt2jVZV0yY8KlghQQf7oHPWhFNmPBG0LgnA1rSxImEPpbNeASdhdw5sqFG/cZSh5gtWzZpmNXUPI1+Og+kcV2/fh1On3NStQ4eLBjatGkrFJvuiczxmfuki6cuqnRufKJirV8Fz3nuXLmwaNlKUcA2GjMfPn7E8lVrf9GQ8E7QcK9YoQIShg6K6SUzI1H4UNh76zHGHzuD0iVLYtOWLRaRPJa70rHoFDkkqoQLhpffvmPVyw9Y//ojpkyZIp+JFTkiwoYIhm03HiJHrIiW3+mcIxnCBg2MIXvPiUNBhAsbFt2bNbPoH9miPaauCh8mTHiEcjfB+dgnNHgbiTmuXr2KVatWiVI3WfwuX70qn7MLHFjWmDWrV0v2wiTa8IXwY1S0nTt3/uU1OscU582Tx0mU160wnQsT/ww44bP0Y/asWbhw8SJChQqJEiVKivHPLAQbUE+dOoWp40ZbHAtF/jy5kSpFchFNonNBJ0AXOI2i1a9fX9LdrKtlSUnChAl/6cFwa2SOjgTLsox0tN69iP6LaN6ihTRNN2zRGh1btxRhxDPnzqPfkGEieujdYqLMBrD/jSV9d27fRkS7AFhULhsevf2IvrvOYOuNh1KG5N/fO2GPok5RxIgRMXXSJBQNHRQ1wwfHzGfvMPLRG1k3IwR0Grcs6dt06ASqFc2Dycs3IlP08CgSP6qTmvy377j7+j1INcAILVVd2ZRNp9i3iKGZ8F2wdlZpALHsz6c0eOtYZ8aOTjvn7MdPn6Bbh3Yiavn12zcsXLpMtI78+fePDh06YNmyZd62vyZMuITgwYNLL4Z7mRBN58KEnwcneNbMd+3a1UmpOHdOdG7bWoTuHJcskehtwYIFxWkg4sZxov20BvUjbty56+w1dR64oDDlzQcjUe7h4XcpMmdy+ns/yKbBSD4b3PLal7SoppPilbXWf9s4/Tego0DGmogRwoug16mTJ9EoRzI8ff8JZRfvRvDAAdE3T2okihASJx++wMSjV1CmVCnMnD0b12/dQrPoobH+1QcMefQGtcMFQ8OIIRA6gH9hdqpx8xlGLFyNwU1qIG/6VGi49jAShg+FWKGC4vC9Z3j39TuGDh0qja0mTHilAe8TG7wJ7hfLZanbwrVnSL/eKFeqpOX9lk0aCbtfn4FDcOjgQYujZMIXwVN0LrwPpFT3aJgj2oSfxtu3b9GoYUPs2LlT/udEX7VSBcv7jerVRonyDtiyZQt27dopRuPBw0ckbW0EF4BDR48hrUGIjp/losZafC4i/JtRM0Z1ybTgniyDrTISEz4DRYoUkfKnHTt2WET0cuXK5a2GAZtFWVpRqVwZDOzdQwwbNpVGCBYEow9dQqAA/rG6cm5Lv0Tm6BFQNEE0FJ6/EzNmzJDXXn/7jkUvPyBniMBoH9lp/BKkjF0RLwLyXH2KNmNmInzoUIgaIRyuPH2O228/olTpsmjRogXixo3rbcdv4t+FlpEyoMOeNI5bBmVcEhr1KjCbwjWBz8GDB0NJ+6K/fKZqxfLoN2govv33HwYPHiyEIGYQyffAryl0uwT2BfF+cg9NuOlcmPDToOF15OgRZMqQXqJaVSqWd/Z+xAgR0KJJQ3To1hMJ48fDrdt3MGr8JOTOmd2idE3HYfiY8ZLp6PpD6ZiLF50JOhiMQnFh4CLHdDijVlzs+Bntj3BLqt4sI/G54DUvXNi5WKJ3Yv78+QgZIgT69ugq44aOTvw4sbD1+kNsuf4AzTMldtaITcQKHRwlE0XD9q1bkS5tGiy8eB4XP37FkOihf1k0Qwbwj8phgmAtgqKig4PUtqdJk+YXOlwTJrwaHOtksiR5AUta2WtEfn7eD6XLlBHHlyJ33oVEiRLh2dOnNoMPDCAFCBgQwYMEEQ2dcuXKSfkr6WpNmPBqkIygT58+vzAKstKDVOSkQncrTOfChJ+MaK1du1aExg4dPiysT4uXr0TKFLaF7lIlTyYORI0qldGxey8EDRYM+exLoUiB/IgSJTJ27N6Dq9euo0GDBkiZMqUzhWxt3qMzQbE7evkqeKdRNZ+QqjfhNxWD2WuRMX06BA0SRP7n+K5Tqya69uor/8cMbbs8L2ao4Hh76xk61OqE1q1ayWvfrPQqFF//A+yCBLbZ9GfChHeAcy2pwdlwyr6g7//9J4Ge3DmyI2XyZFi4dDk2b9qElWyojhXLS/eNcz3nApIWcB06fvI00qdN7ewz23ftkSxLtKhRZO5gpptBKQYvyERowgfDnyeVRfmDt+Hw4cPSK2oNOhvPnj1z1zZd321qwoQvMPIofEfOfFIDMmpEUNyIlLLnLlwUR8AafJ3ImzunPLOBqWbNmrh68xY2b9uBhIkSYdGiRdJ8Fzt2bEt0iYsCU99cFFgmw7+5fX3QudAUOT9rwu+BmSo2lD558kSe+b9Xgo7uvfsPnL1Ww6ESKpcviwD+/GHf7Sc2v7f/7lPEih1bshB9+/WDXcCAWPri/S/3x4fv/2HDuy/IW6AgfPO8wIwLn034fnAupbbQtWtXhXzjxvlTOHtkP9q1bIY9+w+IBsGWNcsRMGAAV1GAezQYYKCwatasWRE2TBg0a9MeFy9fsby/aet2NG7VVj5389ZtWTsoMlnFwUHux+bNm9s09EyY8OiS8fv378uDoB2j//Nx584dcY5J1OEemJkLE74+SszXyC9Ow4515NSjcJw5DU+fPUPzdh3x5etXMbaq1mmAZavWoHzpn811z1+8xNjJU5E3Vw68f/deXqOiaoYMGSRVyNKPyJEjy+vqICh3P/+n0aLQDIYRKnZny6kx4bvhExpKS5UqhVorVkh2LW8uJ+eYEVwK/u3auw/LLtwRwbt8caPIexyHi8/fxt7bj9GtWwPZZxpBQ0eMkDKSrg9eo1nEENJvcenjFwx68g7v/AVAvXr14BthFKX0CWxCJv4eVKM/f/481i5diLSpU8lrNOLZKE1q6Gmz5qJJ/bpoWKcW+gwaKgEnr84GaGZ78pQp4gjlL1YKSRIlwsePH3Dn3n2EDhUSVSpVQ7QoUbFr714JYiVJnAivXr3GyhUrhLVw06ZNUnJrwqfBnydR0fqDV2LWrFkYN26cZLv5sBbK41rBskKWRXmqc0EvhpzNXMzYyEjcunULgwYNklpH7gRVjIsW/bV5yYQJj3AoGM2hsUBDgcabTuCMGjOtzNdXr14tjkSuHNnw+MkTcUIcFy9Fo3p1UKFMabTq0BmbtmyTnor7D8gWtRTfvn1Hz84dMWzMONkmBfEI3nA0Rph9UAOF0H4KZQxS41JVtRX8vjJI/SsNYP8SfIJiMBvM8+TOjXpNW6J+7RookDePRKCmzZ6Hh48eI3XqVKi16iAyxYiIxOFC4MTjVzj78LmorrJBnWOY2Q/WfHO/e3TripVXniBYwAB49/UbokSMiDkzJ/pKLn6f4PyZ8Hhs375dCDfUsTCiasUKGDtxipByJEuSRK457wfvKDXiWpIpUyasW7cOJUqUwMXLlxEoYEBEjRIF65ctQvjw4eRzNatWxpIVq2RtmjV5AuY6LhThVkdHR9SpU8fL99vEv4GaNWuiTJkyYrMUKFAAkyZNEvp8BQOrESJEcPf2XeVc0IMm1SG1AKioSrBxih45jTrSED5//hzt27eXxZUOiAkTHmEcUB2STgXHFY18Qjj2P32S1/i3vs40H8dh9iyZ5f9IESMKM9TgkaOlea5Pt85IkyoFJkydjvWbt4jRnyVjBslatOvaA8dOnBS1YvI704mh0cXPcJuEMkPxwRvPOhtBQ42OB5/54Gf4fZ+gImvC5yoGs29i5syZOHniOIIECYoiRYuKFoUKhP0OHF/Tpk8XxpmZcxeIYUVQNZ4Uy2SzYmp78aJFOPboIWKmzogOQ6oiZ86cFvV3NbQrVaqE4sWLy3xPh50sUHnz5vW1hrhPcP5MeDw4bq21VBR2dk6vM2B06uxZ+Zx3NklznCVPnhxHjhyRQOyCBQvQqmkji2OhYDZ98oxZWL56DXp06oBtO4vLnGA6Fz4UfiBYGDJkSGdZXOoekVrdo+CqVXDEiBHCDtKvXz/LpMwbhYbfvHnzkCqVUwRh8uTJolJsOhcm/hY07lnqROeV0AwBQUNB+xlsNdLdvXfP8lrvrp1kMeo7aKjwiqsDoKwI+w4ekgd1DOi5s2Gb26XRxt+nY0NjhNtWx4FQukMVt9OyC6Wj1X3TUgzTmPF7cEmXxC3XeuXKlVKOFD50SORPnxKv3r7D4EEDRehxydKliBEjxh+3wdIJOsXsCSI1LZnL2Buk2TLOx66dk+lY+xXNCo9y/kz4LGTJkgVLliwR1Wtl9FOsXLterm+0KJHRpVdfYXZjkMgn9PwUKlRInIsUyZL+8hneqymSJsWNW7eQIH48obDl+mPChFfpXLhmrXELXDXLsuGofPnylkWTkTZGt9g4q44FwXISGmgmTPwNtIfC2ARtdC6MfxtBwz5HjhyYOW8BHCqWR+hQoWTMsv68VPFicKhVVxg8GA1KmzatbJ/1uPwM+yroSBi3TWeCjoNyp9Mw4f9a5sTv07BTx4KvMxVO58I7GYRMeB3+RpeE2V8yNZXOmRFDm9WUkgnizqOnqNRjBNq2aYNFixe7ent0KpIlS+au4/Br0PuPzpJmPk1H32+Azc8UbqzftCXGDh+CZEkSy1y9duNmDB4xWkRQK9asK/dm3bp1vV33QjNo7OXjunH67DlhtDKC68rZ8+eRMEF83Ll7D+/evUfs2M4dJxM+CH4gc2EEy6OMUJuH86enOhest2WTLA0z3sTMWrDko2HDhs4+d+zYMbmBTJj4G7BGliVOnIitG6T/BPb9tGrVCsXLVRaBPGpXHD1+EpOmz5SUHyO8HKPMLHD7TAVy8mcWjhM8DURjuZNmKgh9nZ9hLaKWWhDWxqWpVfF78Pyzj4sGsUemYr0D7r3WCxcuRMAAAdC3QRWLY0HEjBwBHaqWQvMR03D16lV3s3X8q7Bu4uYCqVlN09H3/WBAhxkA1owXLFEGsWPFwpu3b/D8+Qu5xmyKZqaO/Ujbtm3Drl27hIWJJX4MAHlXBo2Bp+zZs2Pc5KkolD+vaCwpFi9bgQuXLqNbx3YYNHyUfJ4ZTRM+FAa7wC/g/fv36Nu3r9wfrFCivgWTByyTpf6Fe4gFArpWiIyOBFWMaYQx4tapUycxzAg20R48eFCe+VkTJn4Hl6L6fJ1ZMm3CdA+Y2hs7dqxk0KhZocrZbKhj2QgzFMorbqzF5mtabmVsvlblV/YbKauCftZ4w5lGi+vAfhWWWc6bOxcvf1znNKlTo2OnTtIf8K+AfTzM/oYJEQzLdhxAqZyZEDZUCMv7OVI5lU6YzsXfN3Ezc8H717xH/Q4oULd79265hxjUZLCT8weF6Dg3s1+BukTUwAgeIjhevnyFOLFjY8rUqdID4V3lky1bthRWHrJHVSpXVnQuduzei207dyFD2jQYOGwkzp6/ID1RNOxMmPAKDBs2DPv27RO7Xu8vOhnjx4/H6NGjLa97uHORLVs2LF26VNiiWEbCCEDBggWdUVpxAmfTN6MJJkz8qUFbwci1MjJRrIUZC1tgJIefZe0qnQEa/Vq2pO9zEqfnnThxYowcOVIcCH6eTGasuzU6M9a12HzWEgp1LpTpSZWI+bdZt+1+0HHjwrpz5w7Url4VBfPmxbPnzzFjzjyJktAgUMIIvwxmLLp26SLjN1KkiOg7ayn6zV6KfvUdULmgE53sncdOwkWuaeo28RNmE/e/A87lNMDVCOf6cvfuXVGtJ5lBuxbNULdWdYQKGRInT5+RYFOVKlWwY8cOcUK8o3yS+hckWGB/6sJlK2Q91Kzl0RMnhdWqfv36QoPOeYIBLHWaTPgg+LGyqM2bN6NHjx7SF6TjlQyCtInYj+FpzgVBg42RX1tYvny5m3/YxL9X6kTHlAuAZgBoXLGEgVFcOgnGEiRraJ8DJ2j+zZpA7X/gIsPXtZlWxe3U4eDv0mmhk6A897Yacfk6I5z87PXr14Vymf8rFa1Zt/13WLx4sUxi0yeMQZGCBSyvFy1UADXqN5aSNZYyuIa2l47Kzp07pbGTY4sN+mSvY/mDT8bevXslCFOlYnl0atMKIUOGwMo16zB34WK0Hz8HkcKFRp60KTB+2QZEjxZNqCxNuB5mE/e/C871DCJR8JQsga2bN7G8lyZVSsydNgmZ8xQUo53q3t6xf3xQMZzifirwxyAYq0HYZ8gg7pw5czBj+nR8+9H/xzXO3t5eIsga6DJhwiPBoCptKGvQuaUD7B64qnDs+PHjzsTCXAJLWujlmDBhBCdOqhfTSKdDQeOfTobqQmjzEEtmbEEZmfjMXgc6AZykOdGq1gS/TyeFjoHy2Wv5FcHP8KGvcxsskWJpH5+Vkk23S/CZ/7v0WROuB0vVaFTHixsHhQs4z05w8WzasJ44dKdPn/7jtnhNmQFhf821K1cQMWwY7Nm9Sxjthg8f7qMvy6SJE5EqRXIhGThx+gwy5cqP1p264tz58/J+/UETUaRNH2w+fBI9evb0lhpx3wwtQSE4rxAmW9u/AyoLcx2oUOZXdjRSk+fJmV0YLn0SuK5xjWTz+cKFjtKH1bxxQyyeOxPDBvRFnNixsH7dOtSqVcu7d9UEwdgXA2Ae/oC3gUQ4FMvjODTeS3Ro+Z574KrMBSOC9KiNtYr0pFmPRS50BSOI9Lo7d+7srp0x4bdAI57GPjMH7lWoZiSS5VBaPkXQUaHRxfe0jIoeNp2Tx48fy/9avkSHQpu09X/luXdLI67ZoO1+bNy4UUggyOISJ1Ysm5mJmD+aul3Tb8N+GtZaTxk7CvaFC1qyYGyUHDJiBNKlSyelmz7xfth/4AA6tG4hjDH1mjRH7rTJ0LlXCySKGQ1X7jzAgNlLse3YGXTv3t1P1VyTYZBrCO9PRm4rV678x0Z+9zKu/Q2Dlwk/Aheyn/78+ced27elyZtZQZ8wPhh0Y1D2v+/fRZ9jyaJZSJ0yhbxHzaaS9kVgX64S9u7Zg3Pnznl5z4gJv49u3bpJsI7tDgygqp0VNWpUec/TMhe2DENGGV2KNJv4t0GjgP0T9IJpTLiV8YkZA9am0gghXz8HuCpFqu6E9l1wbPKhGRGjSrb+rjF7YfLcez2mTJmCrJkywr5QQRw/edJmFnTvgYPiJPxJCZrXkD1eFcuWRrEihZz1x7Rs0kgW5RkzZsCngeV/nKy114dCjrGjRMSUjo3FsSASxoyKKZ0aI2HMaCK65dvBzAFLZtmzx3I3x3lzcPPcSUydNAlZs2bF7Nmz/3i+KObHZ/7vFtBgZMDBuw1HE14Llm9HCB8ey1au/uW9p8+eYeeevdK/wDnJvWPLo9fKCxcu4OTJkwgXLizy5MxhcSwUrHtvWKcWvv/3n1mC7lPgGZkLbwQdCvZU9+zZU3p8SCjAHgy+ps6GW2GqCZnwFPE7OgEqLucW0EjkYLYWPuI2WftHh4ETMh/qVKgho8xO1gxQWlJl8tz/HXiO2XRNGshbt26Jw0f9G5YosRHRJZDNpUen9sifJ7dQAvfsPwgDenW30PhSDGvY6HEoUKDAH6PZzILRac2dI7vN97k4L1q+Ej6VwYiG9pIVq3D//gM0L1fEGQUtwf/L5cmMEYvWwTeDGcWqVarg6LFj8n/XWuVRp1h+BA4UEO8+fMTgeSvQpUsXYSWho/Enxif+791iaCZ8PjheKjs4YNy4ccLEVKd6NYQIERxnz51Hxx69ETxYMBQpVAC79x2Q+UdLZZnp8g5HlGObcynxneKusWLa/FzsH687OjpK3xYNQJaZ2qqTN2HCPWAwpkKFCvAomM6FCQ+DGgXMaLk1W6GOBTMWthwLRpi0tImOgjZXaxM4/+frXCC0v4KLh9LNcrvetYD4BfD81q5VC/v270fxIoVQu2plXLl2HTNnzpASpWXLlrnIaMJr8PrNW6kdHtqvN9p17YHtu/YgX+6cePL0Kbbt2IXYceJg8ODBrpoAec0f/Sh/swZf92k9MUYGI7LpUcSRY9nasVDwdRoa6hT7RpAb/eL584gVOQKSx42FRqULW94LHjQIeterjAPnLmPq1Km/OBcuMT65Z04x8e+BwQ46F0NHjcXo8ZOElINZixjRo2HBzKkYPWGSZANU14hjS0tlvRr8fZ03mXHZvf+As/t+9979mDprNg4cOiK9GB8/fMDTJ48xYcIEydCSFYsBCxNeCX+epHPhD94FlkT9bq1hu4OnORfr1q2TCKSCO0JKtcOHD1teMzaDmPg3nAnWixJa48z/tZHSNWAfBQ1G1Y3gBK90s/xbS6zUsNCSJ36efRg0QGiI8De5YPCZzo06F9rg6dMMTt8GMrDs3rNHFuec2X4ag6SULVWxijSD0aC0hSKFC2Px8hVoVLcWKpUvixTJk2H2fEehh2TWIkXKlLJ9vUa/q7XnGClUsCBmL1gIhwrlZAwo7t2/j9XrN6Jx48bwqQxGrJdm/0mXzp2xfOcB1C9Z4BehxtV7j4rB7VsdC2YY6Ww2KlkAoxavRVuHX5treWxFMqfB/G0HXM34ZDa3m3ANKFaXL29e3LhxA1UrlsPHT5+RLEkiyZxev3ETW7bvFN0u1SzyzlJZzm8UJybb3cMnj3Hr1h1MnDoDjevXwZQZs9Bn0FAkT5oELZo0xJs3b7FkxUpR7x49dBCGjR4rRiH7MMwMhhfDl87NLiFz5syWv2k70ZanjgzvEfbHuQeuvqNs1TFPmzbNXT9qwneDxh+zCSxR0dIjTm40Dvm/a5q3OamylIb9FXQQaCQa61+5PToL6jgQ2pCtFLRaAiVR4ECBZFEhdB806mlmK/4eCx0dUSBvbmeOBZEgXlxUc6iIOQsWSY2mrUW6abNm0pxcpU59dGjVEimSJUXpEsVw+eo1abCkJok6FtbqyrYcw7bt2okCbxmH6mjWqD4Sxo+PI8eOY8zEKZKh8mmsKkYRLY5l1rOOGz9eRL46TZyHTtXLIFyokHj++g2Gzl+Jk5evw7G3E02lb8TNmzclyJAnXQqMXrIOr9/bZhp88+4D7OyC/PF86TjwaueC88jWrVslsEa60FSpUsHBwQGRIkXy0v0w4XZQlLNMmTJYvnotGterI0xRU2fOxoSpMxA7diyZjzhGOaaYKffONYLzW+vWreVB9B86HHMcF+LO3XtoUKcmenTqYAk0tGjcEJVq1sHEqdMxafQIFCtXSQI77tEhMGFC0axZM1iDc17Hjh3d7Xi76lsXL15018ZN+A1oJJkGO2up6VjwNSO0SZeTtVHcTkEDgY4EnQY6EpzY6ZwYFbG18ZqgUcG+DW7PeltGxWxb2hOmM+F6MEJB3vdr166Jc0Y6V55PnvOUKVNaMgOkpSuQ20ngzRopkyWTaDXHhq3eiyRJkkifRrt27VC+2k+RzQQJEsjrbMLULBjHFn/fWGtvXc6WLFkyYR5i81mjFm0s44tMF1QV9YmCU9YMRjzPVEWlmN6ynQcQLWJ43H/yTJwtlod5pVo594nXl+c4SpQof50xUWfw6as3yJsuBRw370bVQjmdlYG9fPsOK/YcRpnyFV3N+MTFzqtAJ7da1arSM5IifmyECxkCY3ZsF0pllnL5RDYyEz+RIkUKyZ717dsXzdt1lNfsAgdG4SJFRONC2QW1zJZjzLuy2xzj6dOnR5EiRbB+/XoMG9AH3fsMkP6Q9i2bO7sfqYvTqW0rONSqJ8xS0aNGlbnQdC68GH4sc2ELXPu5npYuXVpKDd0KD80F0jCgJsa/oLL7r0AjyVru5FKDtjZX0yjkhG1ssKZTQaNTHQAaCWSR0t4IW5kO/R0uAqqJQahoHo0gwqSbdD/oVKgwZojgwfHh40dh8NESNC62tWvXlsbBqNGi4uyFCza3w9dVgNAlkPaR9I9Hjx4VQ5aq6RkyZJDxoWNMtU60PO539dCpU6fGypUrJUpOCuwYMWJYxoRPhTWdMaPghQsXluPgOSErGqOtXuUc8Z4ire/0adPw8NEjeY0OJa83HTX3giUeKVOkwNTVW9CxWmlU7j4CNfuORRuHEsKMdfzydQycsxzf/fkXNWKfSP/MZvMrly5iSf/2yJI8kcUhaj16puzz/v37zQyGDwczTRTZVIE6Zpy4jnHcM3DFeY5/cz3i397Vk8d5jusaDbjNmzdhzfpNMhenT5vGWdmnIm2qVPJ8++4dfPr8Ga/cKXJmwsSfwKChe0X0PNS5YIaD6RVSq5nw/TA2aGtvhUvQUiWmmI0ZB5Y2MSKuk7ZqX+jE/ifwe9wGFwBt0DZuz8xSuA9kHKFjwWuQJVMGPHr0RPof6lSvikrlyiBAwIBYsXqtaNmw56VSpcrCd73v4CHhXlfwO3MdFwtr1J/Sp3QkWF/sEjMQnVA6ExxrRm2S322XhiwfvhV0JNjg7R2gHtH8+fOld4W0vm/evsVcx0XiUPK6s/TsT31Wtu4/Xueu3bqhWrWqGDJ/FZqVt4fjlt0o0+lnw36ypEmxaNE0xIxpmx3HO0GK0tWrV6F7rQoWx4IIEyI4RrWsgwx12wtrT8uWLb11P024DnTa+WB2nesIx7Cxh48PXeO8Yz3Rkl7uV4ECBUUXiPfQjZu38OnTZ9jZBXb2+YuXL8vzjZu3pVGday2Pi3Onlhib8GT4scxFZxvadLwfDhw4gDx58rhrmyZblAkXwYixPrS3wSVwgmN2gpMkI9i2Mgoaof5dBsQIflcpZDlhctsm45PHoE2bNggTJjQWzZ6B8OHCIlPu/GjXohlaN29i+UzS9m0QNUpkdOvTHzt27ED27NlRtU4DlCxWFBnSpsGVq9eEVjVS5MiyPfeAjiYnMToWHEPMWuhCqbX3pgPp8Th79qwoFQ/s3QM1qvxs2CtWuBAat2qLXr16omjRomKsGO9fZomM+kZsJmVki5kjlgqpI8i+krlz56Ff374YsdBJc4BlURkyZpTacjLc+NSGdQbHvn79hgIZnSLERoQOEQyZkyV0lZK8CZ8FHZvWhCNci7ybLEBLsmjkMavPCpDnL15g8oyZ0mehoLMxeORo2d8pM2YK3e6Tp89w584dS58h10mzL8jE34JBXSYLKla0Xbrqq50LTvK9evWSBYzGBw+yffv2zthVTHjuZMzJ6k+OAK8NNQ+0odpWOYMxQk1HQctdXAKNGhqa2lPBbZuMTx4DlhLdu3cPo4YMRNLEiTBv4WJ8//4fateo+stnHSqWx6ARo7B582YpmZo+fbpEu5nViBghAmrUrCnsTHrt3QIuos+fP5coIg1WOo4cSx7tSHLRJXMMx3K8ePFMZhVASrHY5FqlYnln54r3GsUIC5Yog3379ll6C5TEQe9HlriNGjEcL1+/QaAA/vHl23dEjRwZo8aMQY4cOeQ77BvZtHmz9PPQiWSG6Xd6KD4BnOu43hANBk1E0jgxUKVQLmRMmsDymeev3yJBnKDeuJcm3APOJZxbrHt3NEPq3Q4G5zs+unfvjrJlyyJr5owYPGK0kFXYFy6E12/eYP6iJcJ4xX1m2dTxk6dFG4hMntSHopPP+5QBPjOD4UlgTMQzbFB/8DZQId6j4WOdCy5GrG3lTcYmukuXLokXxSbQcuXKeffu/TOTMcuctAzCuj+CDoBmK4xlT7bYmqy56+koqLOhTd06wfPznCQJs6fC46Fli/lyOTVov3v/Xq5LaBsiZUHs7BAyREgpdaPhz2ZIPv5Wg4ELPBdBo+ChsreQ8cmjHMkNGzZg6NChEtkjwoQOLQ4RMy3/ckaE5z56tKg2S85UyIuECwpeHy0lOXPmDPr07o3C8aOiQ+lMiB8uJM49fol+e8+jZo0aWLd+vTTxE7y+nLN9A3h8zZo2xeo1a5AkdnQkihUNxy5ew9IdB0Sno0vNcjhy4SrOXLuFlp27e/fumnAHmAnVzKiOaXUuNNDhXUEszdQScePGxf6Dh1EwX17cuXsX7bp0tzSfBwjgHxnSpcX9B4+klJHzN4OuenwM9pCi1nQuTHgnArrW0HcNPJLN4+rVqyhRooSl3IJpPjIqnDp1ynQuvBAakVZ1bKWdZWTEOrKs6twqosf3aJBywuNnjdz1nNBV30JrYI2fN3sqPDfdSTx68gThw4dDyuTJpB55/6HDzvopiPMXL+HBw4fS6GuE0bH4nS6FS+DiriJWKobIbXBcedTiThYV1sWT375/jy7iKG/YvAUTJ06U7A2FqHxqaY5nI2HChFi5YgWev3iJcGGdZxP2Hjgkz0anQJtOiblz5iBZpDCYYJ8RAfw7nb/kkcJgZsnMyDt3ByZPniz0wr4NpFZft34dJrRrgOLZncgGGPiYvnYb+sxYLA3dGw6eQPp06f6q4d2E90H7G7Q8V8svOSe6xE7nlVCWNNIfkwRj285dzioHnHpEgIOHj8r9yPWyfu0ayJE1C+7du49J02diyJAh0stVteqvmWgTHgF/ntRz4Q/eBdLI29vbI0uWLF7rXCiry5/gkYqyadKkkYeCxifT6+6laOS+eRaVodKw6rNfAycwTsi8BpzQNNpJo1IbPOlQ0LnQRm2eb81IsCGYkx0nTTqqWlrBiZQRc40eOUVlAlga1LwLfv160lHg9Zg0bYaIMWXNlBFJkyRG5559MHfqJMT+Ebl++Ogx2nTqKml39lvYuiZ8jddUdSlcm47XBZPjR+mLNXvlEdeeY4w0lKWKFcX4kcMs81LGdGmFOrdZ2w6oVq0a0qZNi38RpMKlEdKtdz+MHjrQYkw9evwE/YcMR6pUKRE/fnxn10JLSkjP2jt3SotjoQgSMADKJIoGxy1bPOX+9cz7kvMP1eZL5cyEEjl+kg5wPNYvWRBr9x3Fku37YV/MHr1797EYpiZ83zyrxCNct7hmKe015yBeU/YV0dnwLmE9gr9NgWLSba9Zs8bJCQoYEFGjRRMq7rt370qgddn82ciYPp3le+yHK17BAf3790fu3Lkt4rSeLbLnkdfSI+1IE67DiRMnpFrEy52LAQMGePvFJm0mJwOWSbkHNGI8m8WK0dB/DcZaVW361rHCyVpF8ZhyNqpr8286HT4Zfvl6VqlSBePGjcOHj5+EIapD6xZo1b4zshcoIs5GoEABse/gYXEW2PfETKItaBZKwcjf73ppbI0d1UzheGFvhEdNljQSmjas/8vcVaq4PQYMG4m5c+f+0/0XrVq1Eq2Ng0eOoFD+fFJisXHLVgQPHgJt2rWzOV9qyWPgALZrjvm6Z8+1nnFfcm25c+cu2pcvYvP9fOlT4ur9x6hfv4EYdib8xjyr85cKsvJBA5n9YLb0mrwaDIDwYdxfwqFyZWTLnMmZY0HQkWhSvw5atOuEQ4cOIVGiRBaaeNeQqPiUa2kkkvCR8GPOT82aNTFlyhRR46bj7WXOhXsNeo/ClStXpG66T58+7j5wRuY8q/aXkxFvKjYs8ub+V8AFmZOwTsAafTZCI0CMlHtnJMivXU9m8Vj2Qw536juwD4mlLq5F0qRJETt2bIwePdoibMcJnVSxdsGcyqZIVct7X+uArcFsFcvglNWL44CGJbNczHa5dgxpSZVHGvq6yLGvwJZTo/0GPA//KnjsjG7SyTpy4rhcx0aNGssCw74Xl5AuTRqsunwPDiliO7vfv33/D2uuPkCWrFk95bx65n3JMRg4UCA8fPbC5vt8PXToMP/0ePGL86z2fhkZ0HRMM1PHJmmfsm7pvooe0OfPiBsnts3PxY4VS55J2kGBUh4P720ei2cFUzzyWroUyPJR8GPORbZs2XD+/HlUqFBBWhGsy6CpS+VW+Iy75jdgUyEbuWk8lSxZ0t3b4Q3m2Q1OvKn+pSYqLQtQ41JTojo5q9Kyb2V68qnXkylv9guEDRsGyRInxuFDh4TFif0FKorn2uxFpUqVJMrMa8cyGB6za3sn+Bk2ehPalM3rzWyHa2uW/+b8/q7XQyfH3fv2o6R9UWfvsc/g9JmzKFzU3kdeX68ExQj5cAuaNm+OunXrou/us2iZOTFCBwmMp+8/of+es7j2/A2GNm3qqef1T/clx8Xq1auxbOlSPH/+DPHiJ5DoLxfQ36GovT3mbtqNakVyI2SwnwbSg6fPsXLPEdSuW8/Z77qn18iE26+nZ4LXjdl17QEzQinYuX+2hDy9EtxHOhdKjMLnPfsOWMpRjdh34KC8RrY3ChqrlodSuvv0a+ndVTL/IvLly2f5m3aEXgPN6rknE+2jnQsaPE2bNpVaMFsiHya8F8r8pL0YfHCyY9SaCy6NTFOnwO1gOQ9LL7Zt24Zly5bh2dOnkvlxqFJFFK75epvmTdCsYQMRWOLCyEY+0haSpcctTjivWYoUKSwaJErewAWCD2Opm7URpewm2hzJxcsrrvf27duFOu/Rw4ewCxJEiB+obmvkdmc5QNasWTFg6AikTpHC0kdC5duO3XvBn3//7ubv/tdRpEgRqQXv368f5p29hWihguPOyzcIEDAQRo0a9YtQokfiT2UqXDNq1KiO/fsPIFvKJEgVLRIOHz+CCqtWoXnz5ujUqZOL32XErkTx7SjTeQiali2CxLGc1MTHLduA0GHCol69epbP6v2ixh3HvW8MoPzrUAeC86CxnJMZgp07d8p8S00YZlhJY83yEYpMeiVtrdK4c5xxbaWTQSP+9t27GD1+Elo1a2wxBs+ev4DJ02fJuKRWhvY9GjPLpiP89+D64Zewbds2D9+mq5yLOXPmuHqDHMSkQftb8Eag2BJv8lmzZknakg/e1P9ynbRPguoR8BpxYubkR2paPsxonuvHORcwRpnYg0JxLv7Pcc57qUTRwkiUMAEOHTmGIYMHw59/f1Jn27ZFM2dOHoWWDhw6gqlTp7o5w2fUIDE2aeuiq6xOyuRlNKKU3cSrIrikWWRUOkrkyChSMD/u3b8vtaLLly/Dli1bETFiRMtnWfLFjGeuQvbImzsXQoUKie27duPdu/eYNGnSb0t/TPweDRo0QOnSpbF8+XI8evRIlLbLlCnjLr2TP4FMdbzGK5ctw807dxAmVEiUq1BRAk/WYmFkqTp+7BgW92uHrCkSy2scv5NXbkb/sWPF4WQpmC2wbHbZ8uXo2bMHWoycJq9xTitYoAD69usnWj7W94s2A3s3y5AJ94FzlpEunYEysp2RrcnobJBRL1bMGFKafeTIEWGc8yq9LWsad87PzDKfPHkSw8aMw6p165EjWxbcuXtf5rcUyZxK986cOy9lsyxp4b7SIWam2XSETViDpC0eDVc3dHu1c0FdC6oCq9qrgvRsrBE24TPAxZ0ZCkauOfn962UmbgGdCWq5sPGORjoXjZjRoyN3zuw4cuwEVjjOtSwUaAxs2roNdRo3F1VWWyhcMD+69+nvZrYNXby4yHLxMS6qXGz5Ot/nw5YRZUs00TOwYMECcSzq166J7h3bWaKHpMstV6WGRBTXrl3rbMJctWqVGALUZnj+6jXKl68g0UfyyJv4+3ufGSPPwsOHDzFwwACsWL5cxnThUEFQM0pI3P78FUtnz8LGdeuwcs0aRI3q1FfDOWjB/PmoUSSPxbEgeC80LF0Iq/YewexZs1x0Lggy8SxZslQyh+wn4xhirfrvjD3eH6qbYDoXvguafWWAjNkJJ8diLdq3aoGqlSrIXLd63Qb0HjBY5ugJI4ehYYvW0otWuHBhL9lHpetWMgWiVKlS4lwM7N1DaGn5CBUyJPr37IYKZUqhe98BOH/hoqVUmd+lU8wAkekIewDM0i2PcS4uXrwIrwbLO+hgmPD50BIaE64HFwmWWVy/dg1zpk7E0pWrceLUaaxZ6oichexR3aHiT8fiBwoXyI9c2bPh6PETNrf58uUrWTzcWrOqixczg8rcZISm1PkZrff1DiOKUekI4cOjW4e2zsoSkiVJLKUBfQcNlcwNHTYFDQKWTbEXxRyjvqs0sEzJknjx6CG+/fcfJsQMg7whf2asq4X7hkq3n0p53JgxYyzfefHyJbKndBLwsx7D2VMmxqYTrltTWIqrQp6/M/a014j/+5TGXxNug2ZiGeVncKJj65Zo2vBnCVylcmUQIXw41KjfGO1aNJUsxowZM7zMuTCWn3Ksce5LlSqVjDmWeU4YNczZ5zlXHzx8RAxgjmF+jq9xfqdDzL9NR9iEEStXrkTevHl/IW9h1dLu3btFA8it8FuFYyZM+HAwNc0yP0a+yGNetFABpEqeHOs3bUb50iVlIaCTkM6FJtuM6dPiydNnePvWqZFawazHgsVLpR6etcIs+2GknxTAdBgYwbLlOFgrwxJGWkZC63a1vvxvjShmQ+bPn4+iRYtIbwS5tam5wOjh70pjnjx5ImJRtn6fr3PRJG0uezJM+G6QsODV40dIGMg/MgcL7MyxIKIGCoAaoe2wZtUqC6kAjUSOzzuPn9rc5t3HzxA6jG3mM7fAeL8oqYXZW+a7wQwFy1E5N1WtXOGX9/PlzoXIkSJiy/ad4lycO3fOS/ePY5sZNJbmkYGR5Z+s4hgzcTKuW9G/Tpk5Gzdu3ZZ5VYNNOn9rb5zpCP8FuCxybfTwB7wN7Gm2RbFNdjxWVrgHZqjFhAlPhBr3XAyuX78uNJ8st8iSKYMYxHQIFi1bjq9fv2HkuInYvmsPgtjZ4bLQ8f0aGbt0+SpDU6hYozbat2oujsm5CxcxaMQoPH7yBEcOH8aKFSsQPGgQfPj0GV27dkWdOnVQo0YNiXhxYeJCat0fwcWL79+/f99S9mHkf1cV7b81orhdsr9RGKpgvjwoXawobty8hWnTpkrUkDX8Wtuu4PnieeR+3HFBY+DuvXvyzGzPhPHjnbFfmPB9WLZ4MUqHDIzdbz8hdwjbtMZJgwTC569vpbyQ45pjuED+/Ji5fgfK580q94Di0u172HToJLp17+4h++fVvUYmPBe8fkqBaqun04nONTBevX4tGWayWBrF9rzi+mv5Kccc58R27dqhUaOGyFe0JIoXLYwYMaJj5+690mvBkkVlDlR9C+2hMx1hE9ZwqZSa49wlKvo/wXQuTJjwBDB6PmLECBFzI6gpwexC2NChsHLbRsT40UB178EDVK/bEC9fvULX9m2xaPkKfPz0CbPmLUCl8mUR/Uc9OcFFbf3mLciXOyfuP3iIanUbWt6TfpegQRHGLiDGD+6EtIni4fnrt5iyajMmTJokTfbFixeXRUnZvKwb+5TXnRkE1Szh+2QmscUW5R7QqWDfxNRxoyVrwwbEAwcPI0LYsLh7+zbq1a0Lx4ULLVzpyu1OJE+eHMdOnMD+Q4dFQEpB523itJlIlSI5Kpcviy69+vopVpR/kfL0+auXiB0pJKIE+opzH21n3M5//AK7QIGcNeZ36NgRpUuVQqlOg9GgZAHEix4Zh85dweRVW0QHhvTLHgWv6jUy4TXQ/oS1GzZJFtmIs+fOSwDj3v0HuHDpsrxGZ0Sbpb2ySZrOD+dw/vb06TOkB3X7tm3SM8I5vGrVqvLQ0lEtaeU+0ukwx6wHwA/0XKxYsUIeiu7du4uzrKANQO0L9/bVucq5cKtwkGcrYZsw4dPrFxmdz5IxA8YOGyyG8poNG7Fq7Xpkz5LJ4lgQdB5GDOqPYuUqiUDkotkz0KBFa2zZth1FS1dAtcoVkThhAhw5fhyOS5aLkb91xy7pPYgaJQoePHwoz8WKF8fcOXMwp0cLRAzjJDQZPnRIdK5RDg+fv8SsWTNRoEABi5NA2Grsc0tElp8hqwrpcp8/eyZN0tWqV0fmzJld/I6jo6MogNOx6DVgEKbNmouUCeKgULpkuHE/PLYdO4Zy5cpi8eIlFqIAZasilShZiuhUNapbG3lyZseDR48xbdYcnDl3DgtmTsOVq9fhl2CkPJXMzZ07ksWhE5g+fXovY6z5HVgiQipDLka89mRkshUFIwPZnj17xAhizTgZb1xC/DhxcPTZQ5QLExTt7r3C1tcfUSDUz4jyvc/fMPfVJ5QsXdrZgsi1avmKFUKT23bsLHmNhhiZrawXTxMmjOD8y/mvZ/+B0mORO0d2GcfMDDdp7UQgsWvvPgliXLpyVZxa72ALU4Yrzgl0GBo2bOisz8wa3CfeA0bHgkEbk4TFvfBHGjnP2a4XgmQVLK0jWKLN4J2RfU9YKFu0+O16/tfOhZFbnIsCVR/5oDFhesEm/jXQiGJmgjckJ3kKFdHQ4yJDhrOOHTuiRNEiGD9yqMX4ozGdImlS9B86HG1bNEW8OHEs20uTKiXChwsnHOUsFerarg3Wb9yM9x8+YOykKRYmJ26/UMGCaNS4sfRVsEEvQ4YMKFiwoIjh5UufwuJYGFEpf3Ys33kQt27dEoNOS5xcYrhxTUSWv12ndm3s3LULmTOkR5KE8XHwyFEx7NKkSSNCf3y2jsDTOC6SP69kLOhY9G1QBbXs81o+c+rqTVTqPgJDhw5F7969nWmpcN/ZwMv60PGTp2L0hEnynQzp0mLhrBnIlCEdBg4bKWJpfmFeMlKesqSud8+eP8rlnMAxNGjIEGTPnt1b9o8GSrOmTbFp82aEDBYMAQMGwLBhw5A6VSrMmDlTlON1/Rg3bhzGjhmDd+/fW77P0jXqYtiiBK5eq7Ycr33IwCgc0g4t775EgZB2yBQ8MG59/oYVrz4iXNSoNvWPuEgucHSULB3T+mST8oqo8r+YYfJLIIsYe8FYWlm1TgNEjxZVHIZr128gXLiw+O+/70L5PXuBo/S2cUx5B1uYscGb8zidHm3a5jxpDToWBHuT6FwzE8yHlsKQPtqa0tmE30emTJkszgXnZ9oQnDs9Cq5yLg4ePCiMUWRv4jMjVaR45OCkg8GmTD7U6TBhwjeDvP3kMqchTAElZiKo9BsndhzJELC058qVK0IJS7YOstUw6vXt21fRUCBaN2v8S1S5Ts1qGDdlKpavWoN2LZs7M9JodAX7oQpMwTf//vyJMV2sWDGJ+HJRoBNBqkzCOprw3/fvCBDQdjRF90MzAMp08zeNfdSQOHDgABxnTkOuHNks2584dYY4UGRoolE3fvx4EVXTCDwXsvOXLuHq9etInTCuM8eCSJ0gDmrZ58HcRYvQpUuXX7RU6MTNnj1b6GSzZsqEdq2cMkQsE2vTqZuUjtFA8AvQ3hcayY0aNkDs4IExp3RWpIkSFpeevsaIQ5dQvVpVrFy1WoI+Xg3WfO/ZvRtjWtdD8ezpETBAAOw7fRFtxs5CjerVsXHTJhljJBcYNGgQ6pUsgDrF8iNMyODYfOgk+s1ehmpVq2L1mjW/GGW8vvv27kWzzZuROYQdMgULhP3vPmPLm08IEjgwatZvgCZNmvxWq4QGk1cZTaaonu9HoUKFkDhxIjx/8RJd2rcR4gxm2TKkTSNsfrFjxcLEaTNkXubYY4CF49ajiC7cAmOGWZ0EPnOtIPGFBoTpeHB9cSIKeSkPln/p/tIZ4dzKLLHJpvdvlUUZwTXao7O6rrobWK9N5gE+FPTUGaWlk8FGTKOSr1kWZcI3ggZCl86dsWr1aovqeODAgVCpXFnEjxsHh48dl0grG65nTZ4gwkX+4A9lHarh9NlzKJAxNVLGj40RC1cjXtyfmQkFvxctShRZvIyYu3CxLFT2hQrK/6Sa/f7ff+jWrZszjZffIXWaNJg/by5evn2HMCGcTxIrdx1CpIgRxTDnffu3atpc0GjAs2RLHQuC937j+nWwcu06fPr0GV+/fRVWLDoY6dKls/Czk9EpauRIKJHFeWZDkSVFIoxftkEaJpm6tdZSYQCD1HitWrUSfYuwYcPg1avXUn7GPpff6Rj4JqgjSDpAu/++Y2HZbAhl53S9MseIgDlRwqKo425x9KZPn+6l+8YsGHtnBjaqhjK5fzq6OVInxfi29VG282BZH5hFGjt2jDiRPetUsnyuXN6siBstEkp1HIQtW7bA3t7+l2OfOm2a/Ibj/Pl4cO8eUkaNimw5ckgJiGYiaCzt3btXxgbHWBxDRtCrYIrq+Q1wLpw/f4GMrwFDRyB48GD4/PmLXF8aXkGDBReFd85hdDpotNPm4ZykWig03L26wdsIFdnj+sV7Qok5+Mx9Y58Ij4fBYBVq1c+azsW/i7meoB3nKueCEUfNWujztWvXZFAyc8FGUc1c8NmECd8GjmVGSy+cP4/eXTvh2MlT2LlnL9YscUTc2LHlM3VqVMO2nbuE77xWwyYI4N+/MHTcvXsPKRPExtROTXDs0jVxLg4dPYbsWZxnF54+e4Yr166LUc86Xk7sy1auFurAWtUcEDNGdGEjoWAT7ystd+FiwMWM4ELB/2l00uDm4kIjnCUmjgsWoE7/8RjcpDoSxoyKdx8+YvaGHZi/ebfUm9NI94jSDWZ2+Js5smX95T0eU56cOTBv0WJEihARIUOEkP6TmTNnSsq1aNGiYkweOngQN+4/srn9m/cfy/FZN5sbFz9mcUgduWnTJskw8diY5eE58SvQ8ofdO3egbOLoFsdCYRcwABySx8SALZstzrBXgVkrjkWjY6HIkCQ+YkaOKEY/j4GOX/WieX75XLrE8ZE8Xiy5htbOBcHjoeo3HwSNJgau+DqNJZZgUfRM7w2C2gN0MBkQ8yqYonp+B8y2MjPNueXYsWNSUsReNSrQ6xhkZoDzqBruHH/sg+K45FjgHMhMtmeo1f8JnNe5T3QWtESKz7xXmAn89PmzhTWK9wpV7rXk1sS/lbm4c+eOJAfoLOv4ZtCIWWbOsyQMoCA212xPcy6MGQvWUadIkUIikvHixfslFXjv3j2LYqoJE74F7KEgn/PiuTORIW1a9B86Ak3q17E4For8eXIjZ7asePT4sdD/jRg7QV6vWigXAgTwj4xJEyBRrOjoO3AIHGdPR9gfRg4Xox59Bzo1CJ6/gEIly8rrnOTJ8oT/gA7demLdxs2yOMydN0+yGayTZXTWuJgR3A4jZqRtpQZEuHDh0H/AAPTp3Rv5mvdA1Ajh8PLNO3z68kUa/vhwC8MNJx42XzOIwG3zfmd/B9Pu3Cca//cfPLD93bv3ZMHNmjmj/L9q3XrUrVMHo0aPlrlk8ODBUvK0bc8enL56C6kS/DzHr96+x/R126VEgQv078BMBRt1/TLoYH358hWhg9i+ZqHtAuHbNydhQ690LrRh29iPZwQzb/yM6kCEsEHvKa8HDeKi/srvQGOJ5YjNyhdF9SJ5EDJYUKzbfwz9Zi1FrZo1pffHK5rd1VknTFE9vwGOW5aJ8GGd2aYToXMy+95YssjSPAqQscdI+x7U4fUOB4PjUB0L7g8zvCzjLV3cHnly5RQSkDkLFmLjxg2y/+xv4/76JYa9fxWfP3+W4D+dYgb6XRLUZUCnbdu2Eoxjz6iKSJJljA4013uO9fbt28s26YB4ekM3qTWVXtMWzLIoE74RGzZsQJJECZE0cWL0GzJMUsgpXWhuSp0qBVauWYdYP7x9IlgQO8v4H9OqDhx6jUS2fIVQvGgRMYI3btkmDgkbpxgJO336tNxXnAQodrdr/0Fx1B2qVEGFChUkDU9HnQ6GsabWCN70nAD0ffZjzJk7VyLGdA5YUsRJwiWlYZdAp4JN6cGDBUPqlClw+tRJKc3htlhnzwxCjhw5MH32PFQoU8pZrebV6zeELrdN8yZo2cSJwq5Hp/ao2aAJunfrhhUrV0qtMA3DWrVqonKP4ahpnxdZkifCjQePMX3tNrx490HKD0w4IW26dNh48TSaZfx1sdhw7SGSJ01qadr0KjCrRuN9yY4Dv/TNHDx7GfceP5XyNI5JNnqvO3AM9Us6lf0pHjx7gWMXr6Fn5epu+m0601OmTEbTckXRoapTVkOJC6JHCAeHniNEVTZPnl+zJZ7VZ0Fjjg+tv1dueK8skzHh+aVvNNw3b94s8xevd7SoUfHw0SMpSyRlZ7ly5SyZAI5TzS57FegkcL+4D/x9EmBcvnwZE0YNR6liPyPQNas6oGQFB8nO3L59W2iaTdVu3525OH36NBo3bizOLp1Grv+sGLAVpGN2l5n+fv36WcYnMxYcM/PmzbP08DEzzLHtac4FPSETJvwiaJjv27dPGrhfv3qFfPYlpCmbkzNLl8jeZI3zFy4K/ev3H9GhBPHiStS0dC6nEhEp9RjRHTPX7cCs1WsQ2M4O9kXtUbtOHQsbg7EhO23atM4WMZYdqcGiDoW1Y6HOBj/HDIamwrnfjKIx2+DWDCIdFdZeMpLFfgo6BV+/fZMG9E3bdggnNh0lRsJYQsaUun25SmjWsL5TT8rRY8JuRZaVOtWrWbbL7wzo1R25ixTHyZMnZaLihLZw4SL5rdmLFmHc0vVilDFjQceCi+JzCNYAALuFSURBVJ0JJzRo2BAODg4YsPcc2mRJgqCBAuLzt++YfuIatl1/gFGjOnr5qaLDSsrg/rOXwi5QQJTJnQWBAgTA9mNn0GniPKROnUr6hXhNy5Yth+GOqxEnSiQUyJhKxi7VspuPmIaQoUKifPnybi7J+vDhI6oX/rW3JnuqJIgTLbIYgJ7pXLBsho3qXBs5vvlbHNfUs6HzTCNP72Ov1kEw4fGg4c0HA6vDhw9HuVIl0LVDW0SMEEF66IaPGYexY8fKnMs+I2Vv8i6DnUEpiuiRZY5U5iXtizh7P1TIkGjeuAFatOskVOLMJJuq3b4X3759Q5s2bSQbwSAgs2t0dBm4tKVT8fDhQ5l3dWyy3YHZjGrVqjkjB2GfJuc598BN9AZU72Utq7H2mfXTFNqgl8QaPnMCNeGTwMV9165d0lzKG5BlOaQR5E1FL510qgcOHhSDOHSoULh24wYiR4qI9GlSY+bc+bKIsBdCsXvvfuzYvRfD+vdBpozpf1KhLl2OsUvWoX6pQggSOBCCBrHD01evpbF58ZKlloZmhXXvg/5vVMd2KWNB6Gv8LiMTnEy0LIb/W6tc/w48LwMGDMDMGdPx6fMX0d7o37Mbtu3cjeZtO4ioX9zYsaR8i43c/G0qftMxYCajVQcnOlBlINm9aT1ChnTe+5AgfjzR5mBGRSc0zhV9+vSRhY09HNzvP5VC/YvIlSsXevbsKedq4fk7SBI+FK6/fIcnb98La41bjXOPwsCBg6Rkq8P4Oeg+dSECBvAvfT6ZM2fClClTLWVJpCV+9PAh6gwYJ70YJBw4e/0WwoUNi7lz57n5mmsZVbCgv2ZreL+4t9TKtaADTgpczgsF8uTGs+fPhWCArHILFy5ErFixLBTC3qGDYMLjwXmNY2vRokVirFObSMd3uLBh0K9HV6ES5/Vn4EgNdV57ryw30jHG7PPNmzdlXUueLKnN8pjEPwI47CFh9pnfM/UvXAGeSs8oufT3d1lUrsl0LAheT7Yt6DxkDTKesQycpX9c/5m1YPZby6cVzGwppbinOBf0cugFM7pL44KGEg2Mli1binPBA6GnTNYSlk+wGdWECe/Gs2fPhBLz5KlTiB0zpkyes2bNkjpYZhCYDn7y+DGmTRiDIgXyywR89dp1NGrVVhq6aUyzN6JyBbJFxRUdh7UbNiJvrhwoV7qkbI8MTxTIK16kEIbMXylKwDEjhcflO/fx9es3DBs+3JljwYWG1H90BngP0SHgQ7MUXLB4L2mZhUs17Wq4MAVKI53pd/c2atOxmDJ5MlpmTowVl+8jf6ECuH7jJho2b4V8eXKhf8/uiBI5kpR4TJs9F4OGO2kTkMiBc8CQIUNkO5ptsYXnz19IszozKrYWRLeWbv1roHggszo0buigpY0cGRUrVvRW6m9G7MkExogZnXeOPxpWxkwcwWDU/AULhNKc5YeM6tdo1FT6ZdzDUMO+P96r6/cfQ5VCuZy9x9K6s9duoU7TlvAM3LhxQ5xhlpX07d7FYmBSvblclZpCnMAyAs0oeocOggmPhwZxWHrStEHdX/p5eJ3LlCiGbn36W4Q/tamaRptXZa54b3FfKGpZrEghvH37TtgHNVBlBGm71dDkWsl+OmXAMvUvfgd/nlQW5U/6HlgZ4BJ4XW2BQX86Fwo6DszwuqSuzaAgHQna7wyy8ndZMRAxYkR5nyx9nK/5zM96mnPBCZM/TudB1bo5gTL1TNo2Li40lnhS2Kzp3jSKCRMeiUaNGooDsXTebGTJlEEmTEaX6jVpITcOU9qMyrft1A1BRwURliNG2CeNHoHchYuhX89uuHP3LmbNWyAZCPL409iePGakxUho1bSRMEit3bgZYUKHxrfv33H2+m0xvuloG4XkGF1gLSQXAGNjtjoV3KZqUPB1XQz4TAOcDgSfrdmi3NKoTfD3GdlavHgRHj54iGfPnopj0SpzYiw6f0eaFafPmScUrxNGDoedXWCLMdm8UQNcuHQZy5cvF4YfNoNxAWUNMpW39x08hDGTpqBXl47OFrOxk6fAv39/on9hwn0gzSp7YXwaaJwY1bZpWJNxh7W7vP+4YLGPiCJNVO/+W9ARZb3wgDnLhbggT9rkMtau33uIJsOnIkqUyChZsiQ8AywzoJHZvVN7ZwZmjOjR0a5Vc8niMcNPg9Js8PZbYFBKGaFsgVk8FSjVsaF9OF6RudK+EO4jS3wTxI2LrJkzoVzVGpgxZx7q1vzZ2/Tg4SOMnjBZHF+l1mVQi9819S98N0qUKCF9NrTHXdI/Yune0qVLhS2K6z1LqcnAqGAQljY9y6xYAu1pzgUzFnQslD+eHu6UKVMkIssfJ2jo1K5d2/K/CRPeBU7+ZDnYv/+A1Pqfv3gRBw8fEXG6ooULYsKoYShRwQEDe/dA0sQJ0blnX9Rt3Byb16yQ3gH2UCRLkhgXLl7CkH69UaViBRQqUUYYcDZv24GyDtWRO2cOiVau2bAJ4SNEEO+e9a1cTBi9JTWskb1HMxYa1VIYeyq0RpdgRJffV+pZljl5ROSL2QcyQrBmvHCBfIgRNQrWb9qCqinjYNKxq7j/+p0wVkWNGgVFChawOBZGkHVk1dr1MvkwYsIyM253woQJotY9bdYc3Lp9G+VLlxKjb/Hyldi6Y6cEKWxlLnwyTNVlt4GGVMsWLYStKVuWzChdvCiuXL0mmi1cyJj5ppP6t+eaJXlcb2r0GY1YUSIieNAguHDjDiJHjoQuXbri1KlTkp10zT3jlt+lTkC61KlEs8Ya2X6wo/EzVL7l/fG3mjImfBby5c2LZavWoGmD+s7mRo6fxctXIEP69BbHQimT+T+fPTtzpSW1/I1o0aPj8PHjaN28CapULIce/QbKWpU/Ty5xLJauWCW0tMw86z2iQS7df27P1L/w2obuqFGjupidcC1Yorl+/Xpp2mZw06WADrPerEiyBQYPvUxETykFCXagMwrLgWkEJ1OzKciEd4Bp3SVLlgh1KpuGL1w4L5N7l1595X0uBMw+hOk3AGOGDpJa1CPHjkvD9tTxo5E5d37MnDsP/Xp0k0mW6WEK6BHMXnAiZpT+zJkzuHD5Ci5fvSbZCUYHmI7kPWLUo9DSJjVajEwetmB0MjTir1EyLhaMerkVmu5kz8miRQslS/Hfj/1Y7jjXojxL54JvjDl0SZyM7bee4OHDR3IMtsBsD8Hacq2X53ng32TDIrbv2oMt23fK34xqM7PBBjPfBFN12e1gcygdi4mjh6Ok/U92miPHT6ByzboyPuj4/+255lhj5I3MaMygk4wgePjIuHL5smVdouJ9lSpVpYzJJTYtt/4uo9dHjxy2WWZy49ZtZ2shy4V535psUX4HjRo3lshwncbNJHtFhsFrN25i4LARuHTlqpSIciwZs85epeCtoptcM5jZYx39qnUbMKRfH2TKkAGjJ0zCiDHjJUjGcT5o8OBfdMm4r1reqnTnJnwXIkeOLIEX0g+zQsHoXLBygr1hLLN1LWj7M5lQr149N9khrhrtrI1lUx7TvTTiZsyYIVSUynjDTAZZM8iiYGTBMWHCK7Bu3Tq0aN5cFvy4cWLj4uUr8jr1KMqULC43Bxuuj588hRjRoklZFKOnGkViFLJooYI4cOiI/L9n/wHcvH0HgQMGQov2nSRKz7Qhadm0OdPaGKGRwqZkGuTGhmyCn6Oj4FKTqS5EnND5WRpOqprqlqjnuXPnhIKTBAust2SvFMH9KJgvL4rkz4vJ02ehUrky4lgQ+jzm8CW8+/IVTTMmQqMMCVFp6V6sWb9RFlCWeym4LcfFy5AyZUoR2TEaWM2bN0edOnVkH2hckeSBTWUUuHOJb9unwlRddh9YCsXyQqNjQWRMlxaVy5eVzAWz28aSIveea44paq8sXrxYsiIcmxXzZ0e1wrmEGnrdvmOYMHu2rFtcHK3HoHt+lw2T7Hthn5XxGPndsROnSOkaSxF4//Ie0NJFMwPmN0CNr6lTp0opeP5ipcRp5ZzPOZpOLN8nNIjEceVVmSsV3aSjzUAYm3GbtGqLeY6LkD5dGiRKkAC379xFkiRJpM/O2lDUUlwty6Ujbap2uwAv0NBxC7j2sx2BQTyd5zj2rLWPeM3JjsnMLseAUma7BNoQrVu3llJUtzrHrvo0FXY54GhcMRpKikHyJytIX0Xngv0YJj+9Ca8EKdTImFOscCFh7KDaNSNITRvWQ+e2rS2fo2HTtE177Nl3AOHDh5PUsJFmVsqRyAaybAV6DRgkE/XkmbMlOk/uaDbPklVDxcr4Pp0IljpxcaFRQmfAKHRnHQ0irNmfuC11PrRpkJO6W4wROja8R7du3SqaAmwkpxOVOWMGnDx1Wha60iXspWfkw8ePYugp4sSOhSIF8mHJrt3yf4RgdggSMABWVMyFgvN3wqFmHfTu1gUZ06eThWnkuInYvW+/9FzZchgYrXWvoqdPgqm67P6G5zrVq9p8L1OG9NK/xGCUkSHqb8416ZB379wpdLgOBXOiT30Hy3uJY0VHvOiRhfKW2UzrRnP3/C71PUhk0LxtRxw6ckzmkKfPnstxnTl7DiNHjZL7WQUEuS1mClUjga/zHuHDzGj4TlCniLSdDGqRbpilngyqGqP8vM50PDjOvbIkjoEuNSh79eolpezLli7F4mUrETZcOFnLyOppKyPBdYnf535r8M3UafEdiBs3rtAk85ozK8EKDva9sXzUCI5Hrt1MBDC7xX4KzmfWtPVU6maGg4EUBgyZtXArXOVccBJkTTkfGrE1gp4NB2Xq1Km9VCXWxL8FTn5sPuIzJz5GBZlFixA+HEYNGSAT5onTp2EXODCaN3Se9uOYbd+qOVav2yC9Bq9ev0GaVCnlPbIY8fV379+jTaeuKFAgP2rXriMRSJZH6T1Ao0ib3jSrwGe+rs7Dn8DvcuFRFhFG9fU1o7HhlgZtZgwOHzqEooUKYMv2HSKYRF5zbvPNm7dSGkZjSOpxAwbE5WvXnH1/xOABqFyzDk6fPY8t1x+iRKLoiBoyKBaWzYrmm46jjEN1i1NEul5OTOyz8MswlhioKJZXlDb4drBUkHTOtnD9+g2JnFlHQ917rs+ePStGXt0S+TF9zbZfRPqIEtkzot/sZVi7du0vzoV7fpf3AUu7+Jg9e7Y4FQR7LMaOG2dhUtRt8W86FgwW8MH7nvMF732eC1P/wneCPXBkb+P1VIYlIziG+KBjqdFhr8pe8f6iw8NxR/0V0q+rJtKfwECVlkVpsMzUabEBH5aJDxYsmPRasMKIzgJLo9jjyN5Pa3D8kRiEZcqcw/hM24nEG7zeLJ3iNWeDN0vNWYHgHrh5pbR2LAht9DZhwjPAiZGlDyNHjhQaTqMhI8Jr+fJYIjHBgwZDpEgRESLET9VoRbw4ceTGev/+A0IEDybbPX7yNHr0GyCTBb1+RqV4Y164cEFuNC4IWjLBh9Za8z06GuoUuGbi1mY5fpYOBReAv23SZsaQdHIjBw9An4FDUKdGNWdKrNSbGD6wL3bu2YuUyZNJ2di8hYtRvXJFRI8WTT4jDsPA/ihSqhx67TqDBGFDIGnE0EgRKQwWlc2Gaiv24/b7Lxg0aLAwRLnUkOuXoCUGmpEym3JdB2puDB82DE3q10XSxD/ruR89foI5jotQtkyZX4x3955rZupChwyOpHFiyv8Rw/6a4g8QwD8ihA4pJUoedY35PgNqzBaybID3A41N7d8wbkvLTLQkUucJr2QRMuHx4PVihlmvHyP81u9z3bDOXnmVsc5tq5gjS9n57Jo1ivvN/aUDzO/rNpi159pn6hD5XCRJkkQ0eFyLBAkSoG/fvqKfRIdCnQo6GQx6/i3MMJwJHwuyrjDiSOYD1hQaQUan+PHiYuuOXdixa48s1jTYs2fNjK07d+HJ06dCNWvEqTNnZeI8fe68TPRxk6eRRZ+lT/TQmXkjWPrHm0wjjkodq5OzMUqlzgXxO+Eubo/RSs1SaPmTa8HJngsVv6PlSPw9MktwAeAC8uLlSxTOn/+X73KRK5Q/r1DItmzSENt37kbRMhVRs2plJEmUSPjO6XDEjxcP3799QeH5O5A2SliECBwIh+4/Q9BgweDouFDq230reN3dmuLXBdoroo2eCa+s92eanf0PZFSrWc0B6VKnxuWrV0WQ0n+AAGjV+mep4t+eax6XXaBASBU/lvy//ehp2GdzErZU3HvyTFikEqR8LfMIa9GNzd22fte154vvxYwZ84/bMjb1Enr/ehWLkAmvMeC5BukawGfON8r4Z+zt4TzOvgi+55k9DcbsN50DI5mIS5S63FceD99j8EyJSThO2bvE9zzC8PT18GGZi78B5yMGVPnwSJjOhQkfB05sLMGjwR88WDCECuUU4eFE3rNzB4n6jJ88FXsPHBQhK5b9OC5ZhmqVK4q43YBhI9Gz/yBhhVLDn6nr3gOHyPbevn0jGQo6EyxjYA+RlvNpY7aWPmkjtjoUxhImzWIos4YuJNb1rHydbFLuEbqjGA4zNnv27LHUVlJbpkyZMuIEcX+5n/2GDJf3X756aXM7dDzYuB4pYkSsXDQfw8eMw6TpMyWLw/1jxqN1s8ZieK3buAl9Bg5FgP/8oWPnLtJv4tsoZI3gteFirpkjt0QN3VKe5hPh1YxXHOO8b1k6N2ueozQ5k3Uta9ZsYkgx2k/jhGOKKXtj345bzzVLkUaNGoU37z8ia4rE6DNzMRLEjIpEMZ0yci9ev0WLkdNF82r9urXi9IQPFw6Dhwxx1hdk/N2/PV/GbanasRqgxsixOhZmqZ3vhkb6eR15nXm9ed21BI5zqzoe+r4a7DT4PSJ77VonSMVbdf3iOsWglZbscV+V7ZBQp4LQ+5Tb4D3+Tzd6+/Mk58If/BT8/fc7CWA/AtKHEmS48QxwMmEZDRva/+mbzoPQr18/IQ/o26MrHMqXExpZcuWTuenCpUvYumYlokWNgsKlyyNJwoR49OQJLl25ggkjhwm3/sy5CzBg6HBEjxoVpUsWEwraZStX4+WrV9JIOXHiRGE7M5Y5qRPCBj1eTy15MtLCcjJW5WyWQvDByVopW2mY04lQ+knibyLGzEqwmYqaG3ScWOK0cfM2rFq3XowzNlmxQY/NW1TQfvXqNdKlSY2Fs6c7K1+8dfsOchUuhm4d2qF+7Z8qnlxQuvbqh227duPY3h2W15+/eImMOfOiTdu20jDrm0EHjE3GNBI1qkwwSuObnQbXgNeX45nQngKvPHYaUjRG2J/A3qh4ceNIn9Oly1dx7sIFlC5VCmPGjnWxT886g2A9z9LwKVSwIN69fIa+9R3QZ8ZiXL//CJmTJRS2qD2nzst2BjWuLixSV+8+wOB5K7DlyGmhsaVz4lnniyUGPHadXzh38G812Lh9r1Ru9onwK+umcdw49bm9+SUroA3emgFXYVTO0145F1nfU5qZp6OjJVzcN6MIIMF91xK/KFGiyDrnWdfSs+21v96318+Q7OgqD9/2+QylgFDhfeRxuwdm5sKEjwInqVkzZ6JhnVqoVfUn80vCBPExd9okZMiRF+26dJfoe80qDugzaAgqlCklDFE16je2fJ6LdpRo0bBkxWqn0qfYsdHI3l40KQjqP6juBCdN1ZLQJjZbzE6cYPl5vsa6RE6iRm0LW7XTv1s0uB3y9FP1l0rGpHalWiqbpfnbXbt2RY5sWTB78gTcuHkL46dMx47de2RhoHHErMarVy/hOGua0O6yRKx2o6ao17QFmjWsj5gxomPv/oPoN2QY/PvzJ6VRRpDlZuW69SiYN7ezDEfL9h0RIGBAUVT27WBpgl5HtzIR+XZ4N+MVf5cCrHQsmGGsXb2q5VqsXr8Rzdq0R5q0aSUTZw0a5nQM+VnuN+9nayeEBtCs2bNRrWpV1Ow7BnGjR0HYkCFw8NxleS9k0CDYPLonokVwyroliBEVE9s3RPH2AzB27Nhf6pM96nxxDuP+E9wG5wi+xvmD29bgg0a7TZpa3w3r3h1bvQ1abqRrjbIxefVcZMys6bgjOB55f2nviLE/UNnPTO0LhT9PoqL1B78E07kw4aPA3grSpZYuUeyX9yKED49cObJh1979MulFjRJZJrxjJ04hV65cEmVnFJ99CcxMaHmSljpwImVE0dicbV2Tr5kKfU+zF5x8VYeCC4lGZ35XykEDg4w2/B6pMCkwxggR67QpxMR+EjZk8/3YMWPi5YvnUhdOJ4OKxmxeHz98CE6dOQeH2nURNkwY1KtVHaFChsLajZtw9PgJlCxWFLmyZ5PfIy3mpNEj0L1vf1EgV4QLGxZfv31DxRq10bxRA8mEnD57DuMmT5Osy8q163H1+g353OGjx6Q2nnR1bFL1zeC1ZjmURhOpSs4II8cHnTi/Dp/AeMVAQdbMmaTsTsHrQdKBLdu2Y9asWZKBM5ZH8b7hteM9aKxZt9VMSv71rdu2CakBHXXSJ6ZLHA837j9CjaJ5LY6FgnTMFfJmRZ+ZS35hPvSo80WDUZ0i7bdQhjv+rWOSYAmmGnYmK4/f6L/gHGMsL7IG1yVjOZV3MNAZy/8I1WciNLvG8ic6xHSMTe0LE26F6VyY8FHQ6KStZjNCIz2cDHft3ScCb1euXUOvPn1E6p4PW0JZfOZ3XNquEUbxO2X9oKFtTRfrEuikkIFh8aJFomZNxhr//gOgTIliSJwwAY6dPC3809w+a8CpEK5idjT66zZpjg4/VIzjx4sjzbGJEybEotnTLU4Ny5uGjBwjqquk2CUTFlG8aGEUKZgfGXLmRYa0adG5fRv49+8POQoUFVrajt17yec0ghwvblw0btJERPe432y4rVy5smRmfDOM0WM6cMOGDsXde/cs7w8eNAj9+vdHyZIl4VfhExivLly8iMb1att8L0+unFixZp0YYspAxvvUmLFQWleNnNoCP8ceCmoNODkrFdF54jwEDvTr8vby7Tu8ef/Boj1jdC486nxp5kMjvTwGjf5qLT63qVoY/J/GqTpRJnuU74QGmrjOqICpLXA8G8cX4ZV6EtbikcZyKO0d5L5wzeN6o71D/KxvLl/zUPihhm7PgulcmPBRoMIpJ7EFi5dadCiMvQP7Dh5CiODBhVqVqttcmGvVrGmTDpmTKHsidPJ0jWOhzg0XCO6H1kW7dlKlgcA+CDZgt2rWGLfu3BWF75UL5yFRgvhiTLH0KGqUKHjw8CGSJU2M9GmcWKqIVCmSY+ywIShX1al8a9HS5VLyxT4K631o0aQhZs93FOE/o2CgGkwsJYsf18npYCM7j4VGGI+NUWD+TUElLmhVqlSBX4JGjxkB79q1CxJGj4IxAzsifeJ4uHbvEUY4rpZMF2uHmfXyq/Buxiv+PgUrbeH+gweWUiGFZhRVI0LrvG2pzVpDx/3nL1+ROXkirNl7BM3KFZXXbzx4jIGzl2Lz4VP4Ripo//6F652lh0ayAo84X7xPmR2jc2ssu+R+qIOkGRkj/qWSPb8MGuVce9jIbQ1ec75HZ5rEBprp8Eo9CevyP3V8OW6VsESdDYKvm06FCbfCdC5M+ChwwiOT0/xFSxAuXFjUr1lDnvfsP4CuvftJBiCwXWDUa9pSyoT69uuH0qVL/6IWbeScV3YOt+wDnRIaHUwNu2WhZ405SzSmjhstZUrJM2RFlYrlkSBePNRs0ESyLSxjouDdsRMnsXP3XhHuGz6wn8U4ypwxvWhPvH33DlNnzbU4HdYg+xMdiPsPnEfJNm/bjidPn6FAXicF8pu3botA4JChQ+Vc+Ta4pyZdF04yFwUOEAALerVCyGBO0fGEMaNifLv6KNtliLAN+WXnwrsZr1h+Nmf2bOkBYhmjgsKVsxcslL/J2MZr0LBhQyROnNiSsdAov1I3/6l8hI5i2rRpsGj7frSpXAIVuw1Du3GzUaNIHtTqNwZ2/31H8QRRESxwQHz8+g0bV63A8aNHsGrNWmclV7bq0t3qaNBw5Nxh1Dng34Q6GTxG69JMkz3Kb4BOAp1Ll7QlyNJEJ4JZOkK1lLwic2Vd/qcN5kaKWnMc/gFm5uKPMJ0LEz4O48ePF5rK8ZOmYtykqaIq/fnLF5kIOfFmypRZmo3phNgSdaRBwIldm+tcS4jGiZWRVE76/D7/duskzz4KitPlyJoFxcpVEqM+TcoUmDR9Bg4cOiwZCDZfK5atWo0W7TpJ43a5Uk4lOpzcGV2lAfLo8WN57ez5C8ieJbOz32LJ1aXLVxAoUEAx1gIHCiRZkl4DBiN3juxIlyaVbGvg8JEIHTqUZCl8G4y1wWR9WrduHW7cuI7QocMIHS+PyZbRqdHjw4cOonTOjBbHQsFxU7lADrQfN1t+419l7PFssJ9i+fLlKF25qjgYaVOnEma3UeMn4dnTZ6haqYIYYivXrEOJtWtFZZYsTrzmWqahmjA0xDSq6hJatWotWhsLw4dBl5rlMGzBKizdcQDBAwXA2+//Ye3VBwgexA6v339A5BBBRTWcgnh0Mq3HgDUtLZnmtBnbNfOCMeLL+UTpPpX6k9AyFGM/l5m18P1QR9IWdE1SemKvJlywVf7H+4t/m4KhJjwKpnNhwseBk+2OHTvE0GAN9bOnTxEzShQxGmrVquVMIdoWWxMnTWYeNCKj5RS2okicWGm80HBQ5+V3Ynh/ylrs27dP6mfzFC0hQn52gQMLfe7y1etQoWxpZ44FQYdi2co1mLNgkcW5WLVug0S2AgYMIHS6Dx49xqDhI7F4zkxnx06tj9dv3uDQkaNIlj6L5XX2oWTNnBGTp8/E0lVrcPnKVUyYMMHXKWsba4PZqDtkyBBRYSbV6N3rl9CgQQPkyJ5dGINsHRujx9+//4cggW0v1EHtnMpxXFMu5xfh2qj8wYMHMW/uXNy8eRPhwocXFW4qtbumEZW9OytWrJDyI+rR6D0YMUJ4rF++GMmSJpH/WzVtJNlIGvqHDx8Wek7jvtE4V+ExbYi25RAy4EBHoWePHli286DwrzC08PbzV9QrWQBNyxZFhDChcPb6bXSbPB8vrt3Clk0bkSplCvnNsuXKyxyj6ss6H/GeZokdAw7cJ7c4GjzPL1++tJTqGXu6+OAx8ffMXgu/A2NZn3VwS8eAGvLeQbjwN+KRJhgV8Ay2KL8F07kw4SPByY29C3y4BBocrGtVFVzVmWADmpH1ScWMuE39X38jfPjwvyhlu9W5oOHBkg7qUkQIz1Kq4Lh9564ohNPIn+u4WJyArJky2vw+PzNp2kzR4aAeBwXx+F1GTlOnTIFbdzaKunZe+5KoVK4swoQOhfWbt2L/wUNo1aoVHBwcpCFb+fNXLF+OEWMnyDlgL8rAQYORMaPt3/ZKuHXx0tpgKrUPHjwYdUsUQNea5SSTRew7fQG1B4yX93r1cmpUt0bGTJmw7sBBdKhWRpiCjFiz9ygSJ0r0C2f7vwDXisUNHDhQdCoSxI+HjOnS4tqNG3JP5s2TB9NnzHCmdu0SyOjEQMH58+elTI0Bg3XLF4vjrKAB36NzB+QuXAybN2+WRnsdI8oepcGCP5WPVKhQAcWLF0ft2rVx8ACZ5f5DwUyp0bPOT2rlFPFiYU6PlshcryPef/uOmkXz4tW795g6ZTIcFyzAvPnz5XyoPoUKaSq1rNHR+FOdPIMfLM3U2naFGpEa5TYNOr8DXkujVootcAxrQ7d3ZAysyyV9u2Col8K/2dD9J5jOhQlfBWWu4GKtDZMEJ2a+zgihChTxsypaREOAD/ZR6HfcEykk1S1/g0rZ3O6aNWvg6OiIy5cvY/TQgShTorg0as9ftFQarTds3mopebh5+47NbVLD4u27t9KfQScofdo0QglLRI4UUfZx4cJFmD59GiZMnS7Hzjr1KVOmoFixYhaDSlGuXDlnVLo+AdbUhywX0YXUJadDa4MXLVqE6JEioHutCsK8pcieKinqFMuHOY6O0pxrK3vBKHSFtWvRZsws9KxTEeFDh8SHT58weeVmbDp0AiNGjPAx58irYM0W45KxTmeZjkX3Tu1Fd0bP0649+0RPhVoR7dq1c9Vvcrvx4sWTbXBMGx0LRYJ4caXXiBTMxn1V9igtKeL9pAQNLt2/dPgPHzqEusULYNLKTaiYL/svnwkVPBiKZk2HTQdPoEedivJap+plpVejU8eOmDhpksU45Lg1Mtmpo0F4dJ28GUH2/dDsFtcka3V2BccQxzYzrJo5N417E34FpnNhwtdAVW+VRlLTztp3oY6E8sbTgNWSKa0zdQ/rBQ0VOhCzZs3EtWvXLa/rb7MMiQZHj34DsXrdRiehOyp629mJoUC6WRpNM+fOR3WHiqLXobh24yZWr9+AIgXyo0jBAsicMYOUdLGsKmXyZNixey8K5M+PDBkyyEOP808GsU8ymI3GLEGnj8dIJ+369etCFUvHgNokjHJrFFiv2dUrl5E7dVJnjoUib7oUGL9sA+7evYuECRP+8j7VTlu3aSOG8Lr9RxEvelTce/wMb0m726qVKJ3/a3CtWBwzDGRsa1TXOZVs7pzZ4VCxPObNmyfn0LVlHLyudMqfPX+Bp8+eWe4DUiSz94ikDewd4n2u2UZr9ihCMxi/+93Tp0/j0+fPyJ8hlTgXpGO2BbJGhQ4Z3PJ/xDCh0LFaGdQfNEHoRKlGrMw5+nsaLFBmnT/VydPxYGDDug5fj4fv8TPWmjzGfhMTvgs6dxk1TWyBY5nX3Oy18UXg9fSMsih/3rtmk7VMqz8oMswMcqxYsZA3r3PxXdfCdC5M+DrdAm2ANDoU+jondRoxNF5pANCZYFSIi7Rbo0Lc7pgxY6RfgQsAoTW0dB4C/ajFjh0rJhrUqYkVq9di285dYoy1ad5EfpvUuVQU//zlM/7Dfyhcqhwa16uLRAnj48Sp05g2ay5iRIuGIf37iAOiPRf6W7fv3sPY8RN8rOPgFmOWxhmvC//n5NW7Vy/cuHnTmaOWPn16iZZHjx5dXue1DB0mDB6++OmcGPHox+tk5nEJZCKiE0GBwlu3bkkpHLM7nDj/RbhWLI7ZuNLFi9rcRq7sWTFr3gK5J92iicIm/P79+mHY6HEY2LsHTp4+gxr1G4tTkSZVCslesITq2LFjoqDN66rsUczY6VjhPa1ZBVv3tR4LG/ljRY6I5TsPiqNhxLsPH8XhLJkjI95++Ci9OR8/f0GmZAkti23q1KktbE86dpVaVku0/lQnz8+SnlQzrfpZY7+FZvBojLJviw9+NlWqVDJW2Q9iwneBcxevr4rqucRYqJk44zg2s1cmvBKbNm2SLDTXXgbkyCqp4onsg2N/o1thOhcmfAWsVW+N4lQayeTkzIWakzqNkr9tTmMDMZWqw4Zxqosl6FR8+fpVfmPYgL7C1NS2c3cRtFMnZ8GSpbAvXAjp06YW1qjZUyYgn30p9OzcAfsPHUGvAYMs+846dtLWqmPBKO7IcRPkvVdv3oqBRQPDLxizNA65aLJZvUmTJjJ5BQzAiDSQO21yBAoQADuOH0fuXLmweMkSKf0iSpUqLYrlF2/dQ5LYTk4Hweswfc02ZMyQAVFtlNkYwXFRv359Tz9W3wDXisXRIb9//4HNbdy9d18MJxr5bgGvQ6/evdGpUydcuHgJFy9fkQxGjOjRcPbcBQQNFhQF8+XFoaNHZVFj9kT3lfcXx5BmJDl+XOoXoZMaJkxoOG7dg6bliqDjhLmIEzUSGpQqhNAhguHcjduo038c3n/6jPmb92DBlr3wT+G7798RIbTTtjQgwQcza5xT+LsMKPCZD80u/GmOsW6gJaznJ2ZsyK7F3pQ4sWLBzi6wlF3OnDkTo0ePFiOV8wbFAtX5NuGzwbFKx5JK7Bw3tsqjVLTOrf1QJrwRvizA9ydwfmGPWvbs2aUvjtkLkuowO71w4ULTuTDhd2FUveVkrE6FimvRyNEI4N82p9GAYUpwxvTp8j9LOTqVLS2/t2TFKsk4BA8eDA2at8KqRfNFYbt0paqYPXmC7EPP/gNRtU59bFy5FHFixxJ1bZaXnDl/AbMmjxd2p4o16ohjcvjYcXTu2Qf58+TCw8ePhTWKzd9U8Ga03RbVrk/Dn6JsasxygSV4bDQMI4UNLYbevB6tEC2ik5DZi9dvUav/WNSpUxuHDh2WNC37SebOmYNKPYajeTl7ZE+VBHcfP8PElZtw5totLFw0xMuP2bfDlrGr2TntH2D0aviwYWjVrIlFjJF4+/Ydps+ZJyVFdADJ2NWwUSNXkwZUr15dnMEePXqIlgsfpGLu0r4tnjx7iiXLV8p9Tr2Y/Pnzi9gjn+PEiSOldGqg6Rxgq+eBzkCzZs3Rr18/NChVUB4Tlm/AxBUbJZvx8s07BAoYQHoysqVMjNsPn2Damm14+uq1CPBtOnQSE8aPR5YsWSzbpTOhRp91No7PfzIAbTXQGsHI4aOHD7F03mxkyZRB5jvS9tZr0gIODpXx9evP/rKyZcti0KBBvo4B7l++1xhUefLkibPyOGsH3bX9UCZMeCTu3bsnGX7OYydPnhTWPTrGnNNZueEe+HzLxYQJg24BoaUIbM5mBI91+myK84jJl7SZOXPkkPSgGl288TjpHzx8VFTCgwYJgnv3H4gBVKW2UzQ8bpzY2Ll3r2QrFs6aLlHH6bOdBPAspUw/aqzZg8H/48aNJ8exces2tOncDSPHTZS+g40bN6Jy5cq+wrGgQcqIKhdNPrP0gxE6a8YtLrBa2nHi+DEUyZwGj1+8Qv8GVS2OBRE2VAgMb14LT548xYYNGyzXnpmMXHnzo/+cpSjUqjfqDBiHD/4CY/6CBWIAmnA7NCJPo5k9KxznfPBvXlc6ATFjxUJZh+qYNH0mjp88Jc61fbmKMv4pDtm4Xm1cv3ZVjF3SBbsWXLy0R4YN44tmz0C9WtVFaX77+tWIGT26jH/244wcOVLYn6pVqyZjjM4/xxiNNT5rD4/1mGvUqBE6dOiAeVv2YsqqLfj67bs83rz7gO///YcFvduge+0KUi5Vu3h+bBjRDVHDh8XHz58xt0dL7N6zx3JMRqNPGaN4/+ucw/fcS2FNnD17Frt370bfHl2FPU5LHxmYmDh6hDgWo4YMxPljB9GnW2fRe2nZsqW7f8+E10Kz6nSqmenifafq9KrSzXvO6LRqn486syZ8ELg2e/TDG8FxuWfPHikbZkkmM78E6cfZd+Ye+HzrxYSJH6ADETNmTBnsfOYNwUnaPU4FDRI+tI5b6w65YDNquHvzetw4fwpjhg0WZ6B7n/44fPw4alSphPq1ayJa1CgSdYoYMQKq1K6Hb1+puOu0HVLRlipmj207d1uatpntiBI5MkZPmITSDtUQL15cERfjzXvlyhV5pkjc6DFjED9+fB99zWlEcSGkI6F9MFwklaKTC6UulkbQSSA7yqfPXxAzckTYBQ6ELCkS/bL9BDGiIkbkCFIeoqAjSXHF48dPYNWqVdi1axc2btokaVwTf3ctVXBSDVplYuO9tWzZMoloDR4xGiUqOKBVh854+fIVVi9egP69uqNlk0bYsmYFShe3R/v27X+55r8DWaGiRI6E+rVqOHudBAmtmzURo4r7cOH4YcycNB4vXzyX8jg15Glw8Zn7rs6t8fd5PLyfjx07jkmTJiFRokQIHTwY0iWOh5ypk1p6K4zsUcxwbD92FsnixkDO1MmwZPFiec9o9Fkzsf2tAch9ZqaU2ytaMP8v76dIlhRxYsXE+YsXpXyydvWqGNy3pzgYFy5ccNdvmvAeMMjCdYtrmYq0GjNwWi6rRAamWrYJrwB7Ksg+WaRIESn/ZJCT9smAAQPcTXpiOhcmfBVooLIe0D2sTwQX5Pz58knUlMYG6THTpEkj/RUTJ05E4kQJMWn0CNHPyFOkBFq064jzFy+JENfHDx9QKH8+dGjdAnu3bECenDnw/MULhAoZCrfv3pX+CgUXji9fv+DoiZOo1aCxOCKkkR0zcQqKFC6CpUuXyULDhUQXGd/QqE1DSKPcZNNh9FiZu4xaAC5Fc7UEIKhdIHz+8hXPXv1qjH749FnKVmw1abMZm6xZCRIk8NLzxeOwlZHx7RA1+G/fLAxsfPB/Ohh8j/XiY8eNw4kTJ8SwJ5Y7zhX9FQXHNkua+J3Vq1e7+rd5D6dKkdxC8WoEXyd4zvfuP4BC+fNKRvDZs6diiFtD993WmGOkuESJEnjx/LmoslOdO15029G4uNEiyxh+8eYdEsWMisePH/3SBG/U0NFz6F7xM+4r5xrtIfvwg93O+tjef/ggDryipH1RBA8WDEuXLnXzb5rwGRoYvPa8ZzTIxQfHgVH7gjCZpHwqY5QHP7wRzDwzkERWRT5zrqF9wtLVOnXquGubpnNhws+DhjAjl2RdoYd+6fJleZ2LOdlpUqdIjvHjx+Ho0aOoVLaMNJk61K6PcOHCYMm8WTh39AAWzJiK6NGioWL12rh+86bcfD27dMSLFy+F5YYLRsF8eSzGxqp164Vys1TFKvAfMJAYXSx7IEXmsOHDJRLvm6PcynTDc8jFke+pFoAaWraiuUmTJkW4cGHx4OkLBA4YAFNXb/nldxZs3o237z9IKYxPLP1yS3Tep0PLL4z0zgQdDKOyMB16UcUOEULuGWtEjRJZMnN0PF2L5MmT4/TZ8zZZdM6ed4rI0/G+e/++/B0zRnRx6A8dOmQhdSD0WSPALmUQqCUTKVxoxI0aCYfPX/lFOZng61RujxIuDI5fuYFYsWM76xsiuH3e/3zovrvXAFS9DpYh8N6Z5+iUKTFi09btePzkKQrly2d5Tfubjhw54ubfNOH90KyENm3ruOXrWkJKFjY+m83cPhCkovXohzcjWbJkUq6qAcCCBQtKUMa9MNmiTPhZcKLu3bu3UFtyIQ4V0ikSbhc4MDq2aSnlTuOnTMP2XbsRxM4O779+kM+NnTRFjKUFM6dJf4Vy+6dLkxp5ihYXNe0h/XpLkyvVsj9+/GSJRj15+hS9+g/Cg4ePUKVKFRQuXBh58uTxFf0TfwKzFCoIpVFUNUJVJd0Y4bUVzeX3mjZthr59+0oj7YTlG/Hk5WuJKFN5e+XuQ5i1fgdq1qwpWSXvBh0n5ar3iw2WSt3MDAGvpVIC88HXjE3ILEd88/at9B2RftkIjvvHT564qT6XfUVkIyGlbd2a1S2vv3r1Gn0GDUG4sGElM7htxy75zVAhQ+Lrl2/OaKgVaqD9LoOQLGky7DxxDg1LFULVXiMxc9121Cn+swyJbGR0dsvmzoINB4/jxKXrmN6hq5sYn9wKfpcPZuS4kA8eOVpY0KpULCeO1aq169FvyDBxqtKl+ckax/6vl69eSfbQhO+DzpWaNeT/qptCmGrZJrwaHIcMsLLvgo7FpUuXpPw8WrRo7tqe6VyY8LMgy8HUqVPRqW0r1KleVXoi5i5ciNnzF6Hv4GEIETy4MDOJMRXAP0KFCollK1fjzLlzaNeyucWxUIQMGQLly5SC4+Jl4lzce/AAr16/wZWr1ySan71AEdy5e08WBjaElypVCn4F1KUgU48adkzhqyNBI4jGEQ0tNtb+jt6UaNiwoWxrwoTxQv+5YtchLNm+X95jTXmbNm18RLMqMxRkuKJDxeNRuuM/iab5NrBsSBuiucDwWftn2CPD0iga1nSUQ4cOhUEjRmHc8CGWciYa+aRiJntUyZIlXf27adOmlSZtik9u37VHSg7v3LuLmXPm4+OnT+LARIoYAXsPHBRWNRr23B+yt+n1MGYtfjfmiDp166Jp06bIny4F6pcsiJ7TFor+BZ3cWw+fYPPhk6LgfuXufczfvBuVKlWSY3YL45Nbwe/z3uH5ZlaVx8C+rKGjxlg+w3moYd2fCumnzpxF605dhMKX954J3wfOnbx2xsyFe0vrTHgDfEEJs1vA/jeWP/GZ8wy1Lkhus3XrVsyYMcNddPjmSDbhJ8HFmgZ+1UoV0LxRAxGrGzJqNN69e2+ZzD98/IDuHdsD/oCpM+eIMXns5En5Po0oWwgdMpQY1vz+kBGjxTigk0G8ePlKFIvJF+2bVHWNVLLaIMsovfa10MBm9F4jxYyWMqpNpi4eJ40jTd27Rl+Ekxd1DjiZkRGKmQB+n70vLJtStWLvBM8Dj1uvNR80wHlO/JoRwOvEc66iSYRGUjkWWArH99lcPWjQYDHQr9+4iQplSuPCpUtYt2mz6LNwzPTo3h1NmzVDkiRJXPXbpFPlWCIr0669+5yoOYMFw9zpk5E1kxNrEssQGzZvLZH6Hp3aC3XzvLlz0bVbN3lfnSEt1bOm1FXQ2T9+/Dh6Tp+O2FEiIWPSBDh/4w7O3biDAP7Z8wA8ffkawUOHg4ODA+7cvi39WXHjxUPz5s1lfP4O3Ac6orZ+2zVia3Tg6VTXqFFDyp14Lajz8enjRzjUqieMdAH8B8DV69eRMH48vH//QRovTfhurRmjnoVfCViY8F1ghQfL8NhzQQpyok+fPjKnDR48GPPnz3fzNv39Z6vw1I/hzJkz8kxvzDPARZmsHTSM3NtobMLjrzmZD5bNn4Nbt28L1WutalXQtEE9YaihcnaXXn2FUnPnxjVSS25ftqJkMy5duYrsWTLDcdY0Z9vkrULGHPL8U+eC6sI0blin2LhxY2TKlMlXNGUbnQmWOjEazIyE0muKQXf9ukQtmCLlmKZhRsOJ2h+Xr1yR7dAIrFS5Mrp06eLpfPvuVax1771JA5W9Olz0tT6az6xH1Ui+XwHPLXtJ1DhWLRkt2+D5Zmpcr/HBgweFuYsiSzwnvFfsixQSQ2nR0hV48uwZFixY4GrdC/4unQuylZAhjJSrFco4z/pdvXYduYsUx9hhg3Hz9m2MnzJdHAVeH3UCuS9qqHEMMzJs61odPnxYhKE4tnm8nz9/QqCAgRAvfnz5f9vWrfj85QvsAgXEpy9OzhazMnnz5RNRTVuOpWa5lH3Opd92CXSw2NPDfWdWT8Hm9eHDh6OEfRHJ6lEbh/S0m7buwIFDh7Bp82YhN/CNMNdNv6PE7ZHX0rPttb/et7cvkezyTg/f9vlEeYAQYbzluKlXxEoP0rozMMT5mM8sk6L4LAk93Aq/E34zYcJqoSfI2DRq/CRZnPv3dGK7IXJmy4olc2chS54CaNm+E1Y4zkOD2jXRs/8gZEyfDrv37ceYiZPRqG5ticiSxWXUuAlCKUuwtrx8+fLCo++b1HKN6q+qlk0tARpVV69exY7t23H3h64HlYpTxo+NsycuiCFJMNo7pWNjRAwbCtuOnsG0+fNw5fJl0Zuwxfrj0fvsXsVaGn3urWNWY5K/z8Zmv+RYENpYKgxnP0qj6FSoo0lwfKhzwQWIhATbt29H+1Yt0KppI8u2eA9VrlUPHTt2wLZt213lbPOaMBDADAkjaMWLFPrlMwnix0PihAmEfa1OjWoYPma8LHjsy1EaXe3/4TPvWWPWxXjdGQTgwwg6Kg6VK4uRT9V4onLBnKiUPzsCBgiAFbsOYvLKzWjerBkmTpr0W6IDwqXfdglaYmhNFsDaZ85l7E3hdiJGCI9Z8xzF0ZjGDEzs2E777MuN038VZm+FCZ9SGmurf+vatWsWIgu3wnQuTPgpaDkLWTa4sM+YPU9oYgf37fXLZ5nByJ83t+hR8Hvx48W1NNgx6khuf5ZL0bC5fOUqXr1+LeU8FOfyjQu5UQiMhszcuXOxeNFC6Rvx79/JCEyTMC5ufPmCTtXLomHpQmJYff32DTPWbkPfmUtQpWBOFM2aTj6bIUkCZEmeCNV6j8K2bdtQqFAhT91n9zRUM6JGw4uGHsuaXOuYcPs0tmkkap8JX7NFj+vboYYtxz2PUR0Lgg4jzwPPHY9dz/nixYuFEKFJfec0hXRA2rVshso164rSK/sqXANeE95zBJvGrTNhdBqo5M3fN2rT6H4aCROMvRh8/0/9MTzuZk2bAv99x7cf6t+tK5VAG4ef/SNJ45RHtIjh0X3KArTv0MEZ2YDS+WopmWa6NCrtmnGqpWnGrIUeixJD7N+/X/aVmQo6Y9w2S6n0+HVs+5VouAkTPha+oELBLWCgtH///rK2cs5hwJFZC5ZJUUzVPfD9FDYmTBjACKs2G1P8a/N2p4g7FbNtIYhdEFmwWc999PgJWeAPHz0mTDbr16+Xsp/oMWOhWvXqQiXL2mvfsGAbdRn0b2V64rlhozsfZXJkQL0SBeDfn38s7ttOyj/Y4Nq0XFFxLAg+NyhVCLnTJsesDU7nU8HXmN1g85dn4G8UazUzQ2PPrUrK/DyNXRVp5DP/9w3X3q0w0qwS6rgxmsXXeezW55xGbaKECZxpLyiSJ01q+YxbQFY1srbNWbDwl/cYAGAJY5EC+eG4ZKlkkJS+leD+KXi99aHlXb/DgQMHpHSS9McKKnZbg4xmpKm11vLg9tWpUO0CdS60B8MtTp4tsK+pbt266Nq1K+zt7WUcs4xKWb74UFFLv0qbbMKECc8B++jI0DhixAiZxxhEpfZX1apV0aRJE3dt08xcmPCz6Nixo9SB3r9/H6vXb0TmjBmcvc/eiS07dtIaEerYKTPnSKQ6W7asyJs3rwjtqXCYb4FG+hmxN3KnqxIsVcB37tyJmTNmoFyeLOhT3wF5mnZHyRwZkTl5Ipy5dhsdq5Wxue1CmdKg25QFsj1juUv0iOEs2QWPhrV4mT67pqFaHRNCv+MWpidr6lG/6FjYOlZeXzbw63lTp5RjSzMKLAXcvXsXPn36/IvjfubsOctn3AKWWtWrXx+jxo/Ht2/fUc2hovT1rFm/EQOGjkCmDOmwc+9ezJy7QO5tzUCp6J+RdUfLvEg48Kfrxt4LInLY0Hj04hUCBQyAMCF+rRtn03fwIHYYOnSoCE3lzp1b2K5Ym8zfMToTOl7Yz0THQ6mqf7cvdNSUjtRa+4PnXX+D95oSDfCzdDDUueH45nX0i7TJJkz4GPgAXQqPBOeRZs2aCWPdzZs35TWWXP4NG53pXJjwUzCWs9DIII1avXr1MHu+o+hSVK1UUYwhUsa279pDjIFIESOiRIXK8O8/gHjpLHtiQ7NvA6OUVPulsUEYRdHobIwaORKbt2yBXeBA0qy6bOdB7Dl1Ac9fv8Hrdx/QacJcef3Za9vRTn6OkVujY/Hx8xccOn8VFR2qeGpU3bpZltftTwaTMRKspSpuZXr6l2qijcdK45aGKY1j1TBhJkLul0iRULFiRWnqZl9S+1bNLdt4/foNuvXpL5kFNmjzXKvaK0t52OT9uz4MOg18f8rUqbJtBa/b4aPHcfL0WUnh0/FnnwQZnHjPq1FPI9tYxuaaa6flWCGDBUWAAP5x/+kL7D9zEdlTOWVgLty8izGL12LDwRNSNhWIDsCLx1jlOB8zZ85Eu3bt0Lp1a/ks6Xv5mxxv3Cfeiywp4zng/vyuLI+NsHQgmH3Q5nRhzwoe3OIkUZGbgqAMmvDcZs6cWZit2EhLqPPtHmfahAkTrsSPMmK/hsCBAyNRokQesi2TLcoDYLJe+Dwjmwu0st5wUWc/AEsFuLCzKfLGzVtiSND2Zv001btr1aol7/vG60kD8Pbt22JM0MFYtWoV9u/bh0+fPiJBwkRimJ86eQJ96zugTO4soo69+9R5tB0zSwwmZi7WHzgugnZs5N4+tg9CG6K3bz98lAxHqgSxMaNLM6ff/PoVPaY6YsGWvZINiR8/vqcdGw1bzcBodF0NLs2k2IoM0ykh6xOvKydO9zSDewV8Yp08HQtm/ayN9lixYsl9MWbMGKEpzJwhPYoUKoDHj59g5rwFYlTHixtHRO9Onz0n3+Xfz54/R948ecRx+NN9xetGmmKOZ36f//Pvffv2SS+H7hPvbQYESOHqXqY2bjdVypTS68H7o9f0RYgRKTzm92qNF6/foEK3YYgUNgxq2udBxDChsePYaazacwSlEkdH7NDBMerQJXEymO1kKRKdApbjGUu1NPtAx5j9YL+7xpx/NDhizHiwZIHMUblyZEOxwoXkNxYsWSaBEtZLs9Ge39Pf0TK2P/2ed8E3zrMmbOOfY4u6vtfDt30+Xg5vY4siOxTnL+vm7Tlz5kg5OIWI3QrTufAAmJMkfLyxxmtEJprly5fL33ytTOnS0pxprUDpE6+nNYc+wf+NlLIsZaEx2K5tW7x//w7Fs6VH+FAhsPnIaVy7+wBFs6TDlE6NnW332MVrKN1pkDgMOdMkQ/U+o3DkwlUkjhkNrSuXRKr4sUUHYMTC1RLBpSOSJ10KRAobGrtOnseTF6+kTIQ9Kp4Fpemkc6D9I5qFUKpYFaWydh70WtKBNDYk+yRnwCPYsDwDbC4mg4iRiYkP1v9HjRpVPrNp0yZMnTJFmJu+//cf7AIHxtTxo5Ejaxb53v0HD9GkdTuhku3Xows6dO+FokXtMXr0aFefFzrGfGZG8cXz53j/4QOSJk6E5MmS4sTJ07h24wby58+P2bNn23Qw1Fg3ardYg844maBiR4mIyOFC4+jFa0JkEDhgQMSPHgUrBnVCsCA/SwSW7TiAVqNnwLFcdgzedx52sRJg+YqVss88Z8amcwX3jVkIGvtupW5mJjVnzpxo26Ip2jRvanmdZWnV6zXEjdt3RBNDHS7N2PF4fap+gk+cZ024D/+cc3HDSfTVI3E+bjZvcy543ZgVTZ48ubPXqbdDPSq9Jm6BWRZlwk/CupyFEx6jrAMHDhRDnP/7FCE0a0PV+n9rDn3u/7lz58Tg46RA40GjpCNHjkTwwAGwYWhfRAkXRl7rXKMc+sxcjOlrtuH6vYeIFz2K5bfTJ4mPuNEiYc+p8yiYKTWGNq2JnI274v7T56g/aILlc6TnpMFbq3ZtHD1yBFeevUPBosWkCSxZsmSeen60vIkGotb/E9pAS4NKhe5cqjGn4+FRBpZHOgN/y4blmdBmbesGeGY06KhxH8lixAezQ4yc9+rSSWieFdGiRsHEUcOROU8BvHz1Gh1bt0SfQUPRuXNnoXN2bR/Ixo0bLdmr0UMHoVypEmKs8/8Fi5eiQ7ee0gfBkikjWKakApD8PPs6WNZlDeq4UMPi/NkzuH7/kbyWLnE8HL90Ha0qlXDmWBBl82TBmCVrsfT8bRSJHxXDDx2X0qgb168jSNCgyJcvn5QsGemZ1Tlzz7yzZMkShAkTGk0a1HP2Oks827dugdKVquLUqVOipMvzReeF8wONPt4zPsVhNWHChM+DdR+lMcBkUtGaMOEK0BgkC45PgbWhSmOEJV3ElStXxKi6f+8ewkeIIEYcy0LWrl0jEUuChgqNe9aqS+nTqVMY17a+xbEgOGl0rFYWS7cfgOOWvehay7kB5g9ORhoRJ2okhA8dEm8/fpIIypfPnxGcAoP29qhUqZK3KI9r3wWNRG1iVdpPPW/cf23k9cwac492BrTpnNvyaXXydMAZabdu1tcyNR4z3+f9dPr0aTkO+8IFftlO1CiRkTZ1Khw7eQrdO7ZDj34DpV+CY8q1QQJSHVPoMnvWLChf+idFLM9Z1UoVsG7jZunxMDoXNKzPnj2LNWvW4MyZ06JunTlLFjRs2NBms3mZMmVw8sQJxIwUHveePMfZ67fl9USxnGc29XeTxI6BJ/fvInxQO/z3/Tt2bd2M7CmT4Nr9u5IlzZI5M7p17+7sOvJ8uee6MhsSL04cYdOyRrLETjXSLIckNDjB6+fTHFYTJnw//HkSFa0/eCXI8GhkeezevbvMTwoGJyhqyoyxe+AzQrcmTPyDsDZUWffouGC+lJAo4kaLjBTxYuHMmZNSgkKjpmWFYqiQP5u8v3znQYxctBbVq1dD4cJF5LVMSX9V7A0SOBBSJ4yDGw+corKKE5evS6S2S00no+zF67d48/4DuvfoKelQjy4N4vEywszMCyeyEiVKIHXq1DKR/W47jLrSmWB5lGYstAdAG1/V0fDMjJRbnAHXnB8jGxb/dk/TuWeCjdnMlKmOgzqh3E8a73ywYVmzSdRMifijQVrB7zDbQcP4w4efbEpuwft370RnJncOp3FvjXy5c6HPoCGiv8HxxIZvCj+2aN5c+osKZEiFD58/Y+6cOVi9ahWWLlv2i7I1+66Y3bz7+Bl4lJ9/qHMze8HSKCPIZnXs0nXkihIKy87fxtfv/2FQ42ookDG1vL/1yCnUHzxR9od0jjx3NO7VOec5YWBBG73/hJgxY2LD+vVyvq3LTk6eOSvPmpHR+0CVyn2Sw2rChAmfAQZYVEz08OHDUhJlzOpybmrRooVkYN0Dn7GCmTDxj4GGJ40yLvg0LtgwNXHiROTLkBIZ8ufAwm17MbhJdTgUzCkGAg2GORt3iYjX5FWbsWbfUZTPmxU17fMhTMgQ6DFlgTTAEtfuPULUCOGc/R6/f+XOA8SKHEGMJtJt7jt9Ee3GzULiWNHF+CLGLeM2/KFkyZ/RYY8qDdq7dy/q168vBlKKZEnx5OkzKUWhvgEjvRoJ57Mtg5xGFcta+LsqdqgN3WpMuaW+3D3OkWudAdeeH83K8LPaxOuTauQ12q09F4SOR80Y8TzSmGcGY/a8Bejbo6uzbRw4fASXr15Dt47tMG/hYrnGWbP+LJ1yDVKnSYPzFy4IZbQ1nfSqdeuxZOVKyR4oa1OsmDHx+MkTZE6WAJM7NELwoE4G/MPnL1Gl50g0atgA6zdsdKbTwf3nOGzTpo38T80X9mCMWrQWudIkQ2RDNnDC8g149PwlDn/9bHFCQgX/afTTyaAuxrq1a1GjRg0L4xOdYDZ/834n5SPPIftFuN90ilwCsyoseRw6eix6dOpgKWHgHDJo+ChpstfyRC1xULY4n+awmjDhq+HPk6ho/cFLQcdCnYtx48ZJZYJ1z8XfwJxtTJjwYrDsiZFcGmxaYjJ58mQ0r2CPDlXLoEjrPqIpUaVQLst3aBzUss+LzYdO4PKd+0geLyZGLlqDBZt3Y27PVghiFxiRw4bBo5evMWbJOmRKlhCBA/28vUk7yz4KPlLVaC3CeK/evhODqEGpwlh34JhkQbYdPS3pUaXn9KjSILLoMBOSIW0ajBw8AJEjRRTjZ+3GTWjZvrMcP1l/WCPP/ggaQrYMcms9Bo2mu8QW5dF9E65xBtx6fmzpafgU9ij+Nhu4ef2UHtWYvSBUY4KUz2Q0ImpVr4owoUJhw5atGDBsBFKnTIEjx05g4rQZYki7tf6fTG7z5s3DXMdFqFuzOsKFDYPde/ejQfNWePf+PWLGiI6gwYLi3bv3IrTH/Vl/5w4yJk1gcSwIlgv2qlsJVXuNlExgtmzZxKnQc0zhTYKlUS/fvse7jx+FUS5fsx4olSuzEBlsP3YaJy7fkM+F+/oF0ewC4JZdSDkvB89dlkxjiKBBkCdtCszbuEv6U9hfwmvZsUMHLHB0RMli9ujQshmev3ghx1S2TBnMX7BA+lZsgd9nFHHUqFE4dOSYsEW9fvsGy1aulmwRe8m0iZv3Ah1x7VPyaQ6rCRMmfBZIEW4sifIImM6FCRNe7FjQgFajloYAlcDpHDQpUwQHzl4SdqaqhX86Fkbkz5AKhy9cxfi2DaR8o3zXIeg5bSGCBA6MpHGi4+bBxzh66TpKdRyE6kVyIVyokNhy5BSW7jiAChUqSP3k9u3bxeigMbRp40b0nOYo206WNKloF5QuXdrD+wTmz58vvzdx9HCE/tHzwuMvaV8Ul69cxaTps1ClShVpRNUIq0sG+d9qT/xt38TvxPWsM1KuPT/GY/Jp7FFaykOHmMehY8ca7HegY8gxNGPufMvrPAenzpzFpctXROFeswtuAYkLmJ4/duwoSlV0QLnSpTBy3ARkz5oZQ/v3QfSoUfHx0ydR9+4zcAi6dWiHsGHDYPLKtahfsqCzhuwcqZLIPpHdhhkXXi8eI88xWbByZM+Ou9evSHbv6cs3QktL1jSWOpGSmRTMwQP4R9PwwXDw3SfsfvcFIb9/RPmuQ2X7we0Co3rRvBYqZ9LEtmrVSsrL6EAM6ddb+kQUDhXLw6FWXXTp0kVKI7WEyjhWOIaoZxEnThwsWDAfYyZNRqBAgSUDxPua3PSqCq5wKQvoUxxXEyZ8LfyYzsXcuXM9fJumc2HChBdQx2o0mgaasVyBJULsPwgRxA5tx84SrQlmFR6/sK14zVIMRkUJGj3tqpRC69Ezf/wfwWLIjx83Dh0nOE0YMaJHR9euXaUkiWUZVBRW0NBTNWYaWDRs/mR8uKdP4OjRo8iZLYvFsTDCvnAhjBw3EdeuXZPSEC1x8qw6cY9oorbl4KhTwO0wms9rTGfJLWUpPpU9imODEXga4hwvqopNGMvT6tatKxmqAwcOyPinwc7MHJ0OZgXY+E0H997du4gcJYqk4gsWLGiJuv8OHBuXzp1FzLAhMHTUGGnwnjZutKUHgT0dDWrXxJWr1zB11mwsnjsL8xctwfqDxxA9QnjZz1QJ4uDV2/eyrzS+9VoZz3HPXr0kkxA6eBAkihkVZ67fxq2HTyz7QbOCrtWQx28tlQz2Qf2jQtTwCOQPWP/6I6at2oTvP/wvNpSzPCpqtGiIET0aHCqUc3Zc3O9WTRqjSp36ohdDR4Hni9lDdSo1Y8YyBhItcNyqBoY6ezrOOOb4zGtlTb/s0xxXEyZ8JTylodt7QdpZlkeRdpbzCecZZkszZMjgru2ZzoUJEx4MLuBsPKbRwmglDSou5DSOWIKhlJRsbGapB40Ago5FogTxkTRxYjhu3Ye6JQogTIjgzhSyl2zfjxLZf97sWVMklufoEcLh5JWbyJQxI7Jnzy4P7gcNPJa1/M54Yx+DW4wP9/QJ0FB+8+a1zfd4jvQzRsfFrXXiro3IekYTNZ1G0gVzOzRSeX15btR5cW1Zik9mj+Lv0yBXgUojONa5jxxvdETYR2AEzwcZzej4JkuSBKlTJseFS5fFEWF/Dxc1I22rLTBKT0aoAhlTYe/piyhSsIBNTv2SxYoKPe3Xr05R/A7j5kq2gWAGI07UiAgaJIil3pj7znOt55i9C6vXrBHBOrK1SRbKzk5Y07jQ3r59C5cvXsS3/5wcjXrhg6NN5J/3SKIggRAjUAB0f/Aa83q2QsIYUbFs5wHRigkbJqzNezFhgvgW6kd1rHmejU6lkdSA+8SHjjEtaaBTws/o+DOOG5/quJowYcJ7sWfPHgn6pEuXTspbCQaIWI7KkmXaE26F6VyYMOEBYAaC4m5c1Gkg8G8aUkuXLMGHHxkMImuWLChdpoyoXq5btw61q1dB/Vo1RTV8y45dUtJx6uxZfPr6DWU7D0Hz8vbSX3Hm6i3ppWAwtFGZwpbt3bj/WJ5jRYkoJVXG9CaNEbdEJd1ifLhUGuSSgc+SFpaHsAQqUULnLD2zFyyUchQajzT03FMnbuxjEUXoUKFcpM316CZq1VLQHgSlAaXRR7YlpR/1C+xRfwKdU1tihXSkeT8MH9AXlcqXtTQkr92wSUT2aLQz6/E7sD8iZowYGDB7GQIFDGhTqI5QmuZjJ07Jc/hw4TB3+mT5zoo16zB20hTJDhiF7HhttNSLf5OdiQ6PakXwOvI6XLx40ZnjRI6smuF/dXBKhQmKIY/fSA9G7rTJ0bxCMSlR7DRxLi5cvIykSZzoYxXHfqiOx4gRQ8Yvrzt/29qp5Lji2OaY4/7ysxwbRr0Xa+dcx51PdlxNmPBV8IyGbm/EsGHDpLyyV69eltfYA8n/hwwZIiKjboXvWLFMmPDB4EJPjnljNNfR0VEM/cZlCqOmfV5pnN548AR6T1+Ew4cP4duPmokTp06L4jCNhlLFiiJh/HgoWKIMOrVtjd1796HFyGmWbSaNEwPLunZA9Ijh5X9GY+lwkNXmzI270kxL8S73wq3Gh5YG0XihUUmHioYYzwMNGxpkNPAZ0WeUmIYTSz+6d+qA/Llz4dGTJ5g8fSZWrlknk1vEiBHdVQ+ufSx6/rnvWpLGSK5b+ybcAh6v6pJoczl/m8eh7FcqhOgX2KN4vmjEcrwy46YUtVoWZcsgJqienTdXDlS2KgkqXrQw1m/aLO//ybnguejTty+aNWsmmYfN23fgydOnzqhvuQ/zFy1GpIgRMGHKNIQNFRIJE8RDsiROGb4OrVuIsF/H7r1w+/ZtYVnSbfM4bF0nzezRmWnevJmlLCp/hpTYcfQMwgb41dAI5M8fQvn3h3M/tDKIcnmzotf0hejetz+WzJtlcbCePnuGoaPGigAe7xEdx+o4WIPjSkkPjCWEvCYce8Zxw/8106Tj07c6riZMmPAcXL9+XYRNrVGkSBEJDLkHfsv9MmHCC0EDkgu3irspDh06hPnz56FBqUJCJXvzwWPpoaiQLxumdWkqjsXIlnUwvUtTfHr9CuWr1sCdu/fkuzSCMqZPhzPnzokBMnXcaHEeQgQPLixRVNnecfwslu7Yj9IdB+HQ+Sto0LAhjp84IfXrfwNj1Ny1FJY8/lu3buHOnTti4LPEiU4GDU8Kf9GxYEaBxhAjIFGjRUeTVm2ROG1G5CpkL+JnzGiwWZWgUcqIslvoZLWPRaGsRnxdswm24NbfsgWtd1daVtdkhAj+b618raDTETlyZHG2+OyTauJ1jBgNckKP3SWD+NKlS8hhUO42Ilf2bNJvs3XrVmfX0RZY4sfyKjrzwYMFhUPt+th38JD8/r3799GpR29s3rYDT58+w8d3b8UBT2lFr1ihTGmEDBlCqJEJHgPHgWzj3j156LgxXieqZF+4cBHRIoZD5LChhVyBe7vnrVOmxIgbn77i3pfvuPPYSdiOsAsUUIgXSM1bqFQ5DBs9Fp179kHOQvZ48fIl2rdvb1Ga53nkdXep50nPsTFLQWfCOG7ohPD+4/2o6vYaLOAz4ZMcVxMmfAf8OTV0e/QD3tfHETduXGHPswZfixcvnru2aYYsTJhwBzTCyYWbizWNI3r/5K5funSpfIY0sTPWbsPXH5HIDEnio3/DqtIkevj8FQxpWkMoY/M264EpM2ZZ9AFCBA+Gz5+dDJpMGdIhaLBgTmJmd985Uc9u3On0XqaMWDJkhIv0lW6FW6PmdCxIUWpdf08ozz5LxPR/NqhSpIzniA9GjVliYixPMcI1WQwjJa2qd2u5iEbSXQv3ZE3oLGh9uzW4PzToNJrvXvYon8TuYxwj3B8lJ+CDDiQzVbb2kaU89+8/+EWjYsWatXBc4nS/1KxZEwUKFJC+CpcyTgR7NKj5EDVKFGGIqli9tkWdndc9aBA7tKxgj5NXbmDL4dO4fPUqSleqgiiRo6ByhbLInSM7QoYIKQ6KNkDzOrVt0wbrN2yQc83rWqhQIalDpkPDY1qyeDHypU+JC7fuIm3ieIgbNRLYJdL74SvMCBwOceycltOnX7+h84PXCBzAP569/NlndOzSNbx8+05KskKFDoM5jotlTBQrVlxKEtjroY45xwmfeY7d2vNkZB1TmmBCnSSeI14nIwWvCRMm/l20bdsWjRs3xtWrVy2ieQySHj9+XPS33APTuTBhwp0ZCy7s9+/fx8ABA3DmrJNKLhdyUlgGDhgQ9tnSS9Zh48HjeP/ps2QvKnYbJpFPbTBlw3aZXJmxetNmcS6eP3+BfQcPo3b1qli2arWwKNH4WbFihRgi/F0aHjQmaPR4NFxbLqQZA5ei9UY1Zy2Z0Sh/7NixkTZtWumzcAmuLSPSKK4KvamDoa//qUnYrb9nDf4uP2/txHAfeLw0YAn3skf5RHYfa60RPXYjK5r1+CG9MdWxG9WrI2VJzDbUa9ICb9+9Q/y4cRA2TBiJ3m/ftk00G4y1v9ZgqRmF6ChOx7K0VCmSy31z9/59UePOkDgeRi9ehw8/ei/uXL+GlPFi4tyFc6haZyNSJU+GBw8fCg0zGxmZNWNNMUX4OrdrjeRJk+D0mXOYMms2Tp48Ke/xuj15/BiZMibHyzdvcf7GHSSPG4s3PF77CwD7a0+RMbgd7PwBB99/Fm2NFpWKYtiCVXjw7AXevv+IVqNmiM7G5cuXRa+CzZM6bjlO+eCYURYo9/Q8uQSj86vz199m7UyY+CfhR0T0jMidO7cI2k6YMEGelS2KYp9uFTxVmM6FCRNuBBd8RhX5YCmDP/yH6RPG4P2Hj2jVvhNSxo+NuT1aWhR7KdpVb+B40a8IGiQwLty8ixpF81i2Fy5UCHz8+An3HzxEs7YdxGBgLwKRI0cOMbaiRYv2C7OTZ8EWzaq1wchIL/+nEW10JBSaTWAEmIYQz5Ua+oyY2hLp09/gd13bWG6M4hrryRn55uuucS7+hkWH50EzJUYHQ8tb+BqNYfewR/lkdh+XtEZccoZIg8yMRMmKDkLFOnbSVGRKnw6jhgwUZ4PHRkG4dl17YPr0aaKZkSJFit+KPm3btk16NcjGFjxkKESLEUMc3ofvv1oci6FNa6BSgRyWMUqhyNajZyBunNjImzsXjp88hUmTJsmx7Nu6EdGjOTm8ObNlFdYp9j8xckd9jugxY+DYpevSQ9Vi5HRsPnJK7t186VIifdL4IkDJLGWHFIlRKV92XLnrlKlx6DEC1+49FOroRX3bomb/cVKSxSZ2OkcExyuzFu7pebIFvZe0H8MIjkk+SBEcKVIki7PqkzJkJkyY8FrQiXCvI2ELpnNhwoQLMDZHajSRoEHAxZ/GDRfonRvXSvSV9d7fvn9HvwZVLI6F0l+yHCpXk24omiUtNr84JdkKggYPKWgZNc2cp4AY3mPGjJGaaTZ3asOpd+hz0GDW8gw+uK88BzR+tGlZnQqjc8HvKCWripORQeh3hovRKFUngUa5a4ys30XSabApzahL8AgWHS3D0p4Bfdbft8Ue9Sf4NnYfdYb02DVCzutAI5b7zHKkEWMnyGvTJoxBqB+GLY+NLFKXr17D9NlzpUTq4MGDvz1O9hZUr15d/tZrzGtA+kRmDHOmSYbKBXNaPs/PsKma99ut52/Qp5tTA+OqteuFsWrv/gOyDwqqfpcvU1IyFxUrVkTevPmkP6h6kdzw798f2o+bJRTQe05fwJBmNaS/yohdJ84hUIAAiB89MpqVL4ri2TMiSOBAiBc1kpwnKeH6IRrJ/VZK6r9tuOa9xP4nZst+18PCscSeDF4L3s8+LUNmwoSPhS/XuahUqZIELulMsIrAtRl+t8B0LkyYMIAGkdYpq5I2GzypnLtv7168//AedoEDI36ChBIlzZY5kzgW8t2vXxDMLrBkLqwRN1pkRIsQDh+/fMF3lsfYBcanL18wevFanLl2C3ny5BFmhjJlyogh7tmgMbN//35s2bJFjBhGgjnZ8Ji0hEcj8kYjh4Y7jSAaRVqrzs/RQOF+82FdJuOaKKsxQm9sOtWI/Z+MLN2+0UlR+k0eA5vuaVy6VFrlXvpXZe5RJ9RozGmzMx0M3Z5H0NLyePh9n+ZgqM6FUcGb54DXg5kq9krs2L5djiFf7lwWx8KIEvZFMGn6TCEDoMZEiRIlXPw9Y9ZKS4sWLFggdcP8jbzpbGc+8qZPgS4T51mya6WK22Px8pWYPmeeM+eCiBMrttwT/FzOnDmlJ6TZ8KkIEyIYggUJIkJ5958+x8A5y9GxehkRwCQOnbuMqau3oFqR3OhT34msgOA9f/LqTZSt4BRc4NjRrIpLjE9uuc4cF5y39L50CRoAUC0edWx8WobMhAkTHg/e+8wkswyKcw7ZHKllQbpv9zZwW8N0LkyY+AEapoy0cmHm4styi1OnTgmlLP+nARM4UCDEihgOz+/fkVKHDzGiW4yU9GnSYNHSFXjy8jUihnGuRP363Xs8e/0Gdx49lbrwqr1HS3nUs1ev0aVLFzRt2tTLrgONpTq1a+PAwYNSBhIsaDCpYWfp1YABA4Tj3xh9JtTZ0Gi6MZtDQ8ioJuxWWEfo+axZEbcYWUYnRdXPjf0PdDCURtWj6F/5GR670n1q3bw2euux8aHbdC8tLQ3AhQsXSv8NezkiRYqIypUdZOx4hUP6J3D/NOul4Dngeec5Z2nRqlUr5RzR4bIF0jIT0aJGFVX33zkX1lkrXv9ZM2eibs3qmL9wkRj9tsDXed65DzoWqB4/YtyEXz67/9BhxIoZU8YQ97tDhw7iiA8eNAgv375HhbxZsWTHAUxauQmr9x5B1hSJhCGKhA0MINQunt/ZuRgybyVevH4rkUM2S5IQIUqUKEiTJo1sn9ebD/eWJ6lj8idoVlIzfb4pQ2bChLfDl+tcODo6SmCBcxCVufkgmyPnUM5HdDLobDCz4ZJe1J9gOhcmTPwwTFkiwEWVAndjx4zBs+c/jZOQIYKjXq0a0huxaNlyBPLvDx2qlsaQ+SuxZMUqVCxbGvaFC6Jb734Yt3Q9eter7Oy8TlnFDME3XL37UDIENCAqZM0lzaQJEjgXlftbuBQV15KnFi2a49z585g3fTLy5HSqR794+QoatWyDzp07Ydq06c6i9saeCiMzkzoc/A0aeO7dT6VyNUboGdFlf4kaO24pI+LDaLyqc6GOErdrbczbapB1bQ26tYHLUjllLlKjlOVQ/Jxb+yh02zTQa9eqhbv37qJSubJOTcdnz0nD3a5dO7FkyVKLSrN3gMelLEfWEXOee63vL1myFLZs3ozd+/bj1u07iB0rprPPzlu4GOHChrHohLgGmrU6ceIEXr1+jcrly0r/xsIte9GwdGFnjj5V7hds3iPli9dv3kSKZMnk9Ru3bot4hTp8BGmSt2zfIU6RMZPHEik6F4UzpxXHghjcuDpOXb0pfRahgweTPqtJKzahcKveKJEjIyKEDik6N9fvPxJV8nr16uIWf/MH2HfSr/8AKYXUY3IvdF//9BkJlgQObMmWmPoXJky4EkId67thZ2fnrM+C8zQJLA4fPiwPBlI4HyZNmtRdWhemc2HCxI+IHz35Y8eOoXfv3siTNjladKiPWJEjYv+Zixg4ZxkmTZuJPVvWo0GdmihRvjJOX7sl9LJ9Bg5GjqxZnMS52rYSlW1mKNhIGsC/PyzbeRBr9x2V81y7dm307dvXUjLjUVBDmMdBI886Ks5oOZ0n0uVu2bIVIwb2Q95cP2vEkyRKiMljRiCffSlpNmWZlkLLfVQcj30h/NstUX5mETSiT2PGOnqv5VDGbVpnGFxz/Er/6pJxpc3iLjWHG2k83VKDrt/VUjFlE1ODlJS83EdO6O6hpZ0xY4Y4FmsWO1oUziuVKwOH8mVRslJVTJ48GW3atIF3QZ1ELaOzBu8tluuQlYR6EVGjREaV2vXQs0tHcXAfPnqMidNmSP9DscKFsG7TZqGCdQu0HI9K3Iy+kZWpVMeBaFauqJQqklBh/LKN+M+/k9O3Z99BcS5u3rotzsiHjx+Rs6A9CuTLI47b4aPH5D4oXLiwhYWMY5KRvNSpU0vmcd3wbqjSYwQOnr+MMa3rOdufrCmToEjr3tJEzjGUIWNGtOjQWRz4VPFiYdSgjkgVP47sF4MUjRs1wspVq0RM72+uw+/mFiUe0HPFMcmyKDqmnDd8onCjCRMmPB+aHeeDc4Kufe4JHBKmc2HChAHjx48Th2Fm1+YI8EN5t3SuzMiQJAFyNe6KJq3bY4XjXDRuUA/d+/RHg5IFcOrqLWTJWxBJEiXC02dP5TuHL13HliOnLLoV5I6mAiZLKjwaagjTsKARR0NdKU9p5PI1La05c+aMRRnZGokTJkTC+PFx9uxZi3NB41cVmPmgY0HjylZU35iJ0Ag2n2lYK5uT0uiqcaPRe+7bnzIVLmUSrPssXGpiNSoU/86Y/1uWJkboVcCM2+Kx0rniQ88nX6OjoRP4n/o7Fi9ehIplSlscC0WK5MlQukQxLFq0SBiZvKsJ10gJbMu50GwSmwejR4smAng8t7UbNfu5jQABJGuxc+9eUZonVatbQINfaJvXrEPaVClw4eJFJEicBJ0M/RV0ZHp364yGzVtLydO3798kaBA5UiSkSZUCG7duFxG+SJEjo2vXrrIfNLy573od7969i06dO6OKgwNajpyOgplSY+mOA4gYJjQalSksWYqD5y6j2+T58O/PvzSer123Tpwdlh0GCRgQw5vXROwokWS/0yaKi1ndmqFw674YN26c1EK7BxxrqivjEvTe0IABrxWdPnWaOG51LPKYTeYoEyas4c+TyqL8eemp5rrJcijNVFDolHMcBfVYEsWMLXsx3JsRN50LEyZ+NObyZmOpQsd2DSyOhYI0koUyp8GWI6dFuCtlsmSyOLPMKU6c2KhTtx7OnTsnte+sE6ehQw0MGjXsZdBSC4+G0RCmIaAsTjwe7p8xCkEoKwSjtNaTBvf1w8cPYvRxf2n80lDW8h6joWHdoK0GPh0ZjZ6qQac14BpRVQYhZVDS6L0qJduCdSaB+85tWNPWEi7VnOv54PHwPLn0W+5habJ2fPRzWs9u3LZS+WqU2CXhOeN+P378BEmTJLb5frLEibFyzTpvbcLV/hDV9XAJPP+DBg9Gmzat8ezZcyRLkgSvXr/CvfsPhOjg5avXQmowaNAgN2f36PhS+2L8lGmS1SH69egm1/nho0fiQESJHEnO57Pnz3Dh0iXs2X9AKGe7d2wn2YqVa9ejX//+wtam157XVsvcCF43srjVrFVLejyu/qCcnbZ6C6au2iyZk88cCwH8SwZ027EzyJolCz5/cSJ8+PTlK/I07YH6JQugU/WyTvdaoEColC8bhjmuttw3bqWG1eyrLd0VhVJHW4PHxHuM85fJHGXChN9GmTJlJNjBeYLrD0ujqlSpIiXbzPp6BEznwoSJH8aRluGECWnbUw8bKoTF0Dt7/oLQUe4+dR5t2rYTo8Ya0aNH9/Rzq4YwDR81vPlMw4RRVv6tSsoEI8c81nkLl6BV00bOtrV7737cvXcfrbJmle3Z6k34EwWpkUpW90mh+6aPP9V4u6R7wYgqo63KtGNNW+saqCFly2hzK3uUrRIqTSXbyqKo86XOlbEfxJj5UaOS26SDevL0GVSpWP6X7Z08c0YECfWcelc5C8cKj0XHnS3w2NhXsGjRYuzbt08iZ1zg7ItFE9EmLnLcf6rc0xGhajVZmlzrnDM7yP4U9m5w/E2dNQf9e3ZD5EgRLZ9hydXjJ08xafQI5Mud0+JkvzNoTui+KrkD/+bYM5YV8bd4jw8bNhQfPnwU54igY5E8Tky8evdOHAvS4saMFA5DmtaUrOjl2/excNteTFyxSSirm5W3t1BWU1yTv8WAgEdTw9L54jjjNTI6H3pu+Zo6FoTJHGXChN+kog0dOjRatmwpGYrkyZN7ym+YzoUJEz+QKFEioZndfOgkcqZ2avRUUBxr6xEnkayPnz5i/JSpUsYRJ05c4eT3Lig9rFHPQaOe2iitRjFfY2MxMysjxo6X16pXrohgwYJizYZN6D1gsGRcaOBx8vkTS4Qa/0YGKf1N7c8wGjFGelIadL/r21DmLv0+t69idHps6jQZaWv5ntJsumTg6vmiAadlIMbftsUexd/Wch/rJnmXjDE+lLHKVsMto8zaCE4GL+6TZn6MQoA0Ktn4P378eHEu0qRKadnWoSNHsXb9RjRq3NhdmggeDWYJfnfuCZ5THjePic3NCp6ToUOHCj2iE72xHd6+fYf48eNj6tSpwmL2J/DaUP26bt26EombNW+BXIMaVSojRPDgWLtxM0ZPmIS8uXJIaaBG8bm/8xwXS/Mi7xGFMcpvZE6jk8HfatSokfzPBu8J7RogVYLYiBw2DAq26oW7T55LRoJzxvxerXH66i0Ubt0HF2/dk+2ECBoEY5asQ53i+YVZat2B48iQPr2MT2tqZpeYzmzRInMMGaFjQu9T634kXi8lHtBzYTJHmTDhdzFr1ixP/w3TuTBh4gdoLOTImRNzNm5HusTxUSpnRll43374iF7TFuLRsxeIGjkySleqJlHVwkWKSPkGI4JeDWNUX6FGD40JZh20TInGihoP/EyzZs2cjLDxEzF01BjL9wsWLIjBgwfLd/8U/TZG643lP9ZCckblam2KpeGiCt222Jm4DWXu0uNSVio1XLldNaaNtLVGKtvfGbh8nzSg3KbRiLfFAKVN8jxm6yjy70qoaAjSKHQJ2sCu54j7YjxXfKijQiN2586dKOtQHcXti1jYotZt2IRUqVOjQoUKPqIJl8fM8cPr96fzr2NXrzsXvNGjR6N1s8bCzMbrMmbiZMycMx9FixZF1apVJdJGB+BPSJIkiTgjsWJEx849e0XHgghiZydBAWbo+HrWzJmkoZsOB3swWrduLc4JKaiFXjp9eikh4LY0Y6HikHqu2Z/Ur18/0bCglg01Lq7ceSDq3c9fv0WuNMmw7/RFtB07S8qk2jqUkizFun1H4bhlD5oOn4rEsaLhwJmLmD59urMxxfuX44//P3ny5LfZRKVFZmmasqVxX7nPuh3rbIU+87e058K9mi8mTPwTYLzBM8qc/cFPwd9/f+Ks8wPQJlam3T0DjIxduHBBFj23MNyY8HmgAcnmaxp1MSJFQOwoEXHyyg28/+gUDWQEm+wxLVq08HAKWSN+V29tS82aEWMtp+H/bCLlM408jWTSWGNUVqP1NEJIu0vjg8fskniO9b6oYU6oAaJUlrpPxj4NYwaD/4cPH94Z7SvBLIWqgPOz/A11lIxGHbdp3bROGJvBuS88bt6X6pjYqjPX7fO8cB9ZZ299rvVYjSVnxs/aOhcE3+d7t2/f/q06uLEOnsejzgZ/h3MJn3kt+R4NRrJGsXmbInMxokdHhYoVJQPgWtVvrwKvJ/fRpdp/7iv7FjTTw2tapkxpFCmQH0P69cbTZ89QuWZdXLh0GVkzZ0TY0GGwa99+Oadjx45F8eLF/7gPTZo0wemTJ7Ft3UqcOX8BXz5/QbKkifHo0WNUr99IHAwFz3GpUqUwe/ZsRAwfHsXtC+Pb129YtW6DjKOhw4ZJVo/3j3U5HfeJNMHHjh7BsKY1sGjbPuw+eQ7pEsfD4fNXESNiODx49hIlc2TEqFZ1nI3FWeu2o/tUR/mb1I8ss6J4IDNZLAmjaB9/k9/RzIT1OLV1f/L7yhqnzokRuj1um9/TXh3jdwnPVOs2102/A4+8lp5tr/31vn14g2TPznv4ts+HTwYEDekjj9s9MJ0LD4A5SfotkJOfhglpadU4ImsCKWRTpLCt+ku4tQHTJRhLgmgE0JjR+nwVJSM0Sk6jk8anluUQRuNXI5buafa11U/A32UUVaP13E8aJDR8lC2Ir2t011iWoca/blNLo6yzMApt0uZneUw8Bs0k6O8og5URetw8j2TQsVWzr46PtRFvBM8tG/M1k0DwN9norsfvEv2vjiVeL5diOEZdCDU6lZ3rd06PTwfPP88bS8+sj12V0hll17HM5sLq1atj9WJHpE+bGrUaNsXJ06exYOY0JPvRyM5z3LxdJ+zauw8HDx6U6/U7HDp0CGXLlkWvLp1Qv/bPnqj7Dx6iVMUqiBQlijhm7FchM5VwvmfKgMljRlrGnZRU1W+MazduYtv27eLE2ro/OP67desmv8keC17KIOwP+vTJyeH/9h07x/dF/OjOmyU/f/mKdLXa4jOlvvGf9G6kTxIfoYIFxf6zlxAwYCD07tNHeqWUspnjQcfp7yiTVXuE51jnJh1vdGB5L+m2tLzPWMbH+8Izs2Hmuul38M85F88vePi2z4dL6qecCzPXacKEFbig0lBgKQQXXP5PY9I9+hLumaTZrKxlIzS+uV01LDQ6rg3Mf1KztmZ1srX/LjkfLvUT0MAylk5oLbrunzo9qvugUGfHWE6lUVWXjG/NYNDQ1oixbpMGHb+nUVZj/4Q++F06QrwWRn5/QpvO9ThslX5Yq2zrftJp0HIR7puyV1k7ljRc+T/3VRtprUvZjDCybLlXb8CjnNy/gdIW8/oaGbM0Yk5nUMUY1ZAnSJJw5+49bN2xE8P697E4FgTP8YhB/ZA+R15RKidV4u/AbBzLyXoNGIT1mzcLDe2Dh4+wYvVahAodWnpYeK5Z0tSwYQN8+vQZjx4/xqZt21G8iFM/Bg2lXl07oXCpctizZ49kN2zdH7wnxowZg/Pnz0up5NUrV/Dlm5Mx37ScPUYvXotYkZ1KAY0IHCggooQPi8t37iFC6FBYNbAjksZxEtKjknfDoZPRu1ev/9s7DyinqvWLf1hAbIBKU7oFxUp5z0qRakUECxZ8Kk1BqiCgYAee2AVEARUFARsW9CEoiIJYUIqooHQQVBBEsYHtv/bBnf/hkkySmWTS9m+trMxkknvPPSeZfPt8zZ4aO9a9h/2iBdFKJuOGOaPA4/uY4pXveW5m4H8P/sZCCfgd7z8hRHZ16C4M0nqGENqAHWTs2mAHasmSJakeksghYMwefvjhEYUFvpQREoMbBQENJXzJ0+iOFR4Pu+UwBGgI+6FCNBLYoI3drLGLixt2IiOJGrwex+a4cD7U7F+3bp27rV692hkZhMYIezMwgZq9KgDzHDAGhiAF47R5XhjYNGKYUB00toPw2MzRoCGEe+6+4viYf64F/hYExl+40rPsXYB1C2eIM1clGFZCoUHDGQInXEd0XCcMVKwNQl5wHb4x7cPEcYwTz8trLSOBa4fHALuIy5YtCzsXhQUEBD47uCbMAe4xDwiHYlgc+1/gMYToTHp5sisRi7k9vX69XY5ZskQJq3XC8a7scyxgkwDJ4HsWK26jnxxns+a8b1e3bWtTpkyxjz76yE4//XT7aO6H1v7K/9gt/fq4+b6ma0/7730PhI5xTI2jbJ+993Z14LGmXFcKY//zgVwP9PEoU6qE7Vu8uJ19Sh1rVGfHTuScRV/sMr6NW350pWzxEbj56otCwsLN3/772oPdr3bvz+nTp7tz+Z3gI30+/TA8FifAZwg3imHmGQH2oGHYH86Ha8M9xYsQQmSF54KJpwBlCT/55BMnNCZPnpzvph5CJLO/hP9lH60vAo/h5x2wEV4kWIEJzw96KsK5ov3jB2vX4zMEw5NJ0zg2nsv8ARiGeZVkhQHs500wBAlGF4xxhikx94H9N+JJ8WKvDRjZGB+EEGLzKWIg/oLVoziPQS8MQ5/YDM0Hj2MuwvWb8OPYOReAxhjHGSwDG+z7weNw/H44lD8OljzNTw4F5hj5COiADbEF0LSxb9++dtJJJ1kqwJxinfw5oEDEXPiVjZA4/cSYMSHxu2Hjxp1KyALMD7wLlauGzw8Kgnk+66yz3M0HG1W9evWyQ6tWsRcnjnOlaZ95fpKVKlnS/lWrpg17ZJSde+YZTlis+/pr++XXX93nDO9nJkszH8j/fOAGD8cNl7Vw3oojKx9iJxxe1Y6pVsluf+JZm1ClpxMeAAng/f5p8Aca/+v4XcZf/sBSdnS1SrZ8+XL3uWIHXfyM90gsydd+cYJgmWNcC/9nYS18EU3vBdYj08LyhEhuE71kZF8XsWwibcXFvHnzbP78+fbaa6+5UoS4vfrqq/bmm2/u5JqOFfxTDVcWMhHwy4b3IrOJZT3xRczQHxoH9CiQvIxpvBexc884aBjRDCGJBAUFDAGGSMDIwC343ubx/cpNeB2ei2P4YojeCD6PZS+Z6InjUMjAUOTurX+drErF8cOwRjgSjem8KgdFAq9hcy8KFCY/428sJUvRxevAePA3zCnXEL8zYTwceB6EFUJ5cDxeP8A5gqKEifM4L+fG9yxhDtlvxA9JYZOzcOPg88LNcTTwWlQ6QjIwGsg1aXi6G8MTT0+w1hdfbKMfe8xOOeUUSyXc8aeXL/hev+iii5x3a+zEZ93cjxj9uA2/7+6dEqCnz3zHlq9Yaf0H3Fyg/+fIn8IYenfv4krQDrz7XitVqqSrwrXmq6/cc3r2vclef+l5u++hh23v4sWdUGOTQI7JL7vMdUWvCjTdrFK+jM3/coV77kM92lnrm++1UzveaM1OPMH22auY/e/9efbDT7+4SlEoTwsvBsrT+riGfz9utcOKFw+VUCb0ivFzEunzGYSC3Pd++KWkCfOn+FlKNPrezB4SuZaRCnCIzCJtxQViV9E4yq/Ig/AolAjMj7jAP1KECiSTVatWJfX4onCJtp70IAAavb4nIK9uxTRc+U+Uhq+f1Ev8nW48L9qxg2MDvvEd6RyAIRcMlSB+Mnm4PAGWuQ2ej7v7+f2ywHhQdSjS6yE8ODZ+seF3P7wLIOwrWH4zCF7jz6sflub3AfDzItivwhmBnuHpP5fQ20FBGQR/h3EdKRQlnLeDfPrpp24jZug9d1nL8851ZWonvTLZdZzHK6699lq76aabUp4s6OcMBOcAv7dv3971YUFVrJdf/Z/7PF3V5jLnUZj6xnQbNnKUS76GRyS//88xh7Nnz3Y/f7xgoT088jG77pr21uO6Tq5ULd7/j4992m4fPMTq1D3dvt2w0VWHw3sNwgjhW+xiSwHJ4gS4P6BUKXt30RK7tGld6//oeJs5/1NrUPMYm/bALTZu6ts2efZcW7l+g/35119W64hqNv62Hlbzyutdh++BHS8LjRMlsO984jlbt2GTE74LFixw68d5Y4lZP1Hbfw/G4iXksYLvbRyTvXOCn6VEo+/N7CFRaxkpdDRtSEYp2iwjbcUF/pEjDtcHbun8fqFgFyZZpUPxTxgfqipVqoSN6xaZRazr6XsHYDSyYpO/6+17M5jwDOMRX9j88g+G1/hf+gz3YeM53KLVnIfBgePTq8KEcyZ9+p6EoCDgGJGj4J8neK3YIQWoxITr4/FYgpblcSM17ooFv7KN/xiFE+5h6GFs7ArNsbGqD+YBoSwYC8eYV+iZfy42SmMyOeaGu8eMt6dgY98NPo+eC+bG4G/0GjGsKwheh/dccH3DzX0wDG7cuHFWtUplO7/5OTZ95tvWrlNXq1DhELum3dW25x57OKGB/IPBgwdbq1atLFWwYEFeniwkwd92220uzwB9Hy5qc5V7HGvYsGEju/XWW6M2eMwLhrBhPR4Z9bgde3QN69uze+gzhzXvePWVNuf9D+2td2a5DrYw7IcNGxYa93HHHeeSxeFRZ4I0q5m1ueIKe3j4cBvV91prWPtYu+L2h6zJv4632kdWsxXrvnU3dPM+9tDK9vhNnV3Pi16Xnme3P/6s/bb9d7u8WX1b9fW31vfhse73o6tWtNVLv3ClauE9GTBgQKgfBd4zeK/TsxDLeyWv/12sPhft9YlA35vZQyLXErliIvNJW3HBxDOfSB1vY4GVP5IJPlTqc5E9RFtPlmqMVJmHO+HsGs0+E4zf93fGWREJx8Q/ahrPkaoQhYNhDjgOq0j5ieGEYoZN27ibjteEayjHilJ+JSh6NoK78AwpAsFOwfESKXSIia1IemZpWvbA4N95boZlUej4jcRiHQPmB69jAiy8R5grPI5NEDwH64Z7Pg+9PPw54v8zhF35YojgWEh+ZkNGv6GgP/e8hmAVKZyrauXK7nXX9+tvdU89xUYPfzC0A3ht+6ut10032y233OJ6RBTEOC8o0bxY/HujRo1cgzrk2uD9WLVqVfczxl6Q/7OYUxwPomv779vtrGZNwo7prKaNXdUqJI+XKLG/Db7tZpdMvnTZchv6yEjr3bu33X///Va5cuWQgMa4unXrZgsXLrAr7xzqel1UKV/apn/0ib09/1PnrahRtaL1uLi5S/Tmedud29iemzHHXpk1156d/q6rmlXriEOtz+Ut7NkZc2zKe/PcYwvmzbObBwywu4YMCX1eWUXN/5xS4LPiU7DQQPA9hcfYPLOwq43pezN7SMRaZkRIVCaMMcWkrbjAFwh2HH2w05L27jKRUwRLveLLHMY3vQc07Bmbj51+luNkkzcYJqzkgvc9buG+3GNtrMddcoZaMTGaO+zMS2AfDVaPYYfe4LH9jsG4Bow7WuJ5OHAO7tzHix8PDoHG6lG4RhhK9AYwPAX/KwDDl9ikjnkr0RrbBc/tV+HhXPA6+WXoJ/LnlUTLRmVYM4o7XBMNfq6lHw/P5HXAxGF/ndAA8ZmJE23KG9Nt43ebrP8N1wdKvO5mN/bqYZNefsVeeuklu+qqHd6Awoblk2nQRoLCC9eIcFiI7Hirr0UC/Wswx0+OHGF9BtxiWyKEoX2/ZYtbs0YN6tmKlavt8tYXucdRHrdRg/rWpPn59vTTT9uNN97o1gbHxLVh7YcNG+4SxqdNnepEwSFlDrQ132x0KZuXNKlrjf913E7n2o5iCpu32CVNT7OZ8z61td9usp6tz7WrBw23/fYubu2bN7EDSuxn0z5YYLMWLrRHH33U+vTps5Nw8L2E/Jyxyzs/L9G6yvtlnIUQIr+kbeDYCSecYEuXLnVfwn4DE7jMhUhHEO6xdu1a1wMBwpjGKD0F/LLnFzp2eBhCxZKR/GKHIex/wbNMLZKkcc/KTDD0WX0H0KBksjmMUhg7OB7GgZ9ZBQownAeGLb0VOB5uTPpkojnumQien12oeKpF+eFJhB4ezBMMJsw1k8bpQfHDvmhosdEfvTMwtGLdHfNzR7jTG8yb8I1+v1oP1xHr7K8n7uHZQGla5JVVqFAhJCyY78K5p1DFY1gTiCasAf4v+sY2msHBGH5q/EQnao44fNcQ0IMOPNAOLl/ezVuqoAcH8xEpfIJimJ5reP9QXhehZonY1UQDPrzXG9ava2c2bWwvvDR5F4Hx62+/2fjnXrBmjRvaqSedaGv/SfIm++67j/3n0tYudwPrQO8iG9FB9MJL1LRZM9dAr+uFZ9uL/+3jEr3vfvolW77um9Cx/vzzL5dbseWnn+3SxnVt3YbNdmKNw+2/4yZZlXKlbfrQ26znJc3tyrNOd/kZN/3nAps0aVKof4s/t4BiO1jxyX8e38PhSkcLIfKgyD99LhJ+s6wibcUF+gtgN+6+++5zX+5wTU+bNs0aNmyY6qEJsQv4AqeB7yc3+4au31wMsDs0av9DNOfVn8L3SsB4gMBAiAgMRSQ84/z0RDAnwU/SpAEBwxyx4TBqcU4YuRgPXoPx+30vVqxY4W44Fw0mvxpWLPhiIp6KUdjJd6Ere+4Zqg7FbuWYC46JO7TsAxIOdtEGuH72kAgnYMKNHzeWhqUIBBQrvhcj1qZ3kbxQrGoV7KHgh7fhHoY21oh9LBD7jwpI738417122YqVu5xz8+bvXXfqSH1bCgPOH6srhUuuZyiYn5TMZGk2PSwIOAbFZoerrrQ//vzDLrz8Sps2/S37btMmmzXnPbvkP21t3fqvres1HWzl6tXu/Rik3D8lklnBDTDPhp6BQYMGuc7f/R992pZ99Y09c2cv26f4Xtawyy129cBh1m/EWDv1mn725JSZdmvb1vb4azOcF2PD9z/YJ8tWW4/WzXepINWueWMre2ApJzCCc4v3Kd+z9NaBcL0vAD/PyezELUTWgU2ORN+yjLTeqkDyYceOHV15RXyJokpUvXq7NlYSItXQyKUxSMPIr9KEL296CIK1//MChhZLofpChUmp/vP8ZGcYGhQE7G3h96Xg7jfzJPwQnqABF0v1mWjP8Q3laMfCmCB6WGbXr+XPPAc/AT4v8UKhhZhyxgOzczGOiTmKJEz4OD1MWDs/5MlP3I81Rj0YwsYcF3i8gtWqKBgB80t4rSzrylA2hDodccQRdsUVV9igIffayGEPhMaHORjywEPuWOgnkUo4f5h/v28J8d/fXDu/8lgw7A4JoBMmTHAJpRDLF1xwgUt8juTlQOM8dOWePOV1a3Vec3tu7BjrdeMAu+qazqHnVKlUycY/PtKN9ZkXXrKr21y6y3GmvjnDbQxARDAMD+sAIeL3n8D32ID+/a33sCdt93+uAdcz4+NFboz7713ceSruHPNc6NqXfvW1uz+mWsVdzrvH7rtbjcqHOG9OUKTiM8NwSPzO4+XV+yKVndyFENlJWouLGjVq2NSpU23u3LnOKEOFDiHSEcYv01Cn4cvqUTBm/SZtecU1B5vfMfQnHDS6EELi996gwUoRg+PA6GC4E3cs/fr2FBS+OCKxhDNFe47fTyMaED64HlwXXxepCV40cUMhwnNzfpkHEy2Wn8/3m/MF1y9W48xvvsjcA4bShCsv7M8Ze4n4f8O6wosBTww49dRT7cEHH7TOnTtZs/Na2YUtW7jE5Zde/Z/NW7DQVVric1MJ5ouhRJHWE2tDLwPXH/iCevTo0TuqR5UsaSccd4y9O+tzlweBnhn33ntvWM8IumifecYZ1qf/rbZt23ZXYeuF8U/Z8EdH27BHR1n58uXszltusg8++thGPfHUjvdh0aKhz8pH8+ZbnwG32pIvl7rjXX755Xb22We70DSA9YCIxfhxg/dg1OjRzivYtm1bW716tXvevsWL2Z577Gnf/fCjzV28zImG1o1Ps0MPKWf3T5xsP/7yqy1ascbKH7Sj8hn5488/7fPV66xJjROcBy8oUvF/hjk7fDzc+1O5FULkB3gakhH0U8SyibQWFwD/pOvXr5/qYQgR9X2KL3WEFvFLHTuYuMWzM+gn87LZVbTGejS4OAY/KZv3EBZ8HkOo6OUIHj/W+vh8HownGuDRnh9raBQN57yaMvnHoggJCgV6ZBhTjvWBcOHcxhrmxbFH67oejXDJtMxliQQN6+D80ssU7KKMalAwMkeMGGGD77nfPa927dr25JNPWuPGjS1d8BPcg+8NX0xwfVlhje/bkSNH2u23324d215pfXp0t2LFdgiA51582XkikMty/fXXhz33Q0OHWocOHaz3TTdbn/63uF4gzuO3++62bt16u7xtR3e+FuecbSVK7Gf3Dn3Ynpn0klWtVMne/eBDO/KIw+2uO2611WvX2pz3P3CeE3T9hkcEYoTlnP2+HijTOWPGDCf+Ro0caT/8/Kvttttvtv8+aJD3l710Vz/X0Ru0qHei1b32JpefcfIx1V1SNxn58jT7dtP31qxZs11EKj778koIIVJN2osLITIFxLLDUwCDFV/48Zbk85N5WRHID4vJqwGWv3MZPCaEBfMDMDaKiYLErvsJo4xfjwQrUtEA9jt55yU24qkqBQMORh09RWxsRwMc50WSPb0GDFvxSwLnBY6FY8SS9MokeBCsvuUn0zLMK5o3J685okcmKHqwIYOO3BgLzpOOVfYYxuNX++J68bpY5QzhTmwSB09e586dXe+JQ6tVtQF9eu/UMRsdyud88KE99NCDtn7dOrtz4MBdksfx2URvEITdovngSf+qYxe0bGEHlyvrOna/NnWa9b2+h3Xu0NY9f+WqNfbR/Pk2f9GnVvP44+z6Lp2tS68+tmnzZitXtox7z82bN8/lCPbt2ze0rjhvMAyuU6dOdt1111mrVi3tty2bbeOWH+yiRqeGhAU4qOT+9vzA3tb8hsFWv1N/V2HqwBL72evvz7f3Pv3C9dhA3yaGGqrikxCFyG7Z5WXIqYRuITIRGC3wVuSn1jcFRbDKVDiYDI4QF1Qdwn1QWMCYRsI3DDJ4ABCugdjwvIz2vAxd7v4Hu3xH2/1n4i7LkPplYxMBDDsa875ooCHPLsOYB84tx4C/QwBEw6/mlRcwJP2kePzMpGv/OIDzBgMbYwj29Yn12lnFKtyY8R5JR2FB4GmDKIcRTu8EvWl+c0JeIx7r3r27rVm92kofdKCd2aRR2Pdss0YN7Y8//rQXX3rJPT8SDz/8sHXp0sUWf7nUru97k11yZTtb+Omndu+gO0LCYsWqVfbeh3PtzDPPcp8fiJe2nbu6krTvTPuffTx7pi147x3r1L6tvfHGGy6UlwZ/MAwO73l8DhHOtGjRp9a+eWPbsvVnO+7QyruM7ehqleyqcxra5h+32sOTptitjz1jm7b95TxSKEOrik9CiHRF4kKIQgYGB8vI4p6hPDSeaFj5pU79Lt4wGGGQQVCwY3fQ6EVyMCsq5ZWnECQv4cEeEn4CbiwCwe8DQfGUn14XkeCY/BwKen3CeQbYY4HXAcOWnbWDgg7GbbRqXgTHhIhhAj3Hg8f8cC0cB2uH4+Ie52ap2nhLrWLMBan0g/cHRFBe4WeFITBQvYwdrulpwVxwXHzvrFmzxj788EOXE1Fi//1t0+YdFdqCwKOA19/ev5+9+uqrtnjx4rDPw/rCUP/ggw+c0MDnqVjRHSLvo/kL7JHRj1uL1pdbuXLl7KSTTnKPf/jRPCu+1172+IihdmjVKu6xkiVK2I29e9oZTRrZxIkTQ5XOGAZHzwI8argmVGED1SsdbCX328c+XRG+PPC6jZutaNFidulll9vMmTPtrZkzrXnz5qF1B6r4JEQhk4xStFmGwqKESDLBBG0Ym0zOhQHid8VmmAh33/E3Pg+GEAxRPJeJvDTu2S0cYHcVzfoAd4L93Ay/3waIx9CP9bncdWapVpbojLdDdqzw+PGOlQnFuEfoDeYdORkULIxhj8V498PY/BwTrn8wARw39ijh+WhExzJ2GMLwWuVHWEBQ3PXf/9qrr73m3ot7FStm57Vo4QztVCR80xDH9eN9w+prnBOsCSpjPf/88zuEW5HdrFnjRjZm3Hjr3b2rlS1TOnQsJGmj38fp9U5zXoaBQ+51ZcyPOuqoiOfH5wrVCKtXr2533nGHXX/jgNC4UF0KuSrIqcC6vvv+B66rdzjv5IXnn2dtO3UNFWCg94zCgqFRECs49tzFy+2ihqfahDdmuWTuwyv+fx+nj5Yss6kfLLCb+ve39u3b73Iu5VYIIdIViQshkkgwQdvvywBYMpLJmGymxqRjlpTlji7DLCAgaLTght8hNvywkmADP+B7MBLpPfDBLjxCw3h8dqKmAZ0OMMwGhjR/ppEOQxNeH8wp5hvjxxrgmtjhPJy3iIYxmw4SGJVYz3Ad1xG6RlFEYzqWXg44DhKW8yMsULL1ogsvtG3bt1mP6661Y4+uYYs++9wee3Kcvf/eezb51Ved0Cps/OaOMNxZ5QxCGV3FH3vsMTdX+Cx07NrDyvxTBrblpW2sd7cu9q86tWz58pV2//ARtnzFSpdwjWMWL75XxGpr4SpJjXv6aSdkEEYHMYBO2zfccIPzlGBtIAYjvY//+uv/c5H8MDh8NtmNHZ8PbCI0atjQRrw41cb0v87env+Zndt7oF3Y8BSrXvkQm/fFCnt51lyrVbu2tWnTJuJ4VfFJiBSQhX0pEo3EhRBJIthtOdi3wK+I41cigsAI1wcDBg93ucOFI9FI9Ut1BsOh/CpPzH+IVoo1P9cNo9nvkp1OwDhlCFQw4dpPguf6YA6xjrjhNXg+Xg8DkWIQ4HHsJrPnAcExYKjimDA08To8F4YzjF4ckyVXaYBGA0IHx2AjwVgLCODahg8fblt/2mpvvDLJKhyyI4m4Qd3TXGWkps1bupj+/v37W2FDQxzzzLnAZ+Dtt992Y77i0tbWvfO1zkvx+ZIv7OY7BtnCRZ9alcqVrHPP3qHjVKpYwcY+9qjVOuF4F9r07YaNVqdOnbjGgrBDCKxmTZu68Ux4YrTVPfVkW/vVOmt4dnN75bUpdnPfG1ynboL3+bOTXnK9RrAWEKX0fGF9kYjO4gK4ru49eth1nZdZqxuHWKM6x9o+exWzCW/Mtm2//+7CrHr07Ok8FrHkBAkhCpEsDGNKNJohIZIE8wtg0LECDmBFHN+bwKRVAgOEcfiM5WcYVLQ8h3D9JPA7DFI/cRYGUCzVj/xjBMFxWKGJN4YCpYungt4AXDeun8IiUq6C710KijNcGwQBhALFng8TszkX/usgBNBNHfkwfpJ3cI7hJYmWewGBgvMjYR/HQy4Cksf9HJ5w4P34+utT7OJWLUPCglSscIjrizHphRcsVTAfBXNAEY0chtPr1bVBtw4IhT8hmfrJkQ+7+T7u6BrWp+eOUrRHVj/C3n3zdTv1pBNt8RdfWrfefZ2x36BBg7jHMn36dFu8ZImNHHq/1TvtFLcmEC4vPzPeftu2zS5v19GJHLDxu+/sljsH2xsz3rLWrVu7Bnd+Qj8+ayhNS28jS9MiLK1P33629sft9t2v261e/fo2duxY++zzz61r1667VLkSQohMQJ4LIZL14fonQZsJneGa03HXOpKhy7Aq5mHEgn98Grkw1Bhqxb9zd94fC6B4YYKxX73KN7bxdyQl49roqUhlYnAQ9v7A2CpWrOi8QSBaV2KGlkUrk4u/Y05xXB7L790Qbr3wOsw7zgFjE0KE5YHxN/wOAxvrHmm9ISwoOLkeuEf4EI4Nw9wPpQuWwt2y5QerVmXX6kQAj28OCKZUgPcR5gjv/eXLl1uvrp12EVy4xnPObGbjnnluR0f3/fazJV98aY3PaWG77b67LV7yhTPgx4wZE5M3KMg777zjSt2i9KzP0UcdaY+NGGpXdexsTc4933kZtv7T7b1bt25OyHCsTOjPq/8EysriJoTIALxiK4k+bjYhcSFEIdTxh0HBBOdggjYMYPyz8huhAb+MJcNo4oE5ADSEg14EHN/fYcffOT6/JC6P5XsiKJowJoyNO/rpAsYH4x0GHcQFjHZ/btm4jjkU9Caxk3k07xBFGufKb1qIUCkYlZHEAV4D4xnnO+igg0IiAWPBazFmjAOhVEHPCTu9+6Fx/rrinBg/QrO4/vBYMXwL44PB/f6Hc12YURCUXK1WtaqlElZYgiHOa0MCdzh2332HSHvxxRedxwOJ27NmzXJz26VrNzvzzDOTUoq39gnHuzVo166dC6HC/CLxG+vGzuLAD+8K19ldCCGyEYkLIZJIuARtv9wmDA+GOwUb4cFQYYgLS6rGE2ZE45YGqt9ojI9hLPgd52I4FT0dvoEdDLXBOHB8GMDpCK4hXOlYeAQgNli5h+FqLGVLgYV5ieaFYagTPAYML8Oc4LUwOBESE0mkMMGf8fjBvAk2ZMQYGNbF9w5zLTgGHz+HhmtMUcr34n/+8x/X2brVzLetUYP6ode+MWOmTZn2pt16662WSpjYjXFDGEEMvfDyZOel8EFo0qtTplmzM85w+RF4L9asWdN1Iw/XUDJe6tata0888YTNX/jJLt6L5ya97NYEHgeUKQaYd4SoAb9gA9dOCJElKOciKvqPJ0SS8RO0uTNO45KdnwFDXWBAsmQtjX72TYi1XwUJ7p7TgKbQYH6E30sDhm5S3L6FCIxLGOo0wnEPQcE+FIDz74uvcN2uowGjFgKDuSc7KhTtyG2hiAlCj0mwezPGQqMY4w+XpB0MiYoGQ6YYvgVxMWfOHLui/bV22skn2TE1jnLVolBiFZ29L7nkEkslGCM8NPC+YI4uuugiGzJkiCsp27ljOxeGtGr1Gut/+0D7cetWu/jii3dqVIf1Y/W1gngJGjVqZEdWr24duvSwewffYXVPOdm2b//dJr0y2f577/2u4haFBcdNrxK9eHgP4DF5K4QQuYTEhRCFAI0LCAsYHjAQmZzt75Cz1CUbscFQZU+MgoBj8XzcrecOMQ2hZFSOCpKf3hrxgjAZGn0QFbhOJD/7Rj5FVnBcfjJ6PJ4ihjrhXDAoKRpxCyZZ00OBY8drFEOMQMwEK1KFwx+7X40Mt5EjR7qeEePHj7fXpr1p5cqWtTvuuMOF9qRTRS9cA4x8eJtGPvGkjX5yrB1QqpR98+23rjTsbbfdZpUqVXLrzMZ7bFgXr0gMguOMHTfO2rdr5zp3Q9Rs//13d64W551ndw4cuMtrmFdBb1FBBY4QIg2R5yIqEhdCFBL0XOSVmwAjFQYk8zNiTeKOBowuVkliOUzsqMJ4Q2WbRJ0nGokUFchnwTxhvuiNgcfCD1NBOJpf8peECyfyhQ/DoygCY4UeKXb9xnrjZ1bRYjgcxslxxWoUMwcn3rViqJsfmoOfW7VqZaeddlrodx43HUJ4OE/0LME70bRpU9elGmuK5oEIW4KQo9eNidJsQJmI60DncFR0QgdvdAbHmNBQ77DDDov4GuVVCCEKm8WLF7uQ1s8++8z9X4THt3fv3vkqZpEIUv8tIkSOwDyFaAY2d82x4+0btvHmXIQzehCbjnscByIHt3QOgaIoopHP0CUICzSRA36vB3a9BtGuD83kECMPkYXOzP45WQo1P6KLYTHIm4CIoNEL/EpB9GZgnZkAHMkoZu+NaOI0ElhvJt+H6ytBT1mkqmWFDcdGjwvGj3Vq0aLFLusJrwaEHB5PxnXguCeddJK7CSGE7ZZe35k//fST64nTsmVLGzp0qH3xxRd23XXXuU0QbCKlAokLIQoJ7iBHM1jZZ4EVnrirTXGSH/zSqTDCYVAmu7pTQcUQvSwIc2L51XAN45ibAFGBztoMI4t0boiKBx54wO30EITW4J/x8ccfH5qngoB1Qk8Lv2keCFaswli53nhvsDM2BRJDbCgA8Px45xSGN44dLuQqUnnUdIBjw1rgBnEVDqw1vlzhzcD4Kc4YppZO1ySEyALSLCxq2bJldu6551rPnj3d79jYQmGLhQsXSlwIke0w1COWUBsY1UwIJsHXxGK8M7eAYTE4NwzXguZwFEYIFMNd6JHADSIC18AqSvBacEcej+HnvK4NuRc33HCDlStT2h4fMdR1cf5y2XK7b+hw15X6nnvu2cmL4eerxDt2JpHDKGaJWYK/YccdY8W68PgwkrE+9Grguvyu4Li+eOeV3pBIIVfRwnjYsyMVhjq9bQgtQ/WtSIIY84hxQsgFk+QTUTlKCCGSzddff23du3fPs7FnOE444QR38/8foj9QvXr1LFXIcyFEIUEDMVJ3Zh/8c4C48HtV0Kj0e034hm84o5N/g+GV7GTtZMDr5y40yvbS+M6PQEI/BDi0n3/6KTugVEn3WOmDDrI6NWtas/NaugRnJAn7MIQpXoHh9znwvQYYP67DF0JcR4ZIMU6Wa4b3Aj1f8Y4DggVhXvnJQ0BxAb+McqoMdYhKnBueqXDd5wGuz+8Ng88aBBXmmg0VhRCiYBRJUsO7Igk70sSJE933C8KkUoXEhRCFBA38WHbC/cRuGKS+FwO73gxzwo4uw4fi6eKdbtBo9r0xeAxGMXb4MW/52bUPghKsLZufExIWpFixotbmkovtloH/DYVeEa4Z5jqYBxMLbJDHtYHxy9wREhSIzMFgaBzGgPcAk5yjdRAHnEsKnHhLokJYwNPD0Dy/uV0qQo0gatatW+fugx4MVuniGCksGCK3cePGUFNFIYRIR8qXLx/ROxErS5cutbvvvtv1MoInN1VIXAhRSMDwoaGJWyyeBIYG0cDFDTuwLHXJLt8QHJkiLGj0ItwF14NrwPgZ2sKEdvxjZOneRFWZwnlKliwR9m+lSpZ054Ehivh9f7wMCfKNUzYbhPiJ1AXdz63gaykUYKT7JWV9YeXnjOC8TFbGz2gsB7CLn9eaU7zgHq+Jx7BmpS0KC79rO8QROounAowHnbjpoaBHiV4temgoLBgahWtIRO8LIUSO4/6tplfOBUE/I+QOIom7efPmlkrSc4aEyEIY4hMP/u40DCdAgUFjkaErmQANdZZqxW4yrwuP8wZgeCfCW+GDOfvf1DfCHvP1N6e79UEpP3+8MEgxVoDxIDwHxjU8ATS880ogB/gbdt1xg/cD68Wu67x2ik78TGOe+TIYd+nSpZ1hjfOyD0Re0BPEuY4HnpslXv2wPAi0VIbYYX4gTMuVK+fmAe8fvocgRvEzPTa8fnp8MkWACyFEPOB7pXPnzq6KYr9+/SzVyHMhRCER7ODLnW8SKVwKBi12umEkYTefxh52rvMTppPsKk/hoIeCRh5+RzM4ln1l2dhkU7VqVZs9e7bdedc91rtHV9vrn1CasROesdden+aeEzRAGcIUTIpm4nC8c8VmhhQX7NYNcA4mJTOZHceH0cwO23xeLHB+/d36WBK02WAx6I3xS+qm2gPAdeF7iuOC4MDnBR4o9nRJZO8LIUSOk4yci78L8NK//7YePXq4jcYxY8aEvk/x3YL/h6lA/2mFKESCHXzxD4Bx7ZFEAgxa/A3GEgxPCBT8E0mksIiWGB4vNOropWDfAVw3xs4QKBh98FAks2O3DzpQQ1w8+vgYe2bSi3b0UUfa8hWr7OtvvrH6p51qb89+144++uiQmPA7qDMsjVW3mDuRX/y8Cz+PggnrmDeWIA5WesI93gusmhUOPxcHx8Nr/ARt/B3Cwy+VS5i/4wstPJ9iOB2MdAogzAFDDnm9+IzAK5aOPTyEECKRoK/FW2+95X5Gc1Hy73//28aOHWupIPXfEELkGH7pz1jDpGA8sYkab4n0WMRS0pYdw/MKLcF1ocY2qxsFd8eZcMvjRMpTSBYnn3yyy6fYbbcidsqJ/3ZzekaTRnbEYYfaXfc9aBUrVrRBgwY5g/TII490tcNr1KjhBJDfhwIGekEbELJMsH/zRQfWmOIi3K47QrMgGhBnG65yFt9b7APBMrc8PuYeIU7BUrkUTqxa5YtO/IyQvHQw0jEGiCOKc5bspZcnnXt4CCEymGT0ufg7/y/FdxUERjqhnAshUgj7WcSyEwzDjmVNE91VO5qBz9h1GJbcUQ8CYxTCglWJ6JWAQQtjHInP2DmH4Y5btDyFZIAx3nHHHfbHH3/aM89Psi++XGYzZr5j/W653X79x6ty6on/svPPOcvWrlntXM2TJ08OlYbF9axZs8YZtDD+6dXID34JVQoBPMaEb3osQKRdd1QXqVy5cij/w4fJzjgG6qez94OfzwFwz+RoQNHHa6YY4e/A78WRShgCRTGB96afW4E5w2MSFkKIhHboTvQty5DnQohUfgD/KaEJYjHWGK8Pg5DlNgsDGGcwSmFgQkAAGNgM2cJ1oCIRjFwYnhASDNkpbAERDXguRo0a5crSrlixwl0bfra//rQXxj/l+l6Afr16uNK0Dz/8sNWpU8cZ8rgmXwwUpBkhDWCuJdeVFZog5Ji8nZdxjOdRlOC1frgck83DwfOwGhmbETLciGFGfC5geB69UvDkYIypwi8AwHK5yq0QQojUIs+FECkExhx2pf1d4VhA6EeyhQUMaAgfxOQffPDBoWpFDDeByIBhS0MUu/5r1651xifDttJNWPjzXr9+fVdV4+yzz3bdTG/o0S0kLGisQmDst+++NmXKFPcYqxDBGC+o94geARyTRrFfPpahSkFhwQ7lvhilkc1qU7GG2zE0CiFeWD8IQ74nfY8FBbD/OrwGRQXwulTBsYJoXh4hhEhME73dEn+z7PJeyHMhRIqBAQljcPXq1fneCeduOsNeCgp20nFjV2a/uzGrJMGYg2FKcG52R84UMF7MO/hX7Vq7/L34XnvZccceY+vXr9/pcQoCwA7q8ebAcPefydb0GERKsvbnnmFL7JhNIxu9HuIRdX65VhyPQgHiEZ4ahLNByIYTVBRGeI5fyaqwUW6FEEKkFxIXQqQBMN5hUOZnF5glXmGUMtm7IPX8YVjCUxEuIZvJvpmM7zGAIc5E5uUrV1rZMqV3ei6M6hUrV1mt2rXzPB7mP96eHDw/5hheIAqMSEa6P/dMrvcbw+Ee7yEck9XIYgHCghXM4BHBNVOsIOwJx8TfUDqY7y162piUnurStH6RBCGEyLhStFmGwqKESBNgxOUXCIyCigoayjAombgdFBbYxWbCbzok9MaKv+Me9DJUq1bNNR66f+jDu4SaPfPCi7Zu/Xpr3LhxnsfG6/ITJsXwJ6x9pMRjeIdQEQrJ5BQjfqlcrAc8GghRwj2vMZZz81g4Bt4/LDAAmOTNzuR4X0DUUJhRVPl5D0IIIYS+EYRIE1j5Jt5mcjQQYfjHG5rjJ79CoKA3QDBBFwYmErQZApXortmJguVyKXr88LBw48VjLCeLzqYDBgywcy68xK645GIrVbKkTX1zhk16ZbKdccYZVr169YjnpaCLR1wwpImVteAxCOe1QNI8vFl+mVrfc8FkbDyHxj4ex2PRcnJwPpwfz6PHAu9BlqAN9tZg+BHOhfcaxYlyHIQQOUUyStFmGRIXQqQJMOLQuwDx/fEY7zCQWXY0HmBElitXzgkaCAf8jth5H+yEYzyZ4qXAOPOTc1KrVi0bMmSIPf3009ZnwK3uMcxNhw4drEWLFnkKByZiIyyNDeqiwc7bWDsIN4wZ8+/3m8CaMEyO1aAAnos1ww3HYUNFjgN/jyXZH+8XvOfwXL5/WOELxw5XdYl9TGLp8i2EECI3kbgQIo2g1wBhMDSUYzGW8xIWrCDERmN8DKVj8TjCaWDk4u/4HQKDfRYQZ58JwoJN4QoCOnOjgR6MehjcCFWKVsUL88iEaBj6mDu8Ptqa4e/Mj2FSNXt/MIcCv2MNcI6gWMDjGB/EDF7LZH6cO9Z5wLnWrVu3U0d1hkexYWAk4aAcByFETlIkSTkXRSyrkLgQIg0FBoxUGHow7hFrH28uBZOWAXe4Eb7idyyGV+Kbb74J9UdgmdV4w7IKC/+a+DOMeu68JypUC/kmfnUsgnnkDj9DsCguWDEK9/BgwPuAuY0kMnAc3OgdwOsoOCAYIBxwfD7Xvza/LwXGwudh3fzmeMyNiAU+j2FVbEoXi4dCXgwhRE6hsKioSFwIkYbAkGMCdTywLwGb8zFO3jcOcY9+FJlQ9QnjRm8NGN8QWnyMnadhYBeWZ4Wii7kGEDYQBBAiGAfGg7nHnDMxmiIiEkyMp7DDPbxWCE9isnSw8hOFJsQhzoff2YSP4is/4WF4Dcvh4poilb31ieU5QgghcguJCyHSFIbFxAO7ZEcqIwtDFaEzmSAsAHJQ2PWbggKwwlFh4XsBKBz4O35ml2zMLytqxdpoD8ehAKE3Bq9HLgWOTa+GD9cWj2NeeE6KAx433lAxvAZJ/Tg2emZEKnsbS2lcIYTIPorAfZyc42YREhdCpCks+xnrDjSMUvZLCALjHInDjPHPBNgZmtWqKCZS0fkbBj7mF94LzK+fYO03nsP8Ytz4mQnb8UChwTArEE6gMNQNYgueAoRSYVw08pkzgZA63KKtOcPM0IUd3gccD2PHNVOoBqtHsSQx36fhniOEECL3kLgQIk3Bbjh27RkOlBcw7NipOQhLlbISULpD451Vj2DkYuwFTdhO1JpgZx9jw5wy/wFjhBHPkCJ6INgPIp7QLRwH4gSw4zoFBtcPj2FOmKzPMrS+kY9j4P0DocCk/bzAeHG8r776KiRC8RpcDz0ifvUoPkaPCUvjqueFECKbyU9Po1xD4kKINAaeCBiJKAcbDAOiIQfjj12Z4aFgkjFDZ/A6hlili7jIK9nYDxGCUZxqUeE3jcOuPuYbhj3HijAzXgvu/TwZ5ofEIy5wDKwX1hFrx/P788U8DKwvxpOXkY/kcBwDCeaRBAaECULq8P7xK1Nh7BA7OAe8Gr54ZRdvhEIx30Q9L4QQQkhcCJHm0DjcuHHjTl2U2RUaRh3LkLKRHhOOsXPN+P9UCAuWSA2eO5axpIsYYtdyNrzj2Og98MfIx+EtoDcpP9fA0rq8RYIhYzDq6ekJZ+QzsR9CACIjeC7ktgCK0OA58Tu9KT48rnpeCCFyBlWLiorEhRAZACvwwJCEsGBCM4xL7DYHd8ZZHhT3jMXnbnthwBh+Grjs40CjNRF9KQoLigNeC9aAfUjyugaKjPyIi1iT1enVwNzCs0CPFQh2/WaTRrx/IFTpFcFzkLzN6wl3Tex/ES7sTj0vhBBC+EhcCJEhsAoPPRMMX4lk4PoJxfBiwDgsDE8Ads55HpZExXj9pOJ08EjECgxw5L2g9wN2/mPJgfG9GIU138zz8MvDAvTdgPeLwoDeBrwfkDeC51HM8Fh+Mjm8T0IIIf5BORdRkbgQIkPwY9xZoSga7D/g5wUkAyYUwxDFjjmNVBrXhVk2NtG5IDTSkeicym7lLDHri0k284N4w80vD4vrYOlhhMshrIseMObisA8H14lNAPF8X1jgHOHCooQQIrcoInERAxIXQmQQjOGPp08FjchkGuMsG8tGcJlS7jZIXgLMT3QubDC/LHGL5Gp282ZYE3MsWFULooA5OYDvGb8HBcOp/LWiCGTFK3Yd9/NNhBBCiLyQuBAiw4g3VyHeXgvxQOMVhi+M3UzJo0gFkZLbY51nCAOICIRn+RWjfMHgl4flefA7PRV+DwqKiqC3Bj8jN0OJ2kIIEfxnnKSwqCKZEyocCxIXQmQYDINJZYgOoZhIh7GkMww3gtCLlggeDpaERYgTe1tAJDBUCrBiEwQIcykoShgeF+xBwaR7vzoVStL64VNCCCFEPEhcCJGhzfVQtagwPAUsd5upoU7pAI13Cox4O6XTs0ABQDEHsbBhw4aQCGAZ2vLly7swKIgREixPC9HBksb+Y/SMCCGECIO3qZM4/syqqZa4ECJDm+ux83YywO44d7qZpC3yD7wKmEPcw4Bn0rTfcC9ecDw/pwKiAMdnbgVCm1iS2C9JS1iaFu8hCB3lVgghhEgEEhdCZCgIXUG/hURWgYIResABBzjDE8dmpalM8Fqwt4ZfOSmdwrUwh37uBMrGYg1R2ja/4+TaM5GeJYqZWxGtB4Wa4AkhRJyoFG1UJC6EyFDQuwC3eCpH5QV2rpHPAXBMVh5KZxiyxT4P/JkGdjrBxGmINoYrYbwIcUOYFHIq8jPfWDe/Qle43Iq8UBM8IYQQiUTiQogMpmLFis6wRCfo/OIb5cgHwA0/p7uwAL5RTa9FMqtjFQQ2p2PXdOY7QMTBg8DysvF4iXAcXDMrQfllaYUQQiSBIsnIucguJC6EyHBgmMYqLmiAB8Nw/CZqmSIs8upInq5QYNC7gvFi7nljaFe4ULfg46waBZGCUDaEW4XLrRBCCCEKE4kLITIcJPIinClSkzcYoagwhVAcGJ5B4RDscZCJwiIdwZrAI8TqTvQQ4Xd4Kyjk2CAP60fhEQ4+H6BcLDwUFIsSFEIIUUgo5yIqEhdCZDgwLFF69Ntvvw0ZqDA6kTAMIxTiA8bt6tWrQyFPkShMYQGjmB6TRCalp8uaVKhQwf2MXIqtW7c6AYF1YCgX5hrPwzrh3vdgBMFrUWEK64rwJ6wrXieEEKLQu+gl6bjZg8SFEFkAq/6E69oMgxa9ENKt4hOMbIwTSemomMSKR5kOwpTKlSvnhBzC1XBdFH3wPuDmezfYPRuvw3xgrdj0jmLPz4thNSwhhBAiHdE3lBBZQriqP9gxh7Ga6j4VzBegt4L9GWBUw+OSTaD6E64L884wJ4gE/gyRACHBDtoQHmx+B3GBNcN60QOFG0QI5o3PUxiUEEKkCIVFRUXiQogsBR4LdPGmNyOVUFjAMMaOPsUFDOlsAyIA10URRWFB8DvmAEIB4U0Id/LzJtjYDuvH57BBnvIrhBBCpDsSF0JkKRAVSOJOdagRu32zxwMMbuzcp3tlp/yycePGsI/7YU74Gd4IrFHQExGpsZ28FUIIkQ4pF0nIjyhiWYXEhRBZSrTk7cKCOQZMYgbp1uCuMGDOBZOzg920fdTYTgghRKYicSFElsLQo8IGhjETkJnMLGyn/Ak2vou3m7YQQohUk2VuhiSgbzUhshSUKsVOeWFWiYLhzKRldo3OZSjwMB8IdULIE0Kh/CRuhTsJIYTIJiQuhMhS0DjvwAMPtM2bNxdamVd6KYIdwHMVCi0ICyRqQ1xgbpScLYQQGYqqRUVF4kKILKZMmTKu0tAPP/zgekkUBHhBkIgNsPsOzwju061/Rjp5LVDpCX08/L4jyqcQQogMRlFRUZG4ECIHPBgQAPkVFzSKcRyEPWHXHcni7Dad6zAUjN4a9vSAGEPPC8ybEEIIkStIXAiRI8Sbf4FwHhjHEBLwUPz8889OWOAYvAlzniFUwULjO3bihsBAPoWEhRBCZBtyXURD4kKIHABhOeyOHSswkCEo4LnAayEwcj1BOwib3HFeWXYXoVDIsRBCCCFyDYkLIXIACAQYu+vXr485lIneCYT7yEsRXnxhTumdCNf4TgghRJahhO6oSFwIkSMgxAmgehRCeGJFwmKHcIBXwk/Mhqjww56UqC2EEEJIXAiRcwIDO+sbNmxwYU5KyN4ZCAjMCROy4Z3APTwU6Kotj4QQQuQ48lxERZ4LIXI0/4L5AZmQR4HcBiRN8z7ZXbQBvRI4p4SFEEIIERsSF0LkGNh9R8IxPBfJNNQTBUWQ/3Mix01BQS8O5geCAqiLthBCCO8bI0nVoopk1SRLXAiRw/kX6H2RrjkV9CDA6KeYSHSncZwDAgL36FcB0YUSskDJ2UIIIcJ8cWhSoiBxIUQOCwx03F67dm2oAVw6QRHhi4lEeCwQEsa8ivLly7vfgZ+sDZRfIYQQQsSPxIUQOQzyCsqUKRNXidpMhiFQ9FSgAZ5EhBBCiDi+STRZUdgRWCyEyGkPRrZ1kmZIlf878jXgqYGoKF68uKsAJWEhhBBCJBZ5LoTIcX755Rfbtm2bZRpMuvaFBCtKQUTAE4McDfT0gHg64IADnKdCuRRCCCHyjXIuMtdzMXbsWKtXr57VqFHDmjZtarNnz071kITISrZv355xIVEMa4L3AbkSDHWCiChXrpzLpahUqZL7GQKjdOnSzkMDTwW8FvJYCCGEEDnkuZgyZYqNGDHCBg0aZMcdd5wNHz7cunbtau+8847beRRCJA4Y6ewfkWiRgVAkJmEX9Ng4FsaJBGzcly1b1okJJKOjrG64pGz8Dedl0rYQQghRIOS5yEzPxZo1a2zw4MHWoEEDF8rQoUMH+/nnn23p0qWpHpoQWQcMdOzqM8woUUAMoPncfvvt5z7HBYGeCYgEhDzBY8E8EYgJnAM3eSSEEEKI1JKW23kdO3bc6XeIChg+lStXzvcxsXuJ2PJkgJhu/15kNrm4nvAIwnj/7rvvEtb3AsfZunWrEwEIvcovEBRs/MfO4rjF8nnOxbXMVrSW2YXWM3tI5FrCVgsW5Eg/0n18OSwuevToYbNmzQr7t6lTp9qBBx7ofkZIxUMPPWTnn39+gXY/ER6xePFiSyarVq1K6vFF4ZKL60nvQKL+ueOL4qeffor7C8PvcQGRAiGxZcuWfI8jF9cyW9FaZhdaz+whUWuJUN20pciu1QgTddxsImXion///hFVbsmSJUM/Dxs2zNXgf+SRRwp0Pux8HnbYYZYMcB34UFWpUsUli4rMJtfXE0Y8boloWEfi+WcMLyW+XLCZwBKy+c2ZyPW1zCa0ltmF1jN7SORaLlu2LGHjEjkoLuiZyIvp06fb6NGjbcyYMQmJ2U52LX98qLKtX0Auk6vriWvGtX/77beubGthAiGBpGzkVCCHIlHk6lpmI1rL7ELrmT0kYi0zIiQqKWMsYtlEWuZcgAULFlivXr3s9ttvt1q1aqV6OELkFEjwRh4GBEa4cCR6EgoqPvBFAk8FvJUQFThusOKTEEIIITKHtBQXcK+1a9fOLrvsMmvSpImrFAVQJUYlJYUoHGDgV6hQwVV82rRpUygpG2KAuRD5ERJ8vZ+oDTEjhBBCpD/Z5WXIGXExYcIEV2Vm1KhR7kZQnrZly5YpHZsQuQYMfwiBDRs2hDwVsfSsgJjwn0ePBI6H8Ccmj8tLIYQQQmQPaSku+vXr525CiPSAIUtoVhdNWMAzAcGApGwkhW/bts09TmGRyFwKIYQQolBJ+7yQ1JOW4kIIkV5AGEBgwKOYFwhdxA0CAuGMLKSA0CqEP8lLIYQQQmQ3EhdCiJiAaIBXAt6IYMgTQKgTnkPvBBLCEUal0CchhBBZgzwXUZG4EELEBMKcICCYlI2EbggNFlqAmChRokTIO4F7eSqEEEJkFwqLiobEhRAiJhDeBK/E999/70QFS8jiJu+EEEIIISQuhBBxUaZMGeehQFlaeDLUmE4IIUROobCoqMhzIYSICwgKiQohhBBChEPiQgghhBBCiFhQykVUdov+FCGEEEIIIYSIjjwXQgghhBBCxIRcF9GQ50IIIYQQQgiREOS5EEIIIYQQIhZULSoqEhdCCCGEEELEIiySIS6KZFeolcKihBBCCCGEEAlBngshhBBCCCFiIru8DMlAngshhBBCCCFEQpDnQgghhBBCiBzMj0gG8lwIIYQQQgghEoI8F0IIIYQQQsSCPBdRkedCCCGEEEKIDOWvv/6yLl262NChQy0dkLgQQgghhBAiJook4ZZ/tm3bZn379rVp06ZZuqCwKCGEEEIIITIwLOrWW2+1Pffc02rWrGnpQk6Ii99//93+/vtvW7RoUVKOj2ODZcuWWZE0e9OJ+NF6Zg9ay+xBa5ldaD2zh0Su5fbt29Pajtr++x+2aNmqpBx306ZN1r1794jPmT59etjHr7nmGqtcubK1adPG0oWcEBfJfqPi+EWLFk3qOUThofXMHrSW2YPWMrvQemYPiVxLHCtdxUUy7byiRYvaDz/8kK/XQlikGzkhLtLJVSSEEEIIITKL6tWrJ/X4xx57rF144YWWDSihWwghhBBCCJEQJC6EEEIIIYQQCUHiQgghhBBCCJEQJC6EEEIIIYQQCaHI36whJoQQQgghhBAFQJ4LIYQQQgghREKQuBBCCCGEEEIkBIkLIYQQQgghREKQuBBCCCGEEEIkBIkLIYQQQgghREKQuBBCCCGEEEIkBIkLIYQQQgghREKQuEgCaB1y1VVX2dChQ5NxeFEIjB071urVq2c1atSwpk2b2uzZszXvQqSIxYsX28UXX2zHHHOM1a5d2+666y7766+/tB4Zzssvv2wNGzZM9TBEAli6dKmdcMIJtnDhQs2nkLhIBuPGjbM5c+bo7ZWhTJkyxUaMGGG33367ExV169a1rl272k8//ZTqoYk4+O6776xTp05Ws2ZNa9mypS1ZskTzl4Hgc9e+fXs78cQTbcaMGfbAAw/Y+PHj7cUXX0z10EQB+Oabb+zOO+/UHGYBv//+u/Xp08dtABx//PGpHo5IA+S5SDArV660++67zw499NBEH1oUEmvWrLHBgwdbgwYN7IADDrAOHTrYzz//7HZmROZ4D6+77jrbvHmzPf/889amTRsnNLCOIrNYtmyZnXvuudazZ08rU6aME/vwXmiHNLM/n/369bNy5cqleigiAWAz7scff7Tu3btrPoVD4iKB/Pnnn069w5A57rjj9BbLUDp27Gj169cP/Q5Rsdtuu1nlypVTOi4RO/PmzbP58+e7nVEI/fPPP9+qVq1qb775pqYxw0CoBf6v+v9nly9fbtWqVUvpuETBvPvr16+366+/XtOY4Xz66af26KOPWpMmTZzXf9WqVakekkgD9kj1ADKJHj162KxZs8L+berUqTZx4kT7448/rEuXLjZgwIBCH59I3FoeeOCB7mfEdT/00EPOOIUXQ2QGn3/+uR188MF22GGHhR5DeBR2u88777yUjk0UDPyf/e2331yom8hM7z5C25544gn79ddfUz0cUUAP1C233GL77LOPFSlSxL744guXD3XttdfalVdeqbnNYSQu4qB///4R/xl+/fXX7p/ls88+a3vuuWei1kekYC1LliwZ+nnYsGFuh+2RRx7RWmQQW7dutUqVKu30WIkSJVxisMhc4EW8++67XT7U/vvvn+rhiHx696+++mrn3f/ggw80hxnMxx9/7DwX+H48/fTT3WN16tSxbt26WfPmzbUhl8NIXMQBd7ODbN++3a655hoXEyxXfWavpc/06dNt9OjRNmbMGP2TzDD22GMPK1as2E6P7bXXXvbLL7+kbEyiYGzZssXl0bRq1coZLiLzgBGKEFN8X4rMB5uq+F+LyooEohEicvXq1frezGEkLhLAggUL3I4aErlxA3Dbw004bdo0mzx5ciJOIwp5TXv16uV2SGvVqqW5zzBKlSrlqkUFqw4VLVo0ZWMS+Qdexs6dO1uFChVcIrDITF544QXbtGmTq/wFYIRibbHbDeGBe5E5IPQUocOwdxAaBb766it3X7Zs2RSPTqQSiYsEgNJr2OX2GTJkiPtwtW3bNhGnEIUIEtLatWtnl112mUtSY4Uh7IRjl0ZkRhIwhCEqmDB8ZtGiRVa+fPlUD03kI64bOVLff/+98yJu27bN3XbffXfnjRKZA0oIIy+RIAcKMfp4vHTp0ikdm8if7YNCGTfffLOrFIX/twMHDrRTTjnFCQ+Ru6haVAKA0YkdNf+29957O6NGpfYyjwkTJriY/VGjRjmvBW+vvPJKqocmYuTwww93IYrwJGJn7bPPPnNeRDXsyjyQJPrWW2+5ClEoQ8vPI3pfiMwC34f+9+RBBx3kNmzwczCMUaQ/WLvHHnvMeaAuuOACu/zyy90a33PPPakemkgxRf7GtpAQQmRhxSiUFUaDJ4hFVIkaNGhQqoclhBBCZDUSF0KIrAUJ3HPnznU5GOo9I4QQQiQfiQshhBBCCCFEQlDOhRBCCCGEECIhSFwIIYQQQgghEoLEhRBCCCGEECIhSFwIIYQQQgghEoLEhRBCCCGEECIhSFwIIXIS9L944IEHrH79+q7TLLqyf/3116G/V69e3d3QGRrgno8FwWPoHu0zadIk9zi61kaCxwvePvroo9Bz5syZYy1btnSldJs1a2avv/56XNfpHxfHaNWqlb3zzjs7Peenn36yfv36We3ate3kk09284Lmg0HOPfdcu+KKK6wg9OrVy4YOHVqgYwghhEhfJC6EEDnJgw8+6AQAjGoY06tWrbIbbrghbIdosGTJkqSM46qrrrLnn39+p9tRRx0VOneHDh2sQYMGrmM8RND1119vq1evjusc6JyL4z7yyCN29NFHu+aCn3zySejv3bp1s3nz5rnOur1797Ynn3zSnnrqqZ2OsXHjRvvyyy9t/vz59uuvv+brWkeOHGmTJ0/O12uFEEJkBnukegBCCJEKXnjhBWe4n3HGGe737du3W9euXe2rr76yChUqhJ4HUXHSSSeFREaiKVeunB177LFh//bSSy9Z1apV3bhAzZo17e2337ZXXnnFunTpEvM5ypYtGzrHKaecYgsXLrRx48bZkCFD7L333rPZs2fbc889F2o0uHLlSicErrzyyp08KHvssYf98ccf9uGHHzqPTzzcf//99swzz9ghhxwS1+uEEEJkFvJcCCFyjj///NO2bt1qmzZtCj122mmn2dNPP20lS5YMPQZjnqIC94Xd5XvLli0urAohXKBo0aL2+OOPW/PmzQt03GrVqtmaNWvcz2+88YYz+P1rgxDB3GzevHkncVGnTh078sgj3c/xsmzZMpswYYLEhRBCZDkSF0KInGP33Xd3YuKJJ56whx56yOUc7LPPPs543nfffUPPO+KII3YSF+HyLZLJ6aefbt988421b98+FJaFsKbKlSsX6LgIcSpTpoz7GaFOEBs+//73v10YVrFixUKPQVCceOKJ7pYfcYE8C3hhhBBCZDcSF0KInGTw4MEu3Gn48OHOiIcxHUxihrjAjjtCppYuXep+T8Y4/KRrhmmBpk2bWp8+fezjjz+28847z4VHrV+/Pt/ngrfm2WefdQnjZ555pnsM3okSJUrs9Dx4b+rVq+cEF8C1b9iwwYkO3CBI8Hs87Labvm6EECIXUM6FECInKVWqlD322GMu5wDJ3UhmRi4CdtiLFCninoOddgiOGTNm2N9//73LDn8iuPrqq3cKc0LoU/DvZ599tj366KNOGEBoIF8iHi/Avffe6248PkQKxQWEEzw5efHuu+9a8eLFXejUtm3b3PPhvWjRokWcVyuEECLb0VaSECKnQelV5AIg9Aj5B9OmTQv9DQnMMOJffvlld7/nnnsm/PxItkZ1KN4OPfTQsM+5+eabbfz48fbLL7/YXXfdFdc52rRp45LDp0yZ4qpCderUKfS3vffe2x3TZ9GiRXbJJZe45HYAIYEKUcjFQOgYclYgOIQQQoggEhdCiJxj5syZLswIYUIAnoqePXu6fIvPP/98p+ciFAqei2SEREUD/S0gCgg8B3gsOMZoIL8CwgWel6BAqlKliq1du3anxyAqIELg5YBnY+7cuda2bVs3Ftwuuugi5/GBN0cIIYTwkbgQQuQc++23n0uQXrx4cegx7N4j5CdYKpVJ3KkQF0g0/+CDD3Z6DM38Dj744ISdA4ntyKFg9SiA0KvSpUs7UbJgwQI3N2jgR+9Ko0aNXFJ4ssrzCiGEyFyUcyGEyDnQjA5Gcv/+/V1TOngsUDkKicwwon0oKvJbKQo9IRB65INyrgcccID7GdWgEIbkc9BBB1n58uWtdevWLhcE1aHQPRveBHTovvvuuy1RIG8CDfOuueYaNxfwYkycONE11vPzLWrUqBF6DcaCBG2ES+FahBBCCCJxIYTIOZBLgQRp5C7cdtttLocAggOdqYOVkygucB8MH4qFzp077/IYKlQ1btzY/QxRg5vPFVdcYTfddJNrYoeQLRj76K5dsWJFGzhwoEvwThQIfRozZow7bq9evZyQQE5Gu3bt3N8hIBCO5YdTwfMDsQXhgYRzIYQQghT5W0GzQgghhBBCiASgnAshhBBCCCFEQpC4EEIIIYQQQiQEiQshhBBCCCFEQpC4EEIIIYQQQiQEiQshhBBCCCFEQpC4EEIIIYQQQiQEiQshhBBCCCFEQpC4EEIIIYQQQiQEiQshhBBCCCFEQpC4EEIIIYQQQlgi+D+hRIpFl6HfrwAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(f\"\\n{'='*20} 最终汇总：SMILES 结构空间离群点分析报告 {'='*20}\")\n",
    "\n",
    "# 1. 准备变量\n",
    "# 确保使用正确的 SMILES DataFrame\n",
    "if 'df_smiles_current' in locals():\n",
    "    target_df = locals().get('df_smiles_current')\n",
    "elif 'df_smiles' in locals():\n",
    "    target_df = locals().get('df_smiles')\n",
    "else:\n",
    "    print(\"警告: 找不到原始 SMILES 数据表，导出信息可能不完整。\")\n",
    "    target_df = pd.DataFrame(index=outlier_flags_smile.index)\n",
    "\n",
    "# 2. 计算\"得票数\" (Votes) - 使用 outlier_flags_smile\n",
    "# 统计一个样本在结构上被多少种算法判定为异常\n",
    "all_struct_methods = ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated']\n",
    "# 只计算实际存在的列\n",
    "existing_methods = [col for col in all_struct_methods if col in outlier_flags_smile.columns]\n",
    "\n",
    "print(f\"参与结构投票的方法: {existing_methods}\")\n",
    "outlier_flags_smile['Votes'] = outlier_flags_smile[existing_methods].sum(axis=1)\n",
    "\n",
    "# 3. 筛选高置信度离群点 (至少 3 种方法认为是结构异常)\n",
    "high_conf_indices = outlier_flags_smile[outlier_flags_smile['Votes'] >= 3].index\n",
    "\n",
    "print(f\"----------------------------------------\")\n",
    "print(f\"总样本数: {len(outlier_flags_smile)}\")\n",
    "print(f\"被至少 1 种方法标记为结构异常: {(outlier_flags_smile['Votes'] > 0).sum()}\")\n",
    "print(f\"被至少 3 种方法标记的【强结构离群点】: {len(high_conf_indices)}\")\n",
    "print(f\"----------------------------------------\")\n",
    "\n",
    "if len(high_conf_indices) > 0:\n",
    "    print(f\"\\n>>> 正在导出 TOP 结构离群点详细信息...\")\n",
    "    \n",
    "    # 提取信息: 药名 + SMILES (可选) + 得票数\n",
    "    top_struct_outliers = target_df.loc[high_conf_indices, ['Drug_A', 'Drug_B']].copy()\n",
    "    \n",
    "    # 添加投票详情\n",
    "    top_struct_outliers['Synergy_Score'] = df_smiles_current.loc[high_conf_indices].iloc[:, 4]\n",
    "    top_struct_outliers['Votes'] = outlier_flags_smile.loc[high_conf_indices, 'Votes']\n",
    "    top_struct_outliers['Methods'] = outlier_flags_smile.loc[high_conf_indices, existing_methods].apply(\n",
    "        lambda x: ', '.join(x.index[x]), axis=1\n",
    "    )\n",
    "\n",
    "    # 按得票数降序排列\n",
    "    top_struct_outliers = top_struct_outliers.sort_values('Votes', ascending=False)\n",
    "\n",
    "    # 显示前 5 行\n",
    "    print(top_struct_outliers.head())\n",
    "    \n",
    "    # 保存到 CSV\n",
    "    csv_filename = f\"{current_dataset_name}_Top_Outliers.csv\"\n",
    "    csv_path = os.path.join(OUTPUT_DIR, csv_filename)\n",
    "    top_struct_outliers.to_csv(csv_path)\n",
    "    print(f\"\\n[完成] 结构离群名单已保存至: {csv_path}\")\n",
    "    print(\"请检查这些药物是否具有独特的大环、长链或稀有杂环结构。\")\n",
    "\n",
    "else:\n",
    "    print(\"\\n没有发现 Votes >= 3 的强结构离群点。\")\n",
    "    \n",
    "# 4. 最终可视化 (SMILES Space Venn Visualization)\n",
    "# 注意：这里必须使用 X_smiles_pca (结构空间的 PCA 投影)\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# 画正常骨架\n",
    "mask_normal = outlier_flags_smile['Votes'] == 0\n",
    "plt.scatter(X_smiles_pca[mask_normal, 0], X_smiles_pca[mask_normal, 1], \n",
    "            c='lightgray', s=10, alpha=0.5, label='正常骨架')\n",
    "\n",
    "# 画异常骨架 (颜色越深，得票越多)\n",
    "mask_abnormal = outlier_flags_smile['Votes'] > 0\n",
    "if mask_abnormal.sum() > 0:\n",
    "    sc = plt.scatter(X_smiles_pca[mask_abnormal, 0], X_smiles_pca[mask_abnormal, 1], \n",
    "                     c=outlier_flags_smile.loc[mask_abnormal, 'Votes'], \n",
    "                     cmap='Reds', s=30, edgecolor='k', label='结构离群点')\n",
    "    plt.colorbar(sc, label='Votes (Structure Methods)')\n",
    "\n",
    "plt.title(f'{current_dataset_name} - 综合离群点分析\\nTotal Outliers (Vote>=1): {mask_abnormal.sum()}')\n",
    "plt.xlabel('SMILES PCA 1')\n",
    "plt.ylabel('SMILES PCA 2')\n",
    "plt.legend()\n",
    "\n",
    "save_path = os.path.join(OUTPUT_DIR, f\"{current_dataset_name}_7_Final_Summary.png\")\n",
    "plt.savefig(save_path, dpi=150, bbox_inches='tight')\n",
    "print(f\"汇总图表已保存: {save_path}\")\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "68ce941e-bf95-4c99-8b85-a18701e9ddc2",
   "metadata": {},
   "source": [
    "# Feature性质空间的SMILE结构空间的离群点对比"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "9a9e64b2-2854-4cd9-b5a8-16696d583920",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "分析阈值: Votes >= 3\n",
      "1. Feature 空间离群总数: 177\n",
      "2. SMILES 空间离群总数:  62\n",
      "------------------------------\n",
      "【重叠】双重离群、: 17\n",
      "【差异】仅特征离群: 160\n",
      "【差异】仅结构离群: 45\n",
      "集合相似度 (Jaccard Index): 0.0766\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 阈值：至少被 3 种算法判定为异常\n",
    "THRESHOLD_VOTE = 3\n",
    "\n",
    "# 特征空间 (Feature Space) 的离群点索引\n",
    "# 确保 Votes 列存在\n",
    "if 'Votes' not in outlier_flags.columns:\n",
    "    cols = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags.columns]\n",
    "    outlier_flags['Votes'] = outlier_flags[cols].sum(axis=1)\n",
    "idx_feat = set(outlier_flags[outlier_flags['Votes'] >= THRESHOLD_VOTE].index)\n",
    "\n",
    "# 结构空间 (SMILES Space) 的离群点索引\n",
    "if 'Votes' not in outlier_flags_smile.columns:\n",
    "    cols = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags_smile.columns]\n",
    "    outlier_flags_smile['Votes'] = outlier_flags_smile[cols].sum(axis=1)\n",
    "idx_smile = set(outlier_flags_smile[outlier_flags_smile['Votes'] >= THRESHOLD_VOTE].index)\n",
    "\n",
    "# A. 交集\n",
    "intersection = idx_feat.intersection(idx_smile)\n",
    "\n",
    "# B. 仅特征离群\n",
    "only_feat = idx_feat - idx_smile\n",
    "\n",
    "# C. 仅结构离群\n",
    "only_smile = idx_smile - idx_feat\n",
    "\n",
    "print(f\"分析阈值: Votes >= {THRESHOLD_VOTE}\")\n",
    "print(f\"1. Feature 空间离群总数: {len(idx_feat)}\")\n",
    "print(f\"2. SMILES 空间离群总数:  {len(idx_smile)}\")\n",
    "print(f\"-\" * 30)\n",
    "print(f\"【重叠】双重离群、: {len(intersection)}\")\n",
    "print(f\"【差异】仅特征离群: {len(only_feat)}\")\n",
    "print(f\"【差异】仅结构离群: {len(only_smile)}\")\n",
    "\n",
    "# 计算 Jaccard 相似系数 (0~1, 1代表两个列表完全一样)\n",
    "jaccard_sim = len(intersection) / len(idx_feat.union(idx_smile)) if len(idx_feat.union(idx_smile)) > 0 else 0\n",
    "print(f\"集合相似度 (Jaccard Index): {jaccard_sim:.4f}\")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 可视化：韦恩图\n",
    "# ---------------------------------------------------------\n",
    "plt.figure(figsize=(8, 8))\n",
    "try:\n",
    "    venn2([idx_feat, idx_smile], ('Feature Space', 'SMILE Space'))\n",
    "    plt.title(\"不同特征空间的离群点差异分析\")\n",
    "    plt.show()\n",
    "except:\n",
    "    print(\"未安装 matplotlib-venn，跳过韦恩图。\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "d6a66872-8a8a-4f36-a255-5bf4bb2a5987",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "三色分类交互图已生成: output\\Interactive_3D_ColorClass.html\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "customdata": [
          [
           0,
           0,
           "Methotrexate",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Methotrexate",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methotrexate",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Busulfan",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Thioguanine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "6-Mercaptopurine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "6-Mercaptopurine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Nitrogen mustard",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Nitrogen mustard",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Allopurinol",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Allopurinol",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Melphalan",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Triethylenemelamine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Triethylenemelamine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Triethylenemelamine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Altretamine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Acrichine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Acrichine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fluorouracil",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mithramycin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pipobroman",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cyclophosphamide",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cyclophosphamide",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cyclophosphamide",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitomycin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitomycin",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Floxuridine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Hydroxyurea",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Uracil Mustard",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Dacarbazine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Methoxsalen",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methoxsalen",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methoxsalen",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Vinblastine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Vinblastine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Vinblastine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Vinblastine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cytarabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cytarabine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thalidomide",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thalidomide",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Thalidomide",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Procarbazine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Procarbazine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lomustine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Streptozocin",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Streptozocin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Arsenic trioxide",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Arsenic trioxide",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cisplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Arsenic trioxide",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cladribine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Ifosfamide",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Ifosfamide",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cisplatin",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cisplatin",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Carmustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Bortezomib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cisplatin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Teniposide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Teniposide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Doxorubicin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Paclitaxel",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Decitabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Decitabine",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Decitabine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bendamustine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Etoposide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pentostatin",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pentostatin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carboplatin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Eribulin mesilate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Idarubicin",
           "Erlotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Bortezomib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Eribulin mesilate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Oxaliplatin",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Oxaliplatin",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Oxaliplatin",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Amifostine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Decitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Amifostine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Imiquimod",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Acrichine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Imiquimod",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Imiquimod",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Carmustine",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Decitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Carmustine",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Carmustine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Clofarabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Clofarabine",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Topotecan",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Thalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Topotecan",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Topotecan",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gemcitabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Docetaxel",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bortezomib",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bortezomib",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Carmustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Bortezomib",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Nelarabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Estramustine",
           "Procarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Estramustine",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Estramustine",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "6-Mercaptopurine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Capecitabine",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Allopurinol",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Pipobroman",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Methoxsalen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Ifosfamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Decitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Erlotinib",
           "Pentostatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Imiquimod",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Carmustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Estramustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Erlotinib",
           "Pralatrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Fulvestrant",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Fulvestrant",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Busulfan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Anastrozole",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Vinorelbine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Zoledronate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Anastrozole",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Zoledronate",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Aminolevulinic acid",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Mitoxantrone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Gefitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Dasatinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Everolimus",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Lapatinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Methotrexate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Nilotinib",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Sorafenib",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Hydroxyurea",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Doxorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Nitrogen mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Triethylenemelamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Cyclophosphamide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Mitomycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Streptozocin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Oxaliplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Amifostine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Topotecan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Ixabepilone",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Azacitidine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vorinostat",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Celecoxib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Fluorouracil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Teniposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Pemetrexed",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "6-Thioguanine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Depsipeptide",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Vincristine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Isotretinoin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Dexrazoxane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Rapamycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Carboplatin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Temozolomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Clofarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Gemcitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Docetaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Letrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Nilotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Abiraterone",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Pralatrexate",
           "Actinomycin D",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Thiotepa",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pralatrexate",
           "Mithramycin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Floxuridine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Mitotane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pralatrexate",
           "Vinblastine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Cytarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Daunorubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Cladribine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Fludarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Paclitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Bendamustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Etoposide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Tamoxifen",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Valrubicin",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Nelarabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Capecitabine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Exemestane",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Fulvestrant",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Anastrozole",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Dasatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pralatrexate",
           "Everolimus",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Imatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Lapatinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Sorafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Lenalidomide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Sunitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Depsipeptide",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Axitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Chlorambucil",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Melphalan",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Altretamine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Uracil Mustard",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Dacarbazine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Megestrol Acetate",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Lomustine",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Cabazitaxel",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Vandetanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Vemurafenib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Ruxolitinib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Pazopanib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Raloxifene",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Vismodegib",
           "Antagonistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Crizotinib",
           "Antagonistic",
           "IV. Normal"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, IV. Normal",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "circle"
         },
         "mode": "markers",
         "name": "Antagonistic, IV. Normal",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           2,
           "Methotrexate",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Busulfan",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Nitrogen mustard",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Allopurinol",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Altretamine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Lomustine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Pemetrexed",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Raloxifene",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Abiraterone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Crizotinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Axitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Vandetanib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Ruxolitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Mithramycin",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Mithramycin",
           "Lapatinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Pipobroman",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Cyclophosphamide",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Mitotane",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Methoxsalen",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Vinblastine",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Vincristine",
           "Actinomycin D",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Procarbazine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Streptozocin",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Actinomycin D",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Arsenic trioxide",
           "Mithramycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Procarbazine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Pentostatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Cisplatin",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Cisplatin",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Thiotepa",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Triethylenemelamine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Altretamine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Floxuridine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Hydroxyurea",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Cytarabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Azacitidine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Cladribine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Isotretinoin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Doxorubicin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Tamoxifen",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Temozolomide",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Clofarabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Gemcitabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Nelarabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Capecitabine",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Letrozole",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Celecoxib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Zoledronate",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Pazopanib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           5,
           2,
           "Bleomycin",
           "Lapatinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Raloxifene",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Abiraterone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Crizotinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Axitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Ruxolitinib",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bendamustine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Pentostatin",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           2,
           "Rapamycin",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Idarubicin",
           "Arsenic trioxide",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Idarubicin",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Epirubicin",
           "Arsenic trioxide",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Epirubicin",
           "Pentostatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Amifostine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Docetaxel",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Estramustine",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Estramustine",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Gefitinib",
           "Doxorubicin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Erlotinib",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Erlotinib",
           "Ixabepilone",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           5,
           2,
           "Fulvestrant",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Anastrozole",
           "Bleomycin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Dasatinib",
           "Actinomycin D",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           2,
           "Everolimus",
           "Carboplatin",
           "Antagonistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Vandetanib",
           "Raloxifene",
           "Antagonistic",
           "II. Feature Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, II. Feature Only",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "diamond"
         },
         "mode": "markers",
         "name": "Antagonistic, II. Feature Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           3,
           "Actinomycin D",
           "Cabazitaxel",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           3,
           4,
           "Mithramycin",
           "Vincristine",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           3,
           4,
           "Mithramycin",
           "Everolimus",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Bleomycin",
           "Vincristine",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Bleomycin",
           "Rapamycin",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           6,
           3,
           "Bleomycin",
           "Everolimus",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           4,
           4,
           "Rapamycin",
           "Actinomycin D",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Valrubicin",
           "Bleomycin",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           4,
           3,
           "Epirubicin",
           "Bleomycin",
           "Antagonistic",
           "I. Dual Outliers"
          ],
          [
           4,
           3,
           "Ixabepilone",
           "Bleomycin",
           "Antagonistic",
           "I. Dual Outliers"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, I. Dual Outliers",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "square"
         },
         "mode": "markers",
         "name": "Antagonistic, I. Dual Outliers",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "iG0tQXpdDkC1mSpaY8IJQN+PAUJR4QhAhBK6RV8XE0DcAnYkzRITQLSSSpypjBdAzGrIUOcKEEBSdzVhMgYTQPUAUAc5PQ9AljIo5MsyDkA=",
          "dtype": "f8"
         },
         "y": {
          "bdata": "53lgICKWBkA7fr3sCz8QQJ1XK3oU9g9ANb8svxt0BkBYXXdnvFIIQGO8Z+X89QlAoYCzuxlrEECAYbQcCFUGQKJOBBv4CQhAMLW2dS1JB0A=",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAACARMAAAAAAAAA+wAAAAAAAADXAAAAAAAAALMAAAAAAAAA0wAAAAAAAADrAAAAAAAAAO8AAAAAAAAA5wAAAAAAAAEXAAAAAAAAANsA=",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           2,
           3,
           "Vinblastine",
           "Mithramycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Vinblastine",
           "Everolimus",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Teniposide",
           "Vinorelbine",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Teniposide",
           "Cabazitaxel",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           2,
           4,
           "Paclitaxel",
           "Rapamycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Rapamycin",
           "Vincristine",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Rapamycin",
           "Nilotinib",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           2,
           3,
           "Valrubicin",
           "Mithramycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Vincristine",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Cabazitaxel",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Everolimus",
           "Etoposide",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           2,
           6,
           "Everolimus",
           "Rapamycin",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Everolimus",
           "Imatinib",
           "Antagonistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Nilotinib",
           "Antagonistic",
           "III. Structure Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Antagonistic, III. Structure Only",
         "marker": {
          "color": "red",
          "opacity": 0.6,
          "size": 5,
          "symbol": "x"
         },
         "mode": "markers",
         "name": "Antagonistic, III. Structure Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "khJVFODT/T9a3ENl+9/qP2YqRV8cgew/gEuZRg/y8T8i/xXYqn4BQAbdImGLBeg/W8rKl7pA6j8ytt0NnisBQLwxWxMgKug/AFe2i0Fw7j+RN9rr5tbsP40Io6gADwFAzBhKOOWQ8z+eAZHttwHtPw==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "NH/NEm8OCUCtIQwp4soQQE87IIYoJRNArMyXhMe4CUCHdPEjZU0PQKzUI9wyoRNAemlLopU0CUDfyHkRufEHQE61OpTMWQhAbh2vGkh1BkD0MBw+IrgIQAeEWinVCxdATv6mhVm8B0A8iEU6gBwPQA==",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAANcAAAAAAAAA5wAAAAAAAACzAAAAAAAAAQcAAAAAAAEBjwAAAAAAAADvAAAAAAAAAO8AAAAAAAAA5wAAAAAAAADzAAAAAAAAAQcAAAAAAAAAswAAAAAAAgEzAAAAAAABgYcAAAAAAAMBRwA==",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           0,
           1,
           "Methotrexate",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methotrexate",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Methotrexate",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methotrexate",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Methotrexate",
           "Pralatrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Vinblastine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Capecitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Chlorambucil",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Capecitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Aminolevulinic acid",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Busulfan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Pipobroman",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Methoxsalen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mitomycin",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitomycin",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitomycin",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitomycin",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Pralatrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Floxuridine",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Hydroxyurea",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Hydroxyurea",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Hydroxyurea",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Hydroxyurea",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitotane",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dacarbazine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Aminolevulinic acid",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Mitomycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thalidomide",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Vincristine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Docetaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Aminolevulinic acid",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Decitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Arsenic trioxide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Arsenic trioxide",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cladribine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Ifosfamide",
           "Procarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fludarabine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Estramustine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cisplatin",
           "Erlotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Isotretinoin",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Teniposide",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Doxorubicin",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Paclitaxel",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Decitabine",
           "Procarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Streptozocin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Ifosfamide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Docetaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bendamustine",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Etoposide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Pentostatin",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Valrubicin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Cisplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Idarubicin",
           "Pentostatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Imiquimod",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Bortezomib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Methoxsalen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cisplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Valrubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Epirubicin",
           "Erlotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Nitrogen mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Oxaliplatin",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Temozolomide",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Temozolomide",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Temozolomide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imiquimod",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Everolimus",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Acrichine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Clofarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Topotecan",
           "Pralatrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Gemcitabine",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Docetaxel",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Melphalan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Vorinostat",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Busulfan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Pipobroman",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Oxaliplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Carmustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Busulfan",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Erlotinib",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Erlotinib",
           "Procarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Sorafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Fulvestrant",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vorinostat",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Pazopanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Nilotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Triethylenemelamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Nelarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Letrozole",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dasatinib",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Altretamine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Uracil Mustard",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Nilotinib",
           "Actinomycin D",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Fluorouracil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Dacarbazine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Cytarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Cladribine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Fludarabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Isotretinoin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Tamoxifen",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Carboplatin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Temozolomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Imatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Mithramycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Floxuridine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Lomustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Sunitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Methotrexate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "6-Mercaptopurine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Allopurinol",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Hydroxyurea",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Mitotane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Thalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Vincristine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Megestrol Acetate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Azacitidine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Doxorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Decitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Bendamustine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Rapamycin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Imiquimod",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Capecitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Fulvestrant",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Anastrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Letrozole",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Celecoxib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Zoledronate",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Dasatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Ruxolitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Gemcitabine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Lapatinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Lenalidomide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Depsipeptide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Exemestane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Chlorambucil",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Thiotepa",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Paclitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Vinorelbine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Pralatrexate",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Dexrazoxane",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Mitoxantrone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "7-Ethyl-10-hydroxycamptothecin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Gefitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "6-Thioguanine",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Crizotinib",
           "Daunorubicin",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Teniposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Etoposide",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Pemetrexed",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Vismodegib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Vandetanib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Raloxifene",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Crizotinib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Cabazitaxel",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Abiraterone",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Vemurafenib",
           "Additive",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Axitinib",
           "Additive",
           "IV. Normal"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, IV. Normal",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "circle"
         },
         "mode": "markers",
         "name": "Additive, IV. Normal",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           3,
           0,
           "Actinomycin D",
           "6-Thioguanine",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Melphalan",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Fluorouracil",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Uracil Mustard",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Dacarbazine",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Actinomycin D",
           "Etoposide",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Actinomycin D",
           "Dexrazoxane",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Acrichine",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Aminolevulinic acid",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Mithramycin",
           "Actinomycin D",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Mitomycin",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Thalidomide",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           6,
           1,
           "Arsenic trioxide",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Arsenic trioxide",
           "Ixabepilone",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Arsenic trioxide",
           "Pralatrexate",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "6-Thioguanine",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Chlorambucil",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Fludarabine",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Dexrazoxane",
           "Additive",
           "II. Feature Only"
          ],
          [
           6,
           0,
           "Bleomycin",
           "Carboplatin",
           "Additive",
           "II. Feature Only"
          ],
          [
           5,
           2,
           "Bleomycin",
           "Docetaxel",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Pemetrexed",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vorinostat",
           "Additive",
           "II. Feature Only"
          ],
          [
           6,
           2,
           "Bleomycin",
           "Dasatinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Imatinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Nilotinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Sunitinib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vismodegib",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Cabazitaxel",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Decitabine",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Idarubicin",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Imiquimod",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Carmustine",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Gefitinib",
           "Triethylenemelamine",
           "Additive",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Ixabepilone",
           "Pentostatin",
           "Additive",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Pralatrexate",
           "Bleomycin",
           "Additive",
           "II. Feature Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, II. Feature Only",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "diamond"
         },
         "mode": "markers",
         "name": "Additive, II. Feature Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "S5asd3XJCEAPBAUGiIIJQK7Ze7TDNglA8SPGq80gB0BMNDa2srUGQIoAIE/yfA9Aoifl/4WNEED2JtnFProOQOc/C20Lvw5Aj+LPusjZD0AWmca2Mi4QQMBVNx3hvBBAxCA+TQyzF0Ac03YmePYOQOqQKJiHQwlAqm2Ii1QGEEA8tGRWvYkPQJAgvNbNyA5A6lWGFNkHDkDvO9ImTzcXQNbH0dIO3RRAgF10JPA7EEB0C0QNknQOQLp7u4pSQxdAEGzdufOvD0C78KpjstAQQL/6bdrHpRBA3nJuSJoBDkAHMQUL9DwOQOACtWZMjQ9A4+eCMwQUEEARv6ZVdoQQQPgO/Fp1IBBACM4zFcPGB0APgSECWF4HQELd6rRR0RBA",
          "dtype": "f8"
         },
         "y": {
          "bdata": "bOtAFa83xL/Aa9EUwAXEP0BQ3FjtR64/GPuQkHkDwj9E85D6/AS6P4qRmVYClOw//IJOIC36sT+or3C0zeT9P+b2/k0MHeg/m7tCrz23/D+153P4Zob8P8XRAiLwyf0/WmmYPji/7z/otFxdrginv1QfalGO0bu//I6aShyj8j9Xm5JJvZDzP+qvu4WskPI/Uv7Sijgi6D+YRs83DXG7PxemtA4W9vw/wrRxQN6t7j+2GtM8btjxP6MO49rB8Pw/0G52GEAw6D+m+E2qoz/+P9oY6rF2O/M/MAuLMacB6z8Ku0uXZYH+PxLAQ2V4wP4/8n37tCJO/j/VJ2HaU9UBQPL28/KGBABAzDyHVMoosD/QRc/mgXbOP2HW/7XVqfw/",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAACEAAAAAAAAAAAAAAAAAAAPA/AAAAAAAAAMAAAAAAAAAkwAAAAAAAAAhAAAAAAAAA8L8AAAAAAAAcQAAAAAAAABzAAAAAAAAA8D8AAAAAAAAIQAAAAAAAABjAAAAAAAAAAAAAAAAAAAAcQAAAAAAAABRAAAAAAAAAGMAAAAAAAAAQQAAAAAAAACTAAAAAAAAAJEAAAAAAAAAIwAAAAAAAACRAAAAAAAAAAAAAAAAAAAAIwAAAAAAAABBAAAAAAAAAAMAAAAAAAADwPwAAAAAAACJAAAAAAAAAIMAAAAAAAAAgQAAAAAAAACRAAAAAAAAAGMAAAAAAAAAUwAAAAAAAAABAAAAAAAAAGMAAAAAAAADwvwAAAAAAAPA/",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           3,
           4,
           "Mithramycin",
           "Vinorelbine",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           6,
           3,
           "Vinblastine",
           "Bleomycin",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           6,
           3,
           "Bleomycin",
           "Mithramycin",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           4,
           4,
           "Everolimus",
           "Actinomycin D",
           "Additive",
           "I. Dual Outliers"
          ],
          [
           3,
           4,
           "Everolimus",
           "Dasatinib",
           "Additive",
           "I. Dual Outliers"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, I. Dual Outliers",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "square"
         },
         "mode": "markers",
         "name": "Additive, I. Dual Outliers",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "5Jfg2c6BCUBjIvHK+L0XQKA2EU41AxhATt+AnA2fD0AKx3hz3gEJQA==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "umhK7FVsDkAoGgkrODsJQB1zxc8owQZA+6fj3i19D0A1/i7UHdkOQA==",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAGEAAAAAAAAAAwAAAAAAAAADAAAAAAAAAAMAAAAAAAAAkQA==",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           1,
           4,
           "Vinblastine",
           "Vincristine",
           "Additive",
           "III. Structure Only"
          ],
          [
           2,
           4,
           "Vinblastine",
           "Rapamycin",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Vinblastine",
           "Vinorelbine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Paclitaxel",
           "Cabazitaxel",
           "Additive",
           "III. Structure Only"
          ],
          [
           2,
           5,
           "Rapamycin",
           "Mithramycin",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Rapamycin",
           "Vinblastine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Rapamycin",
           "Daunorubicin",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Rapamycin",
           "Vinorelbine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Vinblastine",
           "Additive",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Teniposide",
           "Additive",
           "III. Structure Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Additive, III. Structure Only",
         "marker": {
          "color": "green",
          "opacity": 0.6,
          "size": 5,
          "symbol": "x"
         },
         "mode": "markers",
         "name": "Additive, III. Structure Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "fzjWhLkn6T9lhgfNSIL/P2JdT3Fev+4/UDa5+6jm7D92hi41L/b8P96hSK/Mke0/3RbhdCbL8z9/4VeduZTvP132rdJ/gew/WlN873l48j8=",
          "dtype": "f8"
         },
         "y": {
          "bdata": "Hhu2cS58D0BUUMYYuI0OQCUF59BQ0BBAGE0Yd2QDCUAyrRSLYpAUQAHndHfo6Q5A8zghNYzWBkAPEOvjxq0UQAcY2Ho7xQlAqgV8rKVmDkA=",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAGMAAAAAAAAAiwAAAAAAAABRAAAAAAAAAGEAAAAAAAAAcwAAAAAAAABRAAAAAAAAAHMAAAAAAAAAQwAAAAAAAAAhAAAAAAAAAIMA=",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           1,
           1,
           "Methotrexate",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methotrexate",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Letrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methotrexate",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Busulfan",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Busulfan",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Thioguanine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "6-Mercaptopurine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "6-Mercaptopurine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nitrogen mustard",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nitrogen mustard",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Allopurinol",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Allopurinol",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Chlorambucil",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Thiotepa",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Thiotepa",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thiotepa",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Melphalan",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Triethylenemelamine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Triethylenemelamine",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Altretamine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Allopurinol",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Aminolevulinic acid",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Acrichine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Acrichine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Aminolevulinic acid",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Aminolevulinic acid",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Aminolevulinic acid",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fluorouracil",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mithramycin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Mithramycin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Mithramycin",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mithramycin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mithramycin",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Pipobroman",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pipobroman",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Capecitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pipobroman",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cyclophosphamide",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cyclophosphamide",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Busulfan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Mitomycin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Mitomycin",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitomycin",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Floxuridine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Hydroxyurea",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Uracil Mustard",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Mitotane",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Capecitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitotane",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitotane",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Pipobroman",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Methoxsalen",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Methoxsalen",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Vinblastine",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinblastine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cytarabine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Busulfan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Thalidomide",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Thalidomide",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Thalidomide",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vincristine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Megestrol Acetate",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Megestrol Acetate",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Procarbazine",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lomustine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Daunorubicin",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Daunorubicin",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Streptozocin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Streptozocin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Arsenic trioxide",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Arsenic trioxide",
           "Oxaliplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Amifostine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Erlotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Arsenic trioxide",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Arsenic trioxide",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Arsenic trioxide",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Azacitidine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Temozolomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Azacitidine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Azacitidine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cladribine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cladribine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ifosfamide",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ifosfamide",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Fludarabine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fludarabine",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fludarabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Cisplatin",
           "Pentostatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Oxaliplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Cisplatin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Cisplatin",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Isotretinoin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Isotretinoin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Isotretinoin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Teniposide",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Teniposide",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Teniposide",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Doxorubicin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Doxorubicin",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Doxorubicin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Paclitaxel",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Paclitaxel",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Paclitaxel",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Decitabine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Topotecan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Decitabine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bendamustine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Etoposide",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Etoposide",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Etoposide",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dexrazoxane",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dexrazoxane",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Tamoxifen",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Tamoxifen",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Tamoxifen",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Tamoxifen",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pentostatin",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pentostatin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pentostatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           2,
           "Rapamycin",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Rapamycin",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carboplatin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carboplatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Valrubicin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Valrubicin",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Valrubicin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Allopurinol",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Idarubicin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Epirubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Anastrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Letrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Idarubicin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Idarubicin",
           "Pralatrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Idarubicin",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Allopurinol",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Epirubicin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Epirubicin",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Cladribine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Ifosfamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Idarubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Epirubicin",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Epirubicin",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Epirubicin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Epirubicin",
           "Pralatrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cytarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Oxaliplatin",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Topotecan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Oxaliplatin",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Mitoxantrone",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Mitoxantrone",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Amifostine",
           "Procarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Oxaliplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Amifostine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Amifostine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Temozolomide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imiquimod",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Nitrogen mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Carmustine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Aminolevulinic acid",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Carmustine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Carmustine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Clofarabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Vinorelbine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vinorelbine",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Busulfan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Nitrogen mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Topotecan",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Topotecan",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Gemcitabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Melphalan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Altretamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Capecitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           1,
           "Docetaxel",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Docetaxel",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Docetaxel",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "7-Ethyl-10-hydroxycamptothecin",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "6-Thioguanine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Bortezomib",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Hydroxyurea",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Bendamustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Bortezomib",
           "Erlotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Bortezomib",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Chlorambucil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Dacarbazine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nelarabine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nelarabine",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pemetrexed",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vorinostat",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vorinostat",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Estramustine",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Cyclophosphamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Mitomycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Decitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Estramustine",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Estramustine",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Capecitabine",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Capecitabine",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Exemestane",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Gefitinib",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Methotrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Thalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Streptozocin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Topotecan",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Erlotinib",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Erlotinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Fulvestrant",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Fulvestrant",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Fulvestrant",
           "Everolimus",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Fulvestrant",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Fulvestrant",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Mitotane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Anastrozole",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Anastrozole",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Letrozole",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Celecoxib",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Celecoxib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Celecoxib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Floxuridine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Zoledronate",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Zoledronate",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Lomustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Dasatinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dasatinib",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Dasatinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Dasatinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           2,
           "Everolimus",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pazopanib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Imatinib",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imatinib",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imatinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Fludarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Imatinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Imatinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Lapatinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           2,
           "Lapatinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Lapatinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Lapatinib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lapatinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Lapatinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "6-Mercaptopurine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Uracil Mustard",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Teniposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Etoposide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Nilotinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Nilotinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sorafenib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Fulvestrant",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sorafenib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Lenalidomide",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Ixabepilone",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Thiotepa",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Acrichine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Mithramycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Methoxsalen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Vinblastine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Ifosfamide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Isotretinoin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Tamoxifen",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Valrubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Carmustine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Ixabepilone",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Nelarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Imatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Lapatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Sorafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Sunitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Depsipeptide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Ixabepilone",
           "Pralatrexate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ixabepilone",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Raloxifene",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Raloxifene",
           "Doxorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Raloxifene",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Abiraterone",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Sunitinib",
           "Actinomycin D",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Vincristine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Paclitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Sunitinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Sunitinib",
           "Dasatinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Megestrol Acetate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vemurafenib",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Vemurafenib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Depsipeptide",
           "Daunorubicin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Celecoxib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Depsipeptide",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Triethylenemelamine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Azacitidine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Pralatrexate",
           "Rapamycin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Carboplatin",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Temozolomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Clofarabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           1,
           "Pralatrexate",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Gemcitabine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Docetaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Pemetrexed",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vorinostat",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Letrozole",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Zoledronate",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Nilotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Pralatrexate",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vismodegib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Fluorouracil",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Dexrazoxane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Mitoxantrone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           1,
           "Crizotinib",
           "Vinorelbine",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Exemestane",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Gefitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Lenalidomide",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Crizotinib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Axitinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           2,
           0,
           "Vandetanib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Vandetanib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Pazopanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Vemurafenib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Raloxifene",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Abiraterone",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Vemurafenib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Vismodegib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Crizotinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Axitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           1,
           0,
           "Cabazitaxel",
           "Ruxolitinib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Vandetanib",
           "Synergistic",
           "IV. Normal"
          ],
          [
           0,
           0,
           "Ruxolitinib",
           "Cabazitaxel",
           "Synergistic",
           "IV. Normal"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, IV. Normal",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "circle"
         },
         "mode": "markers",
         "name": "Synergistic, IV. Normal",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           1,
           "6-Mercaptopurine",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Chlorambucil",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Megestrol Acetate",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Daunorubicin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Actinomycin D",
           "Teniposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Actinomycin D",
           "Mitoxantrone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Exemestane",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Gefitinib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Letrozole",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Actinomycin D",
           "Pazopanib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Lenalidomide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Vemurafenib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Actinomycin D",
           "Vismodegib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Mithramycin",
           "Etoposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           2,
           "Mithramycin",
           "Docetaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           1,
           "Mithramycin",
           "Dasatinib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Ifosfamide",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           6,
           2,
           "Bleomycin",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Melphalan",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Bleomycin",
           "Fluorouracil",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Uracil Mustard",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Dacarbazine",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Megestrol Acetate",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Lomustine",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Daunorubicin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Teniposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bleomycin",
           "Paclitaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Etoposide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Mitoxantrone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "7-Ethyl-10-hydroxycamptothecin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Exemestane",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Gefitinib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Lenalidomide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vemurafenib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Depsipeptide",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Bleomycin",
           "Vandetanib",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Paclitaxel",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Epirubicin",
           "Ixabepilone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Oxaliplatin",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Oxaliplatin",
           "Pentostatin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Topotecan",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Docetaxel",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Bortezomib",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Bortezomib",
           "Ixabepilone",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Gefitinib",
           "Cabazitaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Fulvestrant",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           1,
           "Lapatinib",
           "Actinomycin D",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           2,
           "Sorafenib",
           "Bleomycin",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           4,
           0,
           "Raloxifene",
           "Cabazitaxel",
           "Synergistic",
           "II. Feature Only"
          ],
          [
           3,
           0,
           "Vandetanib",
           "Cabazitaxel",
           "Synergistic",
           "II. Feature Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, II. Feature Only",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "diamond"
         },
         "mode": "markers",
         "name": "Synergistic, II. Feature Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "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",
          "dtype": "f8"
         },
         "y": {
          "bdata": "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",
          "dtype": "f8"
         },
         "z": {
          "bdata": "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",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           4,
           4,
           "Actinomycin D",
           "Vinorelbine",
           "Synergistic",
           "I. Dual Outliers"
          ],
          [
           5,
           3,
           "Bleomycin",
           "Vinorelbine",
           "Synergistic",
           "I. Dual Outliers"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, I. Dual Outliers",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "square"
         },
         "mode": "markers",
         "name": "Synergistic, I. Dual Outliers",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "oPVjOYzcEEAfZVlifAYUQA==",
          "dtype": "f8"
         },
         "y": {
          "bdata": "3hwCL3vqEEBKLFwqzpMHQA==",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAO0AAAAAAAABHQA==",
          "dtype": "f8"
         }
        },
        {
         "customdata": [
          [
           2,
           3,
           "Mithramycin",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Vinblastine",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Vincristine",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Vincristine",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Paclitaxel",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Rapamycin",
           "Teniposide",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Rapamycin",
           "Valrubicin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Rapamycin",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Docetaxel",
           "Rapamycin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Docetaxel",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Vincristine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Daunorubicin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Paclitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Everolimus",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           4,
           "Everolimus",
           "Docetaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Everolimus",
           "Depsipeptide",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           5,
           "Everolimus",
           "Cabazitaxel",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Lapatinib",
           "Vincristine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Lapatinib",
           "Rapamycin",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           0,
           4,
           "Lapatinib",
           "Vinorelbine",
           "Synergistic",
           "III. Structure Only"
          ],
          [
           1,
           3,
           "Lapatinib",
           "Everolimus",
           "Synergistic",
           "III. Structure Only"
          ]
         ],
         "hovertemplate": "Synergy_Class=%{customdata[4]}<br>Synergy=%{z:.2f}<br>Feature_Votes_Raw=%{customdata[0]}<br>Structure_Votes_Raw=%{customdata[1]}<br>Drug_A=%{customdata[2]}<br>Drug_B=%{customdata[3]}<extra></extra>",
         "legendgroup": "Synergistic, III. Structure Only",
         "marker": {
          "color": "blue",
          "opacity": 0.6,
          "size": 5,
          "symbol": "x"
         },
         "mode": "markers",
         "name": "Synergistic, III. Structure Only",
         "scene": "scene",
         "showlegend": true,
         "type": "scatter3d",
         "x": {
          "bdata": "j84RokxYAED5SbeFUCHsP5pk9KMqL/M/MGBmNK268T9tw/28kEXwP2wsm4f9Q/I/EfDfH9qm6z/+pZ4fkijsPyp/ivkzrfI/x2tU3ir96D/WPaRbfKbzP4l2zv23/+g/pcGLMQAB8z8LiBt4TU7tPyk1O+RxKvE/IJelKfpr8T/4n/VIXr3xPxgqqRJeGvA/XwlI2UPA8j+UhpAL/ay8Py4igGV93Og/",
          "dtype": "f8"
         },
         "y": {
          "bdata": "H5oNXRDMCUDmqzE+CmMHQG7iv1VY7BBAP/oGeFI1BkBlPcgRIz8QQHtsE/XGcBBAjIx0BlmDEECKNJizz0gUQHqjQn/A0xBA7RxE8L9cB0B4i8vGlpsQQIzSTOggbxBAkbBkT35vEEC6qf0HcMgTQOu00CQ/AA5AnRrKAw5eBkB1VuTsfaUUQGL7c0BjRglAITx4VeEgBkAsRCbpQ3UQQKtjhIS/8QhA",
          "dtype": "f8"
         },
         "z": {
          "bdata": "AAAAAAAAOEAAAAAAAEBRQAAAAAAAAD1AAAAAAACAQEAAAAAAAIBGQAAAAAAAADJAAAAAAABAVUAAAAAAAIBTQAAAAAAAgFdAAAAAAAAAOkAAAAAAAIBJQAAAAAAAgEBAAAAAAACAVEAAAAAAAAA+QAAAAAAAwFFAAAAAAAAAQ0AAAAAAAAAoQAAAAAAAIGRAAAAAAAAAOUAAAAAAAEBTQAAAAAAAgEJA",
          "dtype": "f8"
         }
        },
        {
         "colorscale": [
          [
           0,
           "rgb(255,255,255)"
          ],
          [
           0.125,
           "rgb(240,240,240)"
          ],
          [
           0.25,
           "rgb(217,217,217)"
          ],
          [
           0.375,
           "rgb(189,189,189)"
          ],
          [
           0.5,
           "rgb(150,150,150)"
          ],
          [
           0.625,
           "rgb(115,115,115)"
          ],
          [
           0.75,
           "rgb(82,82,82)"
          ],
          [
           0.875,
           "rgb(37,37,37)"
          ],
          [
           1,
           "rgb(0,0,0)"
          ]
         ],
         "name": "Feature Threshold",
         "opacity": 0.1,
         "showscale": false,
         "type": "surface",
         "x": {
          "bdata": "AAAAAAAACEAAAAAAAAAIQAAAAAAAAAhAAAAAAAAACEA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "y": {
          "bdata": "AAAAAAAA4L8AAAAAAAAeQAAAAAAAAOC/AAAAAAAAHkA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "z": {
          "bdata": "AAAAAAAgfsAAAAAAACB+wAAAAAAA0IJAAAAAAADQgkA=",
          "dtype": "f8",
          "shape": "2, 2"
         }
        },
        {
         "colorscale": [
          [
           0,
           "rgb(255,255,255)"
          ],
          [
           0.125,
           "rgb(240,240,240)"
          ],
          [
           0.25,
           "rgb(217,217,217)"
          ],
          [
           0.375,
           "rgb(189,189,189)"
          ],
          [
           0.5,
           "rgb(150,150,150)"
          ],
          [
           0.625,
           "rgb(115,115,115)"
          ],
          [
           0.75,
           "rgb(82,82,82)"
          ],
          [
           0.875,
           "rgb(37,37,37)"
          ],
          [
           1,
           "rgb(0,0,0)"
          ]
         ],
         "name": "Structure Threshold",
         "opacity": 0.1,
         "showscale": false,
         "type": "surface",
         "x": {
          "bdata": "AAAAAAAA4L8AAAAAAAAeQAAAAAAAAOC/AAAAAAAAHkA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "y": {
          "bdata": "AAAAAAAACEAAAAAAAAAIQAAAAAAAAAhAAAAAAAAACEA=",
          "dtype": "f8",
          "shape": "2, 2"
         },
         "z": {
          "bdata": "AAAAAAAgfsAAAAAAACB+wAAAAAAA0IJAAAAAAADQgkA=",
          "dtype": "f8",
          "shape": "2, 2"
         }
        }
       ],
       "layout": {
        "legend": {
         "title": {
          "text": "Legend"
         },
         "tracegroupgap": 0
        },
        "margin": {
         "b": 0,
         "l": 0,
         "r": 0,
         "t": 40
        },
        "scene": {
         "domain": {
          "x": [
           0,
           1
          ],
          "y": [
           0,
           1
          ]
         },
         "xaxis": {
          "range": [
           -0.5,
           7.5
          ],
          "title": {
           "text": "Feature Votes (0-7)"
          }
         },
         "yaxis": {
          "range": [
           -0.5,
           7.5
          ],
          "title": {
           "text": "Structure Votes (0-7)"
          }
         },
         "zaxis": {
          "title": {
           "text": "Synergy Score"
          }
         }
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermap": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermap"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "3D Analysis: Outliers vs. Synergy Class (HT-29_SMILE)"
        }
       }
      },
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# ---------------------------------------------------------\n",
    "# 1. 数据准备\n",
    "# ---------------------------------------------------------\n",
    "# 确保 Votes 列是最新的\n",
    "cols_feat = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags.columns]\n",
    "outlier_flags['Votes'] = outlier_flags[cols_feat].sum(axis=1)\n",
    "\n",
    "cols_smile = [c for c in ['Stat', 'Dist', 'Density', 'TOD', 'CBOD', 'Dynamic', 'Dynamic_Updated'] if c in outlier_flags_smile.columns]\n",
    "outlier_flags_smile['Votes'] = outlier_flags_smile[cols_smile].sum(axis=1)\n",
    "\n",
    "# 构建绘图 DataFrame\n",
    "df_plot = pd.DataFrame(index=outlier_flags.index)\n",
    "\n",
    "# A. 坐标轴数据 (加入微小抖动 Jitter)\n",
    "np.random.seed(42)\n",
    "df_plot['Feat_Votes_Jitter'] = outlier_flags['Votes'] + np.random.uniform(-0.25, 0.25, len(df_plot))\n",
    "df_plot['Struct_Votes_Jitter'] = outlier_flags_smile['Votes'] + np.random.uniform(-0.25, 0.25, len(df_plot))\n",
    "\n",
    "# 原始数据 (用于显示)\n",
    "df_plot['Feature_Votes_Raw'] = outlier_flags['Votes']\n",
    "df_plot['Structure_Votes_Raw'] = outlier_flags_smile['Votes']\n",
    "\n",
    "# B. Z轴数据 (Synergy Score)\n",
    "if 'Synergy_Score' in df_current.columns:\n",
    "    df_plot['Synergy'] = df_current['Synergy_Score']\n",
    "else:\n",
    "    df_plot['Synergy'] = df_current.iloc[:, 416]\n",
    "\n",
    "# 【核心修改 1】将分数转换为三类标签\n",
    "def classify_synergy(score):\n",
    "    if score > 10:\n",
    "        return 'Synergistic'\n",
    "    elif score < -10:\n",
    "        return 'Antagonistic'\n",
    "    else:\n",
    "        return 'Additive'\n",
    "\n",
    "df_plot['Synergy_Class'] = df_plot['Synergy'].apply(classify_synergy)\n",
    "\n",
    "# C. 标签信息\n",
    "target_df_name = df_current if 'Drug_A' in df_current.columns else df_smiles_current\n",
    "df_plot['Drug_A'] = target_df_name['Drug_A']\n",
    "df_plot['Drug_B'] = target_df_name['Drug_B']\n",
    "\n",
    "# D. 离群点形状分类\n",
    "def get_category(row):\n",
    "    f = row['Feature_Votes_Raw']\n",
    "    s = row['Structure_Votes_Raw']\n",
    "    if f >= 3 and s >= 3: return 'I. Dual Outliers'\n",
    "    if f >= 3 and s < 3: return 'II. Feature Only'\n",
    "    if f < 3 and s >= 3: return 'III. Structure Only'\n",
    "    return 'IV. Normal'\n",
    "\n",
    "df_plot['Outlier_Type'] = df_plot.apply(get_category, axis=1)\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 2. 使用 Plotly Express 绘图\n",
    "# ---------------------------------------------------------\n",
    "# 【核心修改 2】定义颜色映射字典\n",
    "color_map = {\n",
    "    'Antagonistic': 'red',   # 拮抗 -> 红色\n",
    "    'Additive': 'green',     # 相加 -> 绿色\n",
    "    'Synergistic': 'blue'    # 协同 -> 蓝色\n",
    "}\n",
    "\n",
    "fig = px.scatter_3d(\n",
    "    df_plot, \n",
    "    x='Feat_Votes_Jitter', \n",
    "    y='Struct_Votes_Jitter', \n",
    "    z='Synergy',\n",
    "    color='Synergy_Class',      # 使用分类后的列作为颜色依据\n",
    "    color_discrete_map=color_map, # 强制使用红绿蓝\n",
    "    symbol='Outlier_Type',      # 形状代表离群类型\n",
    "    opacity=0.6,                # 半透明一点，方便看内部\n",
    "    size_max=8,\n",
    "    hover_data={\n",
    "        'Feat_Votes_Jitter': False,\n",
    "        'Struct_Votes_Jitter': False,\n",
    "        'Feature_Votes_Raw': True,\n",
    "        'Structure_Votes_Raw': True,\n",
    "        'Drug_A': True,\n",
    "        'Drug_B': True,\n",
    "        'Synergy': ':.2f',\n",
    "        'Synergy_Class': True,\n",
    "        'Outlier_Type': False\n",
    "    },\n",
    "    title=f\"3D Analysis: Outliers vs. Synergy Class ({current_dataset_name})\"\n",
    ")\n",
    "\n",
    "fig.update_traces(marker=dict(size=5))\n",
    "# ---------------------------------------------------------\n",
    "# 3. 添加阈值平面 (X=3 和 Y=3 的分割线)\n",
    "# ---------------------------------------------------------\n",
    "# 绘制 X=3 的面 (Feature Threshold)\n",
    "y_range = np.linspace(-0.5, 7.5, 2)\n",
    "z_range = np.linspace(df_plot['Synergy'].min(), df_plot['Synergy'].max(), 2)\n",
    "Y, Z = np.meshgrid(y_range, z_range)\n",
    "X = np.full_like(Y, 3) \n",
    "fig.add_trace(go.Surface(x=X, y=Y, z=Z, opacity=0.1, showscale=False, colorscale='Greys', name='Feature Threshold'))\n",
    "\n",
    "# 绘制 Y=3 的面 (Structure Threshold)\n",
    "x_range = np.linspace(-0.5, 7.5, 2)\n",
    "X2, Z2 = np.meshgrid(x_range, z_range)\n",
    "Y2 = np.full_like(X2, 3) \n",
    "fig.add_trace(go.Surface(x=X2, y=Y2, z=Z2, opacity=0.1, showscale=False, colorscale='Greys', name='Structure Threshold'))\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 4. 美化布局\n",
    "# ---------------------------------------------------------\n",
    "fig.update_layout(\n",
    "    scene = dict(\n",
    "        xaxis_title='Feature Votes (0-7)',\n",
    "        yaxis_title='Structure Votes (0-7)',\n",
    "        zaxis_title='Synergy Score',\n",
    "        xaxis = dict(range=[-0.5, 7.5]),\n",
    "        yaxis = dict(range=[-0.5, 7.5]),\n",
    "    ),\n",
    "    margin=dict(l=0, r=0, b=0, t=40),\n",
    "    legend_title=\"Legend\"\n",
    ")\n",
    "\n",
    "# ---------------------------------------------------------\n",
    "# 5. 保存与显示\n",
    "# ---------------------------------------------------------\n",
    "output_file = os.path.join(OUTPUT_DIR, \"Interactive_3D_ColorClass.html\")\n",
    "fig.write_html(output_file)\n",
    "\n",
    "print(f\"三色分类交互图已生成: {output_file}\")\n",
    "fig.show()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
